Unnamed: 0,Unnamed: 1,Unnamed: 2,Unnamed: 3,April,May,June,July,August,September,October,November,December,January,February,March,Total
District,,,,,,,,,,,,,,,,
Anjaw,1.1,Total number of pregnant women Registered for ANC,TOTAL,43.0,31.0,40.0,37.0,37.0,38.0,15.0,31.0,22.0,27.0,25.0,21.0,367.0
Anjaw,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,12.0,13.0,11.0,10.0,7.0,9.0,5.0,14.0,6.0,9.0,14.0,12.0,122.0
Anjaw,1.2,Number of Pregnant women registered under JSY,TOTAL,35.0,24.0,34.0,35.0,32.0,32.0,12.0,24.0,17.0,21.0,18.0,19.0,303.0
Anjaw,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,10.0,9.0,13.0,9.0,13.0,11.0,14.0,16.0,17.0,11.0,9.0,11.0,143.0
Anjaw,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,29.0,20.0,33.0,31.0,33.0,33.0,11.0,22.0,14.0,20.0,14.0,18.0,278.0
Anjaw,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,20.0,22.0,17.0,11.0,22.0,17.0,15.0,19.0,16.0,13.0,19.0,15.0,206.0
Anjaw,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,15.0,13.0,16.0,13.0,14.0,18.0,11.0,18.0,22.0,10.0,12.0,7.0,169.0
Anjaw,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0,3.0,0.0,8.0
Anjaw,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,1.8,Number of pregnancy test kits used at SC level,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Anjaw,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,0.0,1.0,1.0,2.0,0.0,3.0,1.0,4.0,0.0,1.0,3.0,2.0,18.0
Anjaw,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,0.0,4.0,0.0,5.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,10.0
Anjaw,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,0.0,1.0,5.0,2.0,5.0,3.0,2.0,4.0,0.0,1.0,3.0,2.0,28.0
Anjaw,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,0.0,0.0,3.0,0.0,1.0,2.0,1.0,2.0,0.0,0.0,3.0,2.0,14.0
Anjaw,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,4.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Anjaw,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,4.0,11.0,6.0,10.0,11.0,13.0,17.0,11.0,10.0,8.0,10.0,9.0,120.0
Anjaw,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2.0,4.0,4.0,0.0,4.0,5.0,10.0,6.0,6.0,7.0,5.0,4.0,57.0
Anjaw,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2.0,3.0,6.0,0.0,6.0,12.0,7.0,2.0,5.0,17.0,2.0,4.0,66.0
Anjaw,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,2.0,2.0,0.0,3.0,6.0,4.0,3.0,5.0,11.0,2.0,4.0,42.0
Anjaw,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Anjaw,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Anjaw,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Anjaw,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Anjaw,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
Anjaw,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Anjaw,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Anjaw,4.1.1.a,Number of male live births,TOTAL,4.0,8.0,3.0,5.0,12.0,5.0,9.0,8.0,8.0,3.0,5.0,7.0,77.0
Anjaw,4.1.1.b,Number of female live births,TOTAL,0.0,4.0,8.0,7.0,3.0,10.0,9.0,6.0,2.0,6.0,8.0,4.0,67.0
Anjaw,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,4.0,12.0,11.0,12.0,15.0,15.0,18.0,14.0,10.0,9.0,13.0,11.0,144.0
Anjaw,4.1.2,Number of still births,TOTAL,0.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,4.0
Anjaw,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,5.0,0.0,2.0,0.0,0.0,0.0,0.0,1.0,2.0,2.0,0.0,3.0,15.0
Anjaw,4.2.1,Number of Newborns weighed at birth,TOTAL,4.0,11.0,7.0,12.0,14.0,15.0,14.0,12.0,10.0,8.0,13.0,10.0,130.0
Anjaw,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,2.0,0.0,0.0,1.0,1.0,1.0,4.0,2.0,1.0,1.0,0.0,1.0,14.0
Anjaw,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,4.0,12.0,7.0,12.0,15.0,15.0,17.0,13.0,9.0,8.0,13.0,10.0,135.0
Anjaw,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Anjaw,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Anjaw,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Anjaw,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Anjaw,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Anjaw,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2.0,6.0,3.0,3.0,6.0,5.0,10.0,9.0,6.0,8.0,9.0,5.0,72.0
Anjaw,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2.0,5.0,3.0,4.0,4.0,7.0,7.0,9.0,7.0,7.0,6.0,3.0,64.0
Anjaw,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,5.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,0.0,1.0,12.0
Anjaw,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0,3.0
Anjaw,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,5.0,0.0,2.0,0.0,0.0,0.0,0.0,1.0,2.0,2.0,0.0,3.0,15.0
Anjaw,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,4.0,6.0,0.0,3.0,2.0,19.0,4.0,2.0,7.0,6.0,5.0,15.0,73.0
Anjaw,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,2.0,9.0,4.0,9.0,9.0,18.0,7.0,3.0,20.0,9.0,8.0,35.0,133.0
Anjaw,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,6.0,15.0,4.0,12.0,11.0,37.0,11.0,5.0,27.0,15.0,13.0,50.0,206.0
Anjaw,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
Anjaw,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Anjaw,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Anjaw,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Anjaw,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Anjaw,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Anjaw,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Anjaw,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Anjaw,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Anjaw,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Anjaw,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Anjaw,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Anjaw,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Anjaw,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,1.0,1.0,0.0,3.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,8.0
Anjaw,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,1.0,2.0,1.0,1.0,0.0,0.0,1.0,2.0,8.0
Anjaw,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Anjaw,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Anjaw,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,0.0,1.0,1.0,0.0,4.0,4.0,2.0,1.0,0.0,0.0,1.0,2.0,16.0
Anjaw,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Anjaw,9.06,Number of IUCD removals,TOTAL,1.0,2.0,0.0,0.0,1.0,1.0,2.0,0.0,2.0,0.0,0.0,1.0,10.0
Anjaw,9.07,Number of Oral Pills cycles distributed,TOTAL,87.0,62.0,86.0,206.0,80.0,93.0,75.0,63.0,108.0,72.0,79.0,69.0,1080.0
Anjaw,9.08,Number of Condom pieces distributed,TOTAL,113.0,66.0,73.0,350.0,100.0,76.0,74.0,54.0,57.0,95.0,67.0,34.0,1159.0
Anjaw,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,4.0
Anjaw,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,4.0,9.0,6.0,12.0,25.0,24.0,8.0,4.0,22.0,40.0,8.0,15.0,177.0
Anjaw,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,2.0,1.0,,,,,,1.0,2.0,,-1.0
Anjaw,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3.0,7.0,6.0,11.0,11.0,14.0,16.0,12.0,10.0,7.0,11.0,6.0,114.0
Anjaw,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,17.0,8.0,14.0,23.0,16.0,22.0,21.0,22.0,22.0,13.0,14.0,18.0,210.0
Anjaw,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,10.0,6.0,13.0,14.0,13.0,6.0,21.0,18.0,22.0,13.0,16.0,11.0,163.0
Anjaw,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,13.0,8.0,8.0,9.0,17.0,14.0,5.0,16.0,19.0,18.0,6.0,14.0,147.0
Anjaw,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2.0,4.0,3.0,2.0,6.0,13.0,12.0,11.0,7.0,6.0,9.0,5.0,80.0
Anjaw,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,17.0,6.0,13.0,23.0,16.0,22.0,20.0,22.0,22.0,13.0,14.0,18.0,206.0
Anjaw,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,10.0,6.0,13.0,20.0,13.0,7.0,18.0,18.0,22.0,12.0,16.0,11.0,166.0
Anjaw,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,13.0,8.0,8.0,9.0,17.0,11.0,8.0,16.0,19.0,18.0,6.0,14.0,147.0
Anjaw,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,5.0,1.0,3.0,0.0,2.0,1.0,2.0,0.0,1.0,2.0,1.0,0.0,18.0
Anjaw,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,2.0,5.0,5.0,2.0,11.0,13.0,11.0,8.0,10.0,6.0,6.0,6.0,85.0
Anjaw,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,10.0,6.0,15.0,13.0,10.0,11.0,21.0,20.0,23.0,14.0,13.0,12.0,168.0
Anjaw,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,13.0,7.0,8.0,16.0,12.0,9.0,9.0,16.0,12.0,14.0,7.0,14.0,137.0
Anjaw,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,12.0,2.0,1.0,22.0,20.0,9.0,10.0,10.0,14.0,8.0,5.0,7.0,120.0
Anjaw,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,0.0,0.0,0.0,1.0,2.0,3.0,0.0,0.0,0.0,1.0,0.0,0.0,7.0
Anjaw,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3.0,1.0,1.0,10.0,10.0,4.0,7.0,5.0,5.0,4.0,4.0,2.0,56.0
Anjaw,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,6.0,0.0,0.0,9.0,8.0,5.0,3.0,5.0,6.0,4.0,1.0,5.0,52.0
Anjaw,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,9.0,1.0,1.0,19.0,18.0,9.0,10.0,10.0,11.0,8.0,5.0,7.0,108.0
Anjaw,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,12.0,2.0,6.0,10.0,7.0,4.0,8.0,9.0,8.0,7.0,1.0,8.0,82.0
Anjaw,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,11.0,2.0,6.0,10.0,7.0,4.0,8.0,9.0,8.0,4.0,1.0,8.0,78.0
Anjaw,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,0.0,0.0,0.0,1.0,1.0,2.0,1.0,4.0,1.0,1.0,0.0,0.0,11.0
Anjaw,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,0.0,0.0,0.0,2.0,2.0,0.0,4.0,4.0,1.0,1.0,1.0,0.0,15.0
Anjaw,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,0.0,0.0,0.0,3.0,3.0,2.0,5.0,8.0,2.0,2.0,1.0,0.0,26.0
Anjaw,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,0.0,0.0,0.0,6.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,13.0,22.0
Anjaw,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,13.0,14.0,12.0,18.0,9.0,9.0,28.0,9.0,2.0,14.0,12.0,22.0,162.0
Anjaw,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,12.0,26.0,21.0,21.0,12.0,23.0,16.0,11.0,25.0,9.0,19.0,10.0,205.0
Anjaw,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,33.0,29.0,33.0,21.0,16.0,25.0,17.0,37.0,33.0,31.0,29.0,29.0,333.0
Anjaw,10.4.2,Number of Immunisation sessions held during the month,TOTAL,17.0,11.0,13.0,19.0,16.0,25.0,15.0,19.0,15.0,13.0,13.0,11.0,187.0
Anjaw,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,12.0,7.0,9.0,14.0,7.0,22.0,10.0,14.0,12.0,10.0,6.0,6.0,129.0
Anjaw,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2.0,2.0,0.0,0.0,4.0,2.0,0.0,7.0,11.0,7.0,5.0,6.0,46.0
Anjaw,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,4.0,0.0,0.0,2.0,3.0,0.0,0.0,1.0,2.0,2.0,4.0,2.0,20.0
Anjaw,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,3.0,2.0,0.0,7.0
Anjaw,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,4.0,6.0
Anjaw,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,72.0,42.0,67.0,77.0,58.0,61.0,47.0,38.0,47.0,45.0,53.0,48.0,655.0
Anjaw,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Anjaw,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,1.0,,,,,,,,,,,-1.0
Anjaw,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,1.0,,,,,,,1.0,,,1.0,,-1.0
Anjaw,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,33.0,33.0,8.0,8.0,8.0,8.0,8.0,8.0,8.0,8.0,8.0,7.0,-1.0
Anjaw,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,1.0,2.0,-1.0
Anjaw,14.05,Number of RKS meetings held during the month,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,2.0,6.0
Anjaw,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,3.0,2.0,4.0,4.0,3.0,4.0,4.0,4.0,4.0,4.0,3.0,4.0,-1.0
Anjaw,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,14.0,11.0,9.0,11.0,13.0,11.0,2.0,24.0,10.0,10.0,6.0,5.0,126.0
Anjaw,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,,,,,,,,1.0,,,,-1.0
Anjaw,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Anjaw,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,0.0,0.0,2.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,3.0,0.0,6.0
Anjaw,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2.0,10.0,9.0,13.0,21.0,36.0,6.0,8.0,17.0,2.0,9.0,4.0,137.0
Anjaw,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,0.0,7.0
Anjaw,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,9.0,25.0,15.0,24.0,32.0,27.0,20.0,15.0,13.0,4.0,10.0,10.0,204.0
Anjaw,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,0.0,0.0,2.0,4.0,0.0,0.0,0.0,1.0,0.0,1.0,5.0,0.0,13.0
Anjaw,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,11.0,35.0,24.0,37.0,53.0,63.0,26.0,23.0,30.0,6.0,19.0,14.0,341.0
Anjaw,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Anjaw,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Anjaw,14.11,In-Patient Head Count at midnight,TOTAL,4.0,26.0,5.0,31.0,39.0,44.0,9.0,16.0,6.0,25.0,5.0,29.0,239.0
Anjaw,14.12.1,OPD attendance (All),TOTAL,2184.0,1378.0,2486.0,3122.0,3184.0,2796.0,2049.0,2042.0,1787.0,1909.0,1698.0,1825.0,26460.0
Anjaw,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,12.0,17.0,19.0,18.0,28.0,8.0,17.0,7.0,13.0,4.0,6.0,4.0,153.0
Anjaw,14.14.a,Number of patients given AYUSH treatment,TOTAL,278.0,308.0,130.0,132.0,170.0,120.0,0.0,173.0,100.0,100.0,135.0,127.0,1773.0
Anjaw,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,44.0,59.0,60.0,29.0,79.0,83.0,30.0,43.0,28.0,11.0,33.0,45.0,544.0
Anjaw,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,0.0,3.0,1.0,0.0,1.0,25.0,0.0,2.0,0.0,4.0,0.0,0.0,36.0
Anjaw,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Anjaw,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Anjaw,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Anjaw,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Anjaw,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,15.2,Number of Widal tests conducted,Number tested,39.0,56.0,105.0,177.0,178.0,112.0,3.0,0.0,10.0,20.0,5.0,6.0,711.0
Anjaw,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,1.0,11.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,14.0
Anjaw,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,1.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Anjaw,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,17.0,15.0,0.0,12.0,18.0,12.0,8.0,10.0,10.0,1.0,1.0,5.0,109.0
Anjaw,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,17.0,16.0,12.0,14.0,18.0,12.0,8.0,11.0,10.0,1.0,1.0,6.0,126.0
Anjaw,15.4.1,Number of blood smears examined for Malaria,TOTAL,12.0,13.0,35.0,64.0,101.0,0.0,154.0,54.0,52.0,5.0,3.0,61.0,554.0
Anjaw,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,1.0,4.0,6.0,0.0,4.0,0.0,0.0,0.0,0.0,1.0,16.0
Anjaw,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,1.0,2.0,11.0,3.0,0.0,5.0,6.0,3.0,0.0,0.0,0.0,32.0
Anjaw,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,6.0,,,,,,122.0,128.0
Anjaw,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,0.0,,,,,,10.0,10.0
Anjaw,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,1.0,,,,,,8.0,9.0
Anjaw,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,124.0,129.0
Anjaw,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,4.0,,,,,,304.0,308.0
Anjaw,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,0.0,,,,,,50.0,50.0
Anjaw,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,2.0,,,,,,81.0,83.0
Anjaw,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,273.0,275.0
Anjaw,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,4.0,,,,,,51.0,55.0
Anjaw,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,0.0,,,,,,20.0,20.0
Anjaw,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,2.0,,,,,,11.0,13.0
Anjaw,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,60.0,62.0
Anjaw,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,2.0,,,,,,276.0,278.0
Anjaw,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,0.0,,,,,,20.0,20.0
Anjaw,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,0.0,,,,,,5.0,5.0
Anjaw,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,291.0,293.0
Anjaw,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,7.0,,,,,,453.0,460.0
Anjaw,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,0.0,,,,,,20.0,20.0
Anjaw,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,0.0,,,,,,3.0,3.0
Anjaw,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,7.0,0.0,0.0,0.0,0.0,0.0,470.0,477.0
Anjaw,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,5.0,,,,,,131.0,136.0
Anjaw,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,0.0,,,,,,10.0,10.0
Anjaw,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,4.0,,,,,,5.0,9.0
Anjaw,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,136.0,137.0
Anjaw,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,0.0,,,,,,50.0,50.0
Anjaw,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,0.0,,,,,,2.0,2.0
Anjaw,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,48.0,48.0
Anjaw,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,801.0,,,,,,420.0,1221.0
Anjaw,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,771.0,,,,,,15.0,786.0
Anjaw,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,30.0,0.0,0.0,0.0,0.0,0.0,405.0,435.0
Anjaw,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,903.0,,,,,,1481.0,2384.0
Anjaw,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,897.0,,,,,,140.0,1037.0
Anjaw,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,1341.0,1347.0
Anjaw,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,903.0,,,,,,199.0,1102.0
Anjaw,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,897.0,,,,,,15.0,912.0
Anjaw,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,184.0,190.0
Anjaw,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,5.0,,,,,,62.0,67.0
Anjaw,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,3.0,,,,,,1.0,4.0
Anjaw,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,61.0,63.0
Anjaw,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,35.0,,,,,,15.0,50.0
Anjaw,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,40.0,,,,,,0.0,40.0
Anjaw,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,55.0,,,,,,8.0,63.0
Anjaw,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,20.0,0.0,0.0,0.0,0.0,0.0,7.0,27.0
Anjaw,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,0.0,,,,,,80.0,80.0
Anjaw,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,20.0,,,,,,0.0,20.0
Anjaw,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,20.0,,,,,,20.0,40.0
Anjaw,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,60.0,60.0
Anjaw,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,0.0,,,,,,7.0,7.0
Anjaw,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,2.0,,,,,,0.0,2.0
Anjaw,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,1.0,,,,,,1.0,2.0
Anjaw,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,6.0,7.0
Anjaw,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,516.0,,,,,,1073.0,1589.0
Anjaw,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,30000.0,,,,,,1000.0,31000.0
Anjaw,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,3416.0,,,,,,250.0,3666.0
Anjaw,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,27100.0,0.0,0.0,0.0,0.0,0.0,1823.0,28923.0
Anjaw,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,0.0,,,,,,243.0,243.0
Anjaw,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,100.0,,,,,,0.0,100.0
Anjaw,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,95.0,,,,,,2.0,97.0
Anjaw,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,241.0,246.0
Anjaw,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anjaw,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,0.0,,,,,,3.0,3.0
Anjaw,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,0.0,,,,,,3.0,3.0
Anjaw,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,0.0,,,,,,2.0,2.0
Anjaw,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,4.0
Anjaw,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,0.0,,,,,,705.0,705.0
Anjaw,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,200.0,,,,,,0.0,200.0
Anjaw,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,170.0,,,,,,50.0,220.0
Anjaw,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,30.0,0.0,0.0,0.0,0.0,0.0,655.0,685.0
Anjaw,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,265.0,,,,,,496.0,761.0
Anjaw,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,256.0,,,,,,97.0,353.0
Anjaw,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,9.0,0.0,0.0,0.0,0.0,0.0,399.0,408.0
Anjaw,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,103.0,,,,,,658.0,761.0
Anjaw,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,93.0,,,,,,67.0,160.0
Anjaw,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,591.0,601.0
Anjaw,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,0.0,,,,,,48.0,48.0
Anjaw,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,200.0,,,,,,0.0,200.0
Anjaw,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,0.0,,,,,,0.0,0.0
Anjaw,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,180.0,,,,,,2.0,182.0
Anjaw,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,20.0,0.0,0.0,0.0,0.0,0.0,46.0,66.0
Anjaw,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Anjaw,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Anjaw,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Anjaw,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Anjaw,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Anjaw,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Anjaw,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Anjaw,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Anjaw,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Anjaw,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Anjaw,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Anjaw,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Anjaw,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Anjaw,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Anjaw,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Anjaw,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Anjaw,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Anjaw,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Anjaw,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Anjaw,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Anjaw,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Anjaw,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Anjaw,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Anjaw,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Anjaw,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Anjaw,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Anjaw,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Anjaw,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Anjaw,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Anjaw,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Anjaw,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Anjaw,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Anjaw,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Anjaw,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Anjaw,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Anjaw,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Anjaw,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Anjaw,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Anjaw,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Anjaw,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Anjaw,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Anjaw,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Anjaw,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Anjaw,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Anjaw,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Anjaw,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Anjaw,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Anjaw,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Anjaw,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Anjaw,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Anjaw,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Anjaw,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Anjaw,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Anjaw,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Anjaw,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Anjaw,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Anjaw,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Anjaw,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Anjaw,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Anjaw,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Anjaw,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Anjaw,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Anjaw,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Anjaw,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Anjaw,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Anjaw,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Anjaw,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Anjaw,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Anjaw,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Anjaw,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Anjaw,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Anjaw,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Anjaw,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Anjaw,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Anjaw,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Anjaw,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Anjaw,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Anjaw,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Anjaw,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Anjaw,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Anjaw,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Anjaw,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Anjaw,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Anjaw,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Anjaw,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Anjaw,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Anjaw,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Anjaw,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Anjaw,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Anjaw,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Anjaw,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Anjaw,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Anjaw,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Anjaw,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Anjaw,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Anjaw,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Anjaw,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Anjaw,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Anjaw,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Anjaw,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Anjaw,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Anjaw,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Anjaw,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Anjaw,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Anjaw,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Anjaw,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Anjaw,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Anjaw,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Changlang,1.1,Total number of pregnant women Registered for ANC,TOTAL,297.0,294.0,353.0,364.0,395.0,306.0,174.0,281.0,175.0,237.0,251.0,290.0,3417.0
Changlang,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,87.0,92.0,105.0,105.0,93.0,56.0,30.0,57.0,42.0,62.0,95.0,95.0,919.0
Changlang,1.2,Number of Pregnant women registered under JSY,TOTAL,253.0,244.0,315.0,235.0,251.0,244.0,139.0,250.0,150.0,215.0,189.0,263.0,2748.0
Changlang,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,131.0,134.0,134.0,140.0,175.0,139.0,143.0,136.0,111.0,108.0,100.0,103.0,1554.0
Changlang,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,208.0,224.0,197.0,240.0,247.0,223.0,106.0,209.0,114.0,153.0,176.0,193.0,2290.0
Changlang,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,204.0,182.0,203.0,191.0,240.0,198.0,156.0,146.0,139.0,135.0,135.0,161.0,2090.0
Changlang,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,113.0,121.0,111.0,94.0,155.0,122.0,129.0,99.0,91.0,116.0,98.0,91.0,1340.0
Changlang,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,10.0,0.0,7.0,11.0,1.0,3.0,4.0,1.0,1.0,2.0,3.0,0.0,43.0
Changlang,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Changlang,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,74.0,44.0,73.0,55.0,72.0,83.0,78.0,94.0,31.0,55.0,50.0,53.0,762.0
Changlang,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,1.0,4.0,1.0,3.0,0.0,2.0,8.0,3.0,1.0,0.0,2.0,1.0,26.0
Changlang,1.8,Number of pregnancy test kits used at SC level,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,2.0,5.0,6.0,4.0,2.0,1.0,1.0,3.0,0.0,8.0,4.0,6.0,42.0
Changlang,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,2.0,1.0,0.0,1.0,2.0,1.0,1.0,0.0,1.0,2.0,6.0,1.0,18.0
Changlang,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,4.0,6.0,6.0,5.0,4.0,2.0,2.0,3.0,1.0,10.0,10.0,7.0,60.0
Changlang,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,3.0,8.0,6.0,5.0,4.0,2.0,2.0,3.0,1.0,8.0,11.0,7.0,60.0
Changlang,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,5.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Changlang,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,70.0,97.0,77.0,80.0,82.0,136.0,112.0,111.0,106.0,121.0,96.0,75.0,1163.0
Changlang,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,50.0,78.0,49.0,66.0,69.0,118.0,94.0,95.0,90.0,101.0,76.0,42.0,928.0
Changlang,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,21.0,3.0,280.0,94.0,0.0,17.0,18.0,0.0,0.0,0.0,0.0,861.0,1294.0
Changlang,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2.0,2.0,197.0,56.0,0.0,24.0,12.0,0.0,0.0,0.0,0.0,570.0,863.0
Changlang,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Changlang,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Changlang,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Changlang,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Changlang,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,0.0,,,0.0,,,,,,0.0,0.0,0.0
Changlang,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Changlang,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Changlang,4.1.1.a,Number of male live births,TOTAL,39.0,61.0,40.0,50.0,42.0,75.0,55.0,65.0,50.0,63.0,55.0,47.0,642.0
Changlang,4.1.1.b,Number of female live births,TOTAL,32.0,40.0,43.0,34.0,43.0,60.0,56.0,48.0,55.0,65.0,50.0,33.0,559.0
Changlang,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,71.0,101.0,83.0,84.0,85.0,135.0,111.0,113.0,105.0,128.0,105.0,80.0,1201.0
Changlang,4.1.2,Number of still births,TOTAL,1.0,2.0,0.0,1.0,1.0,1.0,2.0,1.0,2.0,1.0,0.0,2.0,14.0
Changlang,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,0.0,0.0,0.0,0.0,1.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Changlang,4.2.1,Number of Newborns weighed at birth,TOTAL,68.0,95.0,83.0,82.0,82.0,133.0,110.0,113.0,105.0,124.0,104.0,80.0,1179.0
Changlang,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,13.0,12.0,5.0,7.0,5.0,10.0,8.0,11.0,10.0,14.0,13.0,5.0,113.0
Changlang,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,67.0,95.0,83.0,82.0,82.0,134.0,110.0,113.0,105.0,126.0,105.0,80.0,1182.0
Changlang,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Changlang,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Changlang,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,51.0,61.0,62.0,50.0,57.0,97.0,76.0,88.0,83.0,113.0,56.0,64.0,858.0
Changlang,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,23.0,28.0,23.0,19.0,32.0,47.0,39.0,42.0,34.0,22.0,34.0,37.0,380.0
Changlang,6.3,PNC maternal complications attended,TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Changlang,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Changlang,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Changlang,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,2.0,3.0,1.0,0.0,0.0,0.0,1.0,0.0,4.0,0.0,6.0,0.0,17.0
Changlang,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,5.0,2.0,12.0,0.0,26.0,1.0,2.0,2.0,1.0,0.0,21.0,3.0,75.0
Changlang,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,7.0,5.0,13.0,0.0,26.0,1.0,3.0,2.0,5.0,0.0,27.0,3.0,92.0
Changlang,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Changlang,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,,,,,,,,,,,0.0
Changlang,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Changlang,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Changlang,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,,,,,,,,,,,0.0
Changlang,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Changlang,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Changlang,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,,0.0,0.0,0.0
Changlang,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Changlang,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Changlang,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,,0.0,0.0,0.0
Changlang,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Changlang,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Changlang,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,1.0,4.0,7.0,5.0,2.0,1.0,4.0,3.0,2.0,2.0,8.0,39.0
Changlang,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,6.0,7.0,3.0,24.0,1.0,3.0,0.0,2.0,4.0,0.0,4.0,1.0,55.0
Changlang,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,3.0
Changlang,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Changlang,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,6.0,8.0,7.0,31.0,6.0,6.0,2.0,6.0,8.0,2.0,6.0,9.0,97.0
Changlang,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Changlang,9.06,Number of IUCD removals,TOTAL,9.0,4.0,2.0,11.0,7.0,10.0,3.0,7.0,6.0,2.0,3.0,12.0,76.0
Changlang,9.07,Number of Oral Pills cycles distributed,TOTAL,101.0,204.0,154.0,433.0,175.0,191.0,204.0,131.0,138.0,211.0,158.0,149.0,2249.0
Changlang,9.08,Number of Condom pieces distributed,TOTAL,226.0,119.0,193.0,1071.0,282.0,456.0,352.0,143.0,342.0,791.0,235.0,324.0,4534.0
Changlang,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,6.0,19.0,16.0,86.0,19.0,12.0,86.0,28.0,62.0,110.0,33.0,79.0,556.0
Changlang,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,9.12,Number of Institutions having NSV trained doctors,TOTAL,2.0,,,,2.0,3.0,,,,,3.0,1.0,-1.0
Changlang,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,167.0,144.0,202.0,124.0,125.0,193.0,190.0,202.0,183.0,194.0,173.0,255.0,2152.0
Changlang,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,205.0,193.0,163.0,188.0,138.0,183.0,158.0,194.0,208.0,191.0,207.0,238.0,2266.0
Changlang,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,196.0,163.0,167.0,156.0,160.0,159.0,147.0,131.0,173.0,167.0,123.0,222.0,1964.0
Changlang,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,171.0,148.0,152.0,127.0,140.0,143.0,120.0,151.0,130.0,148.0,135.0,154.0,1719.0
Changlang,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,87.0,112.0,124.0,98.0,96.0,139.0,129.0,155.0,97.0,89.0,109.0,129.0,1364.0
Changlang,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,194.0,179.0,158.0,184.0,136.0,149.0,155.0,193.0,214.0,188.0,192.0,237.0,2179.0
Changlang,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,185.0,159.0,164.0,151.0,158.0,121.0,145.0,130.0,171.0,167.0,127.0,221.0,1899.0
Changlang,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,162.0,145.0,149.0,125.0,138.0,114.0,114.0,150.0,124.0,148.0,128.0,156.0,1653.0
Changlang,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,51.0,52.0,63.0,40.0,51.0,105.0,55.0,68.0,68.0,71.0,48.0,55.0,727.0
Changlang,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,195.0,180.0,169.0,155.0,152.0,163.0,166.0,208.0,201.0,158.0,153.0,183.0,2083.0
Changlang,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,186.0,139.0,169.0,154.0,158.0,178.0,138.0,145.0,157.0,148.0,94.0,166.0,1832.0
Changlang,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,180.0,162.0,132.0,136.0,146.0,148.0,149.0,144.0,120.0,123.0,110.0,109.0,1659.0
Changlang,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,117.0,44.0,161.0,164.0,153.0,149.0,108.0,135.0,129.0,132.0,108.0,119.0,1519.0
Changlang,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,96.0,33.0,89.0,38.0,107.0,76.0,60.0,72.0,56.0,83.0,73.0,113.0,896.0
Changlang,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,53.0,21.0,72.0,69.0,75.0,73.0,45.0,63.0,58.0,68.0,53.0,62.0,712.0
Changlang,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,54.0,22.0,76.0,83.0,73.0,66.0,58.0,65.0,63.0,56.0,49.0,55.0,720.0
Changlang,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,107.0,43.0,148.0,152.0,148.0,139.0,103.0,128.0,121.0,124.0,102.0,117.0,1432.0
Changlang,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,96.0,74.0,118.0,86.0,142.0,95.0,86.0,95.0,67.0,114.0,96.0,139.0,1208.0
Changlang,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,96.0,66.0,118.0,84.0,142.0,77.0,77.0,95.0,70.0,114.0,96.0,136.0,1171.0
Changlang,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,49.0,22.0,36.0,38.0,47.0,37.0,34.0,33.0,26.0,37.0,40.0,35.0,434.0
Changlang,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,34.0,14.0,36.0,29.0,50.0,31.0,24.0,39.0,31.0,35.0,35.0,53.0,411.0
Changlang,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,83.0,36.0,72.0,67.0,97.0,68.0,58.0,72.0,57.0,72.0,75.0,88.0,845.0
Changlang,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,39.0,48.0,44.0,33.0,46.0,55.0,44.0,49.0,64.0,58.0,46.0,77.0,603.0
Changlang,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,29.0,69.0,77.0,41.0,53.0,61.0,63.0,66.0,46.0,37.0,66.0,61.0,669.0
Changlang,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,19.0,51.0,34.0,46.0,103.0,59.0,46.0,55.0,48.0,53.0,63.0,85.0,662.0
Changlang,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,60.0,58.0,68.0,59.0,64.0,60.0,57.0,63.0,52.0,45.0,64.0,52.0,702.0
Changlang,10.4.2,Number of Immunisation sessions held during the month,TOTAL,57.0,56.0,66.0,50.0,63.0,59.0,54.0,63.0,52.0,44.0,63.0,50.0,677.0
Changlang,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,31.0,27.0,40.0,24.0,35.0,32.0,26.0,29.0,23.0,15.0,41.0,31.0,354.0
Changlang,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,13.0,,14.0,2178.0,14.0,15.0,13.0,0.0,0.0,0.0,62.0,2309.0
Changlang,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,0.0,0.0,0.0,0.0,0.0,4.0,49.0,100.0,117.0,123.0,129.0,138.0,660.0
Changlang,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,0.0,0.0,0.0,0.0,0.0,11.0,44.0,59.0,68.0,104.0,119.0,141.0,546.0
Changlang,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,0.0,0.0,0.0,4.0,11.0,18.0,38.0,13.0,29.0,24.0,137.0
Changlang,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,6.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Changlang,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,63.0,58.0,108.0,79.0,93.0,77.0,21.0,31.0,43.0,47.0,37.0,42.0,699.0
Changlang,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,3.0,1.0,0.0,9.0,3.0,3.0,28.0,2.0,2.0,3.0,1.0,0.0,55.0
Changlang,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,4.0
Changlang,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,46.0,0.0,0.0,0.0,0.0,0.0,97.0,0.0,0.0,0.0,143.0
Changlang,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,96.0,0.0,0.0,0.0,96.0
Changlang,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,4.0,0.0,0.0,16.0,0.0,0.0,250.0,0.0,0.0,6.0,276.0
Changlang,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,3.0,2.0,1.0,1.0,2.0,2.0,4.0,1.0,4.0,3.0,3.0,2.0,-1.0
Changlang,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,3.0,2.0,3.0,3.0,3.0,3.0,2.0,3.0,3.0,3.0,4.0,3.0,-1.0
Changlang,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,32.0,35.0,32.0,39.0,38.0,31.0,149.0,133.0,138.0,70.0,140.0,138.0,-1.0
Changlang,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,3.0,5.0,-1.0
Changlang,14.05,Number of RKS meetings held during the month,TOTAL,1.0,2.0,2.0,1.0,2.0,3.0,2.0,1.0,0.0,1.0,2.0,0.0,17.0
Changlang,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,10.0,11.0,11.0,11.0,11.0,11.0,11.0,11.0,10.0,11.0,11.0,11.0,-1.0
Changlang,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,42.0,53.0,48.0,55.0,46.0,29.0,43.0,33.0,28.0,28.0,34.0,30.0,469.0
Changlang,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,,,1.0,,2.0,1.0,2.0,1.0,2.0,,-1.0
Changlang,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Changlang,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,41.0,17.0,43.0,81.0,93.0,48.0,39.0,41.0,22.0,13.0,18.0,19.0,475.0
Changlang,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,98.0,89.0,135.0,219.0,186.0,132.0,160.0,112.0,64.0,73.0,81.0,84.0,1433.0
Changlang,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,24.0,24.0,53.0,68.0,86.0,64.0,47.0,32.0,30.0,15.0,25.0,29.0,497.0
Changlang,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,160.0,146.0,195.0,255.0,250.0,251.0,231.0,177.0,146.0,153.0,145.0,130.0,2239.0
Changlang,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,65.0,41.0,96.0,149.0,179.0,112.0,86.0,73.0,52.0,28.0,43.0,48.0,972.0
Changlang,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,258.0,235.0,330.0,474.0,436.0,383.0,391.0,289.0,210.0,226.0,226.0,214.0,3672.0
Changlang,14.10.2.a,Number of death cases of Inpatient males,TOTAL,1.0,0.0,1.0,3.0,2.0,0.0,3.0,0.0,2.0,1.0,2.0,0.0,15.0
Changlang,14.10.2.b,Number of death cases of Inpatient females,TOTAL,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,5.0
Changlang,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,2.0,0.0,1.0,4.0,3.0,0.0,3.0,0.0,2.0,1.0,3.0,1.0,20.0
Changlang,14.11,In-Patient Head Count at midnight,TOTAL,205.0,94.0,249.0,501.0,530.0,831.0,420.0,330.0,232.0,230.0,258.0,238.0,4118.0
Changlang,14.12.1,OPD attendance (All),TOTAL,8842.0,9774.0,12693.0,15855.0,13085.0,13367.0,10223.0,8838.0,7297.0,7429.0,7973.0,9016.0,124392.0
Changlang,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,16.0,25.0,22.0,23.0,38.0,36.0,23.0,22.0,22.0,14.0,12.0,30.0,283.0
Changlang,14.14.a,Number of patients given AYUSH treatment,TOTAL,879.0,827.0,1054.0,1139.0,1287.0,919.0,853.0,1083.0,768.0,1015.0,1042.0,1118.0,11984.0
Changlang,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,749.0,531.0,574.0,517.0,667.0,186.0,782.0,830.0,735.0,645.0,749.0,656.0,7621.0
Changlang,14.14.c,Number of Adolescents counselled,TOTAL,13.0,2.0,0.0,0.0,0.0,26.0,0.0,0.0,0.0,0.0,2.0,8.0,51.0
Changlang,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,214.0,201.0,327.0,287.0,389.0,294.0,250.0,304.0,135.0,195.0,272.0,260.0,3128.0
Changlang,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,3.0,5.0,14.0,11.0,8.0,7.0,26.0,9.0,2.0,8.0,14.0,11.0,118.0
Changlang,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,55.0,64.0,63.0,62.0,57.0,3.0,0.0,10.0,38.0,27.0,44.0,8.0,431.0
Changlang,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,37.0,79.0,29.0,38.0,61.0,3.0,11.0,25.0,32.0,18.0,40.0,25.0,398.0
Changlang,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,62.0,74.0,52.0,42.0,43.0,26.0,11.0,51.0,17.0,20.0,46.0,34.0,478.0
Changlang,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,154.0,217.0,144.0,142.0,161.0,32.0,22.0,86.0,87.0,65.0,130.0,67.0,1307.0
Changlang,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,15.2,Number of Widal tests conducted,Number tested,138.0,143.0,261.0,346.0,591.0,272.0,53.0,120.0,102.0,93.0,151.0,162.0,2432.0
Changlang,15.3.a,Number of VDRL tests conducted on males,Number tested,1.0,1.0,2.0,1.0,5.0,1.0,1.0,2.0,2.0,1.0,2.0,2.0,21.0
Changlang,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,1.0,2.0,33.0,3.0,4.0,9.0,2.0,22.0,2.0,8.0,5.0,17.0,108.0
Changlang,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,80.0,69.0,87.0,52.0,71.0,45.0,25.0,53.0,21.0,21.0,48.0,43.0,615.0
Changlang,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,82.0,72.0,122.0,56.0,80.0,55.0,28.0,77.0,25.0,30.0,55.0,62.0,744.0
Changlang,15.4.1,Number of blood smears examined for Malaria,TOTAL,445.0,833.0,1936.0,3990.0,3936.0,2654.0,1426.0,1233.0,947.0,641.0,701.0,931.0,19673.0
Changlang,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,2.0,14.0,26.0,99.0,59.0,39.0,46.0,52.0,50.0,42.0,16.0,15.0,460.0
Changlang,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,7.0,17.0,96.0,80.0,48.0,55.0,83.0,35.0,16.0,19.0,6.0,463.0
Changlang,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,0.0,0.0,,460.0,,,,,1320.0,,1780.0
Changlang,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,0.0,2000.0,,2000.0,,,,,1500.0,,5500.0
Changlang,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,0.0,1050.0,,0.0,,,,,1400.0,,2450.0
Changlang,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,950.0,0.0,2460.0,0.0,0.0,0.0,0.0,1420.0,0.0,4830.0
Changlang,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Changlang,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Changlang,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Changlang,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Changlang,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,2200.0,2000.0,,400.0,,,,,4500.0,,9100.0
Changlang,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,0.0,1500.0,,1500.0,,,,,27000.0,,30000.0
Changlang,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,200.0,2400.0,,300.0,,,,,31500.0,,34400.0
Changlang,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,2000.0,1100.0,0.0,1600.0,0.0,0.0,0.0,0.0,0.0,0.0,4700.0
Changlang,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,0.0,0.0,,80.0,,,,,1430.0,,1510.0
Changlang,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,0.0,2000.0,,2000.0,,,,,0.0,,4000.0
Changlang,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,0.0,1450.0,,500.0,,,,,1040.0,,2990.0
Changlang,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,550.0,0.0,1580.0,0.0,0.0,0.0,0.0,390.0,0.0,2520.0
Changlang,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,900.0,800.0,,0.0,,,,,470.0,,2170.0
Changlang,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,0.0,500.0,,1000.0,,,,,1000.0,,2500.0
Changlang,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,100.0,1060.0,,300.0,,,,,1050.0,,2510.0
Changlang,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,800.0,240.0,0.0,700.0,0.0,0.0,0.0,0.0,420.0,0.0,2160.0
Changlang,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,950.0,950.0,,595.0,,,,,850.0,,3345.0
Changlang,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,0.0,500.0,,0.0,,,,,0.0,,500.0
Changlang,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,0.0,555.0,,100.0,,,,,600.0,,1255.0
Changlang,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,950.0,895.0,0.0,495.0,0.0,0.0,0.0,0.0,250.0,0.0,2590.0
Changlang,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,0.0,0.0,,0.0,,,,,350.0,,350.0
Changlang,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,0.0,0.0,,200.0,,,,,1000.0,,1200.0
Changlang,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,0.0,0.0,,200.0,,,,,885.0,,1085.0
Changlang,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,465.0,0.0,465.0
Changlang,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,0.0,0.0,,1000.0,,,,,0.0,,1000.0
Changlang,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,0.0,2000.0,,0.0,,,,,500.0,,2500.0
Changlang,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,0.0,500.0,,50.0,,,,,500.0,,1050.0
Changlang,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,1500.0,0.0,950.0,0.0,0.0,0.0,0.0,0.0,0.0,2450.0
Changlang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,100.0,200.0,,50.0,,,,,,,350.0
Changlang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,100.0,0.0,,0.0,,,,,,,100.0
Changlang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,0.0,0.0,,0.0,,,,,,,0.0
Changlang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,200.0,200.0,0.0,50.0,0.0,0.0,0.0,0.0,0.0,0.0,450.0
Changlang,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,0.0,0.0,,420.0,,,,,0.0,,420.0
Changlang,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,0.0,2520.0,,0.0,,,,,0.0,,2520.0
Changlang,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,0.0,500.0,,0.0,,,,,0.0,,500.0
Changlang,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,2020.0,0.0,420.0,0.0,0.0,0.0,0.0,0.0,0.0,2440.0
Changlang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,500.0,400.0,,200.0,,,,,0.0,,1100.0
Changlang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,0.0,0.0,,0.0,,,,,0.0,,0.0
Changlang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,100.0,200.0,,0.0,,,,,0.0,,300.0
Changlang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,400.0,200.0,0.0,200.0,0.0,0.0,0.0,0.0,0.0,0.0,800.0
Changlang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.02,Stock Position of Gloves,2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,0.0,,,,,,,,,0.0
Changlang,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,0.0,,,,,,,,,0.0
Changlang,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,0.0,,,,,,,,,0.0
Changlang,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,0.0,,,,,,,,,0.0
Changlang,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Changlang,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,1380.0,1100.0,,700.0,,,,,800.0,,3980.0
Changlang,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,0.0,600.0,,0.0,,,,,1000.0,,1600.0
Changlang,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,280.0,400.0,,0.0,,,,,1200.0,,1880.0
Changlang,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,1100.0,1300.0,0.0,700.0,0.0,0.0,0.0,0.0,600.0,0.0,3700.0
Changlang,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,3100.0,3100.0,,0.0,,,,,3300.0,,9500.0
Changlang,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,0.0,0.0,,3000.0,,,,,5000.0,,8000.0
Changlang,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,0.0,1600.0,,1050.0,,,,,4900.0,,7550.0
Changlang,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,3100.0,1500.0,0.0,1950.0,0.0,0.0,0.0,0.0,3400.0,0.0,9950.0
Changlang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,200.0,100.0,,300.0,,,,,0.0,,600.0
Changlang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,0.0,600.0,,0.0,,,,,0.0,,600.0
Changlang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Changlang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,100.0,0.0,,0.0,,,,,0.0,,100.0
Changlang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,100.0,700.0,0.0,300.0,0.0,0.0,0.0,0.0,0.0,0.0,1100.0
Changlang,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Changlang,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Changlang,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Changlang,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Changlang,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Changlang,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Changlang,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Changlang,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Changlang,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Changlang,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Changlang,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Changlang,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Changlang,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Changlang,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Changlang,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Changlang,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Changlang,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Changlang,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Changlang,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Changlang,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Changlang,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Changlang,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Changlang,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Changlang,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Changlang,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Changlang,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Changlang,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Changlang,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Changlang,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Changlang,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Changlang,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Changlang,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Changlang,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Changlang,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Changlang,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Changlang,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Changlang,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Changlang,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Changlang,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Changlang,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Changlang,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Changlang,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Changlang,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Changlang,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Changlang,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Changlang,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Changlang,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Changlang,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Changlang,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Changlang,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Changlang,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Changlang,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Changlang,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Changlang,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Changlang,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Changlang,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Changlang,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Changlang,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Changlang,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Changlang,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Changlang,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Changlang,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Changlang,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Changlang,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Changlang,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Changlang,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Changlang,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Changlang,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Changlang,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Changlang,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Changlang,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Changlang,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Changlang,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Changlang,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Changlang,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Changlang,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Changlang,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Changlang,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Changlang,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Changlang,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Changlang,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Changlang,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Changlang,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Changlang,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Changlang,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Changlang,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Changlang,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Changlang,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Changlang,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Changlang,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Changlang,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Changlang,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Changlang,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Changlang,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Changlang,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Changlang,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Changlang,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Changlang,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Changlang,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Changlang,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Changlang,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Changlang,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Changlang,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Changlang,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Changlang,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Changlang,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Changlang,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Changlang,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Dibang Valley,1.1,Total number of pregnant women Registered for ANC,TOTAL,11.0,12.0,12.0,14.0,15.0,10.0,20.0,10.0,8.0,10.0,8.0,8.0,138.0
Dibang Valley,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,7.0,4.0,6.0,6.0,9.0,3.0,11.0,8.0,5.0,9.0,6.0,6.0,80.0
Dibang Valley,1.2,Number of Pregnant women registered under JSY,TOTAL,10.0,12.0,12.0,12.0,15.0,9.0,20.0,12.0,7.0,9.0,8.0,8.0,134.0
Dibang Valley,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,8.0,11.0,7.0,1.0,15.0,5.0,4.0,9.0,11.0,9.0,5.0,7.0,92.0
Dibang Valley,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,7.0,5.0,11.0,7.0,15.0,8.0,11.0,9.0,8.0,7.0,8.0,6.0,102.0
Dibang Valley,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,8.0,7.0,7.0,9.0,5.0,8.0,5.0,10.0,4.0,7.0,5.0,7.0,82.0
Dibang Valley,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,6.0,11.0,12.0,13.0,5.0,8.0,20.0,6.0,4.0,8.0,7.0,1.0,101.0
Dibang Valley,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,0.0,4.0,0.0,3.0,0.0,4.0,13.0
Dibang Valley,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,1.8,Number of pregnancy test kits used at SC level,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,2.0,0.0,0.0,1.0,2.0,2.0,1.0,0.0,0.0,2.0,2.0,1.0,13.0
Dibang Valley,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,2.0,0.0,0.0,1.0,2.0,2.0,1.0,0.0,0.0,2.0,2.0,1.0,13.0
Dibang Valley,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,2.0,0.0,0.0,1.0,2.0,2.0,0.0,0.0,0.0,2.0,2.0,1.0,12.0
Dibang Valley,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,2.0,0.0,0.0,1.0,2.0,1.0,0.0,0.0,0.0,0.0,2.0,1.0,9.0
Dibang Valley,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,3.0,2.0,8.0,9.0,4.0,12.0,5.0,6.0,9.0,9.0,6.0,7.0,80.0
Dibang Valley,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,3.0,2.0,8.0,9.0,4.0,12.0,5.0,6.0,9.0,9.0,6.0,7.0,80.0
Dibang Valley,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,3.0,2.0,8.0,9.0,5.0,12.0,1.0,6.0,5.0,9.0,7.0,7.0,74.0
Dibang Valley,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,3.0,2.0,8.0,9.0,5.0,12.0,1.0,6.0,5.0,9.0,7.0,7.0,74.0
Dibang Valley,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0,0.0,6.0
Dibang Valley,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Dibang Valley,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Dibang Valley,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Dibang Valley,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Dibang Valley,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Dibang Valley,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dibang Valley,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Dibang Valley,4.1.1.a,Number of male live births,TOTAL,2.0,2.0,6.0,7.0,2.0,3.0,1.0,4.0,4.0,4.0,3.0,3.0,41.0
Dibang Valley,4.1.1.b,Number of female live births,TOTAL,3.0,0.0,2.0,3.0,4.0,4.0,5.0,2.0,5.0,6.0,5.0,5.0,44.0
Dibang Valley,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,5.0,2.0,8.0,10.0,6.0,7.0,6.0,6.0,9.0,10.0,8.0,8.0,85.0
Dibang Valley,4.1.2,Number of still births,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Dibang Valley,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,4.2.1,Number of Newborns weighed at birth,TOTAL,5.0,2.0,8.0,10.0,6.0,14.0,6.0,6.0,9.0,10.0,8.0,8.0,92.0
Dibang Valley,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Dibang Valley,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,5.0,2.0,8.0,10.0,6.0,14.0,6.0,6.0,9.0,10.0,8.0,8.0,92.0
Dibang Valley,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Dibang Valley,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dibang Valley,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Dibang Valley,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,5.0,2.0,8.0,10.0,6.0,14.0,6.0,6.0,9.0,11.0,8.0,8.0,93.0
Dibang Valley,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,5.0,2.0,8.0,10.0,6.0,14.0,6.0,6.0,9.0,11.0,8.0,8.0,93.0
Dibang Valley,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Dibang Valley,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0
Dibang Valley,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,0.0,0.0,0.0,3.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,4.0
Dibang Valley,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,0.0,0.0,0.0,12.0,0.0,0.0,2.0,1.0,1.0,0.0,0.0,0.0,16.0
Dibang Valley,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,0.0,0.0,0.0,15.0,0.0,0.0,2.0,2.0,1.0,0.0,0.0,0.0,20.0
Dibang Valley,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Dibang Valley,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
Dibang Valley,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dibang Valley,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dibang Valley,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Dibang Valley,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dibang Valley,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dibang Valley,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Dibang Valley,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dibang Valley,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dibang Valley,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Dibang Valley,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dibang Valley,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dibang Valley,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Dibang Valley,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
Dibang Valley,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,7.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Dibang Valley,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dibang Valley,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,0.0,0.0,0.0,7.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,8.0
Dibang Valley,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dibang Valley,9.06,Number of IUCD removals,TOTAL,0.0,0.0,0.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Dibang Valley,9.07,Number of Oral Pills cycles distributed,TOTAL,46.0,54.0,36.0,162.0,109.0,121.0,119.0,70.0,41.0,49.0,28.0,25.0,860.0
Dibang Valley,9.08,Number of Condom pieces distributed,TOTAL,80.0,120.0,244.0,653.0,850.0,353.0,338.0,246.0,115.0,76.0,70.0,64.0,3209.0
Dibang Valley,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,3.0,0.0,3.0,2.0,2.0,1.0,19.0,0.0,2.0,3.0,0.0,3.0,38.0
Dibang Valley,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,9.12,Number of Institutions having NSV trained doctors,TOTAL,2.0,1.0,,,1.0,1.0,1.0,,1.0,,,1.0,-1.0
Dibang Valley,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,5.0,2.0,8.0,10.0,6.0,14.0,6.0,6.0,9.0,10.0,8.0,8.0,92.0
Dibang Valley,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,12.0,6.0,7.0,7.0,10.0,8.0,13.0,8.0,5.0,7.0,9.0,6.0,98.0
Dibang Valley,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,7.0,6.0,10.0,4.0,7.0,8.0,9.0,12.0,9.0,7.0,8.0,5.0,92.0
Dibang Valley,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,4.0,13.0,7.0,5.0,9.0,5.0,8.0,8.0,15.0,8.0,8.0,6.0,96.0
Dibang Valley,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Dibang Valley,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Dibang Valley,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Dibang Valley,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,5.0,2.0,8.0,10.0,6.0,14.0,6.0,6.0,9.0,10.0,8.0,8.0,92.0
Dibang Valley,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,9.0,6.0,7.0,7.0,10.0,8.0,13.0,8.0,5.0,7.0,9.0,6.0,95.0
Dibang Valley,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,7.0,6.0,10.0,4.0,7.0,8.0,9.0,12.0,12.0,7.0,8.0,5.0,95.0
Dibang Valley,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,5.0,13.0,7.0,5.0,9.0,5.0,8.0,8.0,15.0,8.0,8.0,6.0,97.0
Dibang Valley,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,3.0,1.0,6.0,5.0,3.0,7.0,7.0,4.0,9.0,6.0,8.0,4.0,63.0
Dibang Valley,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,9.0,6.0,5.0,7.0,10.0,8.0,4.0,8.0,5.0,10.0,9.0,6.0,87.0
Dibang Valley,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,7.0,6.0,9.0,4.0,7.0,8.0,8.0,12.0,10.0,7.0,8.0,5.0,91.0
Dibang Valley,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,4.0,13.0,7.0,5.0,9.0,5.0,6.0,8.0,12.0,9.0,8.0,6.0,92.0
Dibang Valley,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,6.0,4.0,2.0,4.0,7.0,7.0,10.0,3.0,5.0,7.0,4.0,11.0,70.0
Dibang Valley,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,8.0,2.0,3.0,4.0,3.0,0.0,22.0
Dibang Valley,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3.0,3.0,0.0,2.0,5.0,4.0,2.0,1.0,4.0,3.0,1.0,4.0,32.0
Dibang Valley,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3.0,1.0,2.0,2.0,4.0,3.0,8.0,2.0,1.0,3.0,3.0,2.0,34.0
Dibang Valley,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,6.0,4.0,2.0,4.0,9.0,7.0,10.0,3.0,5.0,6.0,4.0,6.0,66.0
Dibang Valley,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,4.0,3.0,7.0,9.0,8.0,9.0,8.0,7.0,3.0,4.0,4.0,11.0,77.0
Dibang Valley,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,32.0,3.0,7.0,10.0,8.0,4.0,8.0,7.0,3.0,4.0,4.0,11.0,101.0
Dibang Valley,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,0.0,0.0,0.0,5.0,0.0,0.0,2.0,1.0,0.0,3.0,0.0,0.0,11.0
Dibang Valley,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,0.0,0.0,0.0,3.0,0.0,0.0,0.0,2.0,1.0,0.0,1.0,0.0,7.0
Dibang Valley,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,0.0,0.0,0.0,8.0,0.0,0.0,2.0,3.0,1.0,3.0,1.0,0.0,18.0
Dibang Valley,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,4.0,5.0,6.0,7.0,0.0,20.0,7.0,6.0,0.0,1.0,0.0,6.0,62.0
Dibang Valley,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,8.0,7.0,22.0,27.0,1.0,19.0,16.0,28.0,12.0,24.0,27.0,22.0,213.0
Dibang Valley,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2.0,3.0,19.0,22.0,2.0,1.0,13.0,16.0,13.0,32.0,28.0,14.0,165.0
Dibang Valley,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,21.0,24.0,14.0,17.0,24.0,23.0,23.0,16.0,11.0,18.0,16.0,10.0,217.0
Dibang Valley,10.4.2,Number of Immunisation sessions held during the month,TOTAL,21.0,24.0,14.0,17.0,24.0,23.0,23.0,16.0,11.0,18.0,16.0,10.0,217.0
Dibang Valley,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,21.0,24.0,13.0,17.0,23.0,23.0,23.0,16.0,11.0,14.0,16.0,8.0,209.0
Dibang Valley,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,8.0,7.0,11.0,4.0,5.0,7.0,42.0
Dibang Valley,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,14.0,9.0,12.0,6.0,15.0,9.0,65.0
Dibang Valley,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,12.0,11.0,14.0,9.0,6.0,0.0,52.0
Dibang Valley,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,5.0,0.0,5.0,4.0,5.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0
Dibang Valley,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,31.0,26.0,41.0,41.0,24.0,29.0,13.0,31.0,37.0,41.0,41.0,35.0,390.0
Dibang Valley,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,2.0,3.0,7.0,5.0,0.0,0.0,4.0,0.0,0.0,1.0,1.0,23.0
Dibang Valley,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Dibang Valley,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,,1.0,1.0,1.0,1.0,1.0,-1.0
Dibang Valley,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,1.0,1.0,1.0,1.0,1.0,,,1.0,1.0,,,,-1.0
Dibang Valley,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,5.0,5.0,4.0,4.0,4.0,4.0,8.0,3.0,5.0,5.0,4.0,2.0,-1.0
Dibang Valley,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,,1.0,1.0,1.0,1.0,1.0,-1.0
Dibang Valley,14.05,Number of RKS meetings held during the month,TOTAL,0.0,0.0,1.0,1.0,0.0,1.0,4.0,6.0,1.0,1.0,1.0,2.0,18.0
Dibang Valley,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,1.0,2.0,1.0,2.0,2.0,2.0,-1.0
Dibang Valley,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,4.0,4.0,2.0,2.0,2.0,5.0,5.0,6.0,4.0,3.0,2.0,5.0,44.0
Dibang Valley,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,1.0,1.0,1.0,1.0,,-1.0
Dibang Valley,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Dibang Valley,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,2.0,0.0,1.0,6.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Dibang Valley,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,6.0,6.0,7.0,0.0,3.0,12.0,7.0,13.0,0.0,3.0,6.0,1.0,64.0
Dibang Valley,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,0.0,0.0,2.0,12.0,4.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,20.0
Dibang Valley,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,7.0,6.0,10.0,2.0,6.0,12.0,10.0,19.0,12.0,7.0,6.0,6.0,103.0
Dibang Valley,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2.0,0.0,3.0,18.0,5.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,30.0
Dibang Valley,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,13.0,12.0,17.0,2.0,9.0,24.0,17.0,32.0,12.0,10.0,12.0,7.0,167.0
Dibang Valley,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Dibang Valley,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Dibang Valley,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
Dibang Valley,14.11,In-Patient Head Count at midnight,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,14.12.1,OPD attendance (All),TOTAL,701.0,577.0,990.0,1124.0,802.0,987.0,982.0,794.0,473.0,644.0,575.0,545.0,9194.0
Dibang Valley,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,64.0,47.0,73.0,87.0,87.0,70.0,36.0,95.0,68.0,66.0,75.0,114.0,882.0
Dibang Valley,14.14.a,Number of patients given AYUSH treatment,TOTAL,72.0,40.0,26.0,47.0,25.0,10.0,60.0,1.0,10.0,65.0,0.0,0.0,356.0
Dibang Valley,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,35.0,29.0,25.0,20.0,20.0,20.0,0.0,27.0,24.0,0.0,25.0,25.0,250.0
Dibang Valley,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,11.0,0.0,0.0,0.0,4.0,2.0,2.0,2.0,1.0,22.0
Dibang Valley,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,16.0,28.0,35.0,40.0,74.0,71.0,39.0,38.0,11.0,33.0,18.0,9.0,412.0
Dibang Valley,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,7.0,2.0,10.0,1.0,5.0,7.0,12.0,4.0,0.0,0.0,9.0,0.0,57.0
Dibang Valley,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Dibang Valley,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,4.0,0.0,0.0,5.0,0.0,5.0,2.0,11.0,2.0,0.0,6.0,0.0,35.0
Dibang Valley,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,5.0,6.0,10.0,5.0,11.0,8.0,6.0,8.0,3.0,4.0,0.0,2.0,68.0
Dibang Valley,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,2.0,0.0,0.0,12.0,0.0,0.0,0.0,0.0,0.0,14.0
Dibang Valley,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,16.0,8.0,20.0,11.0,16.0,20.0,20.0,23.0,5.0,4.0,15.0,2.0,160.0
Dibang Valley,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,0.0,2.0,0.0,0.0,13.0,0.0,0.0,0.0,0.0,0.0,15.0
Dibang Valley,15.2,Number of Widal tests conducted,Number tested,22.0,20.0,31.0,29.0,42.0,66.0,22.0,22.0,8.0,2.0,6.0,15.0,285.0
Dibang Valley,15.3.a,Number of VDRL tests conducted on males,Number tested,7.0,2.0,10.0,1.0,5.0,6.0,13.0,4.0,0.0,0.0,9.0,0.0,57.0
Dibang Valley,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,4.0,0.0,0.0,5.0,0.0,7.0,2.0,11.0,2.0,0.0,6.0,0.0,37.0
Dibang Valley,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,5.0,6.0,10.0,7.0,10.0,7.0,18.0,8.0,3.0,4.0,0.0,1.0,79.0
Dibang Valley,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,16.0,8.0,20.0,13.0,15.0,20.0,33.0,23.0,5.0,4.0,15.0,1.0,173.0
Dibang Valley,15.4.1,Number of blood smears examined for Malaria,TOTAL,33.0,43.0,40.0,47.0,29.0,28.0,20.0,21.0,6.0,7.0,17.0,14.0,305.0
Dibang Valley,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,2.0,1.0,1.0,4.0,3.0,1.0,0.0,2.0,0.0,2.0,0.0,1.0,17.0
Dibang Valley,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,3.0,1.0,3.0,3.0,2.0,1.0,1.0,0.0,0.0,1.0,2.0,2.0,19.0
Dibang Valley,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Dibang Valley,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Dibang Valley,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Dibang Valley,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Dibang Valley,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Dibang Valley,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Dibang Valley,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Dibang Valley,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Dibang Valley,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Dibang Valley,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Dibang Valley,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Dibang Valley,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Dibang Valley,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Dibang Valley,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Dibang Valley,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Dibang Valley,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Dibang Valley,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Dibang Valley,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Dibang Valley,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Dibang Valley,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Dibang Valley,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Dibang Valley,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Dibang Valley,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Dibang Valley,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Dibang Valley,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Dibang Valley,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Dibang Valley,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Dibang Valley,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Dibang Valley,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Dibang Valley,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Dibang Valley,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Dibang Valley,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Dibang Valley,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Dibang Valley,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Dibang Valley,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Dibang Valley,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Dibang Valley,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Dibang Valley,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Dibang Valley,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Dibang Valley,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Dibang Valley,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Dibang Valley,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Dibang Valley,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Dibang Valley,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Dibang Valley,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Dibang Valley,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Dibang Valley,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Dibang Valley,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Dibang Valley,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Dibang Valley,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Dibang Valley,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Dibang Valley,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Dibang Valley,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Dibang Valley,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Dibang Valley,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Dibang Valley,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Dibang Valley,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Dibang Valley,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Dibang Valley,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Dibang Valley,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Dibang Valley,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Dibang Valley,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Dibang Valley,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Dibang Valley,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Dibang Valley,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Dibang Valley,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Dibang Valley,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Dibang Valley,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Dibang Valley,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Dibang Valley,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Dibang Valley,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Dibang Valley,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Dibang Valley,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Dibang Valley,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Dibang Valley,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Dibang Valley,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Dibang Valley,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Dibang Valley,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Dibang Valley,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Dibang Valley,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Dibang Valley,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Dibang Valley,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Dibang Valley,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Dibang Valley,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Dibang Valley,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Dibang Valley,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Dibang Valley,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Dibang Valley,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Dibang Valley,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Dibang Valley,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Dibang Valley,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Dibang Valley,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Dibang Valley,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Dibang Valley,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Dibang Valley,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Dibang Valley,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Dibang Valley,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Dibang Valley,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Dibang Valley,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Dibang Valley,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Dibang Valley,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Dibang Valley,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Dibang Valley,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Dibang Valley,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Dibang Valley,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Dibang Valley,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Dibang Valley,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Dibang Valley,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Dibang Valley,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Dibang Valley,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Dibang Valley,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Dibang Valley,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Dibang Valley,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibang Valley,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Dibang Valley,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Dibang Valley,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Dibang Valley,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Dibang Valley,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Dibang Valley,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Dibang Valley,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Dibang Valley,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Dibang Valley,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Dibang Valley,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Dibang Valley,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Dibang Valley,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Dibang Valley,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Dibang Valley,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Dibang Valley,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dibang Valley,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Dibang Valley,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Dibang Valley,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dibang Valley,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Dibang Valley,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Dibang Valley,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dibang Valley,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Dibang Valley,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Dibang Valley,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dibang Valley,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Dibang Valley,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Dibang Valley,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Dibang Valley,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Dibang Valley,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Dibang Valley,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Dibang Valley,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Dibang Valley,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Dibang Valley,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Dibang Valley,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Dibang Valley,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Dibang Valley,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Dibang Valley,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Dibang Valley,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Dibang Valley,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Dibang Valley,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Dibang Valley,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Dibang Valley,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Dibang Valley,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Dibang Valley,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Dibang Valley,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Dibang Valley,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Dibang Valley,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Dibang Valley,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Dibang Valley,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Dibang Valley,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Dibang Valley,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Dibang Valley,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Dibang Valley,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Dibang Valley,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Dibang Valley,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Dibang Valley,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Dibang Valley,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Dibang Valley,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Dibang Valley,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Dibang Valley,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Dibang Valley,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Dibang Valley,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Dibang Valley,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Dibang Valley,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Dibang Valley,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Dibang Valley,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Dibang Valley,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Dibang Valley,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Dibang Valley,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Dibang Valley,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Dibang Valley,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Dibang Valley,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Dibang Valley,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Dibang Valley,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Dibang Valley,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
East Kameng,1.1,Total number of pregnant women Registered for ANC,TOTAL,84.0,139.0,99.0,125.0,168.0,146.0,127.0,111.0,108.0,117.0,145.0,198.0,1567.0
East Kameng,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,39.0,68.0,50.0,61.0,83.0,64.0,53.0,59.0,59.0,52.0,64.0,79.0,731.0
East Kameng,1.2,Number of Pregnant women registered under JSY,TOTAL,12.0,101.0,39.0,61.0,119.0,118.0,40.0,46.0,85.0,86.0,22.0,144.0,873.0
East Kameng,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,47.0,48.0,35.0,63.0,64.0,82.0,58.0,52.0,53.0,50.0,51.0,81.0,684.0
East Kameng,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,55.0,85.0,50.0,59.0,96.0,77.0,72.0,66.0,71.0,82.0,82.0,141.0,936.0
East Kameng,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,43.0,35.0,26.0,48.0,52.0,55.0,55.0,39.0,31.0,47.0,40.0,66.0,537.0
East Kameng,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,74.0,76.0,89.0,119.0,144.0,134.0,107.0,107.0,85.0,116.0,132.0,178.0,1361.0
East Kameng,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
East Kameng,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,5.0,9.0,0.0,13.0,6.0,12.0,15.0,7.0,5.0,6.0,9.0,14.0,101.0
East Kameng,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,1.8,Number of pregnancy test kits used at SC level,TOTAL,0.0,0.0,0.0,,,0.0,0.0,0.0,,,,0.0,0.0
East Kameng,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,2.0,2.0,4.0,2.0,4.0,5.0,10.0,7.0,8.0,5.0,4.0,4.0,57.0
East Kameng,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,2.0,6.0,0.0,1.0,4.0,5.0,6.0,6.0,0.0,3.0,3.0,4.0,40.0
East Kameng,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,4.0,8.0,4.0,3.0,8.0,10.0,16.0,13.0,8.0,8.0,7.0,8.0,97.0
East Kameng,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,2.0,5.0,3.0,1.0,2.0,7.0,10.0,2.0,4.0,1.0,9.0,4.0,50.0
East Kameng,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,36.0,32.0,34.0,54.0,42.0,67.0,54.0,46.0,55.0,58.0,43.0,46.0,567.0
East Kameng,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,36.0,32.0,35.0,54.0,42.0,67.0,54.0,46.0,55.0,58.0,43.0,46.0,568.0
East Kameng,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2.0,2.0,21.0,0.0,8.0,21.0,10.0,20.0,30.0,20.0,56.0,66.0,256.0
East Kameng,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2.0,2.0,4.0,0.0,3.0,2.0,2.0,20.0,7.0,0.0,12.0,39.0,93.0
East Kameng,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
East Kameng,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
East Kameng,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
East Kameng,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
East Kameng,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
East Kameng,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
East Kameng,4.1.1.a,Number of male live births,TOTAL,27.0,16.0,21.0,29.0,29.0,39.0,40.0,41.0,33.0,35.0,27.0,31.0,368.0
East Kameng,4.1.1.b,Number of female live births,TOTAL,16.0,24.0,17.0,28.0,21.0,38.0,30.0,16.0,30.0,31.0,23.0,23.0,297.0
East Kameng,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,43.0,40.0,38.0,57.0,50.0,77.0,70.0,57.0,63.0,66.0,50.0,54.0,665.0
East Kameng,4.1.2,Number of still births,TOTAL,1.0,0.0,2.0,2.0,0.0,1.0,0.0,2.0,1.0,0.0,0.0,0.0,9.0
East Kameng,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
East Kameng,4.2.1,Number of Newborns weighed at birth,TOTAL,42.0,37.0,35.0,54.0,48.0,72.0,67.0,48.0,60.0,58.0,45.0,50.0,616.0
East Kameng,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,1.0,2.0,0.0,7.0,5.0,4.0,11.0,8.0,8.0,5.0,1.0,7.0,59.0
East Kameng,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,38.0,30.0,19.0,38.0,45.0,68.0,47.0,38.0,37.0,49.0,23.0,14.0,446.0
East Kameng,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
East Kameng,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
East Kameng,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
East Kameng,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,4.0,8.0,5.0,52.0,7.0,11.0,17.0,5.0,7.0,55.0,2.0,5.0,178.0
East Kameng,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,4.0,7.0,4.0,5.0,5.0,11.0,16.0,5.0,4.0,3.0,2.0,5.0,71.0
East Kameng,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,30.0,24.0,28.0,13.0,20.0,24.0,15.0,18.0,23.0,26.0,2.0,0.0,223.0
East Kameng,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,10.0,4.0,3.0,0.0,0.0,2.0,3.0,0.0,0.0,22.0
East Kameng,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,30.0,24.0,28.0,23.0,24.0,27.0,15.0,18.0,25.0,29.0,2.0,0.0,245.0
East Kameng,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,86.0,70.0,79.0,86.0,69.0,70.0,64.0,86.0,96.0,41.0,38.0,61.0,846.0
East Kameng,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,115.0,86.0,117.0,66.0,82.0,92.0,78.0,78.0,75.0,53.0,56.0,83.0,981.0
East Kameng,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,201.0,156.0,196.0,152.0,151.0,162.0,142.0,164.0,171.0,94.0,94.0,144.0,1827.0
East Kameng,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,5.0
East Kameng,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
East Kameng,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
East Kameng,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
East Kameng,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
East Kameng,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
East Kameng,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
East Kameng,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
East Kameng,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
East Kameng,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,3.0,11.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,17.0
East Kameng,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,3.0,8.0,1.0,5.0,5.0,5.0,3.0,2.0,2.0,0.0,14.0,10.0,58.0
East Kameng,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
East Kameng,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,6.0,19.0,1.0,5.0,5.0,5.0,4.0,3.0,2.0,0.0,15.0,10.0,75.0
East Kameng,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,0.0,0.0,,,0.0,0.0,0.0,,,,0.0,0.0
East Kameng,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
East Kameng,9.06,Number of IUCD removals,TOTAL,1.0,10.0,4.0,2.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,3.0,22.0
East Kameng,9.07,Number of Oral Pills cycles distributed,TOTAL,118.0,149.0,162.0,219.0,229.0,154.0,127.0,162.0,145.0,194.0,143.0,200.0,2002.0
East Kameng,9.08,Number of Condom pieces distributed,TOTAL,177.0,195.0,158.0,379.0,329.0,142.0,215.0,246.0,335.0,257.0,276.0,379.0,3088.0
East Kameng,9.09,Number of Centchroman (weekly) pills given,TOTAL,1.0,1.0,2.0,0.0,0.0,2.0,0.0,0.0,1.0,5.0,0.0,0.0,12.0
East Kameng,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,21.0,10.0,7.0,11.0,10.0,8.0,7.0,10.0,18.0,16.0,13.0,15.0,146.0
East Kameng,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,,2.0,3.0,2.0,1.0,,,5.0,1.0,7.0,1.0,-1.0
East Kameng,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,44.0,43.0,22.0,32.0,50.0,61.0,52.0,55.0,64.0,65.0,66.0,99.0,653.0
East Kameng,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,90.0,102.0,67.0,55.0,68.0,79.0,67.0,50.0,96.0,79.0,122.0,211.0,1086.0
East Kameng,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,80.0,83.0,62.0,40.0,64.0,51.0,59.0,65.0,71.0,86.0,102.0,199.0,962.0
East Kameng,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,63.0,82.0,48.0,44.0,37.0,39.0,45.0,48.0,55.0,52.0,100.0,139.0,752.0
East Kameng,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,,,0.0,0.0,0.0,,,,,0.0
East Kameng,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,,,0.0,0.0,0.0,,,,,0.0
East Kameng,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,,,0.0,0.0,0.0,,,,,0.0
East Kameng,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,44.0,43.0,22.0,32.0,50.0,61.0,52.0,55.0,64.0,65.0,66.0,99.0,653.0
East Kameng,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,90.0,102.0,67.0,55.0,68.0,82.0,67.0,50.0,102.0,79.0,122.0,213.0,1097.0
East Kameng,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,80.0,83.0,62.0,40.0,64.0,51.0,59.0,65.0,71.0,86.0,102.0,203.0,966.0
East Kameng,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,63.0,82.0,48.0,44.0,37.0,43.0,49.0,48.0,60.0,52.0,100.0,139.0,765.0
East Kameng,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,5.0,42.0,22.0,32.0,50.0,61.0,53.0,53.0,64.0,65.0,66.0,99.0,612.0
East Kameng,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,87.0,92.0,62.0,52.0,68.0,79.0,67.0,50.0,102.0,79.0,122.0,211.0,1071.0
East Kameng,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,83.0,81.0,58.0,36.0,64.0,51.0,59.0,65.0,71.0,86.0,102.0,199.0,955.0
East Kameng,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,64.0,81.0,45.0,41.0,36.0,39.0,45.0,48.0,54.0,52.0,101.0,139.0,745.0
East Kameng,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,51.0,39.0,48.0,53.0,68.0,42.0,46.0,39.0,42.0,30.0,36.0,76.0,570.0
East Kameng,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,10.0,16.0,0.0,2.0,2.0,0.0,1.0,1.0,1.0,3.0,9.0,7.0,52.0
East Kameng,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,,,0.0,0.0,0.0,,,,0.0,0.0
East Kameng,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,24.0,19.0,23.0,30.0,27.0,24.0,19.0,22.0,22.0,16.0,11.0,35.0,272.0
East Kameng,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,27.0,20.0,25.0,23.0,41.0,18.0,28.0,17.0,20.0,14.0,21.0,38.0,292.0
East Kameng,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,51.0,39.0,48.0,53.0,68.0,42.0,47.0,39.0,42.0,30.0,32.0,73.0,564.0
East Kameng,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,18.0,9.0,8.0,14.0,27.0,24.0,13.0,29.0,21.0,15.0,20.0,42.0,240.0
East Kameng,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,18.0,9.0,8.0,14.0,27.0,24.0,13.0,29.0,21.0,15.0,20.0,42.0,240.0
East Kameng,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,8.0,8.0,2.0,4.0,7.0,3.0,1.0,6.0,12.0,12.0,7.0,5.0,75.0
East Kameng,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,9.0,8.0,2.0,3.0,14.0,3.0,3.0,5.0,16.0,9.0,2.0,6.0,80.0
East Kameng,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,17.0,16.0,4.0,7.0,21.0,6.0,4.0,11.0,28.0,21.0,9.0,11.0,155.0
East Kameng,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,5.0,0.0,3.0,2.0,9.0,6.0,1.0,2.0,5.0,2.0,2.0,5.0,42.0
East Kameng,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,2.0,4.0,0.0,2.0,8.0,12.0,9.0,17.0,19.0,8.0,17.0,12.0,110.0
East Kameng,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,0.0,2.0,0.0,6.0,14.0,13.0,10.0,12.0,24.0,16.0,12.0,17.0,126.0
East Kameng,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,7.0,8.0,5.0,17.0,16.0,23.0,22.0,31.0,25.0,27.0,31.0,25.0,237.0
East Kameng,10.4.2,Number of Immunisation sessions held during the month,TOTAL,4.0,1.0,0.0,3.0,1.0,4.0,3.0,6.0,6.0,13.0,19.0,17.0,77.0
East Kameng,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,0.0,2.0,0.0,3.0,4.0,7.0,6.0,3.0,3.0,9.0,10.0,12.0,59.0
East Kameng,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,16.0,24.0,9.0,1.0,2.0,5.0,15.0,22.0,17.0,32.0,36.0,77.0,256.0
East Kameng,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1.0,2.0,0.0,3.0,4.0,5.0,5.0,10.0,34.0,5.0,9.0,27.0,105.0
East Kameng,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,3.0,1.0,1.0,6.0,3.0,5.0,11.0,2.0,4.0,1.0,7.0,1.0,45.0
East Kameng,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,3.0,9.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0,21.0
East Kameng,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,110.0,175.0,151.0,154.0,161.0,86.0,180.0,59.0,67.0,106.0,188.0,187.0,1624.0
East Kameng,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,3.0,46.0,23.0,19.0,4.0,5.0,98.0,33.0,81.0,7.0,5.0,3.0,327.0
East Kameng,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,22.0,6.0,8.0,20.0,19.0,14.0,13.0,3.0,12.0,9.0,55.0,37.0,218.0
East Kameng,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,2.0,1.0,3.0,2.0,2.0,2.0,2.0,1.0,2.0,3.0,1.0,-1.0
East Kameng,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,1.0,1.0,1.0,1.0,2.0,2.0,2.0,2.0,1.0,1.0,1.0,1.0,-1.0
East Kameng,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,34.0,20.0,6.0,13.0,17.0,13.0,14.0,15.0,11.0,7.0,11.0,12.0,-1.0
East Kameng,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,3.0,1.0,3.0,2.0,2.0,2.0,3.0,3.0,4.0,4.0,4.0,-1.0
East Kameng,14.05,Number of RKS meetings held during the month,TOTAL,0.0,0.0,1.0,0.0,0.0,2.0,5.0,1.0,0.0,0.0,1.0,2.0,12.0
East Kameng,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,5.0,5.0,3.0,4.0,5.0,3.0,5.0,4.0,4.0,5.0,5.0,5.0,-1.0
East Kameng,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,0.0,0.0,0.0,4.0,0.0,12.0,9.0,1.0,0.0,0.0,8.0,0.0,34.0
East Kameng,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,1.0,1.0,1.0,,,,,,1.0,1.0,1.0,-1.0
East Kameng,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
East Kameng,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,34.0,30.0,39.0,47.0,45.0,43.0,59.0,41.0,47.0,22.0,29.0,94.0,530.0
East Kameng,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,105.0,98.0,57.0,88.0,107.0,67.0,73.0,83.0,56.0,62.0,58.0,60.0,914.0
East Kameng,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,37.0,34.0,55.0,58.0,65.0,56.0,53.0,63.0,49.0,41.0,43.0,82.0,636.0
East Kameng,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,123.0,115.0,104.0,159.0,174.0,157.0,113.0,113.0,96.0,87.0,114.0,82.0,1437.0
East Kameng,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,71.0,64.0,94.0,105.0,110.0,99.0,112.0,104.0,96.0,63.0,72.0,176.0,1166.0
East Kameng,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,228.0,213.0,161.0,247.0,281.0,224.0,186.0,196.0,152.0,149.0,172.0,142.0,2351.0
East Kameng,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,3.0
East Kameng,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,3.0
East Kameng,14.11,In-Patient Head Count at midnight,TOTAL,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0,12.0,27.0
East Kameng,14.12.1,OPD attendance (All),TOTAL,3955.0,4382.0,3537.0,4297.0,3781.0,3715.0,3081.0,2906.0,2977.0,2738.0,3149.0,4061.0,42579.0
East Kameng,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,,,0.0,0.0,0.0,,,,0.0,0.0
East Kameng,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,6.0,6.0,6.0,4.0,4.0,19.0,9.0,10.0,8.0,5.0,18.0,19.0,114.0
East Kameng,14.14.a,Number of patients given AYUSH treatment,TOTAL,80.0,60.0,0.0,198.0,103.0,85.0,10.0,73.0,70.0,0.0,40.0,1.0,720.0
East Kameng,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,20.0,45.0,29.0,67.0,26.0,36.0,30.0,26.0,51.0,22.0,64.0,52.0,468.0
East Kameng,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,22.0,30.0,34.0,52.0,17.0,39.0,16.0,36.0,0.0,13.0,0.0,3.0,262.0
East Kameng,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0
East Kameng,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,16.0,12.0,25.0,21.0,26.0,25.0,16.0,20.0,0.0,3.0,0.0,2.0,166.0
East Kameng,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
East Kameng,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,43.0,54.0,36.0,51.0,37.0,54.0,46.0,51.0,2.0,49.0,0.0,0.0,423.0
East Kameng,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,1.0,0.0,0.0,0.0,0.0,2.0,7.0,0.0,0.0,0.0,0.0,10.0
East Kameng,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,81.0,96.0,95.0,124.0,80.0,118.0,78.0,107.0,2.0,65.0,0.0,5.0,851.0
East Kameng,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,1.0,0.0,0.0,0.0,0.0,2.0,10.0,0.0,0.0,0.0,0.0,13.0
East Kameng,15.2,Number of Widal tests conducted,Number tested,8.0,13.0,0.0,20.0,10.0,21.0,15.0,5.0,9.0,11.0,13.0,0.0,125.0
East Kameng,15.3.a,Number of VDRL tests conducted on males,Number tested,22.0,30.0,34.0,52.0,17.0,37.0,15.0,34.0,0.0,13.0,0.0,0.0,254.0
East Kameng,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,16.0,12.0,25.0,20.0,22.0,25.0,16.0,19.0,0.0,3.0,0.0,0.0,158.0
East Kameng,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,43.0,54.0,36.0,49.0,35.0,54.0,46.0,51.0,2.0,49.0,0.0,0.0,419.0
East Kameng,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,81.0,96.0,95.0,121.0,74.0,116.0,77.0,104.0,2.0,65.0,0.0,0.0,831.0
East Kameng,15.4.1,Number of blood smears examined for Malaria,TOTAL,57.0,200.0,200.0,311.0,305.0,396.0,334.0,255.0,136.0,58.0,73.0,187.0,2512.0
East Kameng,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,13.0,29.0,20.0,54.0,28.0,20.0,17.0,16.0,9.0,2.0,7.0,10.0,225.0
East Kameng,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,3.0,4.0,1.0,9.0,4.0,2.0,3.0,1.0,2.0,0.0,0.0,0.0,29.0
East Kameng,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
East Kameng,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
East Kameng,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
East Kameng,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
East Kameng,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
East Kameng,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
East Kameng,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
East Kameng,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
East Kameng,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
East Kameng,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
East Kameng,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
East Kameng,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
East Kameng,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
East Kameng,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
East Kameng,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
East Kameng,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
East Kameng,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
East Kameng,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
East Kameng,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
East Kameng,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
East Kameng,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
East Kameng,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
East Kameng,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
East Kameng,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
East Kameng,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
East Kameng,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
East Kameng,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
East Kameng,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
East Kameng,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
East Kameng,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
East Kameng,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
East Kameng,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
East Kameng,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
East Kameng,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
East Kameng,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
East Kameng,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
East Kameng,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
East Kameng,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
East Kameng,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
East Kameng,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
East Kameng,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
East Kameng,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
East Kameng,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
East Kameng,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
East Kameng,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
East Kameng,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
East Kameng,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
East Kameng,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
East Kameng,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
East Kameng,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
East Kameng,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
East Kameng,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
East Kameng,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
East Kameng,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
East Kameng,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
East Kameng,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
East Kameng,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
East Kameng,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
East Kameng,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
East Kameng,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
East Kameng,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
East Kameng,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
East Kameng,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
East Kameng,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
East Kameng,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
East Kameng,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
East Kameng,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
East Kameng,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
East Kameng,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
East Kameng,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
East Kameng,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
East Kameng,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
East Kameng,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
East Kameng,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
East Kameng,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
East Kameng,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
East Kameng,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
East Kameng,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
East Kameng,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
East Kameng,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
East Kameng,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
East Kameng,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
East Kameng,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
East Kameng,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
East Kameng,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
East Kameng,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
East Kameng,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
East Kameng,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
East Kameng,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
East Kameng,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
East Kameng,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
East Kameng,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
East Kameng,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
East Kameng,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
East Kameng,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
East Kameng,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
East Kameng,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
East Kameng,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
East Kameng,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
East Kameng,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
East Kameng,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
East Kameng,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
East Kameng,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
East Kameng,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
East Kameng,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
East Kameng,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
East Kameng,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
East Kameng,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
East Kameng,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
East Kameng,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
East Kameng,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
East Kameng,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
East Kameng,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Kameng,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,1.0,,,,,,1.0
East Kameng,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
East Kameng,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
East Kameng,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
East Kameng,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
East Kameng,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
East Kameng,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
East Kameng,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
East Kameng,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
East Kameng,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
East Kameng,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
East Kameng,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
East Kameng,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
East Kameng,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,1.0,,,,,1.0,,,,2.0
East Kameng,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,1.0,,,1.0,,,,,,,2.0
East Kameng,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,1.0,1.0,,1.0,,,1.0,,,,4.0
East Kameng,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
East Kameng,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
East Kameng,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
East Kameng,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
East Kameng,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
East Kameng,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
East Kameng,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
East Kameng,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
East Kameng,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
East Kameng,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
East Kameng,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
East Kameng,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
East Kameng,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
East Kameng,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
East Kameng,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
East Kameng,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,1.0,,,,,,,,1.0
East Kameng,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
East Kameng,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,1.0,,,,,,,1.0,,,,2.0
East Kameng,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
East Kameng,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,1.0,,,,,,,1.0,,,,2.0
East Kameng,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
East Kameng,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
East Kameng,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
East Kameng,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
East Kameng,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
East Kameng,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,1.0,1.0,1.0,1.0,,,,,4.0
East Kameng,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
East Kameng,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,1.0,1.0,1.0,1.0,1.0,,,,5.0
East Kameng,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
East Kameng,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
East Kameng,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,1.0,,1.0,,,,,,2.0
East Kameng,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,1.0,,1.0,,,,,,2.0
East Kameng,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
East Kameng,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
East Kameng,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
East Kameng,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
East Kameng,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
East Kameng,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
East Kameng,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
East Kameng,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
East Kameng,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
East Kameng,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
East Kameng,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
East Kameng,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
East Kameng,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
East Kameng,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
East Kameng,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
East Kameng,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
East Kameng,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
East Kameng,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
East Kameng,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
East Kameng,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
East Kameng,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
East Kameng,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
East Kameng,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
East Kameng,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
East Kameng,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
East Kameng,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
East Kameng,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
East Kameng,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
East Kameng,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
East Kameng,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,1.0,2.0,,,,,,,,3.0
East Kameng,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
East Kameng,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,1.0,2.0,,,,,,,,3.0
East Kameng,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
East Kameng,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
East Kameng,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
East Kameng,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
East Kameng,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
East Kameng,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,1.0,,,,1.0
East Kameng,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
East Kameng,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,1.0,,,,1.0
East Kameng,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
East Kameng,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
East Kameng,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
East Kameng,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
East Kameng,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
East Kameng,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
East Kameng,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
East Kameng,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
East Kameng,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
East Kameng,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
East Kameng,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
East Kameng,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
East Kameng,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
East Kameng,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
East Kameng,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
East Kameng,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
East Kameng,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
East Kameng,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
East Kameng,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
East Kameng,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,1.0,,,,,,,,,1.0
East Siang,1.1,Total number of pregnant women Registered for ANC,TOTAL,149.0,160.0,149.0,184.0,176.0,190.0,185.0,204.0,193.0,179.0,196.0,173.0,2138.0
East Siang,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,75.0,73.0,64.0,91.0,74.0,90.0,94.0,96.0,73.0,65.0,87.0,83.0,965.0
East Siang,1.2,Number of Pregnant women registered under JSY,TOTAL,125.0,87.0,111.0,133.0,118.0,159.0,149.0,118.0,108.0,89.0,101.0,72.0,1370.0
East Siang,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,68.0,69.0,56.0,66.0,56.0,80.0,117.0,119.0,83.0,68.0,81.0,78.0,941.0
East Siang,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,109.0,109.0,105.0,131.0,129.0,138.0,141.0,124.0,109.0,107.0,105.0,125.0,1432.0
East Siang,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,84.0,92.0,89.0,69.0,96.0,90.0,110.0,109.0,89.0,82.0,92.0,103.0,1105.0
East Siang,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,87.0,83.0,83.0,73.0,103.0,91.0,103.0,100.0,80.0,58.0,47.0,180.0,1088.0
East Siang,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,6.0,0.0,0.0,1.0,0.0,3.0,6.0,4.0,6.0,4.0,1.0,0.0,31.0
East Siang,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
East Siang,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,49.0,36.0,78.0,96.0,153.0,101.0,64.0,60.0,52.0,72.0,51.0,66.0,878.0
East Siang,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,12.0,11.0,6.0,2.0,12.0,1.0,3.0,0.0,0.0,3.0,4.0,6.0,60.0
East Siang,1.8,Number of pregnancy test kits used at SC level,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,2.0,5.0,4.0,12.0,4.0,11.0,6.0,8.0,9.0,5.0,5.0,5.0,76.0
East Siang,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,0.0,1.0,1.0,0.0,4.0,4.0,0.0,0.0,0.0,5.0,3.0,18.0
East Siang,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,2.0,5.0,5.0,13.0,4.0,15.0,10.0,8.0,9.0,5.0,10.0,8.0,94.0
East Siang,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,0.0,2.0,0.0,3.0,3.0,5.0,5.0,6.0,8.0,4.0,2.0,2.0,40.0
East Siang,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,1.0,0.0,0.0,1.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
East Siang,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,99.0,101.0,109.0,140.0,153.0,132.0,160.0,125.0,117.0,138.0,113.0,106.0,1493.0
East Siang,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,32.0,81.0,96.0,29.0,111.0,114.0,128.0,106.0,99.0,126.0,39.0,17.0,978.0
East Siang,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,74.0,14.0,10.0,3.0,7.0,17.0,16.0,24.0,3.0,2.0,114.0,129.0,413.0
East Siang,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,6.0,9.0,2.0,3.0,6.0,8.0,7.0,10.0,3.0,0.0,1.0,35.0,90.0
East Siang,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,1.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
East Siang,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,12.0,12.0,6.0,,3.0,13.0,7.0,6.0,11.0,13.0,9.0,11.0,103.0
East Siang,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,,16.0,24.0,0.0,0.0,0.0,0.0,0.0,0.0,40.0
East Siang,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,,16.0,24.0,0.0,0.0,0.0,0.0,0.0,0.0,40.0
East Siang,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
East Siang,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0,11.0
East Siang,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,1.0,1.0,2.0,0.0,3.0,3.0,2.0,3.0,2.0,2.0,0.0,2.0,21.0
East Siang,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,21.0,19.0,11.0,19.0,29.0,13.0,33.0,17.0,17.0,9.0,18.0,12.0,218.0
East Siang,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
East Siang,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,22.0,20.0,13.0,19.0,32.0,16.0,35.0,20.0,19.0,11.0,18.0,25.0,250.0
East Siang,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,3.0,3.0,5.0,,0.0,3.0,5.0,4.0,2.0,9.0,8.0,5.0,47.0
East Siang,4.1.1.a,Number of male live births,TOTAL,58.0,55.0,70.0,83.0,88.0,86.0,85.0,83.0,63.0,74.0,73.0,68.0,886.0
East Siang,4.1.1.b,Number of female live births,TOTAL,53.0,61.0,48.0,63.0,70.0,70.0,86.0,51.0,74.0,78.0,60.0,58.0,772.0
East Siang,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,111.0,116.0,118.0,146.0,158.0,156.0,171.0,134.0,137.0,152.0,133.0,126.0,1658.0
East Siang,4.1.2,Number of still births,TOTAL,2.0,3.0,1.0,3.0,3.0,1.0,2.0,5.0,3.0,1.0,1.0,2.0,27.0
East Siang,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,12.0,12.0,15.0,20.0,10.0,17.0,14.0,5.0,5.0,3.0,0.0,0.0,113.0
East Siang,4.2.1,Number of Newborns weighed at birth,TOTAL,105.0,41.0,114.0,141.0,157.0,150.0,167.0,135.0,128.0,152.0,135.0,127.0,1552.0
East Siang,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,5.0,2.0,9.0,21.0,14.0,8.0,14.0,14.0,13.0,20.0,2.0,5.0,127.0
East Siang,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,45.0,42.0,103.0,45.0,55.0,64.0,57.0,54.0,128.0,137.0,134.0,125.0,989.0
East Siang,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
East Siang,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0,0.0,0.0,100.0
East Siang,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
East Siang,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0,1.0,0.0,101.0
East Siang,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,3.0,3.0,5.0,,0.0,0.0,2.0,1.0,2.0,0.0,0.0,5.0,21.0
East Siang,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,14.0,6.0,3.0,0.0,103.0,94.0,116.0,89.0,74.0,108.0,88.0,10.0,705.0
East Siang,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,3.0,4.0,0.0,0.0,9.0
East Siang,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,22.0,10.0,12.0,25.0,21.0,20.0,14.0,30.0,35.0,33.0,31.0,21.0,274.0
East Siang,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,29.0,20.0,21.0,37.0,37.0,48.0,37.0,42.0,24.0,31.0,30.0,30.0,386.0
East Siang,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,23.0,14.0,19.0,29.0,35.0,31.0,41.0,49.0,20.0,36.0,27.0,29.0,353.0
East Siang,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,13.0,7.0,7.0,15.0,19.0,13.0,3.0,19.0,3.0,10.0,9.0,5.0,123.0
East Siang,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,6.0,20.0,2.0,5.0,10.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,45.0
East Siang,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,19.0,27.0,9.0,20.0,29.0,15.0,3.0,19.0,3.0,10.0,9.0,5.0,168.0
East Siang,7.2,Number of MTPs conducted at Private Facilities,TOTAL,12.0,12.0,6.0,0.0,2.0,15.0,10.0,5.0,3.0,5.0,9.0,16.0,95.0
East Siang,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,0.0,19.0,13.0,13.0,0.0,27.0,0.0,0.0,0.0,35.0,0.0,12.0,119.0
East Siang,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,0.0,10.0,18.0,18.0,0.0,31.0,0.0,0.0,0.0,110.0,0.0,8.0,195.0
East Siang,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,0.0,29.0,31.0,31.0,0.0,58.0,0.0,0.0,0.0,145.0,0.0,20.0,314.0
East Siang,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
East Siang,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
East Siang,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
East Siang,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
East Siang,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,30.0,11.0,16.0,1.0,2.0,12.0,14.0,3.0,0.0,0.0,7.0,15.0,111.0
East Siang,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,7.0,16.0,7.0,2.0,5.0,0.0,1.0,3.0,,2.0,7.0,12.0,62.0
East Siang,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
East Siang,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,37.0,27.0,23.0,3.0,7.0,12.0,15.0,6.0,0.0,2.0,14.0,27.0,173.0
East Siang,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,2.0,2.0,2.0,1.0,3.0,3.0,13.0
East Siang,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,1.0,5.0,1.0,0.0,3.0,6.0,0.0,0.0,2.0,0.0,6.0,1.0,25.0
East Siang,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
East Siang,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,1.0,5.0,1.0,0.0,3.0,6.0,0.0,0.0,2.0,0.0,6.0,1.0,25.0
East Siang,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,6.0,6.0,2.0,,2.0,2.0,1.0,2.0,0.0,1.0,1.0,4.0,27.0
East Siang,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,1.0,8.0,0.0,0.0,7.0,4.0,5.0,0.0,0.0,1.0,26.0
East Siang,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
East Siang,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,1.0,8.0,0.0,0.0,7.0,4.0,5.0,0.0,0.0,1.0,26.0
East Siang,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,1.0,,,,0.0,0.0,0.0,1.0
East Siang,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,2.0,3.0,2.0,0.0,2.0,1.0,2.0,4.0,3.0,1.0,1.0,21.0
East Siang,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,9.0,9.0,9.0,8.0,8.0,4.0,7.0,6.0,5.0,5.0,5.0,7.0,82.0
East Siang,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,8.0,4.0,12.0,11.0,15.0,7.0,14.0,15.0,8.0,10.0,14.0,6.0,124.0
East Siang,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
East Siang,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,17.0,15.0,24.0,21.0,23.0,13.0,22.0,23.0,17.0,18.0,20.0,14.0,227.0
East Siang,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,6.0,6.0,0.0,,3.0,2.0,4.0,2.0,3.0,4.0,5.0,2.0,37.0
East Siang,9.06,Number of IUCD removals,TOTAL,13.0,7.0,6.0,8.0,7.0,4.0,6.0,5.0,6.0,29.0,8.0,7.0,106.0
East Siang,9.07,Number of Oral Pills cycles distributed,TOTAL,84.0,79.0,101.0,113.0,75.0,105.0,97.0,111.0,207.0,109.0,113.0,66.0,1260.0
East Siang,9.08,Number of Condom pieces distributed,TOTAL,146.0,100.0,105.0,275.0,152.0,115.0,127.0,119.0,193.0,307.0,176.0,81.0,1896.0
East Siang,9.09,Number of Centchroman (weekly) pills given,TOTAL,11.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,0.0,0.0,16.0
East Siang,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,4.0,1.0,9.0,6.0,2.0,9.0,66.0,23.0,18.0,22.0,12.0,2.0,174.0
East Siang,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,9.12,Number of Institutions having NSV trained doctors,TOTAL,15.0,14.0,14.0,14.0,14.0,16.0,17.0,16.0,13.0,15.0,15.0,12.0,-1.0
East Siang,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,115.0,120.0,146.0,160.0,148.0,154.0,225.0,153.0,149.0,188.0,160.0,149.0,1867.0
East Siang,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,122.0,102.0,131.0,124.0,150.0,135.0,195.0,154.0,141.0,156.0,130.0,171.0,1711.0
East Siang,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,138.0,117.0,121.0,94.0,120.0,135.0,140.0,148.0,153.0,155.0,130.0,162.0,1613.0
East Siang,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,140.0,149.0,115.0,80.0,115.0,119.0,142.0,129.0,114.0,130.0,138.0,154.0,1525.0
East Siang,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,88.0,83.0,121.0,122.0,107.0,110.0,161.0,107.0,100.0,157.0,127.0,124.0,1407.0
East Siang,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,122.0,103.0,127.0,124.0,149.0,134.0,196.0,148.0,141.0,153.0,131.0,171.0,1699.0
East Siang,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,138.0,117.0,122.0,94.0,121.0,131.0,140.0,151.0,150.0,155.0,127.0,169.0,1615.0
East Siang,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,139.0,239.0,116.0,80.0,113.0,115.0,146.0,131.0,110.0,134.0,136.0,152.0,1611.0
East Siang,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,60.0,58.0,102.0,105.0,75.0,81.0,145.0,92.0,86.0,132.0,106.0,102.0,1144.0
East Siang,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,118.0,99.0,123.0,119.0,145.0,140.0,182.0,151.0,127.0,145.0,132.0,170.0,1651.0
East Siang,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,158.0,110.0,120.0,103.0,117.0,137.0,137.0,145.0,154.0,148.0,126.0,162.0,1617.0
East Siang,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,117.0,154.0,117.0,77.0,116.0,116.0,138.0,119.0,135.0,136.0,135.0,151.0,1511.0
East Siang,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,89.0,109.0,114.0,91.0,125.0,140.0,152.0,129.0,82.0,113.0,113.0,115.0,1372.0
East Siang,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,40.0,94.0,81.0,60.0,72.0,80.0,91.0,61.0,84.0,119.0,70.0,108.0,960.0
East Siang,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
East Siang,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,67.0,42.0,66.0,46.0,77.0,84.0,74.0,53.0,56.0,73.0,47.0,48.0,733.0
East Siang,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,61.0,46.0,49.0,49.0,72.0,70.0,61.0,42.0,39.0,72.0,60.0,57.0,678.0
East Siang,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,128.0,88.0,115.0,95.0,149.0,154.0,135.0,95.0,95.0,145.0,107.0,105.0,1411.0
East Siang,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,80.0,103.0,86.0,65.0,88.0,104.0,114.0,82.0,108.0,99.0,90.0,78.0,1097.0
East Siang,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,81.0,96.0,85.0,52.0,87.0,103.0,121.0,82.0,107.0,105.0,89.0,78.0,1086.0
East Siang,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,1.0,16.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,2.0,3.0,24.0
East Siang,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,36.0,45.0,15.0,27.0,45.0,38.0,31.0,26.0,29.0,31.0,35.0,54.0,412.0
East Siang,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,37.0,35.0,14.0,40.0,28.0,19.0,38.0,25.0,28.0,45.0,40.0,41.0,390.0
East Siang,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,73.0,80.0,29.0,67.0,73.0,57.0,69.0,51.0,57.0,76.0,75.0,95.0,802.0
East Siang,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,13.0,3.0,0.0,0.0,0.0,2.0,0.0,0.0,1.0,3.0,12.0,18.0,52.0
East Siang,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,31.0,45.0,21.0,27.0,25.0,30.0,26.0,30.0,13.0,18.0,20.0,13.0,299.0
East Siang,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,30.0,51.0,21.0,34.0,14.0,28.0,23.0,22.0,17.0,22.0,27.0,13.0,302.0
East Siang,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,4.0
East Siang,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,91.0,59.0,77.0,88.0,96.0,115.0,93.0,104.0,97.0,86.0,99.0,81.0,1086.0
East Siang,10.4.2,Number of Immunisation sessions held during the month,TOTAL,89.0,60.0,77.0,87.0,97.0,111.0,93.0,105.0,119.0,108.0,95.0,80.0,1121.0
East Siang,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,62.0,50.0,57.0,46.0,47.0,59.0,58.0,65.0,101.0,87.0,62.0,73.0,767.0
East Siang,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,4.0,82.0,63.0,71.0,94.0,74.0,389.0
East Siang,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,3.0,18.0,10.0,61.0,50.0,31.0,173.0
East Siang,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,3.0,15.0,4.0,19.0,8.0,8.0,57.0
East Siang,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,5.0
East Siang,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,6.0,0.0,0.0,2.0,4.0,0.0,2.0,6.0,0.0,2.0,1.0,23.0
East Siang,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,57.0,104.0,78.0,68.0,55.0,73.0,86.0,67.0,61.0,95.0,71.0,67.0,882.0
East Siang,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,36.0,4.0,12.0,21.0,55.0,17.0,11.0,4.0,8.0,8.0,6.0,8.0,190.0
East Siang,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,1.0,19.0,3.0,15.0,104.0,127.0,90.0,60.0,31.0,1.0,25.0,52.0,528.0
East Siang,13.1,Number of Patients operated for cataract,TOTAL,21.0,25.0,61.0,13.0,13.0,6.0,13.0,9.0,10.0,15.0,16.0,26.0,228.0
East Siang,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,16.0,25.0,61.0,0.0,0.0,6.0,13.0,9.0,10.0,15.0,16.0,26.0,197.0
East Siang,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,9.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,12.0
East Siang,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,3.0,3.0,4.0,3.0,5.0,4.0,4.0,5.0,4.0,3.0,4.0,3.0,-1.0
East Siang,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,8.0,7.0,8.0,8.0,7.0,9.0,9.0,9.0,6.0,9.0,10.0,9.0,-1.0
East Siang,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,41.0,27.0,26.0,17.0,47.0,25.0,55.0,68.0,52.0,40.0,54.0,43.0,-1.0
East Siang,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,6.0,6.0,6.0,6.0,6.0,5.0,6.0,5.0,6.0,6.0,5.0,-1.0
East Siang,14.05,Number of RKS meetings held during the month,TOTAL,3.0,2.0,2.0,2.0,3.0,2.0,3.0,4.0,1.0,2.0,1.0,3.0,28.0
East Siang,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,17.0,16.0,18.0,15.0,15.0,18.0,19.0,19.0,16.0,17.0,17.0,14.0,-1.0
East Siang,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,2.0,7.0,5.0,39.0,26.0,34.0,28.0,26.0,25.0,28.0,57.0,57.0,334.0
East Siang,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,3.0,4.0,2.0,2.0,4.0,4.0,3.0,4.0,4.0,3.0,4.0,3.0,-1.0
East Siang,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,-1.0
East Siang,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,112.0,103.0,120.0,180.0,127.0,96.0,145.0,102.0,90.0,120.0,72.0,92.0,1359.0
East Siang,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,284.0,520.0,365.0,478.0,310.0,207.0,234.0,262.0,221.0,194.0,174.0,217.0,3466.0
East Siang,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,123.0,119.0,115.0,158.0,132.0,110.0,242.0,95.0,94.0,98.0,169.0,98.0,1553.0
East Siang,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,426.0,467.0,583.0,556.0,500.0,432.0,311.0,365.0,351.0,296.0,203.0,331.0,4821.0
East Siang,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,235.0,222.0,235.0,338.0,259.0,206.0,387.0,197.0,184.0,218.0,241.0,190.0,2912.0
East Siang,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,710.0,987.0,948.0,1034.0,810.0,639.0,545.0,627.0,572.0,490.0,377.0,548.0,8287.0
East Siang,14.10.2.a,Number of death cases of Inpatient males,TOTAL,8.0,4.0,6.0,7.0,11.0,3.0,6.0,7.0,7.0,7.0,7.0,10.0,83.0
East Siang,14.10.2.b,Number of death cases of Inpatient females,TOTAL,8.0,5.0,7.0,3.0,5.0,8.0,4.0,2.0,3.0,2.0,1.0,3.0,51.0
East Siang,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,16.0,9.0,13.0,10.0,16.0,11.0,10.0,9.0,10.0,9.0,8.0,13.0,134.0
East Siang,14.11,In-Patient Head Count at midnight,TOTAL,794.0,971.0,968.0,1123.0,750.0,776.0,687.0,605.0,626.0,559.0,460.0,561.0,8880.0
East Siang,14.12.1,OPD attendance (All),TOTAL,13121.0,13573.0,16009.0,16044.0,13258.0,17516.0,12307.0,15722.0,8922.0,9554.0,10647.0,11293.0,157966.0
East Siang,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,160.0,160.0,120.0,73.0,113.0,109.0,157.0,116.0,82.0,129.0,117.0,124.0,1460.0
East Siang,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17.0,15.0,11.0,43.0
East Siang,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,131.0,193.0,139.0,138.0,114.0,129.0,131.0,113.0,109.0,126.0,99.0,150.0,1572.0
East Siang,14.14.a,Number of patients given AYUSH treatment,TOTAL,256.0,200.0,286.0,172.0,275.0,270.0,221.0,313.0,230.0,192.0,239.0,273.0,2927.0
East Siang,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,460.0,565.0,697.0,600.0,339.0,508.0,884.0,621.0,328.0,417.0,500.0,522.0,6441.0
East Siang,14.14.c,Number of Adolescents counselled,TOTAL,4.0,9.0,10.0,6.0,6.0,11.0,4.0,10.0,4.0,24.0,31.0,14.0,133.0
East Siang,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,548.0,660.0,803.0,793.0,702.0,713.0,543.0,590.0,491.0,505.0,557.0,583.0,7488.0
East Siang,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,31.0,16.0,35.0,28.0,27.0,38.0,56.0,31.0,16.0,12.0,15.0,26.0,331.0
East Siang,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,44.0,65.0,62.0,68.0,51.0,100.0,102.0,68.0,55.0,73.0,83.0,72.0,843.0
East Siang,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0
East Siang,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,40.0,33.0,51.0,38.0,49.0,63.0,51.0,27.0,20.0,55.0,135.0,70.0,632.0
East Siang,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
East Siang,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,71.0,82.0,53.0,94.0,79.0,70.0,69.0,59.0,64.0,77.0,153.0,113.0,984.0
East Siang,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,155.0,180.0,166.0,200.0,179.0,233.0,222.0,154.0,139.0,205.0,371.0,255.0,2459.0
East Siang,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0
East Siang,15.2,Number of Widal tests conducted,Number tested,253.0,388.0,667.0,663.0,477.0,360.0,296.0,368.0,191.0,174.0,192.0,250.0,4279.0
East Siang,15.3.a,Number of VDRL tests conducted on males,Number tested,13.0,30.0,17.0,19.0,30.0,29.0,22.0,21.0,14.0,43.0,68.0,24.0,330.0
East Siang,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,56.0,55.0,56.0,18.0,26.0,41.0,27.0,35.0,8.0,60.0,42.0,65.0,489.0
East Siang,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,92.0,98.0,72.0,90.0,93.0,97.0,80.0,67.0,82.0,41.0,148.0,103.0,1063.0
East Siang,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,161.0,183.0,145.0,127.0,149.0,167.0,129.0,123.0,104.0,144.0,258.0,192.0,1882.0
East Siang,15.4.1,Number of blood smears examined for Malaria,TOTAL,963.0,1310.0,2418.0,2863.0,1796.0,1551.0,1120.0,951.0,715.0,571.0,704.0,910.0,15872.0
East Siang,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,29.0,35.0,52.0,55.0,36.0,35.0,22.0,17.0,24.0,14.0,19.0,17.0,355.0
East Siang,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,14.0,13.0,22.0,49.0,25.0,26.0,11.0,17.0,10.0,7.0,5.0,6.0,205.0
East Siang,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
East Siang,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
East Siang,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
East Siang,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
East Siang,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
East Siang,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
East Siang,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
East Siang,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
East Siang,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
East Siang,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
East Siang,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
East Siang,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
East Siang,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
East Siang,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
East Siang,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
East Siang,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
East Siang,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
East Siang,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
East Siang,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
East Siang,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
East Siang,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
East Siang,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
East Siang,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
East Siang,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
East Siang,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
East Siang,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
East Siang,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
East Siang,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
East Siang,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
East Siang,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
East Siang,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
East Siang,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
East Siang,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
East Siang,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
East Siang,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
East Siang,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
East Siang,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
East Siang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
East Siang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
East Siang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
East Siang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
East Siang,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
East Siang,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
East Siang,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
East Siang,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
East Siang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
East Siang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
East Siang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
East Siang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
East Siang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
East Siang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
East Siang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
East Siang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
East Siang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
East Siang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
East Siang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
East Siang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
East Siang,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
East Siang,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
East Siang,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
East Siang,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
East Siang,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
East Siang,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
East Siang,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
East Siang,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
East Siang,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
East Siang,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
East Siang,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
East Siang,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
East Siang,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
East Siang,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
East Siang,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
East Siang,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
East Siang,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
East Siang,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
East Siang,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
East Siang,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
East Siang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
East Siang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
East Siang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
East Siang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
East Siang,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
East Siang,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
East Siang,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
East Siang,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
East Siang,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
East Siang,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
East Siang,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
East Siang,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
East Siang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
East Siang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
East Siang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
East Siang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
East Siang,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
East Siang,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
East Siang,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
East Siang,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
East Siang,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
East Siang,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
East Siang,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
East Siang,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
East Siang,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
East Siang,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
East Siang,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
East Siang,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
East Siang,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
East Siang,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
East Siang,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
East Siang,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
East Siang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
East Siang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
East Siang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
East Siang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Siang,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
East Siang,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
East Siang,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
East Siang,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
East Siang,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
East Siang,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
East Siang,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
East Siang,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
East Siang,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
East Siang,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
East Siang,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
East Siang,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
East Siang,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
East Siang,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
East Siang,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
East Siang,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
East Siang,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
East Siang,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
East Siang,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
East Siang,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
East Siang,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
East Siang,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
East Siang,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
East Siang,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
East Siang,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
East Siang,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
East Siang,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
East Siang,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
East Siang,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
East Siang,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
East Siang,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
East Siang,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
East Siang,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
East Siang,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
East Siang,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
East Siang,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
East Siang,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
East Siang,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
East Siang,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
East Siang,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
East Siang,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
East Siang,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
East Siang,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
East Siang,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
East Siang,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
East Siang,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
East Siang,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
East Siang,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
East Siang,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
East Siang,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
East Siang,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
East Siang,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
East Siang,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
East Siang,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
East Siang,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
East Siang,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
East Siang,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
East Siang,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
East Siang,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
East Siang,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
East Siang,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
East Siang,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
East Siang,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
East Siang,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
East Siang,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
East Siang,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
East Siang,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
East Siang,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
East Siang,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
East Siang,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
East Siang,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
East Siang,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
East Siang,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
East Siang,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
East Siang,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
East Siang,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
East Siang,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
East Siang,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
East Siang,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
East Siang,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
East Siang,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
East Siang,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
East Siang,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
East Siang,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
East Siang,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
East Siang,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
East Siang,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
East Siang,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
East Siang,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
East Siang,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
East Siang,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
East Siang,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
East Siang,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
East Siang,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
East Siang,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
East Siang,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
East Siang,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
East Siang,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
East Siang,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
East Siang,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
East Siang,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
East Siang,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
East Siang,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
East Siang,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
East Siang,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
East Siang,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
East Siang,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
East Siang,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Kurung Kumey,1.1,Total number of pregnant women Registered for ANC,TOTAL,95.0,114.0,92.0,81.0,86.0,79.0,60.0,70.0,67.0,61.0,102.0,96.0,1003.0
Kurung Kumey,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,41.0,66.0,44.0,50.0,41.0,42.0,40.0,27.0,20.0,25.0,54.0,41.0,491.0
Kurung Kumey,1.2,Number of Pregnant women registered under JSY,TOTAL,86.0,86.0,67.0,60.0,54.0,57.0,46.0,51.0,33.0,43.0,83.0,86.0,752.0
Kurung Kumey,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,49.0,62.0,53.0,54.0,38.0,41.0,35.0,28.0,24.0,37.0,61.0,31.0,513.0
Kurung Kumey,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,89.0,80.0,59.0,50.0,48.0,45.0,42.0,49.0,37.0,32.0,60.0,64.0,655.0
Kurung Kumey,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,30.0,29.0,22.0,26.0,17.0,30.0,19.0,18.0,19.0,26.0,38.0,28.0,302.0
Kurung Kumey,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,95.0,112.0,92.0,74.0,69.0,77.0,57.0,57.0,61.0,55.0,100.0,87.0,936.0
Kurung Kumey,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0,0.0,0.0,3.0,2.0,8.0
Kurung Kumey,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,0.0,0.0,8.0,8.0,12.0,3.0,5.0,2.0,4.0,6.0,12.0,14.0,74.0
Kurung Kumey,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,1.8,Number of pregnancy test kits used at SC level,TOTAL,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,11.0,5.0,6.0,1.0,6.0,2.0,6.0,5.0,1.0,5.0,9.0,17.0,74.0
Kurung Kumey,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,18.0,17.0,12.0,2.0,12.0,17.0,2.0,2.0,1.0,1.0,4.0,7.0,95.0
Kurung Kumey,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,29.0,22.0,18.0,3.0,18.0,19.0,8.0,7.0,2.0,6.0,13.0,24.0,169.0
Kurung Kumey,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,27.0,18.0,17.0,1.0,16.0,14.0,8.0,5.0,2.0,6.0,13.0,22.0,149.0
Kurung Kumey,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,1.0,4.0
Kurung Kumey,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,38.0,27.0,34.0,25.0,28.0,33.0,35.0,28.0,26.0,30.0,44.0,41.0,389.0
Kurung Kumey,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,37.0,27.0,34.0,23.0,28.0,34.0,35.0,28.0,22.0,24.0,44.0,41.0,377.0
Kurung Kumey,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,13.0,20.0,11.0,10.0,18.0,53.0,7.0,16.0,22.0,40.0,101.0,48.0,359.0
Kurung Kumey,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,13.0,19.0,11.0,10.0,12.0,39.0,7.0,16.0,8.0,40.0,84.0,38.0,297.0
Kurung Kumey,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Kurung Kumey,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Kurung Kumey,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Kurung Kumey,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Kurung Kumey,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
Kurung Kumey,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kurung Kumey,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Kurung Kumey,4.1.1.a,Number of male live births,TOTAL,34.0,25.0,27.0,10.0,23.0,27.0,21.0,18.0,13.0,17.0,34.0,29.0,278.0
Kurung Kumey,4.1.1.b,Number of female live births,TOTAL,33.0,24.0,25.0,18.0,23.0,26.0,22.0,17.0,15.0,19.0,23.0,35.0,280.0
Kurung Kumey,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,67.0,49.0,52.0,28.0,46.0,53.0,43.0,35.0,28.0,36.0,57.0,64.0,558.0
Kurung Kumey,4.1.2,Number of still births,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Kurung Kumey,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,0.0,0.0,1.0,3.0,0.0,0.0,3.0,4.0,0.0,0.0,1.0,1.0,13.0
Kurung Kumey,4.2.1,Number of Newborns weighed at birth,TOTAL,67.0,49.0,52.0,28.0,46.0,53.0,42.0,35.0,28.0,36.0,57.0,64.0,557.0
Kurung Kumey,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Kurung Kumey,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,67.0,49.0,52.0,28.0,46.0,53.0,42.0,35.0,28.0,36.0,57.0,64.0,557.0
Kurung Kumey,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Kurung Kumey,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Kurung Kumey,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kurung Kumey,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Kurung Kumey,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Kurung Kumey,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,0.0,0.0,0.0,0.0,6.0,1.0,4.0,6.0,2.0,2.0,4.0,25.0
Kurung Kumey,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,0.0,0.0,4.0,0.0,6.0,1.0,4.0,4.0,2.0,4.0,8.0,33.0
Kurung Kumey,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,40.0,20.0,37.0,25.0,32.0,48.0,17.0,21.0,24.0,19.0,26.0,60.0,369.0
Kurung Kumey,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,14.0,9.0,22.0,35.0,32.0,45.0,23.0,17.0,22.0,19.0,17.0,48.0,303.0
Kurung Kumey,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,5.0
Kurung Kumey,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,3.0,0.0,1.0,0.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Kurung Kumey,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Kurung Kumey,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,3.0,0.0,1.0,0.0,4.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0
Kurung Kumey,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,2.0,2.0,2.0,0.0,2.0,1.0,0.0,1.0,0.0,0.0,0.0,2.0,12.0
Kurung Kumey,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,1.0,1.0,3.0,0.0,2.0,1.0,2.0,0.0,0.0,0.0,1.0,3.0,14.0
Kurung Kumey,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,3.0,3.0,5.0,0.0,4.0,2.0,2.0,1.0,0.0,0.0,1.0,5.0,26.0
Kurung Kumey,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Kurung Kumey,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kurung Kumey,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kurung Kumey,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Kurung Kumey,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kurung Kumey,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kurung Kumey,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Kurung Kumey,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kurung Kumey,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kurung Kumey,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Kurung Kumey,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kurung Kumey,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kurung Kumey,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,6.0,6.0,13.0,67.0,7.0,6.0,2.0,1.0,0.0,2.0,5.0,3.0,118.0
Kurung Kumey,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Kurung Kumey,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kurung Kumey,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,6.0,6.0,13.0,67.0,7.0,6.0,2.0,1.0,0.0,2.0,5.0,3.0,118.0
Kurung Kumey,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kurung Kumey,9.06,Number of IUCD removals,TOTAL,1.0,2.0,5.0,2.0,2.0,3.0,4.0,1.0,0.0,0.0,1.0,42.0,63.0
Kurung Kumey,9.07,Number of Oral Pills cycles distributed,TOTAL,69.0,51.0,68.0,280.0,93.0,76.0,44.0,100.0,94.0,72.0,123.0,132.0,1202.0
Kurung Kumey,9.08,Number of Condom pieces distributed,TOTAL,112.0,137.0,87.0,209.0,51.0,72.0,27.0,88.0,68.0,38.0,110.0,67.0,1066.0
Kurung Kumey,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,1.0,0.0,11.0
Kurung Kumey,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,3.0,1.0,19.0,5.0,31.0
Kurung Kumey,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,1.0,,,,,,,,,,-1.0
Kurung Kumey,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,65.0,87.0,88.0,79.0,66.0,60.0,67.0,48.0,43.0,47.0,84.0,77.0,811.0
Kurung Kumey,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,80.0,76.0,77.0,69.0,68.0,81.0,64.0,47.0,43.0,55.0,80.0,72.0,812.0
Kurung Kumey,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,71.0,58.0,57.0,51.0,56.0,58.0,59.0,41.0,49.0,51.0,54.0,69.0,674.0
Kurung Kumey,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,71.0,52.0,56.0,39.0,44.0,47.0,65.0,53.0,49.0,50.0,54.0,57.0,637.0
Kurung Kumey,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,44.0,19.0,12.0,17.0,25.0,26.0,27.0,22.0,21.0,23.0,25.0,29.0,290.0
Kurung Kumey,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,80.0,76.0,77.0,70.0,68.0,81.0,64.0,47.0,43.0,55.0,81.0,72.0,814.0
Kurung Kumey,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,70.0,58.0,57.0,51.0,56.0,58.0,59.0,40.0,49.0,50.0,54.0,69.0,671.0
Kurung Kumey,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,70.0,52.0,55.0,37.0,44.0,47.0,65.0,53.0,44.0,50.0,54.0,66.0,637.0
Kurung Kumey,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2.0,0.0,0.0,0.0,0.0,,0.0,0.0,4.0,1.0,0.0,6.0,13.0
Kurung Kumey,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,79.0,73.0,73.0,67.0,63.0,76.0,53.0,47.0,45.0,46.0,76.0,69.0,767.0
Kurung Kumey,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,69.0,59.0,55.0,47.0,58.0,52.0,60.0,45.0,43.0,42.0,54.0,70.0,654.0
Kurung Kumey,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,72.0,51.0,55.0,40.0,49.0,48.0,66.0,56.0,57.0,41.0,52.0,54.0,641.0
Kurung Kumey,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,46.0,60.0,61.0,49.0,55.0,55.0,43.0,59.0,34.0,39.0,56.0,61.0,618.0
Kurung Kumey,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,10.0,17.0,25.0,9.0,18.0,,19.0,18.0,21.0,23.0,21.0,28.0,209.0
Kurung Kumey,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,3.0,,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Kurung Kumey,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,29.0,38.0,28.0,27.0,28.0,27.0,23.0,36.0,17.0,16.0,26.0,30.0,325.0
Kurung Kumey,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,19.0,22.0,33.0,20.0,26.0,31.0,20.0,23.0,19.0,23.0,31.0,31.0,298.0
Kurung Kumey,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,48.0,60.0,61.0,47.0,54.0,58.0,43.0,59.0,36.0,39.0,57.0,61.0,623.0
Kurung Kumey,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,58.0,43.0,47.0,41.0,43.0,33.0,24.0,37.0,33.0,32.0,32.0,48.0,471.0
Kurung Kumey,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,58.0,43.0,48.0,41.0,43.0,33.0,24.0,37.0,33.0,32.0,32.0,48.0,472.0
Kurung Kumey,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,13.0,9.0,12.0,12.0,6.0,9.0,8.0,8.0,10.0,10.0,12.0,16.0,125.0
Kurung Kumey,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,11.0,10.0,14.0,4.0,4.0,5.0,4.0,12.0,5.0,18.0,6.0,13.0,106.0
Kurung Kumey,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,24.0,19.0,26.0,16.0,10.0,14.0,12.0,20.0,15.0,28.0,18.0,29.0,231.0
Kurung Kumey,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,12.0,13.0,9.0,9.0,3.0,4.0,5.0,4.0,11.0,10.0,11.0,8.0,99.0
Kurung Kumey,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,27.0,19.0,19.0,16.0,27.0,2.0,13.0,10.0,26.0,19.0,24.0,25.0,227.0
Kurung Kumey,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,34.0,31.0,29.0,31.0,18.0,16.0,13.0,17.0,40.0,16.0,32.0,34.0,311.0
Kurung Kumey,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,34.0,33.0,34.0,29.0,35.0,31.0,37.0,34.0,31.0,41.0,57.0,55.0,451.0
Kurung Kumey,10.4.2,Number of Immunisation sessions held during the month,TOTAL,32.0,30.0,31.0,29.0,33.0,25.0,38.0,31.0,27.0,43.0,60.0,47.0,426.0
Kurung Kumey,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,25.0,24.0,29.0,33.0,31.0,21.0,35.0,27.0,24.0,33.0,57.0,42.0,381.0
Kurung Kumey,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,10.0,18.0,20.0,15.0,8.0,59.0,31.0,61.0,33.0,44.0,64.0,58.0,421.0
Kurung Kumey,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,12.0,5.0,13.0,11.0,4.0,7.0,21.0,31.0,34.0,27.0,11.0,42.0,218.0
Kurung Kumey,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,9.0,16.0,5.0,2.0,1.0,4.0,1.0,5.0,15.0,15.0,11.0,29.0,113.0
Kurung Kumey,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,2.0
Kurung Kumey,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,148.0,141.0,151.0,179.0,203.0,226.0,76.0,53.0,53.0,65.0,108.0,83.0,1486.0
Kurung Kumey,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,27.0,11.0,3.0,50.0,13.0,30.0,1.0,1.0,5.0,1.0,36.0,0.0,178.0
Kurung Kumey,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,53.0,27.0,31.0,24.0,17.0,35.0,19.0,3.0,3.0,5.0,30.0,6.0,253.0
Kurung Kumey,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,1.0,,,,,1.0,,1.0,1.0,,-1.0
Kurung Kumey,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Kurung Kumey,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,9.0,7.0,11.0,14.0,8.0,8.0,13.0,10.0,10.0,12.0,26.0,20.0,-1.0
Kurung Kumey,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,4.0,3.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,-1.0
Kurung Kumey,14.05,Number of RKS meetings held during the month,TOTAL,2.0,1.0,0.0,0.0,2.0,4.0,1.0,1.0,0.0,1.0,1.0,2.0,15.0
Kurung Kumey,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,4.0,4.0,4.0,4.0,5.0,5.0,4.0,5.0,5.0,5.0,6.0,5.0,-1.0
Kurung Kumey,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,19.0,41.0,30.0,33.0,41.0,35.0,27.0,28.0,18.0,28.0,34.0,35.0,369.0
Kurung Kumey,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,1.0,,,-1.0
Kurung Kumey,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,9.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Kurung Kumey,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,35.0,33.0,28.0,74.0,77.0,32.0,28.0,28.0,14.0,28.0,20.0,16.0,413.0
Kurung Kumey,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,32.0,36.0,29.0,44.0,26.0,35.0,39.0,41.0,22.0,48.0,23.0,24.0,399.0
Kurung Kumey,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,39.0,24.0,24.0,73.0,56.0,41.0,38.0,10.0,10.0,21.0,23.0,13.0,372.0
Kurung Kumey,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,43.0,44.0,42.0,100.0,82.0,83.0,75.0,38.0,32.0,36.0,47.0,27.0,649.0
Kurung Kumey,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,74.0,57.0,52.0,147.0,133.0,73.0,66.0,38.0,24.0,49.0,43.0,29.0,785.0
Kurung Kumey,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,75.0,80.0,71.0,144.0,108.0,118.0,114.0,79.0,54.0,84.0,70.0,51.0,1048.0
Kurung Kumey,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0,0.0,0.0,0.0,0.0,9.0
Kurung Kumey,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0,0.0,0.0,0.0,0.0,9.0
Kurung Kumey,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18.0,0.0,0.0,0.0,0.0,18.0
Kurung Kumey,14.11,In-Patient Head Count at midnight,TOTAL,57.0,59.0,59.0,50.0,97.0,31.0,30.0,42.0,24.0,10.0,37.0,0.0,496.0
Kurung Kumey,14.12.1,OPD attendance (All),TOTAL,3579.0,2883.0,2797.0,4023.0,4200.0,3607.0,2704.0,2502.0,2149.0,2301.0,2636.0,2430.0,35811.0
Kurung Kumey,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,96.0,89.0,73.0,99.0,98.0,113.0,45.0,104.0,96.0,97.0,96.0,110.0,1116.0
Kurung Kumey,14.14.a,Number of patients given AYUSH treatment,TOTAL,65.0,103.0,78.0,179.0,218.0,200.0,273.0,269.0,204.0,222.0,228.0,389.0,2428.0
Kurung Kumey,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,8.0,5.0,0.0,10.0,5.0,15.0,10.0,7.0,0.0,28.0,7.0,6.0,101.0
Kurung Kumey,14.14.c,Number of Adolescents counselled,TOTAL,2.0,5.0,2.0,0.0,4.0,14.0,0.0,3.0,3.0,16.0,12.0,11.0,72.0
Kurung Kumey,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,160.0,80.0,145.0,150.0,233.0,82.0,109.0,133.0,110.0,72.0,114.0,124.0,1512.0
Kurung Kumey,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,0.0,0.0,1.0,1.0,3.0,8.0,0.0,1.0,1.0,0.0,0.0,4.0,19.0
Kurung Kumey,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1.0,0.0,0.0,4.0,1.0,2.0,0.0,0.0,1.0,0.0,0.0,1.0,10.0
Kurung Kumey,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,0.0,0.0,0.0,7.0,7.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,24.0
Kurung Kumey,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,13.0,0.0,0.0,20.0,10.0,14.0,16.0,4.0,6.0,3.0,6.0,17.0,109.0
Kurung Kumey,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,14.0,0.0,0.0,31.0,18.0,16.0,16.0,4.0,17.0,3.0,6.0,18.0,143.0
Kurung Kumey,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,15.2,Number of Widal tests conducted,Number tested,196.0,80.0,150.0,347.0,305.0,177.0,112.0,148.0,76.0,43.0,48.0,46.0,1728.0
Kurung Kumey,15.3.a,Number of VDRL tests conducted on males,Number tested,10.0,0.0,0.0,2.0,0.0,3.0,1.0,0.0,0.0,0.0,0.0,1.0,17.0
Kurung Kumey,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,2.0,1.0,0.0,3.0,6.0,0.0,1.0,0.0,0.0,0.0,1.0,4.0,18.0
Kurung Kumey,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,43.0,12.0,20.0,26.0,45.0,20.0,23.0,17.0,21.0,12.0,24.0,35.0,298.0
Kurung Kumey,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,55.0,13.0,20.0,31.0,51.0,23.0,25.0,17.0,21.0,12.0,25.0,40.0,333.0
Kurung Kumey,15.4.1,Number of blood smears examined for Malaria,TOTAL,172.0,133.0,148.0,376.0,413.0,358.0,357.0,362.0,133.0,65.0,110.0,131.0,2758.0
Kurung Kumey,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,14.0,4.0,0.0,0.0,17.0,8.0,5.0,2.0,3.0,1.0,0.0,1.0,55.0
Kurung Kumey,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,12.0,1.0,2.0,0.0,5.0,1.0,2.0,0.0,0.0,0.0,0.0,0.0,23.0
Kurung Kumey,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kurung Kumey,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Kurung Kumey,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kurung Kumey,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kurung Kumey,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Kurung Kumey,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Kurung Kumey,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Kurung Kumey,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Kurung Kumey,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kurung Kumey,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Kurung Kumey,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kurung Kumey,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kurung Kumey,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kurung Kumey,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Kurung Kumey,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kurung Kumey,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kurung Kumey,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kurung Kumey,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Kurung Kumey,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kurung Kumey,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kurung Kumey,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kurung Kumey,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Kurung Kumey,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kurung Kumey,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kurung Kumey,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kurung Kumey,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Kurung Kumey,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kurung Kumey,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kurung Kumey,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kurung Kumey,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Kurung Kumey,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kurung Kumey,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kurung Kumey,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kurung Kumey,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Kurung Kumey,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kurung Kumey,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kurung Kumey,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kurung Kumey,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kurung Kumey,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kurung Kumey,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kurung Kumey,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kurung Kumey,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kurung Kumey,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kurung Kumey,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kurung Kumey,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kurung Kumey,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kurung Kumey,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kurung Kumey,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kurung Kumey,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kurung Kumey,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kurung Kumey,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kurung Kumey,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kurung Kumey,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kurung Kumey,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kurung Kumey,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kurung Kumey,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kurung Kumey,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Kurung Kumey,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Kurung Kumey,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Kurung Kumey,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Kurung Kumey,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Kurung Kumey,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Kurung Kumey,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Kurung Kumey,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Kurung Kumey,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Kurung Kumey,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Kurung Kumey,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Kurung Kumey,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Kurung Kumey,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Kurung Kumey,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Kurung Kumey,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Kurung Kumey,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Kurung Kumey,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Kurung Kumey,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Kurung Kumey,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Kurung Kumey,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Kurung Kumey,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Kurung Kumey,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Kurung Kumey,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Kurung Kumey,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Kurung Kumey,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Kurung Kumey,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Kurung Kumey,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Kurung Kumey,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Kurung Kumey,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Kurung Kumey,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Kurung Kumey,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Kurung Kumey,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Kurung Kumey,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Kurung Kumey,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Kurung Kumey,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Kurung Kumey,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Kurung Kumey,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Kurung Kumey,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Kurung Kumey,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Kurung Kumey,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Kurung Kumey,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Kurung Kumey,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Kurung Kumey,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Kurung Kumey,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Kurung Kumey,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Kurung Kumey,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Kurung Kumey,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Kurung Kumey,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Kurung Kumey,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Kurung Kumey,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Kurung Kumey,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Kurung Kumey,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Kurung Kumey,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Kurung Kumey,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Kurung Kumey,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Kurung Kumey,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Kurung Kumey,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kurung Kumey,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Kurung Kumey,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Kurung Kumey,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kurung Kumey,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Kurung Kumey,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Kurung Kumey,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kurung Kumey,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Kurung Kumey,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Kurung Kumey,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kurung Kumey,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Kurung Kumey,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Kurung Kumey,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kurung Kumey,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Kurung Kumey,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kurung Kumey,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kurung Kumey,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Kurung Kumey,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kurung Kumey,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kurung Kumey,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Kurung Kumey,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kurung Kumey,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kurung Kumey,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Kurung Kumey,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kurung Kumey,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kurung Kumey,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Kurung Kumey,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Kurung Kumey,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Kurung Kumey,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Kurung Kumey,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Kurung Kumey,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Kurung Kumey,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Kurung Kumey,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Kurung Kumey,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Kurung Kumey,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Kurung Kumey,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Kurung Kumey,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Kurung Kumey,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Kurung Kumey,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Kurung Kumey,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Kurung Kumey,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Kurung Kumey,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Kurung Kumey,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Kurung Kumey,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Kurung Kumey,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Kurung Kumey,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Kurung Kumey,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Kurung Kumey,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Kurung Kumey,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Kurung Kumey,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Kurung Kumey,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Kurung Kumey,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Kurung Kumey,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Kurung Kumey,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Kurung Kumey,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Kurung Kumey,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Kurung Kumey,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Kurung Kumey,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Kurung Kumey,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Kurung Kumey,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Kurung Kumey,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Kurung Kumey,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Kurung Kumey,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Kurung Kumey,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Kurung Kumey,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Kurung Kumey,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Kurung Kumey,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Kurung Kumey,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Kurung Kumey,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Kurung Kumey,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Kurung Kumey,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Kurung Kumey,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Kurung Kumey,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Kurung Kumey,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Kurung Kumey,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Kurung Kumey,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Lohit,1.1,Total number of pregnant women Registered for ANC,TOTAL,319.0,377.0,362.0,415.0,351.0,410.0,300.0,290.0,226.0,224.0,246.0,307.0,3827.0
Lohit,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,139.0,153.0,131.0,134.0,89.0,110.0,76.0,59.0,53.0,77.0,70.0,130.0,1221.0
Lohit,1.2,Number of Pregnant women registered under JSY,TOTAL,177.0,238.0,197.0,226.0,235.0,183.0,116.0,190.0,156.0,107.0,171.0,248.0,2244.0
Lohit,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,141.0,131.0,142.0,216.0,172.0,196.0,141.0,150.0,124.0,114.0,104.0,98.0,1729.0
Lohit,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,192.0,258.0,189.0,198.0,199.0,207.0,174.0,202.0,162.0,164.0,182.0,249.0,2376.0
Lohit,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,156.0,198.0,236.0,213.0,185.0,170.0,219.0,166.0,138.0,157.0,108.0,179.0,2125.0
Lohit,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,85.0,123.0,111.0,60.0,108.0,103.0,133.0,120.0,65.0,105.0,35.0,64.0,1112.0
Lohit,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,14.0,3.0,5.0,3.0,3.0,1.0,0.0,0.0,4.0,0.0,2.0,4.0,39.0
Lohit,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Lohit,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,78.0,66.0,82.0,59.0,52.0,80.0,92.0,104.0,18.0,67.0,87.0,76.0,861.0
Lohit,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,1.0,1.0,10.0,9.0,12.0,11.0,9.0,0.0,1.0,3.0,4.0,4.0,65.0
Lohit,1.8,Number of pregnancy test kits used at SC level,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,3.0,2.0,0.0,3.0,10.0
Lohit,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,0.0,3.0,0.0,2.0,1.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,8.0
Lohit,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1.0,0.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,6.0
Lohit,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1.0,3.0,2.0,3.0,1.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0,14.0
Lohit,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,1.0,3.0,1.0,3.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,11.0
Lohit,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Lohit,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,104.0,97.0,99.0,101.0,124.0,125.0,133.0,126.0,134.0,153.0,105.0,105.0,1406.0
Lohit,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,104.0,92.0,93.0,97.0,117.0,115.0,124.0,104.0,134.0,129.0,89.0,94.0,1292.0
Lohit,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,7.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,1.0,14.0
Lohit,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,1.0,9.0
Lohit,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Lohit,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Lohit,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Lohit,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Lohit,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,0.0,2.0,0.0,2.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Lohit,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lohit,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,2.0,0.0,2.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Lohit,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Lohit,4.1.1.a,Number of male live births,TOTAL,57.0,47.0,52.0,54.0,70.0,62.0,67.0,62.0,63.0,91.0,56.0,48.0,729.0
Lohit,4.1.1.b,Number of female live births,TOTAL,48.0,51.0,47.0,50.0,54.0,62.0,65.0,63.0,71.0,61.0,48.0,58.0,678.0
Lohit,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,105.0,98.0,99.0,104.0,124.0,124.0,132.0,125.0,134.0,152.0,104.0,106.0,1407.0
Lohit,4.1.2,Number of still births,TOTAL,0.0,2.0,2.0,0.0,1.0,1.0,1.0,3.0,0.0,1.0,1.0,1.0,13.0
Lohit,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,38.0,51.0,39.0,21.0,22.0,13.0,6.0,6.0,13.0,18.0,16.0,34.0,277.0
Lohit,4.2.1,Number of Newborns weighed at birth,TOTAL,105.0,98.0,99.0,104.0,124.0,124.0,132.0,125.0,134.0,152.0,104.0,106.0,1407.0
Lohit,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,6.0,7.0,5.0,5.0,11.0,7.0,9.0,6.0,6.0,11.0,7.0,4.0,84.0
Lohit,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,105.0,93.0,99.0,104.0,124.0,123.0,128.0,119.0,134.0,152.0,104.0,106.0,1391.0
Lohit,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,1.0,1.0,3.0,6.0,0.0,3.0,0.0,2.0,2.0,0.0,0.0,18.0
Lohit,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,3.0,0.0,4.0
Lohit,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,1.0,0.0,2.0,0.0,2.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Lohit,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lohit,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,1.0,1.0,3.0,3.0,8.0,4.0,3.0,0.0,2.0,2.0,3.0,0.0,30.0
Lohit,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Lohit,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,1.0,0.0,2.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,7.0
Lohit,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
Lohit,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,1.0,1.0,1.0,3.0,6.0,0.0,3.0,0.0,2.0,0.0,0.0,0.0,17.0
Lohit,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,10.0,21.0,8.0,15.0,15.0,14.0,11.0,26.0,16.0,28.0,64.0,57.0,285.0
Lohit,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,5.0,5.0,2.0,3.0,5.0,4.0,5.0,5.0,0.0,0.0,24.0,13.0,71.0
Lohit,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,6.0,5.0,13.0
Lohit,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,25.0,42.0,32.0,17.0,22.0,13.0,3.0,5.0,11.0,16.0,16.0,28.0,230.0
Lohit,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,13.0,9.0,7.0,4.0,0.0,0.0,3.0,0.0,0.0,2.0,0.0,6.0,44.0
Lohit,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,38.0,51.0,39.0,21.0,22.0,13.0,6.0,5.0,11.0,18.0,16.0,34.0,274.0
Lohit,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,4.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,8.0
Lohit,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,6.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0,5.0,26.0
Lohit,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,10.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0,7.0,34.0
Lohit,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lohit,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Lohit,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0
Lohit,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lohit,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0
Lohit,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Lohit,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Lohit,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lohit,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Lohit,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Lohit,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lohit,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Lohit,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,4.0,1.0,8.0,4.0,4.0,6.0,5.0,6.0,7.0,5.0,3.0,4.0,57.0
Lohit,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,9.0,20.0,12.0,12.0,7.0,3.0,5.0,2.0,3.0,1.0,4.0,4.0,82.0
Lohit,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,6.0,8.0,6.0,7.0,7.0,3.0,5.0,6.0,2.0,8.0,10.0,4.0,72.0
Lohit,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lohit,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,19.0,29.0,26.0,23.0,18.0,12.0,15.0,14.0,12.0,14.0,17.0,12.0,211.0
Lohit,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,3.0,1.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,2.0,14.0
Lohit,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Lohit,9.06,Number of IUCD removals,TOTAL,9.0,21.0,11.0,4.0,4.0,7.0,4.0,3.0,0.0,3.0,3.0,12.0,81.0
Lohit,9.07,Number of Oral Pills cycles distributed,TOTAL,133.0,217.0,104.0,145.0,135.0,111.0,73.0,129.0,86.0,123.0,130.0,247.0,1633.0
Lohit,9.08,Number of Condom pieces distributed,TOTAL,366.0,204.0,529.0,484.0,540.0,378.0,233.0,327.0,362.0,423.0,412.0,263.0,4521.0
Lohit,9.09,Number of Centchroman (weekly) pills given,TOTAL,7.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,17.0
Lohit,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,28.0,36.0,66.0,75.0,40.0,48.0,145.0,57.0,40.0,60.0,25.0,50.0,670.0
Lohit,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,1.0,,1.0,,1.0,,,1.0,1.0,1.0,1.0,-1.0
Lohit,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,218.0,214.0,217.0,212.0,240.0,270.0,256.0,212.0,237.0,246.0,196.0,259.0,2777.0
Lohit,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,249.0,199.0,196.0,175.0,201.0,230.0,241.0,210.0,232.0,261.0,184.0,290.0,2668.0
Lohit,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,310.0,213.0,172.0,141.0,177.0,149.0,196.0,196.0,196.0,167.0,189.0,199.0,2305.0
Lohit,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,233.0,249.0,191.0,140.0,166.0,147.0,148.0,166.0,169.0,172.0,117.0,198.0,2096.0
Lohit,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,128.0,112.0,157.0,134.0,160.0,151.0,168.0,115.0,128.0,204.0,145.0,128.0,1730.0
Lohit,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,249.0,199.0,196.0,175.0,201.0,230.0,241.0,210.0,232.0,261.0,184.0,290.0,2668.0
Lohit,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,310.0,213.0,172.0,141.0,177.0,149.0,196.0,196.0,196.0,167.0,189.0,199.0,2305.0
Lohit,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,233.0,249.0,191.0,140.0,166.0,147.0,148.0,166.0,169.0,172.0,117.0,198.0,2096.0
Lohit,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,36.0,105.0,119.0,102.0,118.0,98.0,101.0,71.0,64.0,73.0,66.0,78.0,1031.0
Lohit,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,178.0,200.0,198.0,175.0,199.0,224.0,226.0,217.0,179.0,251.0,169.0,271.0,2487.0
Lohit,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,218.0,214.0,166.0,136.0,178.0,142.0,186.0,199.0,195.0,162.0,173.0,184.0,2153.0
Lohit,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,162.0,250.0,194.0,141.0,159.0,151.0,149.0,158.0,157.0,170.0,108.0,180.0,1979.0
Lohit,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,90.0,97.0,243.0,196.0,165.0,175.0,131.0,116.0,128.0,124.0,107.0,110.0,1682.0
Lohit,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,62.0,57.0,113.0,84.0,84.0,65.0,90.0,55.0,63.0,87.0,75.0,88.0,923.0
Lohit,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,14.0,37.0,115.0,210.0,0.0,0.0,0.0,55.0,102.0,38.0,84.0,655.0
Lohit,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,55.0,55.0,135.0,109.0,97.0,102.0,76.0,60.0,72.0,67.0,57.0,55.0,940.0
Lohit,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,35.0,42.0,108.0,85.0,68.0,65.0,52.0,56.0,56.0,54.0,45.0,47.0,713.0
Lohit,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,90.0,97.0,243.0,194.0,165.0,167.0,128.0,116.0,128.0,121.0,102.0,102.0,1653.0
Lohit,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,142.0,105.0,128.0,123.0,111.0,98.0,122.0,84.0,81.0,99.0,77.0,111.0,1281.0
Lohit,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,142.0,105.0,128.0,123.0,111.0,98.0,122.0,84.0,81.0,99.0,77.0,111.0,1281.0
Lohit,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,35.0,33.0,70.0,46.0,43.0,34.0,57.0,24.0,32.0,55.0,27.0,36.0,492.0
Lohit,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,27.0,24.0,43.0,37.0,41.0,31.0,39.0,31.0,31.0,30.0,33.0,39.0,406.0
Lohit,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,62.0,57.0,113.0,83.0,84.0,65.0,96.0,55.0,63.0,85.0,60.0,75.0,898.0
Lohit,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,68.0,55.0,21.0,38.0,44.0,41.0,37.0,39.0,43.0,56.0,22.0,25.0,489.0
Lohit,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,45.0,73.0,26.0,57.0,46.0,46.0,35.0,42.0,46.0,50.0,26.0,29.0,521.0
Lohit,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,29.0,79.0,37.0,62.0,50.0,38.0,55.0,41.0,38.0,34.0,15.0,31.0,509.0
Lohit,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,72.0,69.0,63.0,57.0,72.0,65.0,67.0,67.0,57.0,59.0,58.0,69.0,775.0
Lohit,10.4.2,Number of Immunisation sessions held during the month,TOTAL,70.0,64.0,61.0,55.0,70.0,61.0,60.0,62.0,55.0,56.0,57.0,55.0,726.0
Lohit,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,48.0,37.0,44.0,40.0,52.0,39.0,45.0,37.0,34.0,29.0,35.0,34.0,474.0
Lohit,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,19.0,52.0,94.0,143.0,0.0,16.0,0.0,30.0,72.0,38.0,45.0,509.0
Lohit,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,43.0,24.0,88.0,43.0,2.0,0.0,12.0,108.0,97.0,115.0,97.0,111.0,740.0
Lohit,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,3.0,31.0,30.0,24.0,0.0,0.0,1.0,55.0,27.0,68.0,48.0,48.0,335.0
Lohit,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0,27.0,40.0,14.0,11.0,112.0
Lohit,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,9.0,0.0,0.0,0.0,0.0,0.0,9.0
Lohit,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,24.0,4.0,0.0,2.0,0.0,20.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0
Lohit,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,187.0,68.0,140.0,232.0,91.0,62.0,86.0,72.0,49.0,64.0,75.0,114.0,1240.0
Lohit,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,8.0,0.0,3.0,4.0,5.0,2.0,13.0,1.0,0.0,3.0,0.0,0.0,39.0
Lohit,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18.0,18.0
Lohit,13.1,Number of Patients operated for cataract,TOTAL,4.0,6.0,3.0,3.0,2.0,0.0,0.0,43.0,4.0,0.0,1.0,2.0,68.0
Lohit,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,4.0,6.0,3.0,3.0,2.0,0.0,0.0,41.0,1.0,0.0,1.0,2.0,63.0
Lohit,13.3,Number of School children detected with Refractive errors,TOTAL,48.0,60.0,165.0,23.0,36.0,17.0,24.0,166.0,55.0,38.0,72.0,61.0,765.0
Lohit,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,8.0,2.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,12.0
Lohit,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,2.0,2.0,-1.0
Lohit,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,4.0,4.0,4.0,3.0,3.0,3.0,4.0,3.0,3.0,5.0,3.0,4.0,-1.0
Lohit,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.0,9.0,-1.0
Lohit,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,3.0,4.0,4.0,3.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,-1.0
Lohit,14.05,Number of RKS meetings held during the month,TOTAL,1.0,2.0,1.0,2.0,3.0,2.0,5.0,3.0,2.0,2.0,3.0,4.0,30.0
Lohit,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,10.0,10.0,9.0,9.0,10.0,10.0,10.0,10.0,9.0,8.0,8.0,9.0,-1.0
Lohit,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,31.0,20.0,9.0,21.0,24.0,25.0,29.0,28.0,18.0,22.0,9.0,11.0,247.0
Lohit,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,1.0,,,-1.0
Lohit,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,-1.0
Lohit,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,17.0,12.0,17.0,30.0,20.0,21.0,36.0,23.0,20.0,8.0,16.0,26.0,246.0
Lohit,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,73.0,82.0,83.0,125.0,89.0,156.0,92.0,64.0,60.0,56.0,69.0,84.0,1033.0
Lohit,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,14.0,16.0,11.0,25.0,14.0,15.0,14.0,18.0,16.0,10.0,17.0,18.0,188.0
Lohit,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,161.0,149.0,158.0,178.0,197.0,103.0,179.0,141.0,155.0,152.0,128.0,121.0,1822.0
Lohit,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,31.0,28.0,28.0,55.0,34.0,36.0,50.0,41.0,36.0,18.0,33.0,44.0,434.0
Lohit,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,234.0,231.0,241.0,303.0,286.0,259.0,271.0,205.0,215.0,208.0,197.0,205.0,2855.0
Lohit,14.10.2.a,Number of death cases of Inpatient males,TOTAL,6.0,5.0,2.0,4.0,2.0,1.0,2.0,5.0,2.0,3.0,3.0,0.0,35.0
Lohit,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,1.0,3.0,3.0,0.0,1.0,2.0,2.0,3.0,1.0,3.0,2.0,21.0
Lohit,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,6.0,6.0,5.0,7.0,2.0,2.0,4.0,7.0,5.0,4.0,6.0,2.0,56.0
Lohit,14.11,In-Patient Head Count at midnight,TOTAL,259.0,181.0,210.0,268.0,247.0,263.0,171.0,167.0,160.0,164.0,162.0,159.0,2411.0
Lohit,14.12.1,OPD attendance (All),TOTAL,10733.0,10708.0,15607.0,19671.0,12173.0,11651.0,11679.0,9698.0,9324.0,9062.0,8378.0,10238.0,138922.0
Lohit,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,0.0,2.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Lohit,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,11.0,148.0,257.0,216.0,232.0,90.0,173.0,102.0,30.0,70.0,147.0,91.0,1567.0
Lohit,14.14.a,Number of patients given AYUSH treatment,TOTAL,1350.0,616.0,960.0,1085.0,901.0,785.0,696.0,608.0,473.0,440.0,421.0,750.0,9085.0
Lohit,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,302.0,504.0,422.0,398.0,364.0,209.0,383.0,367.0,368.0,59.0,378.0,214.0,3968.0
Lohit,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,401.0,322.0,312.0,417.0,423.0,475.0,340.0,282.0,157.0,88.0,291.0,291.0,3799.0
Lohit,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,13.0,21.0,15.0,31.0,38.0,45.0,31.0,22.0,7.0,9.0,12.0,18.0,262.0
Lohit,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,5.0,9.0,2.0,0.0,0.0,0.0,0.0,1.0,9.0,2.0,20.0,43.0,91.0
Lohit,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,13.0,22.0,43.0,15.0,0.0,0.0,0.0,0.0,0.0,1.0,63.0,96.0,253.0
Lohit,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,96.0,44.0,62.0,27.0,30.0,25.0,24.0,35.0,5.0,56.0,89.0,104.0,597.0
Lohit,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Lohit,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,114.0,75.0,107.0,42.0,30.0,25.0,24.0,36.0,14.0,59.0,172.0,243.0,941.0
Lohit,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Lohit,15.2,Number of Widal tests conducted,Number tested,134.0,270.0,169.0,315.0,173.0,354.0,294.0,223.0,81.0,141.0,141.0,120.0,2415.0
Lohit,15.3.a,Number of VDRL tests conducted on males,Number tested,6.0,0.0,18.0,9.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,34.0
Lohit,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,2.0,13.0,24.0,0.0,3.0,9.0,0.0,4.0,2.0,1.0,0.0,58.0
Lohit,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,50.0,105.0,14.0,128.0,46.0,75.0,58.0,65.0,46.0,55.0,59.0,68.0,769.0
Lohit,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,56.0,107.0,45.0,161.0,46.0,78.0,67.0,66.0,50.0,57.0,60.0,68.0,861.0
Lohit,15.4.1,Number of blood smears examined for Malaria,TOTAL,913.0,1187.0,1467.0,1988.0,1924.0,1444.0,1271.0,942.0,721.0,554.0,534.0,494.0,13439.0
Lohit,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,20.0,20.0,26.0,53.0,42.0,44.0,24.0,13.0,25.0,18.0,13.0,7.0,305.0
Lohit,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,20.0,14.0,24.0,53.0,54.0,37.0,33.0,22.0,29.0,16.0,9.0,2.0,313.0
Lohit,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,2500.0,1300.0,2600.0,2400.0,2000.0,3850.0,3150.0,2500.0,2300.0,1700.0,1200.0,3000.0,28500.0
Lohit,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,2000.0,0.0,0.0,2500.0,0.0,500.0,0.0,0.0,0.0,2000.0,0.0,7000.0
Lohit,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lohit,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1200.0,700.0,200.0,400.0,650.0,700.0,1150.0,200.0,600.0,500.0,200.0,700.0,7200.0
Lohit,16.1.1,Stock position of DPT vaccines,5. Total Stock,1300.0,2600.0,2400.0,2000.0,3850.0,3150.0,2500.0,2300.0,1700.0,1200.0,3000.0,2300.0,28300.0
Lohit,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Lohit,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Lohit,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Lohit,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Lohit,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,600.0,0.0,2200.0,1500.0,1100.0,3400.0,2000.0,1500.0,0.0,3500.0,3800.0,4300.0,23900.0
Lohit,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,3000.0,0.0,0.0,3000.0,0.0,0.0,0.0,5000.0,30000.0,29500.0,0.0,70500.0
Lohit,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,1500.0,,,,,1500.0
Lohit,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,600.0,800.0,700.0,400.0,700.0,1400.0,500.0,0.0,1500.0,29700.0,29000.0,800.0,66100.0
Lohit,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,2200.0,1500.0,1100.0,3400.0,2000.0,1500.0,0.0,3500.0,3800.0,4300.0,3500.0,26800.0
Lohit,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,750.0,50.0,2550.0,2300.0,1800.0,3600.0,2800.0,2300.0,2050.0,1550.0,1200.0,500.0,21450.0
Lohit,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,3000.0,0.0,0.0,2500.0,0.0,500.0,0.0,0.0,0.0,0.0,0.0,6000.0
Lohit,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lohit,16.1.3,Stock position of TT vaccines,4. Stock Distributed,700.0,500.0,250.0,500.0,700.0,800.0,1000.0,250.0,500.0,350.0,700.0,500.0,6750.0
Lohit,16.1.3,Stock position of TT vaccines,5. Total Stock,50.0,2550.0,2300.0,1800.0,3600.0,2800.0,2300.0,2050.0,1550.0,1200.0,500.0,0.0,20700.0
Lohit,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lohit,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,700.0,200.0,1750.0,1500.0,1300.0,1800.0,1100.0,1200.0,950.0,1950.0,1750.0,1500.0,15700.0
Lohit,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,2000.0,0.0,0.0,1000.0,0.0,500.0,0.0,2000.0,0.0,0.0,0.0,5500.0
Lohit,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lohit,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,500.0,450.0,250.0,200.0,500.0,700.0,400.0,250.0,1000.0,200.0,250.0,900.0,5600.0
Lohit,16.1.5,Stock position of BCG vaccines,5. Total Stock,200.0,1750.0,1500.0,1300.0,1800.0,1100.0,1200.0,950.0,1950.0,1750.0,1500.0,600.0,15600.0
Lohit,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,400.0,0.0,450.0,150.0,0.0,1500.0,500.0,700.0,500.0,920.0,600.0,200.0,5920.0
Lohit,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,1000.0,0.0,0.0,2000.0,0.0,1000.0,0.0,1000.0,0.0,0.0,0.0,5000.0
Lohit,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,400.0,,,,,,500.0,0.0,0.0,0.0,0.0,0.0,900.0
Lohit,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,0.0,550.0,300.0,150.0,500.0,1000.0,300.0,200.0,580.0,320.0,400.0,200.0,4500.0
Lohit,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,450.0,150.0,0.0,1500.0,500.0,700.0,500.0,920.0,600.0,200.0,0.0,5520.0
Lohit,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,1450.0,1000.0,400.0,0.0,0.0,0.0,0.0,800.0,550.0,1800.0,6000.0
Lohit,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,0.0,1500.0,0.0,5500.0
Lohit,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lohit,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,550.0,450.0,600.0,400.0,0.0,0.0,0.0,1200.0,250.0,250.0,600.0,4300.0
Lohit,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,1450.0,1000.0,400.0,0.0,0.0,0.0,0.0,800.0,550.0,1800.0,1200.0,7200.0
Lohit,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,2620.0,1420.0,2970.0,2670.0,2370.0,3720.0,2820.0,2420.0,2200.0,1700.0,1500.0,1250.0,27660.0
Lohit,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,2000.0,0.0,0.0,2000.0,0.0,600.0,0.0,0.0,0.0,0.0,0.0,4600.0
Lohit,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lohit,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1200.0,450.0,300.0,300.0,650.0,900.0,1000.0,220.0,500.0,200.0,250.0,750.0,6720.0
Lohit,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1420.0,2970.0,2670.0,2370.0,3720.0,2820.0,2420.0,2200.0,1700.0,1500.0,1250.0,500.0,25540.0
Lohit,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,34.0,14.0,464.0,454.0,404.0,434.0,394.0,374.0,354.0,304.0,284.0,274.0,3788.0
Lohit,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,500.0,0.0,0.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,600.0
Lohit,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Lohit,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,20.0,50.0,10.0,50.0,70.0,40.0,20.0,20.0,50.0,20.0,10.0,20.0,380.0
Lohit,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,14.0,464.0,454.0,404.0,434.0,394.0,374.0,354.0,304.0,284.0,274.0,254.0,4008.0
Lohit,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,1040.0,540.0,4540.0,3540.0,2540.0,10120.0,8620.0,7620.0,6620.0,5780.0,5380.0,3380.0,59720.0
Lohit,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,5000.0,0.0,0.0,10080.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15080.0
Lohit,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Lohit,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,500.0,1000.0,1000.0,1000.0,2500.0,1500.0,1000.0,1000.0,840.0,400.0,2000.0,500.0,13240.0
Lohit,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,540.0,4540.0,3540.0,2540.0,10120.0,8620.0,7620.0,6620.0,5780.0,5380.0,3380.0,2880.0,61560.0
Lohit,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1300.0,1000.0,800.0,700.0,400.0,3700.0,3100.0,2900.0,2500.0,2100.0,1800.0,1300.0,21600.0
Lohit,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,3600.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3600.0
Lohit,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Lohit,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,300.0,200.0,100.0,300.0,300.0,600.0,200.0,400.0,400.0,300.0,500.0,300.0,3900.0
Lohit,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,1000.0,800.0,700.0,400.0,3700.0,3100.0,2900.0,2500.0,2100.0,1800.0,1300.0,1000.0,21300.0
Lohit,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1800.0,1500.0,1250.0,1100.0,900.0,2500.0,2000.0,1600.0,1400.0,1200.0,1000.0,800.0,17050.0
Lohit,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0
Lohit,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Lohit,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,300.0,250.0,150.0,200.0,400.0,500.0,400.0,200.0,200.0,200.0,200.0,100.0,3100.0
Lohit,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,1500.0,1250.0,1100.0,900.0,2500.0,2000.0,1600.0,1400.0,1200.0,1000.0,800.0,700.0,15950.0
Lohit,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Lohit,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Lohit,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Lohit,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Lohit,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Lohit,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Lohit,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Lohit,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Lohit,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Lohit,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Lohit,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Lohit,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Lohit,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Lohit,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Lohit,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Lohit,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Lohit,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Lohit,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Lohit,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Lohit,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Lohit,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Lohit,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Lohit,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Lohit,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Lohit,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Lohit,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,13000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13000.0
Lohit,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1050.0,1050.0
Lohit,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Lohit,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,13000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,300.0,13300.0
Lohit,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,750.0,750.0
Lohit,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Lohit,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Lohit,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Lohit,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Lohit,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Lohit,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,250.0,200.0,450.0
Lohit,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,300.0,0.0,0.0,300.0
Lohit,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Lohit,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0,50.0,25.0,125.0
Lohit,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,250.0,200.0,175.0,625.0
Lohit,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Lohit,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohit,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,100.0,0.0,600.0,300.0,1000.0,550.0,270.0,170.0,70.0,370.0,620.0,420.0,4470.0
Lohit,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,1000.0,0.0,1000.0,,0.0,0.0,0.0,1000.0,500.0,0.0,0.0,3500.0
Lohit,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Lohit,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,100.0,400.0,300.0,300.0,450.0,280.0,100.0,100.0,700.0,250.0,200.0,300.0,3480.0
Lohit,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,600.0,300.0,1000.0,550.0,270.0,170.0,70.0,370.0,620.0,420.0,120.0,4490.0
Lohit,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,1000.0,0.0,3200.0,2000.0,3000.0,7600.0,5000.0,3200.0,2200.0,2600.0,4000.0,2800.0,36600.0
Lohit,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,4800.0,0.0,2400.0,6600.0,0.0,0.0,0.0,3000.0,3000.0,0.0,0.0,19800.0
Lohit,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Lohit,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,1000.0,1600.0,1200.0,1400.0,2000.0,2600.0,1800.0,1000.0,2600.0,1600.0,1200.0,1600.0,19600.0
Lohit,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,3200.0,2000.0,3000.0,7600.0,5000.0,3200.0,2200.0,2600.0,4000.0,2800.0,1200.0,36800.0
Lohit,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,50.0,0.0,900.0,750.0,550.0,400.0,300.0,250.0,200.0,100.0,50.0,50.0,3600.0
Lohit,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0
Lohit,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Lohit,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,50.0,100.0,150.0,200.0,150.0,100.0,50.0,50.0,100.0,50.0,0.0,50.0,1050.0
Lohit,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,900.0,750.0,550.0,400.0,300.0,250.0,200.0,100.0,50.0,50.0,0.0,3550.0
Lohit,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Lohit,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Lohit,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lohit,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Lohit,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Lohit,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lohit,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Lohit,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Lohit,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lohit,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Lohit,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Lohit,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lohit,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Lohit,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,1.0,,,,,1.0
Lohit,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Lohit,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,1.0,,,,,1.0
Lohit,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,1.0,,,,,,,,,,1.0
Lohit,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Lohit,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,1.0,,,,,,,,,,1.0
Lohit,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Lohit,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Lohit,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Lohit,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Lohit,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Lohit,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Lohit,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Lohit,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Lohit,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Lohit,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Lohit,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Lohit,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Lohit,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,1.0,,,,,,,,,,,1.0
Lohit,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Lohit,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,1.0,1.0
Lohit,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Lohit,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,1.0,,,,,1.0,2.0
Lohit,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Lohit,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Lohit,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Lohit,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Lohit,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Lohit,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,1.0,1.0,,,,,2.0
Lohit,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Lohit,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,1.0,,1.0,,,1.0,1.0,,,,,4.0
Lohit,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Lohit,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,1.0,,1.0
Lohit,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Lohit,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,1.0,,1.0
Lohit,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Lohit,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Lohit,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Lohit,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Lohit,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Lohit,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,1.0,,,,,,,2.0,,,3.0
Lohit,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Lohit,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,1.0,,1.0,,,,,,,2.0,,,4.0
Lohit,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Lohit,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,1.0,,,,,,,,,,,1.0
Lohit,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Lohit,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,1.0,,,,,,,,,,,1.0
Lohit,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Lohit,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Lohit,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Lohit,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Lohit,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Lohit,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Lohit,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Lohit,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Lohit,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Lohit,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Lohit,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Lohit,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Lohit,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Lohit,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,1.0,,,,,,,,,,1.0
Lohit,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Lohit,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,1.0,,,,,,,,,,1.0
Lohit,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Lohit,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Lohit,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Lohit,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Lohit,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Lohit,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Lohit,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Lohit,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Lohit,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Lohit,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,1.0,,1.0
Lohit,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Lohit,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,1.0,,,,,,,1.0,,2.0
Lohit,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Lohit,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Lohit,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Lohit,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Lohit,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Lohit,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Lohit,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Lohit,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,1.0,,,,,,,,,1.0
Lohit,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Lohit,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,,,,,,,,1.0,,,,2.0
Lohit,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,2.0,,,,,,,,,,,,2.0
Lohit,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,3.0,,,,,,,,1.0,,,,4.0
Lohit,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Lohit,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,2.0,,,,1.0,,2.0,,,,,5.0
Lohit,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,1.0,,,1.0,,,,,,2.0,,4.0
Lohit,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,3.0,,,1.0,1.0,,2.0,,,2.0,,9.0
Lohit,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Lohit,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,4.0,,2.0,3.0,2.0,1.0,1.0,2.0,4.0,1.0,2.0,1.0,23.0
Lohit,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,2.0,1.0,,1.0,1.0,,,,,,5.0
Lohit,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,4.0,,4.0,4.0,2.0,2.0,2.0,3.0,4.0,1.0,2.0,1.0,29.0
Longding,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
Longding,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
Longding,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
Longding,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
Longding,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
Longding,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
Longding,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
Longding,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
Longding,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
Longding,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
Longding,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
Longding,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Longding,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
Longding,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
Longding,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
Longding,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
Longding,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
Longding,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Longding,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
Longding,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
Longding,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
Longding,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Longding,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Longding,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Longding,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Longding,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Longding,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Longding,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Longding,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
Longding,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Longding,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
Longding,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Longding,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
Longding,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
Longding,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
Longding,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
Longding,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
Longding,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
Longding,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
Longding,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
Longding,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
Longding,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Longding,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Longding,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Longding,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
Longding,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Longding,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
Longding,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
Longding,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
Longding,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
Longding,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
Longding,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
Longding,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
Longding,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
Longding,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
Longding,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
Longding,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
Longding,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
Longding,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
Longding,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
Longding,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
Longding,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
Longding,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
Longding,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Longding,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Longding,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
Longding,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Longding,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Longding,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Longding,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Longding,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Longding,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
Longding,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Longding,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Longding,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Longding,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Longding,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Longding,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
Longding,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Longding,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Longding,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Longding,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Longding,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Longding,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
Longding,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Longding,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
Longding,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
Longding,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
Longding,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Longding,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Longding,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
Longding,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Longding,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Longding,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
Longding,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
Longding,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
Longding,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
Longding,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
Longding,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
Longding,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
Longding,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
Longding,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
Longding,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
Longding,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
Longding,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Longding,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
Longding,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
Longding,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
Longding,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
Longding,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Longding,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Longding,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Longding,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
Longding,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
Longding,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
Longding,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
Longding,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
Longding,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
Longding,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
Longding,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
Longding,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
Longding,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
Longding,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Longding,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Longding,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Longding,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
Longding,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
Longding,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
Longding,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
Longding,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Longding,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Longding,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
Longding,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
Longding,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
Longding,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
Longding,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
Longding,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
Longding,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
Longding,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
Longding,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
Longding,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
Longding,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
Longding,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
Longding,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
Longding,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
Longding,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Longding,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Longding,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Longding,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Longding,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Longding,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Longding,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Longding,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Longding,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
Longding,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
Longding,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
Longding,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
Longding,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
Longding,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
Longding,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
Longding,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Longding,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Longding,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
Longding,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Longding,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
Longding,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Longding,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
Longding,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Longding,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Longding,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
Longding,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
Longding,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
Longding,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
Longding,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
Longding,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
Longding,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
Longding,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
Longding,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
Longding,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
Longding,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
Longding,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
Longding,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Longding,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
Longding,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
Longding,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
Longding,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
Longding,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
Longding,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
Longding,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
Longding,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
Longding,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
Longding,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
Longding,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
Longding,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
Longding,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
Longding,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
Longding,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
Longding,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
Longding,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
Longding,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
Longding,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
Longding,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
Longding,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
Longding,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
Longding,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Longding,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Longding,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Longding,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Longding,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Longding,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Longding,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Longding,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Longding,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Longding,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Longding,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Longding,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Longding,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Longding,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Longding,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Longding,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Longding,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Longding,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Longding,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Longding,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Longding,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Longding,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Longding,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Longding,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Longding,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Longding,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Longding,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Longding,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Longding,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Longding,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Longding,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Longding,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Longding,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Longding,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Longding,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Longding,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Longding,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Longding,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Longding,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Longding,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Longding,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Longding,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Longding,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Longding,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Longding,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Longding,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Longding,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Longding,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Longding,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Longding,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Longding,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Longding,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Longding,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Longding,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Longding,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Longding,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Longding,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Longding,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Longding,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Longding,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Longding,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Longding,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Longding,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Longding,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Longding,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Longding,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Longding,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Longding,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Longding,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Longding,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Longding,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Longding,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Longding,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Longding,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Longding,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Longding,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Longding,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Longding,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Longding,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Longding,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Longding,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Longding,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Longding,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Longding,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Longding,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Longding,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Longding,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Longding,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Longding,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Longding,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Longding,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Longding,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Longding,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Longding,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Longding,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Longding,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Longding,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Longding,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Longding,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Longding,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Longding,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Longding,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Longding,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Longding,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Longding,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Longding,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Longding,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Longding,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Longding,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Longding,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Longding,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Longding,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Longding,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Longding,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Longding,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Longding,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Longding,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Longding,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Longding,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Longding,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Longding,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Longding,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Longding,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Longding,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Longding,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Longding,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Longding,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Longding,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Longding,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Longding,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Longding,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Longding,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Longding,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Longding,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Longding,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Longding,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Longding,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Longding,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Longding,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Longding,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Longding,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Longding,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Longding,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Longding,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Longding,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Longding,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Longding,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Longding,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Longding,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Longding,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Longding,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Longding,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Longding,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Longding,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Longding,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Longding,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Longding,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Longding,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Longding,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Longding,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Longding,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Longding,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Longding,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Longding,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Longding,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Longding,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Longding,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Longding,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Longding,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Longding,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Longding,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Longding,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Longding,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Longding,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Longding,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Longding,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Longding,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Longding,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Longding,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Longding,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Longding,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Longding,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Longding,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Longding,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Longding,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Longding,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Longding,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Longding,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Longding,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Longding,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Longding,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Longding,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Longding,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Longding,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Longding,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Longding,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Longding,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Longding,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Longding,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Longding,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Longding,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Longding,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Longding,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Longding,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Longding,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Longding,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Longding,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Longding,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Longding,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Longding,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Longding,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Longding,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Longding,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Longding,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Longding,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Longding,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Longding,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Longding,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Longding,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Longding,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Longding,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Longding,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Longding,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Longding,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Longding,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Longding,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Longding,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Longding,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Longding,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Longding,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Longding,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Longding,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Longding,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Longding,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Longding,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Longding,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Longding,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Longding,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Longding,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Longding,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Longding,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Longding,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Longding,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Longding,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Longding,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Longding,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Longding,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Longding,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Lower Dibang Valley,1.1,Total number of pregnant women Registered for ANC,TOTAL,73.0,103.0,147.0,101.0,106.0,90.0,95.0,94.0,80.0,79.0,55.0,103.0,1126.0
Lower Dibang Valley,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,18.0,37.0,39.0,29.0,21.0,20.0,22.0,19.0,11.0,19.0,20.0,22.0,277.0
Lower Dibang Valley,1.2,Number of Pregnant women registered under JSY,TOTAL,68.0,94.0,131.0,91.0,106.0,90.0,99.0,89.0,76.0,79.0,56.0,103.0,1082.0
Lower Dibang Valley,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,6.0,22.0,19.0,30.0,26.0,17.0,60.0,49.0,46.0,46.0,31.0,56.0,408.0
Lower Dibang Valley,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,51.0,66.0,93.0,59.0,76.0,58.0,57.0,70.0,49.0,61.0,45.0,72.0,757.0
Lower Dibang Valley,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,25.0,26.0,47.0,55.0,38.0,50.0,38.0,44.0,42.0,25.0,50.0,42.0,482.0
Lower Dibang Valley,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,60.0,83.0,48.0,67.0,33.0,18.0,29.0,25.0,14.0,20.0,8.0,27.0,432.0
Lower Dibang Valley,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Lower Dibang Valley,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,37.0,29.0,74.0,47.0,49.0,59.0,12.0,70.0,68.0,18.0,3.0,49.0,515.0
Lower Dibang Valley,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,2.0,1.0,1.0,0.0,0.0,1.0,1.0,2.0,0.0,0.0,8.0
Lower Dibang Valley,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Lower Dibang Valley,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,5.0,2.0,4.0,6.0,9.0,7.0,12.0,9.0,6.0,6.0,1.0,2.0,69.0
Lower Dibang Valley,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,5.0,2.0,4.0,6.0,9.0,7.0,12.0,9.0,6.0,6.0,1.0,2.0,69.0
Lower Dibang Valley,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,5.0,2.0,4.0,6.0,9.0,7.0,12.0,8.0,6.0,6.0,1.0,2.0,68.0
Lower Dibang Valley,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,5.0,6.0,0.0,2.0,14.0
Lower Dibang Valley,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,43.0,47.0,38.0,34.0,54.0,43.0,52.0,49.0,50.0,44.0,49.0,49.0,552.0
Lower Dibang Valley,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,41.0,50.0,38.0,36.0,54.0,43.0,52.0,47.0,48.0,43.0,45.0,49.0,546.0
Lower Dibang Valley,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,43.0,34.0,50.0,46.0,30.0,2.0,0.0,0.0,0.0,0.0,192.0,397.0
Lower Dibang Valley,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,7.0,10.0,9.0,12.0,9.0,2.0,0.0,0.0,0.0,0.0,8.0,57.0
Lower Dibang Valley,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Lower Dibang Valley,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Lower Dibang Valley,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Lower Dibang Valley,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Lower Dibang Valley,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0
Lower Dibang Valley,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lower Dibang Valley,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0
Lower Dibang Valley,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Lower Dibang Valley,4.1.1.a,Number of male live births,TOTAL,23.0,30.0,20.0,20.0,30.0,26.0,32.0,29.0,32.0,30.0,23.0,27.0,322.0
Lower Dibang Valley,4.1.1.b,Number of female live births,TOTAL,25.0,23.0,22.0,21.0,37.0,24.0,32.0,27.0,20.0,21.0,25.0,26.0,303.0
Lower Dibang Valley,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,48.0,53.0,42.0,41.0,67.0,50.0,64.0,56.0,52.0,51.0,48.0,53.0,625.0
Lower Dibang Valley,4.1.2,Number of still births,TOTAL,0.0,1.0,0.0,1.0,2.0,0.0,0.0,1.0,8.0,5.0,2.0,1.0,21.0
Lower Dibang Valley,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,2.0,4.0,0.0,4.0,1.0,3.0,1.0,0.0,0.0,2.0,0.0,2.0,19.0
Lower Dibang Valley,4.2.1,Number of Newborns weighed at birth,TOTAL,45.0,53.0,41.0,42.0,67.0,50.0,62.0,56.0,53.0,51.0,48.0,51.0,619.0
Lower Dibang Valley,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,4.0,3.0,7.0,3.0,5.0,4.0,10.0,0.0,8.0,2.0,6.0,2.0,54.0
Lower Dibang Valley,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,45.0,52.0,42.0,41.0,62.0,48.0,63.0,56.0,51.0,47.0,48.0,52.0,607.0
Lower Dibang Valley,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,2.0,1.0,7.0
Lower Dibang Valley,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,9.0,10.0,0.0,0.0,1.0,0.0,1.0,2.0,0.0,23.0
Lower Dibang Valley,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lower Dibang Valley,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,0.0,9.0,10.0,0.0,1.0,2.0,1.0,2.0,4.0,1.0,30.0
Lower Dibang Valley,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Lower Dibang Valley,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,3.0,1.0,9.0,10.0,20.0,46.0,42.0,38.0,36.0,44.0,31.0,280.0
Lower Dibang Valley,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,0.0,5.0,8.0,7.0,11.0,5.0,38.0
Lower Dibang Valley,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,0.0,0.0,0.0,1.0,12.0,21.0,1.0,0.0,2.0,4.0,8.0,49.0
Lower Dibang Valley,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,47.0,16.0,42.0,42.0,63.0,31.0,64.0,60.0,56.0,50.0,47.0,8.0,526.0
Lower Dibang Valley,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,47.0,12.0,20.0,39.0,67.0,28.0,64.0,60.0,55.0,32.0,47.0,8.0,479.0
Lower Dibang Valley,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Lower Dibang Valley,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,2.0,0.0,3.0,0.0,0.0,0.0,3.0,0.0,1.0,0.0,2.0,0.0,11.0
Lower Dibang Valley,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,3.0
Lower Dibang Valley,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,2.0,0.0,3.0,0.0,0.0,0.0,3.0,3.0,1.0,0.0,2.0,0.0,14.0
Lower Dibang Valley,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,18.0,10.0,50.0,17.0,19.0,25.0,16.0,16.0,22.0,16.0,16.0,6.0,231.0
Lower Dibang Valley,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,13.0,22.0,44.0,26.0,4.0,16.0,10.0,18.0,18.0,12.0,17.0,9.0,209.0
Lower Dibang Valley,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,31.0,32.0,94.0,43.0,23.0,41.0,26.0,34.0,40.0,28.0,33.0,15.0,440.0
Lower Dibang Valley,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,15.0,10.0,11.0,10.0,12.0,0.0,0.0,3.0,24.0,7.0,8.0,100.0
Lower Dibang Valley,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lower Dibang Valley,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Lower Dibang Valley,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,2.0,5.0,1.0,0.0,0.0,0.0,4.0,3.0,1.0,2.0,3.0,21.0
Lower Dibang Valley,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lower Dibang Valley,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,2.0,5.0,1.0,0.0,0.0,0.0,4.0,3.0,1.0,2.0,3.0,21.0
Lower Dibang Valley,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Lower Dibang Valley,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,3.0
Lower Dibang Valley,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lower Dibang Valley,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,3.0
Lower Dibang Valley,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Lower Dibang Valley,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lower Dibang Valley,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Lower Dibang Valley,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0
Lower Dibang Valley,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,1.0,1.0,4.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,2.0,12.0
Lower Dibang Valley,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0
Lower Dibang Valley,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,4.0,1.0,1.0,3.0,0.0,1.0,1.0,3.0,1.0,3.0,3.0,5.0,26.0
Lower Dibang Valley,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lower Dibang Valley,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,5.0,2.0,5.0,4.0,2.0,3.0,3.0,3.0,1.0,3.0,3.0,8.0,42.0
Lower Dibang Valley,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,0.0,,,0.0
Lower Dibang Valley,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Lower Dibang Valley,9.06,Number of IUCD removals,TOTAL,0.0,2.0,1.0,0.0,1.0,1.0,2.0,1.0,1.0,2.0,0.0,2.0,13.0
Lower Dibang Valley,9.07,Number of Oral Pills cycles distributed,TOTAL,33.0,36.0,48.0,46.0,36.0,17.0,35.0,27.0,26.0,37.0,60.0,51.0,452.0
Lower Dibang Valley,9.08,Number of Condom pieces distributed,TOTAL,64.0,54.0,110.0,70.0,23.0,77.0,14.0,72.0,37.0,20.0,112.0,184.0,837.0
Lower Dibang Valley,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,2.0,1.0,1.0,1.0,10.0,13.0,15.0,16.0,59.0
Lower Dibang Valley,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,9.12,Number of Institutions having NSV trained doctors,TOTAL,3.0,4.0,7.0,3.0,4.0,7.0,7.0,5.0,6.0,5.0,5.0,6.0,-1.0
Lower Dibang Valley,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,60.0,77.0,64.0,66.0,54.0,96.0,69.0,84.0,73.0,71.0,77.0,69.0,860.0
Lower Dibang Valley,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,66.0,69.0,64.0,78.0,50.0,62.0,64.0,86.0,82.0,80.0,70.0,70.0,841.0
Lower Dibang Valley,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,81.0,71.0,45.0,62.0,59.0,44.0,52.0,32.0,68.0,68.0,59.0,83.0,724.0
Lower Dibang Valley,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,46.0,82.0,53.0,49.0,46.0,60.0,43.0,43.0,50.0,56.0,51.0,58.0,637.0
Lower Dibang Valley,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Lower Dibang Valley,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Lower Dibang Valley,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Lower Dibang Valley,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,50.0,56.0,49.0,38.0,46.0,46.0,56.0,57.0,48.0,48.0,51.0,45.0,590.0
Lower Dibang Valley,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,67.0,70.0,64.0,78.0,50.0,62.0,64.0,86.0,82.0,81.0,74.0,70.0,848.0
Lower Dibang Valley,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,80.0,71.0,45.0,62.0,59.0,44.0,52.0,59.0,68.0,68.0,61.0,83.0,752.0
Lower Dibang Valley,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,46.0,82.0,53.0,49.0,46.0,60.0,43.0,43.0,50.0,56.0,55.0,58.0,641.0
Lower Dibang Valley,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,25.0,31.0,30.0,30.0,38.0,40.0,38.0,38.0,30.0,40.0,36.0,35.0,411.0
Lower Dibang Valley,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,64.0,62.0,64.0,76.0,50.0,62.0,62.0,91.0,82.0,79.0,70.0,68.0,830.0
Lower Dibang Valley,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,80.0,69.0,44.0,55.0,59.0,44.0,52.0,59.0,68.0,68.0,57.0,83.0,738.0
Lower Dibang Valley,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,47.0,81.0,53.0,49.0,46.0,60.0,43.0,43.0,50.0,56.0,55.0,59.0,642.0
Lower Dibang Valley,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,47.0,71.0,57.0,61.0,50.0,49.0,58.0,59.0,43.0,49.0,38.0,33.0,615.0
Lower Dibang Valley,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,11.0,5.0,13.0,17.0,18.0,20.0,18.0,9.0,10.0,10.0,10.0,7.0,148.0
Lower Dibang Valley,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Lower Dibang Valley,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,17.0,40.0,25.0,25.0,25.0,31.0,36.0,26.0,21.0,23.0,25.0,10.0,304.0
Lower Dibang Valley,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,15.0,25.0,32.0,27.0,25.0,26.0,23.0,33.0,23.0,22.0,14.0,23.0,288.0
Lower Dibang Valley,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,32.0,65.0,57.0,52.0,50.0,57.0,59.0,59.0,44.0,45.0,39.0,33.0,592.0
Lower Dibang Valley,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,51.0,55.0,28.0,45.0,17.0,17.0,35.0,49.0,29.0,29.0,50.0,53.0,458.0
Lower Dibang Valley,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,53.0,54.0,28.0,45.0,25.0,28.0,35.0,49.0,29.0,29.0,50.0,53.0,478.0
Lower Dibang Valley,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,10.0,6.0,5.0,5.0,8.0,9.0,8.0,15.0,2.0,1.0,1.0,6.0,76.0
Lower Dibang Valley,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,13.0,12.0,7.0,15.0,9.0,10.0,5.0,14.0,2.0,2.0,1.0,1.0,91.0
Lower Dibang Valley,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,23.0,18.0,12.0,20.0,17.0,19.0,13.0,29.0,4.0,3.0,2.0,7.0,167.0
Lower Dibang Valley,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,5.0,5.0,8.0,2.0,0.0,6.0,6.0,15.0,14.0,10.0,5.0,4.0,80.0
Lower Dibang Valley,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,14.0,5.0,4.0,2.0,1.0,5.0,6.0,7.0,0.0,8.0,3.0,4.0,59.0
Lower Dibang Valley,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,4.0,12.0,2.0,2.0,0.0,2.0,2.0,1.0,3.0,7.0,5.0,5.0,45.0
Lower Dibang Valley,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1.0,1.0,2.0,2.0,1.0,4.0,4.0,5.0,4.0,1.0,1.0,3.0,29.0
Lower Dibang Valley,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,46.0,27.0,39.0,36.0,17.0,22.0,26.0,25.0,24.0,22.0,24.0,23.0,331.0
Lower Dibang Valley,10.4.2,Number of Immunisation sessions held during the month,TOTAL,43.0,27.0,37.0,37.0,16.0,17.0,19.0,16.0,15.0,15.0,16.0,20.0,278.0
Lower Dibang Valley,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,26.0,18.0,24.0,25.0,15.0,14.0,11.0,10.0,11.0,18.0,16.0,16.0,204.0
Lower Dibang Valley,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Lower Dibang Valley,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,5.0,14.0,5.0,8.0,17.0,0.0,0.0,11.0,52.0,61.0,36.0,38.0,247.0
Lower Dibang Valley,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,7.0,6.0,3.0,4.0,5.0,0.0,0.0,5.0,51.0,25.0,50.0,44.0,200.0
Lower Dibang Valley,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,35.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,37.0,4.0,8.0,4.0,98.0
Lower Dibang Valley,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Lower Dibang Valley,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,60.0,41.0,73.0,71.0,142.0,73.0,78.0,51.0,24.0,33.0,31.0,45.0,722.0
Lower Dibang Valley,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,3.0,1.0,21.0,0.0,5.0,6.0,1.0,3.0,7.0,0.0,47.0
Lower Dibang Valley,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,1.0,0.0,1.0,38.0,4.0,0.0,0.0,15.0,3.0,91.0,153.0
Lower Dibang Valley,13.1,Number of Patients operated for cataract,TOTAL,2.0,0.0,0.0,2.0,5.0,6.0,6.0,20.0,0.0,0.0,5.0,3.0,49.0
Lower Dibang Valley,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,2.0,0.0,0.0,2.0,5.0,6.0,6.0,4.0,0.0,0.0,12.0,3.0,40.0
Lower Dibang Valley,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,3.0
Lower Dibang Valley,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,4.0,3.0,3.0,3.0,3.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,-1.0
Lower Dibang Valley,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,2.0,4.0,4.0,4.0,3.0,4.0,4.0,4.0,4.0,4.0,3.0,4.0,-1.0
Lower Dibang Valley,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,8.0,16.0,9.0,12.0,9.0,12.0,13.0,13.0,10.0,2.0,10.0,11.0,-1.0
Lower Dibang Valley,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,4.0,2.0,4.0,4.0,3.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,-1.0
Lower Dibang Valley,14.05,Number of RKS meetings held during the month,TOTAL,1.0,1.0,1.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,1.0,9.0
Lower Dibang Valley,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,5.0,7.0,7.0,6.0,6.0,7.0,7.0,7.0,7.0,7.0,6.0,7.0,-1.0
Lower Dibang Valley,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,32.0,16.0,10.0,16.0,19.0,5.0,20.0,16.0,8.0,15.0,19.0,15.0,191.0
Lower Dibang Valley,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,3.0,3.0,4.0,2.0,2.0,3.0,3.0,2.0,3.0,3.0,3.0,3.0,-1.0
Lower Dibang Valley,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,-1.0
Lower Dibang Valley,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,10.0,1.0,12.0,7.0,11.0,21.0,6.0,10.0,6.0,1.0,20.0,3.0,108.0
Lower Dibang Valley,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,46.0,52.0,37.0,74.0,107.0,69.0,63.0,53.0,44.0,33.0,39.0,62.0,679.0
Lower Dibang Valley,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,14.0,10.0,13.0,15.0,26.0,21.0,14.0,19.0,8.0,10.0,2.0,11.0,163.0
Lower Dibang Valley,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,94.0,113.0,109.0,132.0,105.0,131.0,142.0,84.0,87.0,95.0,73.0,97.0,1262.0
Lower Dibang Valley,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,24.0,11.0,25.0,22.0,37.0,42.0,20.0,29.0,14.0,11.0,22.0,14.0,271.0
Lower Dibang Valley,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,140.0,165.0,146.0,206.0,212.0,200.0,205.0,137.0,131.0,128.0,112.0,159.0,1941.0
Lower Dibang Valley,14.10.2.a,Number of death cases of Inpatient males,TOTAL,1.0,2.0,1.0,3.0,2.0,2.0,1.0,2.0,2.0,1.0,0.0,0.0,17.0
Lower Dibang Valley,14.10.2.b,Number of death cases of Inpatient females,TOTAL,4.0,1.0,4.0,2.0,1.0,0.0,1.0,2.0,0.0,2.0,0.0,0.0,17.0
Lower Dibang Valley,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,5.0,3.0,5.0,5.0,3.0,2.0,2.0,4.0,2.0,3.0,0.0,0.0,34.0
Lower Dibang Valley,14.11,In-Patient Head Count at midnight,TOTAL,172.0,61.0,11.0,40.0,37.0,62.0,60.0,166.0,130.0,136.0,122.0,155.0,1152.0
Lower Dibang Valley,14.12.1,OPD attendance (All),TOTAL,3590.0,4264.0,5086.0,6614.0,5969.0,5495.0,4637.0,3890.0,3229.0,3209.0,3389.0,4249.0,53621.0
Lower Dibang Valley,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Lower Dibang Valley,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Lower Dibang Valley,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,63.0,29.0,39.0,44.0,13.0,2.0,23.0,54.0,28.0,12.0,53.0,16.0,376.0
Lower Dibang Valley,14.14.a,Number of patients given AYUSH treatment,TOTAL,26.0,173.0,186.0,35.0,0.0,25.0,29.0,83.0,57.0,42.0,51.0,46.0,753.0
Lower Dibang Valley,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,61.0,5.0,20.0,64.0,59.0,24.0,4.0,41.0,22.0,23.0,15.0,25.0,363.0
Lower Dibang Valley,14.14.c,Number of Adolescents counselled,TOTAL,33.0,20.0,37.0,27.0,7.0,16.0,28.0,19.0,11.0,9.0,11.0,19.0,237.0
Lower Dibang Valley,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,78.0,57.0,123.0,159.0,134.0,64.0,72.0,76.0,23.0,39.0,39.0,73.0,937.0
Lower Dibang Valley,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,0.0,0.0,1.0,3.0,4.0,5.0,27.0,17.0,6.0,2.0,14.0,1.0,80.0
Lower Dibang Valley,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,15.0,18.0,28.0,23.0,22.0,23.0,16.0,17.0,25.0,18.0,17.0,27.0,249.0
Lower Dibang Valley,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,9.0,11.0,16.0,24.0,4.0,12.0,12.0,16.0,16.0,23.0,11.0,34.0,188.0
Lower Dibang Valley,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,47.0,68.0,93.0,53.0,87.0,79.0,72.0,77.0,53.0,64.0,37.0,99.0,829.0
Lower Dibang Valley,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,71.0,97.0,137.0,100.0,113.0,114.0,100.0,110.0,94.0,105.0,65.0,160.0,1266.0
Lower Dibang Valley,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,15.2,Number of Widal tests conducted,Number tested,150.0,127.0,274.0,350.0,382.0,272.0,201.0,116.0,69.0,82.0,14.0,11.0,2048.0
Lower Dibang Valley,15.3.a,Number of VDRL tests conducted on males,Number tested,15.0,6.0,29.0,18.0,19.0,23.0,14.0,14.0,21.0,15.0,14.0,24.0,212.0
Lower Dibang Valley,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,7.0,16.0,18.0,19.0,13.0,12.0,10.0,16.0,16.0,9.0,24.0,26.0,186.0
Lower Dibang Valley,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,47.0,68.0,102.0,57.0,96.0,83.0,60.0,81.0,52.0,65.0,28.0,92.0,831.0
Lower Dibang Valley,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,69.0,90.0,149.0,94.0,128.0,118.0,84.0,111.0,89.0,89.0,66.0,142.0,1229.0
Lower Dibang Valley,15.4.1,Number of blood smears examined for Malaria,TOTAL,180.0,278.0,722.0,1306.0,871.0,794.0,530.0,355.0,173.0,198.0,226.0,316.0,5949.0
Lower Dibang Valley,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,9.0,19.0,36.0,62.0,42.0,19.0,14.0,12.0,5.0,4.0,5.0,6.0,233.0
Lower Dibang Valley,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,9.0,18.0,65.0,112.0,57.0,64.0,29.0,12.0,10.0,4.0,16.0,16.0,412.0
Lower Dibang Valley,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,2030.0,1750.0,1220.0,2740.0,2200.0,1890.0,1970.0,1700.0,3480.0,1640.0,1330.0,,21950.0
Lower Dibang Valley,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,0.0,2000.0,0.0,0.0,500.0,0.0,2000.0,0.0,0.0,2000.0,,6500.0
Lower Dibang Valley,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,140.0,,140.0
Lower Dibang Valley,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,280.0,530.0,480.0,540.0,310.0,420.0,270.0,220.0,1840.0,310.0,310.0,,5510.0
Lower Dibang Valley,16.1.1,Stock position of DPT vaccines,5. Total Stock,1750.0,1220.0,2740.0,2200.0,1890.0,1970.0,1700.0,3480.0,1640.0,1330.0,2880.0,0.0,22800.0
Lower Dibang Valley,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Lower Dibang Valley,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Lower Dibang Valley,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Lower Dibang Valley,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Lower Dibang Valley,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,940.0,580.0,180.0,740.0,360.0,20.0,1040.0,290.0,2070.0,1370.0,2130.0,,9720.0
Lower Dibang Valley,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,0.0,1000.0,0.0,0.0,1500.0,0.0,2000.0,0.0,12500.0,14000.0,,31000.0
Lower Dibang Valley,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,360.0,400.0,440.0,380.0,340.0,480.0,750.0,220.0,700.0,11740.0,11900.0,,27710.0
Lower Dibang Valley,16.1.2,Stock position of OPV vaccines,5. Total Stock,580.0,180.0,740.0,360.0,20.0,1040.0,290.0,2070.0,1370.0,2130.0,4230.0,0.0,13010.0
Lower Dibang Valley,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,760.0,560.0,300.0,1060.0,820.0,630.0,1340.0,1240.0,1440.0,1000.0,870.0,,10020.0
Lower Dibang Valley,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,0.0,1000.0,0.0,0.0,1000.0,0.0,500.0,0.0,0.0,2000.0,,4500.0
Lower Dibang Valley,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.1.3,Stock position of TT vaccines,4. Stock Distributed,200.0,260.0,240.0,240.0,190.0,290.0,100.0,300.0,440.0,130.0,230.0,,2620.0
Lower Dibang Valley,16.1.3,Stock position of TT vaccines,5. Total Stock,560.0,300.0,1060.0,820.0,630.0,1340.0,1240.0,1440.0,1000.0,870.0,2640.0,0.0,11900.0
Lower Dibang Valley,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Lower Dibang Valley,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Lower Dibang Valley,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Lower Dibang Valley,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Lower Dibang Valley,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1320.0,1070.0,680.0,1720.0,1590.0,1280.0,1340.0,1110.0,1350.0,1000.0,780.0,,13240.0
Lower Dibang Valley,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,0.0,1500.0,0.0,0.0,500.0,0.0,500.0,0.0,0.0,2000.0,,4500.0
Lower Dibang Valley,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,250.0,390.0,460.0,130.0,310.0,440.0,230.0,260.0,350.0,220.0,330.0,,3370.0
Lower Dibang Valley,16.1.5,Stock position of BCG vaccines,5. Total Stock,1070.0,680.0,1720.0,1590.0,1280.0,1340.0,1110.0,1350.0,1000.0,780.0,2450.0,0.0,14370.0
Lower Dibang Valley,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1550.0,0.0,1015.0,1885.0,1655.0,1445.0,1750.0,465.0,1260.0,940.0,810.0,,12775.0
Lower Dibang Valley,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,1250.0,1000.0,0.0,0.0,500.0,0.0,1000.0,0.0,0.0,1500.0,,5250.0
Lower Dibang Valley,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,1420.0,0.0,0.0,0.0,0.0,0.0,1135.0,0.0,0.0,0.0,0.0,,2555.0
Lower Dibang Valley,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,130.0,235.0,130.0,230.0,210.0,195.0,150.0,205.0,320.0,130.0,435.0,,2370.0
Lower Dibang Valley,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,1015.0,1885.0,1655.0,1445.0,1750.0,465.0,1260.0,940.0,810.0,1875.0,0.0,13100.0
Lower Dibang Valley,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Lower Dibang Valley,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Lower Dibang Valley,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Lower Dibang Valley,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Lower Dibang Valley,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1830.0,1560.0,1120.0,1690.0,1490.0,1170.0,1220.0,990.0,1240.0,530.0,160.0,,13000.0
Lower Dibang Valley,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,1000.0,0.0,0.0,500.0,0.0,600.0,0.0,0.0,3000.0,,5100.0
Lower Dibang Valley,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,270.0,440.0,430.0,200.0,320.0,450.0,230.0,350.0,710.0,370.0,380.0,,4150.0
Lower Dibang Valley,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1560.0,1120.0,1690.0,1490.0,1170.0,1220.0,990.0,1240.0,530.0,160.0,2780.0,0.0,13950.0
Lower Dibang Valley,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,151.0,111.0,111.0,111.0,111.0,91.0,91.0,91.0,91.0,91.0,87.0,,1137.0
Lower Dibang Valley,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,,2.0
Lower Dibang Valley,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,40.0,0.0,0.0,0.0,20.0,0.0,0.0,0.0,0.0,2.0,20.0,,82.0
Lower Dibang Valley,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,111.0,111.0,111.0,111.0,91.0,91.0,91.0,91.0,91.0,87.0,67.0,0.0,1053.0
Lower Dibang Valley,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,900.0,900.0,620.0,520.0,520.0,520.0,300.0,300.0,300.0,0.0,0.0,,4880.0
Lower Dibang Valley,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,185.0,0.0,300.0,300.0,0.0,0.0,,785.0
Lower Dibang Valley,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,280.0,100.0,0.0,0.0,35.0,0.0,0.0,0.0,0.0,0.0,,415.0
Lower Dibang Valley,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,900.0,620.0,520.0,520.0,520.0,300.0,300.0,0.0,0.0,0.0,0.0,0.0,3680.0
Lower Dibang Valley,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,35.0,15.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,50.0
Lower Dibang Valley,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,20.0,15.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,35.0
Lower Dibang Valley,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,15.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0
Lower Dibang Valley,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Lower Dibang Valley,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Lower Dibang Valley,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Lower Dibang Valley,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Lower Dibang Valley,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2100.0,2100.0,2100.0,,6300.0
Lower Dibang Valley,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,21500.0,0.0,0.0,0.0,,21500.0
Lower Dibang Valley,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,19400.0,0.0,0.0,0.0,,19400.0
Lower Dibang Valley,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2100.0,2100.0,2100.0,2100.0,0.0,8400.0
Lower Dibang Valley,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Dibang Valley,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,490.0,483.0,463.0,1387.0,1355.0,1355.0,1332.0,1182.0,1082.0,917.0,717.0,,10763.0
Lower Dibang Valley,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,500.0,,1500.0
Lower Dibang Valley,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Lower Dibang Valley,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,7.0,20.0,76.0,32.0,0.0,23.0,150.0,100.0,165.0,200.0,150.0,,923.0
Lower Dibang Valley,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,483.0,463.0,1387.0,1355.0,1355.0,1332.0,1182.0,1082.0,917.0,717.0,1067.0,0.0,11340.0
Lower Dibang Valley,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,6071.0,6041.0,3489.0,7867.0,7262.0,6962.0,4327.0,4027.0,6862.0,6262.0,5762.0,,64932.0
Lower Dibang Valley,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,4800.0,0.0,0.0,0.0,0.0,4000.0,0.0,0.0,4000.0,,12800.0
Lower Dibang Valley,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,2500.0,0.0,0.0,0.0,1835.0,87.0,465.0,0.0,0.0,0.0,,4887.0
Lower Dibang Valley,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,30.0,52.0,422.0,605.0,300.0,800.0,300.0,700.0,600.0,500.0,400.0,,4709.0
Lower Dibang Valley,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,6041.0,3489.0,7867.0,7262.0,6962.0,4327.0,3940.0,6862.0,6262.0,5762.0,9362.0,0.0,68136.0
Lower Dibang Valley,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1385.0,1373.0,1352.0,1792.0,1550.0,1445.0,1395.0,1355.0,1315.0,1221.0,1146.0,,15329.0
Lower Dibang Valley,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,500.0,,1000.0
Lower Dibang Valley,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,6.0
Lower Dibang Valley,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,12.0,15.0,60.0,242.0,105.0,50.0,34.0,40.0,94.0,75.0,105.0,,832.0
Lower Dibang Valley,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,1373.0,1352.0,1792.0,1550.0,1445.0,1395.0,1361.0,1315.0,1221.0,1146.0,1541.0,0.0,15491.0
Lower Dibang Valley,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,1.0,,,,,,,1.0,,,2.0
Lower Dibang Valley,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Lower Dibang Valley,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lower Dibang Valley,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Lower Dibang Valley,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Lower Dibang Valley,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lower Dibang Valley,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Lower Dibang Valley,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Lower Dibang Valley,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lower Dibang Valley,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Lower Dibang Valley,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Lower Dibang Valley,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lower Dibang Valley,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Lower Dibang Valley,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Lower Dibang Valley,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Lower Dibang Valley,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Lower Dibang Valley,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Lower Dibang Valley,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Lower Dibang Valley,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Lower Dibang Valley,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,1.0,,,,,,1.0
Lower Dibang Valley,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Lower Dibang Valley,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,1.0,,,,,,1.0
Lower Dibang Valley,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Lower Dibang Valley,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Lower Dibang Valley,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Lower Dibang Valley,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Lower Dibang Valley,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Lower Dibang Valley,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Lower Dibang Valley,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Lower Dibang Valley,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Lower Dibang Valley,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Lower Dibang Valley,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,1.0,,,,,,,,,1.0
Lower Dibang Valley,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Lower Dibang Valley,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Lower Dibang Valley,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Lower Dibang Valley,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Lower Dibang Valley,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Lower Dibang Valley,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Lower Dibang Valley,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Lower Dibang Valley,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,1.0,,,,,,,,,1.0
Lower Dibang Valley,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Lower Dibang Valley,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Lower Dibang Valley,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Lower Dibang Valley,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,1.0,,,,,,,,1.0
Lower Dibang Valley,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Lower Dibang Valley,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,1.0,,,,1.0,1.0,,,,3.0
Lower Dibang Valley,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Lower Dibang Valley,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,1.0,1.0,,,,1.0,1.0,,,,4.0
Lower Dibang Valley,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Lower Dibang Valley,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Lower Dibang Valley,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Lower Dibang Valley,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Lower Dibang Valley,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Lower Dibang Valley,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,1.0,,,,,,,,,,1.0
Lower Dibang Valley,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Lower Dibang Valley,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,1.0,,,,,,,,,,1.0
Lower Dibang Valley,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Lower Dibang Valley,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,,,,,,,,,,,,1.0
Lower Dibang Valley,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Lower Dibang Valley,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,,,,,,,,,,,,1.0
Lower Dibang Valley,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Lower Dibang Valley,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Lower Dibang Valley,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Lower Dibang Valley,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Lower Dibang Valley,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Lower Dibang Valley,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Lower Dibang Valley,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Lower Dibang Valley,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Lower Dibang Valley,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Lower Dibang Valley,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Lower Dibang Valley,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Lower Dibang Valley,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Lower Dibang Valley,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Lower Dibang Valley,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Lower Dibang Valley,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Lower Dibang Valley,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Lower Dibang Valley,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Lower Dibang Valley,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,1.0,,,,,,,,,1.0
Lower Dibang Valley,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Lower Dibang Valley,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,1.0,,,,,,,,,1.0
Lower Dibang Valley,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Lower Dibang Valley,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Lower Dibang Valley,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Lower Dibang Valley,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Lower Dibang Valley,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Lower Dibang Valley,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,1.0,,,,,,,,,,,,1.0
Lower Dibang Valley,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Lower Dibang Valley,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,1.0,,,,,,,,,,,,1.0
Lower Dibang Valley,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Lower Dibang Valley,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Lower Dibang Valley,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Lower Dibang Valley,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Lower Dibang Valley,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Lower Dibang Valley,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Lower Dibang Valley,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Lower Dibang Valley,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Lower Dibang Valley,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Lower Dibang Valley,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,1.0,,,,,1.0
Lower Dibang Valley,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Lower Dibang Valley,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,1.0,,,,,1.0
Lower Dibang Valley,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Lower Dibang Valley,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Lower Dibang Valley,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Lower Dibang Valley,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Lower Dibang Valley,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,1.0,,,,,1.0,,,2.0
Lower Dibang Valley,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,1.0,1.0,1.0,1.0,1.0,,1.0,,,6.0
Lower Dibang Valley,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Lower Dibang Valley,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,1.0,,,1.0,2.0,1.0,1.0,1.0,,2.0,,,9.0
Lower Subansiri,1.1,Total number of pregnant women Registered for ANC,TOTAL,109.0,179.0,201.0,177.0,199.0,244.0,160.0,142.0,139.0,121.0,113.0,179.0,1963.0
Lower Subansiri,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,25.0,48.0,52.0,38.0,24.0,34.0,36.0,18.0,43.0,27.0,27.0,35.0,407.0
Lower Subansiri,1.2,Number of Pregnant women registered under JSY,TOTAL,51.0,114.0,102.0,61.0,78.0,74.0,69.0,52.0,50.0,60.0,45.0,80.0,836.0
Lower Subansiri,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,20.0,18.0,29.0,45.0,21.0,44.0,33.0,20.0,14.0,29.0,16.0,21.0,310.0
Lower Subansiri,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,41.0,67.0,91.0,55.0,73.0,105.0,75.0,42.0,64.0,52.0,49.0,92.0,806.0
Lower Subansiri,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,23.0,45.0,53.0,32.0,42.0,60.0,57.0,39.0,40.0,48.0,27.0,42.0,508.0
Lower Subansiri,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4.0,3.0,8.0,6.0,1.0,6.0,5.0,5.0,9.0,9.0,20.0,37.0,113.0
Lower Subansiri,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,5.0,2.0,1.0,2.0,1.0,2.0,0.0,3.0,0.0,1.0,1.0,3.0,21.0
Lower Subansiri,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,10.0,16.0,16.0,2.0,33.0,20.0,18.0,13.0,15.0,23.0,24.0,27.0,217.0
Lower Subansiri,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,2.0,0.0,0.0,14.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,18.0
Lower Subansiri,1.8,Number of pregnancy test kits used at SC level,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0
Lower Subansiri,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,3.0
Lower Subansiri,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,3.0
Lower Subansiri,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Lower Subansiri,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,35.0,45.0,31.0,49.0,61.0,43.0,61.0,38.0,40.0,35.0,28.0,36.0,502.0
Lower Subansiri,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,13.0,35.0,27.0,9.0,58.0,42.0,61.0,17.0,29.0,31.0,26.0,30.0,378.0
Lower Subansiri,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,35.0,35.0,29.0,37.0,58.0,54.0,5.0,21.0,5.0,9.0,1.0,3.0,292.0
Lower Subansiri,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,19.0,14.0,12.0,20.0,23.0,22.0,1.0,9.0,2.0,0.0,0.0,4.0,126.0
Lower Subansiri,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Lower Subansiri,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Lower Subansiri,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Lower Subansiri,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Lower Subansiri,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Lower Subansiri,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,1.0,1.0,0.0,4.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0,10.0
Lower Subansiri,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lower Subansiri,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,1.0,1.0,0.0,4.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0,10.0
Lower Subansiri,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Lower Subansiri,4.1.1.a,Number of male live births,TOTAL,19.0,21.0,26.0,30.0,35.0,24.0,38.0,23.0,21.0,17.0,16.0,22.0,292.0
Lower Subansiri,4.1.1.b,Number of female live births,TOTAL,16.0,26.0,16.0,20.0,32.0,22.0,25.0,15.0,20.0,18.0,13.0,18.0,241.0
Lower Subansiri,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,35.0,47.0,42.0,50.0,67.0,46.0,63.0,38.0,41.0,35.0,29.0,40.0,533.0
Lower Subansiri,4.1.2,Number of still births,TOTAL,11.0,1.0,0.0,4.0,1.0,4.0,0.0,1.0,0.0,2.0,0.0,0.0,24.0
Lower Subansiri,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,0.0,23.0,20.0,10.0,11.0,22.0,10.0,9.0,14.0,12.0,17.0,6.0,154.0
Lower Subansiri,4.2.1,Number of Newborns weighed at birth,TOTAL,34.0,44.0,38.0,46.0,67.0,13.0,8.0,8.0,39.0,35.0,24.0,40.0,396.0
Lower Subansiri,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,2.0,1.0,2.0,8.0,6.0,2.0,50.0,3.0,1.0,2.0,1.0,2.0,80.0
Lower Subansiri,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,34.0,40.0,38.0,41.0,66.0,46.0,11.0,36.0,38.0,31.0,22.0,36.0,439.0
Lower Subansiri,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Lower Subansiri,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,2.0,2.0,0.0,5.0,2.0,2.0,1.0,1.0,0.0,2.0,0.0,0.0,17.0
Lower Subansiri,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lower Subansiri,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,2.0,2.0,0.0,5.0,4.0,2.0,1.0,1.0,0.0,2.0,0.0,0.0,19.0
Lower Subansiri,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Lower Subansiri,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,4.0,41.0,0.0,5.0,2.0,5.0,0.0,2.0,2.0,3.0,2.0,3.0,69.0
Lower Subansiri,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,17.0,15.0,0.0,5.0,2.0,5.0,1.0,2.0,2.0,3.0,2.0,3.0,57.0
Lower Subansiri,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,3.0,0.0,1.0,6.0,0.0,7.0,4.0,2.0,2.0,54.0,2.0,81.0
Lower Subansiri,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,29.0,3.0,4.0,5.0,47.0,29.0,31.0,7.0,12.0,21.0,12.0,25.0,225.0
Lower Subansiri,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,17.0,4.0,4.0,8.0,17.0,15.0,12.0,28.0,10.0,7.0,7.0,9.0,138.0
Lower Subansiri,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,14.0,9.0,11.0,10.0,7.0,13.0,10.0,6.0,10.0,12.0,6.0,8.0,116.0
Lower Subansiri,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Lower Subansiri,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,15.0,9.0,11.0,10.0,7.0,13.0,10.0,6.0,10.0,12.0,6.0,8.0,117.0
Lower Subansiri,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,2.0,22.0,8.0,12.0,15.0,20.0,13.0,3.0,6.0,8.0,2.0,29.0,140.0
Lower Subansiri,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,35.0,64.0,40.0,41.0,52.0,32.0,17.0,38.0,50.0,40.0,72.0,81.0,562.0
Lower Subansiri,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,37.0,86.0,48.0,53.0,67.0,52.0,30.0,41.0,56.0,48.0,74.0,110.0,702.0
Lower Subansiri,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lower Subansiri,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Lower Subansiri,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lower Subansiri,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Lower Subansiri,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,1.0,2.0,1.0,1.0,3.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
Lower Subansiri,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lower Subansiri,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,1.0,2.0,1.0,1.0,3.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
Lower Subansiri,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Lower Subansiri,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Lower Subansiri,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lower Subansiri,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Lower Subansiri,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Lower Subansiri,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,0.0,0.0,2.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,5.0
Lower Subansiri,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,1.0,0.0,0.0,0.0,4.0,2.0,0.0,4.0,3.0,0.0,1.0,0.0,15.0
Lower Subansiri,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,2.0,3.0,4.0,0.0,5.0,8.0,3.0,4.0,0.0,1.0,0.0,5.0,35.0
Lower Subansiri,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,4.0,15.0,11.0,11.0,12.0,10.0,7.0,12.0,6.0,4.0,9.0,9.0,110.0
Lower Subansiri,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lower Subansiri,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,7.0,18.0,17.0,11.0,21.0,21.0,11.0,20.0,10.0,5.0,10.0,14.0,165.0
Lower Subansiri,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,4.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Lower Subansiri,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Lower Subansiri,9.06,Number of IUCD removals,TOTAL,3.0,9.0,15.0,7.0,11.0,19.0,5.0,9.0,6.0,7.0,14.0,14.0,119.0
Lower Subansiri,9.07,Number of Oral Pills cycles distributed,TOTAL,67.0,83.0,66.0,108.0,73.0,50.0,58.0,39.0,111.0,50.0,62.0,53.0,820.0
Lower Subansiri,9.08,Number of Condom pieces distributed,TOTAL,4.0,189.0,240.0,182.0,179.0,162.0,139.0,7.0,45.0,104.0,21.0,116.0,1388.0
Lower Subansiri,9.09,Number of Centchroman (weekly) pills given,TOTAL,5.0,5.0,2.0,0.0,90.0,30.0,0.0,0.0,0.0,0.0,0.0,0.0,132.0
Lower Subansiri,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,2.0,26.0,2.0,31.0,46.0,72.0,3.0,1.0,4.0,3.0,7.0,20.0,217.0
Lower Subansiri,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,9.12,Number of Institutions having NSV trained doctors,TOTAL,4.0,5.0,5.0,5.0,5.0,5.0,8.0,8.0,8.0,7.0,5.0,8.0,-1.0
Lower Subansiri,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,57.0,65.0,53.0,51.0,91.0,83.0,70.0,80.0,46.0,54.0,52.0,68.0,770.0
Lower Subansiri,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,48.0,72.0,50.0,58.0,89.0,77.0,68.0,64.0,68.0,55.0,73.0,81.0,803.0
Lower Subansiri,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,64.0,47.0,54.0,49.0,68.0,70.0,65.0,105.0,78.0,55.0,49.0,74.0,778.0
Lower Subansiri,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,76.0,71.0,48.0,38.0,67.0,68.0,65.0,74.0,70.0,49.0,58.0,64.0,748.0
Lower Subansiri,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,31.0,51.0,47.0,37.0,60.0,55.0,54.0,7.0,44.0,39.0,32.0,45.0,502.0
Lower Subansiri,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,52.0,68.0,48.0,55.0,116.0,85.0,65.0,64.0,69.0,62.0,72.0,72.0,828.0
Lower Subansiri,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,63.0,49.0,56.0,49.0,83.0,70.0,65.0,96.0,78.0,49.0,49.0,76.0,783.0
Lower Subansiri,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,77.0,71.0,48.0,37.0,112.0,73.0,66.0,74.0,69.0,50.0,60.0,67.0,804.0
Lower Subansiri,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,21.0,36.0,34.0,34.0,45.0,43.0,56.0,3.0,37.0,39.0,24.0,31.0,403.0
Lower Subansiri,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,43.0,90.0,55.0,65.0,112.0,88.0,77.0,65.0,73.0,53.0,80.0,81.0,882.0
Lower Subansiri,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,57.0,45.0,47.0,46.0,73.0,75.0,63.0,90.0,70.0,55.0,55.0,81.0,757.0
Lower Subansiri,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,80.0,68.0,39.0,37.0,66.0,70.0,62.0,61.0,74.0,54.0,60.0,58.0,729.0
Lower Subansiri,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,38.0,62.0,57.0,56.0,84.0,61.0,71.0,44.0,68.0,43.0,51.0,60.0,695.0
Lower Subansiri,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,32.0,41.0,33.0,22.0,14.0,51.0,33.0,27.0,66.0,27.0,33.0,42.0,421.0
Lower Subansiri,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,18.0,21.0,24.0,15.0,21.0,21.0,30.0,19.0,30.0,10.0,19.0,27.0,255.0
Lower Subansiri,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,17.0,29.0,15.0,16.0,35.0,26.0,21.0,22.0,24.0,17.0,24.0,36.0,282.0
Lower Subansiri,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,35.0,50.0,39.0,31.0,56.0,47.0,51.0,41.0,54.0,27.0,43.0,63.0,537.0
Lower Subansiri,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,43.0,47.0,38.0,43.0,51.0,64.0,48.0,34.0,66.0,32.0,53.0,36.0,555.0
Lower Subansiri,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,45.0,46.0,38.0,41.0,120.0,63.0,47.0,34.0,74.0,32.0,53.0,36.0,629.0
Lower Subansiri,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,1.0,0.0,0.0,1.0,2.0,2.0,2.0,33.0,0.0,5.0,3.0,49.0
Lower Subansiri,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,16.0,24.0,19.0,23.0,12.0,31.0,10.0,13.0,41.0,17.0,19.0,21.0,246.0
Lower Subansiri,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,17.0,26.0,13.0,22.0,18.0,17.0,16.0,9.0,29.0,14.0,17.0,21.0,219.0
Lower Subansiri,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,33.0,50.0,32.0,45.0,30.0,48.0,26.0,22.0,70.0,31.0,36.0,42.0,465.0
Lower Subansiri,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,7.0,7.0,17.0,8.0,10.0,19.0,6.0,7.0,26.0,14.0,11.0,15.0,147.0
Lower Subansiri,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,7.0,4.0,8.0,11.0,9.0,13.0,13.0,2.0,12.0,6.0,5.0,6.0,96.0
Lower Subansiri,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,5.0,1.0,8.0,5.0,9.0,8.0,2.0,2.0,4.0,3.0,4.0,3.0,54.0
Lower Subansiri,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,21.0,31.0,23.0,27.0,30.0,29.0,22.0,21.0,29.0,25.0,21.0,32.0,311.0
Lower Subansiri,10.4.2,Number of Immunisation sessions held during the month,TOTAL,19.0,28.0,23.0,26.0,30.0,31.0,22.0,27.0,33.0,25.0,21.0,33.0,318.0
Lower Subansiri,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,4.0,2.0,6.0,2.0,3.0,6.0,4.0,5.0,11.0,7.0,7.0,8.0,65.0
Lower Subansiri,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,0.0,0.0,0.0,0.0,0.0,113.0,108.0,44.0,93.0,43.0,27.0,66.0,494.0
Lower Subansiri,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,0.0,0.0,0.0,0.0,0.0,35.0,13.0,11.0,30.0,6.0,2.0,11.0,108.0
Lower Subansiri,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,0.0,0.0,0.0,3.0,0.0,6.0,45.0,0.0,3.0,50.0,107.0
Lower Subansiri,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,1.0,2.0,3.0,1.0,1.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,10.0
Lower Subansiri,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,37.0,46.0,195.0,98.0,85.0,174.0,87.0,71.0,54.0,61.0,83.0,122.0,1113.0
Lower Subansiri,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,24.0,0.0,4.0,2.0,7.0,0.0,0.0,0.0,0.0,0.0,2.0,39.0
Lower Subansiri,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,3.0,2.0,52.0,38.0,16.0,8.0,24.0,1.0,7.0,11.0,21.0,14.0,197.0
Lower Subansiri,13.1,Number of Patients operated for cataract,TOTAL,1.0,5.0,3.0,1.0,3.0,7.0,7.0,1.0,0.0,2.0,2.0,2.0,34.0
Lower Subansiri,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,5.0,0.0,1.0,3.0,2.0,1.0,1.0,0.0,0.0,2.0,2.0,17.0
Lower Subansiri,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,10.0
Lower Subansiri,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,3.0,,,,1.0,1.0,1.0,1.0,2.0,2.0,2.0,2.0,-1.0
Lower Subansiri,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,6.0,5.0,5.0,4.0,7.0,7.0,6.0,6.0,7.0,5.0,5.0,4.0,-1.0
Lower Subansiri,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,7.0,9.0,14.0,15.0,12.0,32.0,26.0,23.0,30.0,34.0,56.0,36.0,-1.0
Lower Subansiri,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,2.0,-1.0
Lower Subansiri,14.05,Number of RKS meetings held during the month,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,1.0,1.0,0.0,3.0,8.0
Lower Subansiri,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,5.0,6.0,5.0,5.0,8.0,7.0,10.0,7.0,6.0,5.0,3.0,4.0,-1.0
Lower Subansiri,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,1.0,4.0,1.0,1.0,37.0,30.0,3.0,1.0,5.0,1.0,4.0,2.0,90.0
Lower Subansiri,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,2.0,1.0,2.0,2.0,2.0,1.0,1.0,1.0,2.0,,1.0,-1.0
Lower Subansiri,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,2.0,1.0,1.0,2.0,-1.0
Lower Subansiri,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,18.0,51.0,87.0,104.0,88.0,42.0,36.0,27.0,25.0,19.0,22.0,29.0,548.0
Lower Subansiri,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,111.0,104.0,130.0,175.0,156.0,126.0,63.0,81.0,59.0,50.0,51.0,74.0,1180.0
Lower Subansiri,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,28.0,38.0,90.0,126.0,79.0,47.0,34.0,31.0,12.0,16.0,39.0,42.0,582.0
Lower Subansiri,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,257.0,183.0,267.0,403.0,262.0,215.0,134.0,123.0,81.0,74.0,89.0,152.0,2240.0
Lower Subansiri,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,46.0,89.0,177.0,230.0,167.0,89.0,70.0,58.0,37.0,35.0,61.0,71.0,1130.0
Lower Subansiri,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,368.0,287.0,397.0,578.0,418.0,341.0,197.0,204.0,140.0,124.0,140.0,226.0,3420.0
Lower Subansiri,14.10.2.a,Number of death cases of Inpatient males,TOTAL,2.0,0.0,0.0,3.0,1.0,2.0,3.0,3.0,3.0,1.0,2.0,3.0,23.0
Lower Subansiri,14.10.2.b,Number of death cases of Inpatient females,TOTAL,1.0,0.0,2.0,3.0,4.0,2.0,1.0,1.0,1.0,1.0,0.0,0.0,16.0
Lower Subansiri,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,3.0,0.0,2.0,6.0,5.0,4.0,4.0,4.0,4.0,2.0,2.0,3.0,39.0
Lower Subansiri,14.11,In-Patient Head Count at midnight,TOTAL,304.0,286.0,17.0,543.0,1.0,290.0,222.0,179.0,114.0,117.0,8.0,217.0,2298.0
Lower Subansiri,14.12.1,OPD attendance (All),TOTAL,4569.0,4741.0,5433.0,6123.0,4960.0,4959.0,3990.0,4110.0,3043.0,2811.0,3188.0,4315.0,52242.0
Lower Subansiri,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,1.0,0.0,3.0,13.0,13.0,14.0,10.0,6.0,3.0,2.0,0.0,10.0,75.0
Lower Subansiri,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,40.0,68.0,139.0,71.0,76.0,114.0,57.0,118.0,83.0,57.0,65.0,76.0,964.0
Lower Subansiri,14.14.a,Number of patients given AYUSH treatment,TOTAL,198.0,124.0,162.0,122.0,199.0,135.0,113.0,97.0,115.0,0.0,0.0,235.0,1500.0
Lower Subansiri,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,450.0,401.0,484.0,368.0,441.0,468.0,435.0,317.0,262.0,377.0,349.0,445.0,4797.0
Lower Subansiri,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,11.0,7.0,6.0,16.0,7.0,16.0,12.0,21.0,96.0
Lower Subansiri,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,30.0,70.0,115.0,87.0,137.0,84.0,44.0,92.0,68.0,63.0,47.0,161.0,998.0
Lower Subansiri,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,0.0,1.0,0.0,14.0,1.0,0.0,0.0,1.0,1.0,0.0,3.0,1.0,22.0
Lower Subansiri,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,12.0,62.0,16.0,9.0,45.0,39.0,31.0,23.0,10.0,15.0,7.0,38.0,307.0
Lower Subansiri,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Lower Subansiri,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,59.0,62.0,68.0,85.0,15.0,44.0,63.0,71.0,68.0,65.0,63.0,74.0,737.0
Lower Subansiri,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,1.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Lower Subansiri,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,14.0,21.0,15.0,14.0,48.0,21.0,18.0,6.0,15.0,15.0,22.0,11.0,220.0
Lower Subansiri,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,3.0,0.0,0.0,0.0,5.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,13.0
Lower Subansiri,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,85.0,145.0,99.0,108.0,108.0,104.0,112.0,100.0,93.0,95.0,92.0,123.0,1264.0
Lower Subansiri,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,3.0,1.0,0.0,0.0,6.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,18.0
Lower Subansiri,15.2,Number of Widal tests conducted,Number tested,98.0,46.0,189.0,111.0,270.0,73.0,31.0,97.0,48.0,48.0,85.0,95.0,1191.0
Lower Subansiri,15.3.a,Number of VDRL tests conducted on males,Number tested,2.0,18.0,5.0,12.0,13.0,17.0,7.0,3.0,5.0,8.0,2.0,110.0,202.0
Lower Subansiri,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,21.0,48.0,29.0,29.0,34.0,16.0,8.0,8.0,36.0,28.0,42.0,29.0,328.0
Lower Subansiri,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,17.0,22.0,21.0,21.0,35.0,18.0,8.0,30.0,18.0,15.0,30.0,64.0,299.0
Lower Subansiri,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,40.0,88.0,55.0,62.0,82.0,51.0,23.0,41.0,59.0,51.0,74.0,203.0,829.0
Lower Subansiri,15.4.1,Number of blood smears examined for Malaria,TOTAL,106.0,230.0,457.0,746.0,496.0,409.0,122.0,162.0,146.0,51.0,93.0,162.0,3180.0
Lower Subansiri,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,5.0,4.0,4.0,27.0,27.0,11.0,7.0,0.0,9.0,0.0,4.0,6.0,104.0
Lower Subansiri,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,1.0,4.0,4.0,0.0,0.0,4.0,1.0,13.0,0.0,9.0,13.0,50.0
Lower Subansiri,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1370.0,1110.0,2960.0,2650.0,2400.0,,1080.0,840.0,,,,,12410.0
Lower Subansiri,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,2000.0,0.0,0.0,0.0,,0.0,2000.0,,,,,4000.0
Lower Subansiri,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lower Subansiri,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,260.0,150.0,310.0,250.0,500.0,,240.0,250.0,,,,,1960.0
Lower Subansiri,16.1.1,Stock position of DPT vaccines,5. Total Stock,1110.0,2960.0,2650.0,2400.0,1900.0,0.0,840.0,2590.0,0.0,0.0,0.0,0.0,14450.0
Lower Subansiri,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Lower Subansiri,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Lower Subansiri,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Lower Subansiri,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Lower Subansiri,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,2660.0,2340.0,2160.0,1900.0,1700.0,,1740.0,1320.0,,,,,13820.0
Lower Subansiri,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lower Subansiri,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,320.0,180.0,260.0,200.0,620.0,,420.0,200.0,,,,,2200.0
Lower Subansiri,16.1.2,Stock position of OPV vaccines,5. Total Stock,2340.0,2160.0,1900.0,1700.0,1080.0,0.0,1320.0,1120.0,0.0,0.0,0.0,0.0,11620.0
Lower Subansiri,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1250.0,900.0,2690.0,2330.0,2260.0,,1270.0,1000.0,,,,,11700.0
Lower Subansiri,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,2000.0,0.0,0.0,0.0,,0.0,2000.0,,,,,4000.0
Lower Subansiri,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lower Subansiri,16.1.3,Stock position of TT vaccines,4. Stock Distributed,350.0,210.0,360.0,70.0,350.0,,270.0,220.0,,,,,1830.0
Lower Subansiri,16.1.3,Stock position of TT vaccines,5. Total Stock,900.0,2690.0,2330.0,2260.0,1910.0,0.0,1000.0,2780.0,0.0,0.0,0.0,0.0,13870.0
Lower Subansiri,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lower Subansiri,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,780.0,780.0,3600.0,3440.0,3300.0,,2160.0,1950.0,,,,,16010.0
Lower Subansiri,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,3000.0,0.0,0.0,0.0,,0.0,1000.0,,,,,4000.0
Lower Subansiri,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lower Subansiri,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,220.0,180.0,160.0,140.0,560.0,,210.0,250.0,,,,,1720.0
Lower Subansiri,16.1.5,Stock position of BCG vaccines,5. Total Stock,560.0,3600.0,3440.0,3300.0,2740.0,0.0,1950.0,2700.0,0.0,0.0,0.0,0.0,18290.0
Lower Subansiri,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1580.0,1440.0,3275.0,2595.0,2530.0,,1730.0,0.0,,,,,13150.0
Lower Subansiri,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,2000.0,0.0,0.0,0.0,,0.0,2000.0,,,,,4000.0
Lower Subansiri,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lower Subansiri,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,140.0,165.0,680.0,65.0,255.0,,240.0,150.0,,,,,1695.0
Lower Subansiri,16.1.6,Stock position of Measles vaccines,5. Total Stock,1440.0,3275.0,2595.0,2530.0,2275.0,0.0,1490.0,1850.0,0.0,0.0,0.0,0.0,15455.0
Lower Subansiri,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lower Subansiri,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1500.0,1240.0,2990.0,2580.0,2430.0,,1610.0,1440.0,,,,,13790.0
Lower Subansiri,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,2000.0,0.0,0.0,0.0,,0.0,1800.0,,,,,3800.0
Lower Subansiri,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lower Subansiri,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,260.0,250.0,410.0,150.0,410.0,,170.0,100.0,,,,,1750.0
Lower Subansiri,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1240.0,2990.0,2580.0,2430.0,2020.0,0.0,1440.0,3140.0,0.0,0.0,0.0,0.0,15840.0
Lower Subansiri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,80.0,80.0,80.0,80.0,70.0,,0.0,180.0,,,,,570.0
Lower Subansiri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,100.0,,200.0,0.0,,,,,300.0
Lower Subansiri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Lower Subansiri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,50.0,50.0,10.0,50.0,,20.0,20.0,,,,,200.0
Lower Subansiri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,80.0,30.0,30.0,70.0,120.0,0.0,180.0,160.0,0.0,0.0,0.0,0.0,670.0
Lower Subansiri,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,6000.0,5450.0,5450.0,5450.0,4950.0,,3450.0,3450.0,,,,,34200.0
Lower Subansiri,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Lower Subansiri,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,550.0,0.0,0.0,500.0,1500.0,,0.0,0.0,,,,,2550.0
Lower Subansiri,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,5450.0,5450.0,5450.0,4950.0,3450.0,0.0,3450.0,3450.0,0.0,0.0,0.0,0.0,31650.0
Lower Subansiri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,520.0,370.0,370.0,370.0,290.0,,90.0,90.0,,,,,2100.0
Lower Subansiri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Lower Subansiri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,150.0,0.0,0.0,80.0,200.0,,0.0,0.0,,,,,430.0
Lower Subansiri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,370.0,370.0,370.0,290.0,90.0,0.0,90.0,90.0,0.0,0.0,0.0,0.0,1670.0
Lower Subansiri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Lower Subansiri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Lower Subansiri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Lower Subansiri,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Lower Subansiri,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Lower Subansiri,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Lower Subansiri,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Lower Subansiri,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Lower Subansiri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Lower Subansiri,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Lower Subansiri,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Lower Subansiri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,190.0,185.0,,,,,375.0
Lower Subansiri,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Lower Subansiri,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,5.0,15.0,,,,,20.0
Lower Subansiri,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,185.0,170.0,0.0,0.0,0.0,0.0,355.0
Lower Subansiri,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Lower Subansiri,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Lower Subansiri,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lower Subansiri,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1036.0,986.0,986.0,786.0,776.0,,516.0,486.0,,,,,5572.0
Lower Subansiri,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,500.0,,,,,500.0
Lower Subansiri,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Lower Subansiri,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,50.0,0.0,200.0,10.0,20.0,,30.0,50.0,,,,,360.0
Lower Subansiri,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,986.0,986.0,786.0,776.0,756.0,0.0,486.0,936.0,0.0,0.0,0.0,0.0,5712.0
Lower Subansiri,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,3345.0,3045.0,9635.0,9435.0,8365.0,,5865.0,5115.0,,,,,44805.0
Lower Subansiri,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,7200.0,0.0,0.0,0.0,,0.0,3000.0,,,,,10200.0
Lower Subansiri,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Lower Subansiri,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,300.0,610.0,200.0,1070.0,900.0,,750.0,800.0,,,,,4630.0
Lower Subansiri,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,3045.0,9635.0,9435.0,8365.0,7465.0,0.0,5115.0,7315.0,0.0,0.0,0.0,0.0,50375.0
Lower Subansiri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,790.0,755.0,755.0,1020.0,585.0,,440.0,375.0,,,,,4720.0
Lower Subansiri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,500.0,500.0,0.0,0.0,,0.0,500.0,,,,,1500.0
Lower Subansiri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Lower Subansiri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,35.0,235.0,235.0,435.0,45.0,,65.0,50.0,,,,,1100.0
Lower Subansiri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,755.0,1020.0,1020.0,585.0,540.0,0.0,375.0,825.0,0.0,0.0,0.0,0.0,5120.0
Lower Subansiri,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Lower Subansiri,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,1.0,,,,,,,,,,,,1.0
Lower Subansiri,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lower Subansiri,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,,,,,,,,,,,,1.0
Lower Subansiri,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Lower Subansiri,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lower Subansiri,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Lower Subansiri,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,1.0,,,,,,,,1.0
Lower Subansiri,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lower Subansiri,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,1.0,,,,,,,,1.0
Lower Subansiri,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Lower Subansiri,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lower Subansiri,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Lower Subansiri,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Lower Subansiri,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Lower Subansiri,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Lower Subansiri,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Lower Subansiri,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Lower Subansiri,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Lower Subansiri,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Lower Subansiri,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Lower Subansiri,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Lower Subansiri,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Lower Subansiri,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Lower Subansiri,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Lower Subansiri,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Lower Subansiri,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Lower Subansiri,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Lower Subansiri,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Lower Subansiri,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Lower Subansiri,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Lower Subansiri,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Lower Subansiri,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Lower Subansiri,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Lower Subansiri,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Lower Subansiri,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,1.0,,,,,,1.0
Lower Subansiri,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Lower Subansiri,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Lower Subansiri,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Lower Subansiri,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Lower Subansiri,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Lower Subansiri,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Lower Subansiri,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Lower Subansiri,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Lower Subansiri,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Lower Subansiri,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,2.0,,,,,,,,,2.0
Lower Subansiri,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Lower Subansiri,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,2.0,,,1.0,,,,,,3.0
Lower Subansiri,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Lower Subansiri,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Lower Subansiri,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Lower Subansiri,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Lower Subansiri,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Lower Subansiri,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Lower Subansiri,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Lower Subansiri,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Lower Subansiri,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Lower Subansiri,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Lower Subansiri,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Lower Subansiri,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Lower Subansiri,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Lower Subansiri,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Lower Subansiri,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Lower Subansiri,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Lower Subansiri,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Lower Subansiri,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Lower Subansiri,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Lower Subansiri,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Lower Subansiri,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Lower Subansiri,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Lower Subansiri,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Lower Subansiri,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Lower Subansiri,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Lower Subansiri,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Lower Subansiri,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Lower Subansiri,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Lower Subansiri,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Lower Subansiri,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Lower Subansiri,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Lower Subansiri,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Lower Subansiri,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Lower Subansiri,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Lower Subansiri,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Lower Subansiri,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,1.0,,,,,1.0
Lower Subansiri,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Lower Subansiri,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,1.0,1.0,,,,2.0
Lower Subansiri,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Lower Subansiri,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,1.0,1.0,,,,2.0
Lower Subansiri,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Lower Subansiri,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Lower Subansiri,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Lower Subansiri,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Lower Subansiri,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Lower Subansiri,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Lower Subansiri,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Lower Subansiri,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Lower Subansiri,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Lower Subansiri,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Lower Subansiri,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Lower Subansiri,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,1.0,,,,,,,,1.0
Lower Subansiri,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Lower Subansiri,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Lower Subansiri,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Lower Subansiri,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,1.0,,,,,,,,,1.0
Lower Subansiri,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Lower Subansiri,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,1.0,,2.0,,,,1.0,,,1.0,,,5.0
Lower Subansiri,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Lower Subansiri,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,2.0,,2.0,1.0,,,1.0,,,1.0,,,7.0
Papum Pare,1.1,Total number of pregnant women Registered for ANC,TOTAL,720.0,918.0,777.0,958.0,819.0,1020.0,827.0,712.0,310.0,426.0,392.0,670.0,8549.0
Papum Pare,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,336.0,338.0,318.0,470.0,420.0,446.0,408.0,352.0,171.0,256.0,205.0,422.0,4142.0
Papum Pare,1.2,Number of Pregnant women registered under JSY,TOTAL,289.0,276.0,260.0,427.0,380.0,145.0,331.0,295.0,159.0,215.0,209.0,258.0,3244.0
Papum Pare,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,114.0,191.0,153.0,262.0,193.0,447.0,172.0,125.0,203.0,274.0,259.0,302.0,2695.0
Papum Pare,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,353.0,351.0,326.0,474.0,454.0,487.0,392.0,362.0,212.0,290.0,234.0,445.0,4380.0
Papum Pare,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,112.0,127.0,156.0,356.0,204.0,182.0,159.0,151.0,125.0,159.0,167.0,230.0,2128.0
Papum Pare,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,47.0,35.0,319.0,349.0,357.0,430.0,312.0,362.0,431.0,299.0,273.0,450.0,3664.0
Papum Pare,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,0.0,0.0,1.0,0.0,3.0,0.0,12.0,2.0,37.0,52.0,41.0,72.0,220.0
Papum Pare,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,5.0
Papum Pare,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,53.0,51.0,136.0,137.0,77.0,38.0,45.0,6.0,52.0,56.0,44.0,353.0,1048.0
Papum Pare,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,11.0,12.0,19.0,20.0,7.0,15.0,13.0,1.0,21.0,10.0,21.0,10.0,160.0
Papum Pare,1.8,Number of pregnancy test kits used at SC level,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Papum Pare,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,1.0,1.0,2.0,1.0,1.0,1.0,2.0,5.0,1.0,1.0,3.0,1.0,20.0
Papum Pare,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,3.0,0.0,1.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Papum Pare,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,4.0,1.0,3.0,3.0,2.0,1.0,2.0,5.0,1.0,1.0,3.0,1.0,27.0
Papum Pare,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,2.0,1.0,3.0,0.0,0.0,1.0,2.0,4.0,0.0,0.0,3.0,1.0,17.0
Papum Pare,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,1.0,0.0,0.0,0.0,1.0,2.0,4.0,0.0,0.0,2.0,1.0,11.0
Papum Pare,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,194.0,206.0,170.0,218.0,234.0,204.0,229.0,227.0,199.0,208.0,215.0,214.0,2518.0
Papum Pare,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,133.0,49.0,141.0,197.0,189.0,127.0,127.0,188.0,183.0,192.0,200.0,197.0,1923.0
Papum Pare,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,75.0,152.0,128.0,45.0,40.0,32.0,17.0,5.0,7.0,8.0,9.0,56.0,574.0
Papum Pare,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,12.0,18.0,17.0,19.0,9.0,31.0,11.0,3.0,7.0,11.0,8.0,8.0,154.0
Papum Pare,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Papum Pare,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,111.0,158.0,143.0,143.0,225.0,148.0,202.0,215.0,217.0,197.0,159.0,206.0,2124.0
Papum Pare,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,54.0,55.0,42.0,63.0,73.0,51.0,72.0,75.0,65.0,61.0,69.0,77.0,757.0
Papum Pare,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Papum Pare,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,54.0,55.0,42.0,63.0,73.0,51.0,72.0,75.0,65.0,61.0,69.0,77.0,757.0
Papum Pare,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,65.0,37.0,34.0,34.0,53.0,65.0,54.0,67.0,159.0,197.0,70.0,60.0,895.0
Papum Pare,4.1.1.a,Number of male live births,TOTAL,168.0,173.0,161.0,223.0,222.0,178.0,219.0,235.0,194.0,205.0,208.0,214.0,2400.0
Papum Pare,4.1.1.b,Number of female live births,TOTAL,140.0,189.0,156.0,142.0,231.0,170.0,207.0,206.0,220.0,195.0,166.0,202.0,2224.0
Papum Pare,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,308.0,362.0,317.0,365.0,453.0,348.0,426.0,441.0,414.0,400.0,374.0,416.0,4624.0
Papum Pare,4.1.2,Number of still births,TOTAL,2.0,5.0,2.0,4.0,9.0,5.0,7.0,6.0,3.0,7.0,4.0,5.0,59.0
Papum Pare,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,33.0,45.0,53.0,54.0,53.0,36.0,29.0,23.0,29.0,37.0,40.0,45.0,477.0
Papum Pare,4.2.1,Number of Newborns weighed at birth,TOTAL,302.0,361.0,314.0,356.0,413.0,351.0,426.0,445.0,414.0,405.0,374.0,417.0,4578.0
Papum Pare,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,12.0,23.0,12.0,14.0,31.0,18.0,16.0,24.0,22.0,13.0,15.0,14.0,214.0
Papum Pare,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,191.0,342.0,311.0,286.0,354.0,336.0,425.0,440.0,409.0,393.0,369.0,404.0,4260.0
Papum Pare,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,10.0,2.0,6.0,3.0,2.0,3.0,1.0,0.0,0.0,0.0,0.0,27.0
Papum Pare,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,2.0
Papum Pare,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Papum Pare,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,10.0,2.0,6.0,3.0,2.0,5.0,1.0,0.0,0.0,0.0,0.0,29.0
Papum Pare,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,2.0,13.0,0.0,5.0,,0.0,21.0
Papum Pare,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,151.0,10.0,0.0,3.0,225.0,0.0,205.0,213.0,217.0,197.0,158.0,206.0,1585.0
Papum Pare,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,1.0,0.0,0.0,0.0,2.0,0.0,2.0,7.0,2.0,2.0,0.0,0.0,16.0
Papum Pare,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,130.0,10.0,2.0,6.0,225.0,2.0,195.0,181.0,200.0,166.0,158.0,206.0,1481.0
Papum Pare,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,4.0,0.0,12.0,7.0,4.0,4.0,8.0,4.0,43.0
Papum Pare,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,19.0,27.0,158.0,149.0,205.0,11.0,214.0,276.0,224.0,204.0,165.0,215.0,1867.0
Papum Pare,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,10.0,21.0,13.0,12.0,5.0,9.0,9.0,28.0,7.0,4.0,6.0,5.0,129.0
Papum Pare,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,16.0,19.0,16.0,29.0,20.0,16.0,12.0,9.0,19.0,30.0,28.0,34.0,248.0
Papum Pare,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,17.0,26.0,12.0,24.0,33.0,20.0,16.0,14.0,10.0,7.0,11.0,10.0,200.0
Papum Pare,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,33.0,45.0,28.0,53.0,53.0,36.0,28.0,23.0,29.0,37.0,39.0,44.0,448.0
Papum Pare,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,16.0,14.0,19.0,11.0,11.0,12.0,9.0,3.0,3.0,13.0,9.0,10.0,130.0
Papum Pare,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,10.0,17.0,9.0,10.0,11.0,17.0,7.0,3.0,14.0,13.0,14.0,12.0,137.0
Papum Pare,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,26.0,31.0,28.0,21.0,22.0,29.0,16.0,6.0,17.0,26.0,23.0,22.0,267.0
Papum Pare,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,3.0,1.0,5.0,2.0,4.0,0.0,2.0,4.0,3.0,2.0,1.0,27.0
Papum Pare,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Papum Pare,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,13.0,32.0,28.0,38.0,38.0,32.0,29.0,24.0,14.0,0.0,20.0,5.0,273.0
Papum Pare,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Papum Pare,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,13.0,32.0,28.0,38.0,38.0,32.0,29.0,24.0,14.0,0.0,20.0,5.0,273.0
Papum Pare,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,7.0,4.0,12.0,16.0,16.0,9.0,12.0,7.0,0.0,0.0,12.0,15.0,110.0
Papum Pare,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Papum Pare,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,7.0,4.0,12.0,16.0,16.0,9.0,12.0,7.0,0.0,0.0,12.0,15.0,110.0
Papum Pare,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,6.0,2.0,9.0,5.0,5.0,6.0,5.0,5.0,0.0,0.0,8.0,8.0,59.0
Papum Pare,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Papum Pare,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,6.0,2.0,9.0,5.0,5.0,6.0,5.0,5.0,0.0,0.0,8.0,8.0,59.0
Papum Pare,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,0.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Papum Pare,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,0.0,0.0,2.0,3.0,1.0,2.0,1.0,0.0,3.0,0.0,0.0,12.0
Papum Pare,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,7.0,5.0,3.0,5.0,1.0,6.0,1.0,5.0,2.0,2.0,6.0,1.0,44.0
Papum Pare,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,40.0,54.0,60.0,36.0,52.0,68.0,124.0,21.0,93.0,48.0,45.0,41.0,682.0
Papum Pare,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Papum Pare,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,47.0,59.0,73.0,43.0,56.0,75.0,127.0,27.0,95.0,53.0,51.0,42.0,748.0
Papum Pare,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,6.0,6.0,3.0,8.0,7.0,3.0,5.0,91.0,64.0,27.0,30.0,31.0,281.0
Papum Pare,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,8.0,19.0,19.0,17.0,0.0,10.0,14.0,9.0,28.0,0.0,15.0,139.0
Papum Pare,9.06,Number of IUCD removals,TOTAL,5.0,13.0,7.0,56.0,14.0,7.0,15.0,19.0,21.0,5.0,0.0,24.0,186.0
Papum Pare,9.07,Number of Oral Pills cycles distributed,TOTAL,161.0,131.0,182.0,233.0,123.0,122.0,91.0,78.0,119.0,146.0,148.0,142.0,1676.0
Papum Pare,9.08,Number of Condom pieces distributed,TOTAL,539.0,491.0,401.0,354.0,567.0,464.0,443.0,408.0,404.0,535.0,522.0,443.0,5571.0
Papum Pare,9.09,Number of Centchroman (weekly) pills given,TOTAL,7.0,15.0,5.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,28.0
Papum Pare,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,22.0,18.0,13.0,0.0,3.0,1.0,4.0,2.0,0.0,3.0,2.0,4.0,72.0
Papum Pare,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,9.12,Number of Institutions having NSV trained doctors,TOTAL,8.0,7.0,7.0,7.0,7.0,7.0,6.0,6.0,5.0,5.0,5.0,5.0,-1.0
Papum Pare,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,347.0,504.0,357.0,616.0,504.0,528.0,478.0,455.0,449.0,418.0,392.0,417.0,5465.0
Papum Pare,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,217.0,224.0,150.0,268.0,254.0,331.0,271.0,309.0,329.0,251.0,229.0,302.0,3135.0
Papum Pare,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,207.0,219.0,149.0,252.0,237.0,262.0,253.0,250.0,284.0,243.0,221.0,266.0,2843.0
Papum Pare,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,213.0,196.0,125.0,225.0,211.0,242.0,224.0,205.0,201.0,235.0,239.0,240.0,2556.0
Papum Pare,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,0.0,4.0
Papum Pare,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,427.0,487.0,442.0,583.0,685.0,448.0,598.0,547.0,559.0,497.0,439.0,450.0,6162.0
Papum Pare,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,182.0,223.0,150.0,266.0,256.0,327.0,273.0,311.0,331.0,250.0,229.0,302.0,3100.0
Papum Pare,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,171.0,219.0,150.0,252.0,238.0,256.0,253.0,243.0,284.0,241.0,221.0,265.0,2793.0
Papum Pare,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,182.0,191.0,128.0,222.0,211.0,240.0,224.0,205.0,202.0,227.0,240.0,240.0,2512.0
Papum Pare,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,213.0,216.0,67.0,319.0,217.0,312.0,282.0,222.0,276.0,184.0,193.0,195.0,2696.0
Papum Pare,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,214.0,288.0,138.0,294.0,295.0,388.0,303.0,371.0,330.0,216.0,214.0,311.0,3362.0
Papum Pare,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,214.0,211.0,145.0,239.0,219.0,256.0,271.0,259.0,276.0,249.0,219.0,254.0,2812.0
Papum Pare,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,211.0,173.0,84.0,201.0,203.0,245.0,221.0,228.0,201.0,226.0,236.0,234.0,2463.0
Papum Pare,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,109.0,428.0,156.0,473.0,280.0,310.0,294.0,335.0,217.0,247.0,252.0,273.0,3374.0
Papum Pare,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,11.0,121.0,12.0,22.0,27.0,36.0,28.0,20.0,57.0,95.0,21.0,145.0,595.0
Papum Pare,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,36.0,83.0,184.0,311.0,91.0,87.0,72.0,74.0,100.0,118.0,135.0,127.0,1418.0
Papum Pare,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,54.0,95.0,179.0,293.0,120.0,70.0,96.0,104.0,109.0,128.0,110.0,108.0,1466.0
Papum Pare,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,90.0,178.0,363.0,604.0,211.0,157.0,168.0,178.0,209.0,246.0,245.0,235.0,2884.0
Papum Pare,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,143.0,150.0,91.0,187.0,156.0,156.0,94.0,127.0,157.0,137.0,134.0,212.0,1744.0
Papum Pare,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,147.0,149.0,91.0,186.0,150.0,148.0,94.0,126.0,157.0,136.0,136.0,212.0,1732.0
Papum Pare,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,6.0,0.0,0.0,0.0,3.0,0.0,10.0
Papum Pare,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,49.0,44.0,21.0,60.0,118.0,119.0,94.0,68.0,89.0,66.0,56.0,72.0,856.0
Papum Pare,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,44.0,45.0,30.0,49.0,120.0,131.0,96.0,85.0,79.0,68.0,80.0,81.0,908.0
Papum Pare,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,93.0,89.0,51.0,109.0,238.0,250.0,190.0,153.0,168.0,134.0,136.0,153.0,1764.0
Papum Pare,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,23.0,32.0,27.0,34.0,63.0,29.0,33.0,36.0,29.0,28.0,19.0,31.0,384.0
Papum Pare,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,62.0,92.0,67.0,63.0,52.0,57.0,93.0,57.0,47.0,57.0,34.0,48.0,729.0
Papum Pare,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,66.0,72.0,64.0,60.0,52.0,61.0,50.0,70.0,40.0,77.0,34.0,37.0,683.0
Papum Pare,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,82.0,77.0,50.0,82.0,110.0,113.0,103.0,119.0,115.0,100.0,84.0,83.0,1118.0
Papum Pare,10.4.2,Number of Immunisation sessions held during the month,TOTAL,80.0,78.0,45.0,71.0,108.0,109.0,100.0,103.0,106.0,78.0,79.0,79.0,1036.0
Papum Pare,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,28.0,28.0,20.0,16.0,28.0,22.0,23.0,29.0,15.0,14.0,9.0,13.0,245.0
Papum Pare,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,0.0,0.0,150.0,298.0,266.0,209.0,103.0,169.0,179.0,169.0,166.0,159.0,1868.0
Papum Pare,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,0.0,2.0,39.0,260.0,132.0,144.0,91.0,115.0,126.0,202.0,207.0,168.0,1486.0
Papum Pare,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,2.0,40.0,154.0,130.0,132.0,41.0,68.0,92.0,90.0,135.0,98.0,982.0
Papum Pare,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,2.0,2.0,6.0,5.0,5.0,5.0,2.0,5.0,0.0,0.0,0.0,38.0,70.0
Papum Pare,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,332.0,328.0,284.0,236.0,254.0,270.0,242.0,297.0,228.0,283.0,319.0,317.0,3390.0
Papum Pare,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,7.0,7.0,12.0,2.0,7.0,6.0,8.0,9.0,6.0,1.0,1.0,19.0,85.0
Papum Pare,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,242.0,244.0,314.0,301.0,384.0,263.0,248.0,258.0,67.0,88.0,66.0,61.0,2536.0
Papum Pare,13.1,Number of Patients operated for cataract,TOTAL,88.0,83.0,61.0,65.0,35.0,93.0,65.0,112.0,70.0,107.0,123.0,110.0,1012.0
Papum Pare,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,88.0,21.0,61.0,65.0,35.0,93.0,65.0,32.0,29.0,107.0,123.0,110.0,829.0
Papum Pare,13.3,Number of School children detected with Refractive errors,TOTAL,3.0,3.0,0.0,129.0,6.0,4.0,16.0,0.0,6.0,0.0,21.0,36.0,224.0
Papum Pare,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,6.0
Papum Pare,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,5.0,5.0,3.0,4.0,3.0,4.0,5.0,4.0,5.0,5.0,5.0,5.0,-1.0
Papum Pare,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,6.0,5.0,7.0,4.0,4.0,5.0,5.0,3.0,4.0,3.0,3.0,4.0,-1.0
Papum Pare,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,96.0,53.0,47.0,54.0,26.0,4.0,27.0,31.0,32.0,10.0,4.0,15.0,-1.0
Papum Pare,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,4.0,4.0,5.0,5.0,6.0,6.0,6.0,5.0,5.0,5.0,5.0,-1.0
Papum Pare,14.05,Number of RKS meetings held during the month,TOTAL,3.0,2.0,1.0,3.0,2.0,4.0,2.0,1.0,1.0,0.0,1.0,4.0,24.0
Papum Pare,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,10.0,9.0,10.0,9.0,9.0,11.0,11.0,12.0,11.0,11.0,11.0,11.0,-1.0
Papum Pare,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,29.0,50.0,41.0,45.0,35.0,33.0,37.0,37.0,26.0,57.0,42.0,60.0,492.0
Papum Pare,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,4.0,4.0,3.0,3.0,4.0,4.0,5.0,5.0,5.0,5.0,5.0,3.0,-1.0
Papum Pare,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,2.0,3.0,3.0,2.0,2.0,3.0,2.0,2.0,4.0,2.0,3.0,-1.0
Papum Pare,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,160.0,118.0,124.0,121.0,195.0,75.0,177.0,136.0,197.0,204.0,157.0,234.0,1898.0
Papum Pare,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,656.0,752.0,919.0,738.0,676.0,538.0,736.0,722.0,673.0,614.0,560.0,632.0,8216.0
Papum Pare,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,39.0,94.0,138.0,130.0,137.0,63.0,139.0,97.0,71.0,62.0,166.0,174.0,1310.0
Papum Pare,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,756.0,1002.0,792.0,930.0,1150.0,765.0,1033.0,1066.0,818.0,855.0,899.0,963.0,11029.0
Papum Pare,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,199.0,212.0,262.0,251.0,332.0,138.0,316.0,233.0,268.0,266.0,323.0,408.0,3208.0
Papum Pare,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1412.0,1754.0,1711.0,1668.0,1826.0,1303.0,1769.0,1788.0,1491.0,1469.0,1459.0,1595.0,19245.0
Papum Pare,14.10.2.a,Number of death cases of Inpatient males,TOTAL,17.0,26.0,27.0,23.0,16.0,25.0,13.0,16.0,15.0,18.0,15.0,15.0,226.0
Papum Pare,14.10.2.b,Number of death cases of Inpatient females,TOTAL,7.0,26.0,12.0,17.0,19.0,14.0,15.0,10.0,17.0,6.0,15.0,7.0,165.0
Papum Pare,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,24.0,52.0,39.0,40.0,35.0,39.0,28.0,26.0,32.0,24.0,30.0,22.0,391.0
Papum Pare,14.11,In-Patient Head Count at midnight,TOTAL,3542.0,5555.0,5432.0,5564.0,5427.0,5418.0,5271.0,5432.0,4318.0,3545.0,2213.0,5309.0,57026.0
Papum Pare,14.12.1,OPD attendance (All),TOTAL,27057.0,40525.0,34721.0,36071.0,36506.0,32275.0,38513.0,30390.0,28201.0,26771.0,29356.0,32317.0,392703.0
Papum Pare,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,297.0,375.0,317.0,406.0,215.0,138.0,287.0,353.0,254.0,242.0,247.0,227.0,3358.0
Papum Pare,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,77.0,0.0,0.0,0.0,75.0,77.0,102.0,77.0,408.0
Papum Pare,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,332.0,260.0,466.0,540.0,241.0,410.0,522.0,672.0,239.0,297.0,307.0,341.0,4627.0
Papum Pare,14.14.a,Number of patients given AYUSH treatment,TOTAL,507.0,650.0,921.0,750.0,649.0,667.0,785.0,833.0,366.0,318.0,431.0,521.0,7398.0
Papum Pare,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,490.0,588.0,551.0,564.0,500.0,472.0,517.0,1001.0,1034.0,1077.0,1032.0,1124.0,8950.0
Papum Pare,14.14.c,Number of Adolescents counselled,TOTAL,3.0,38.0,16.0,2.0,3.0,5.0,5.0,3.0,24.0,16.0,17.0,0.0,132.0
Papum Pare,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,564.0,1010.0,1262.0,983.0,3556.0,901.0,1145.0,2709.0,1881.0,2265.0,2216.0,3293.0,21785.0
Papum Pare,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,5.0,35.0,67.0,61.0,29.0,7.0,5.0,7.0,14.0,25.0,45.0,51.0,351.0
Papum Pare,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,153.0,376.0,234.0,161.0,196.0,246.0,188.0,203.0,112.0,110.0,103.0,347.0,2429.0
Papum Pare,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,2.0
Papum Pare,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,163.0,354.0,266.0,173.0,142.0,217.0,133.0,153.0,72.0,85.0,114.0,171.0,2043.0
Papum Pare,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,6.0
Papum Pare,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,185.0,317.0,245.0,371.0,259.0,493.0,326.0,178.0,181.0,178.0,292.0,217.0,3242.0
Papum Pare,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,2.0
Papum Pare,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,501.0,1047.0,745.0,705.0,597.0,956.0,647.0,534.0,365.0,373.0,509.0,735.0,7714.0
Papum Pare,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0,10.0
Papum Pare,15.2,Number of Widal tests conducted,Number tested,347.0,601.0,1226.0,1173.0,1911.0,460.0,664.0,514.0,378.0,366.0,503.0,635.0,8778.0
Papum Pare,15.3.a,Number of VDRL tests conducted on males,Number tested,75.0,184.0,842.0,654.0,90.0,123.0,78.0,44.0,80.0,70.0,53.0,72.0,2365.0
Papum Pare,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,195.0,128.0,339.0,187.0,118.0,156.0,121.0,61.0,145.0,86.0,80.0,172.0,1788.0
Papum Pare,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,172.0,388.0,360.0,459.0,454.0,277.0,234.0,204.0,139.0,191.0,101.0,220.0,3199.0
Papum Pare,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,442.0,700.0,1541.0,1300.0,662.0,556.0,433.0,309.0,364.0,347.0,234.0,464.0,7352.0
Papum Pare,15.4.1,Number of blood smears examined for Malaria,TOTAL,316.0,432.0,1922.0,2077.0,1600.0,678.0,957.0,759.0,697.0,462.0,679.0,972.0,11551.0
Papum Pare,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,7.0,95.0,20.0,17.0,18.0,104.0,4.0,3.0,6.0,2.0,3.0,8.0,287.0
Papum Pare,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,45.0,13.0,2.0,7.0,104.0,2.0,1.0,0.0,1.0,1.0,3.0,180.0
Papum Pare,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Papum Pare,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Papum Pare,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Papum Pare,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Papum Pare,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Papum Pare,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Papum Pare,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Papum Pare,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Papum Pare,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Papum Pare,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Papum Pare,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Papum Pare,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Papum Pare,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Papum Pare,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Papum Pare,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Papum Pare,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Papum Pare,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Papum Pare,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Papum Pare,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Papum Pare,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Papum Pare,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Papum Pare,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Papum Pare,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Papum Pare,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Papum Pare,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Papum Pare,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Papum Pare,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Papum Pare,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Papum Pare,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Papum Pare,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Papum Pare,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Papum Pare,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Papum Pare,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Papum Pare,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Papum Pare,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Papum Pare,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Papum Pare,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Papum Pare,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Papum Pare,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Papum Pare,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Papum Pare,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Papum Pare,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Papum Pare,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Papum Pare,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Papum Pare,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Papum Pare,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Papum Pare,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Papum Pare,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Papum Pare,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Papum Pare,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Papum Pare,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Papum Pare,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Papum Pare,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Papum Pare,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Papum Pare,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Papum Pare,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Papum Pare,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Papum Pare,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Papum Pare,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Papum Pare,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Papum Pare,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Papum Pare,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Papum Pare,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Papum Pare,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Papum Pare,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Papum Pare,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Papum Pare,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Papum Pare,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Papum Pare,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Papum Pare,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Papum Pare,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Papum Pare,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Papum Pare,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Papum Pare,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Papum Pare,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Papum Pare,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Papum Pare,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Papum Pare,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Papum Pare,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Papum Pare,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Papum Pare,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Papum Pare,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Papum Pare,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Papum Pare,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Papum Pare,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Papum Pare,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Papum Pare,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Papum Pare,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Papum Pare,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Papum Pare,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Papum Pare,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Papum Pare,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Papum Pare,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Papum Pare,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Papum Pare,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Papum Pare,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Papum Pare,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Papum Pare,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Papum Pare,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Papum Pare,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Papum Pare,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Papum Pare,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Papum Pare,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Papum Pare,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Papum Pare,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Papum Pare,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Papum Pare,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Papum Pare,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Papum Pare,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Papum Pare,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Papum Pare,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Papum Pare,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Papum Pare,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Papum Pare,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,4.0,5.0,2.0,,1.0,1.0,13.0
Papum Pare,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Papum Pare,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Papum Pare,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Papum Pare,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Papum Pare,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Papum Pare,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Papum Pare,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Papum Pare,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Papum Pare,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Papum Pare,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,,,,,,,,1.0,,,,2.0
Papum Pare,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Papum Pare,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,,,,,,,,1.0,,,,2.0
Papum Pare,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Papum Pare,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Papum Pare,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Papum Pare,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Papum Pare,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Papum Pare,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Papum Pare,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,,,,,,,,,,,,1.0
Papum Pare,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Papum Pare,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,,,,,,,,,,,,1.0
Papum Pare,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Papum Pare,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Papum Pare,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Papum Pare,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,1.0,,,,1.0,,2.0
Papum Pare,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,1.0,1.0,1.0,,3.0
Papum Pare,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,1.0,,1.0,1.0,2.0,,5.0
Papum Pare,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Papum Pare,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,1.0,1.0,,1.0,,,,,,,3.0
Papum Pare,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Papum Pare,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,1.0,1.0,,2.0,,,,,,,4.0
Papum Pare,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Papum Pare,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,2.0,,,3.0,1.0,,,,,6.0
Papum Pare,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Papum Pare,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,1.0,,2.0,,,3.0,1.0,,,,,7.0
Papum Pare,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,1.0,,,1.0,,1.0,1.0,,,,4.0
Papum Pare,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,2.0,,6.0,5.0,1.0,3.0,2.0,4.0,2.0,3.0,,3.0,31.0
Papum Pare,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,,2.0,,,1.0,1.0,,1.0,,,1.0,7.0
Papum Pare,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,3.0,,9.0,5.0,1.0,5.0,3.0,5.0,4.0,3.0,,4.0,42.0
Papum Pare,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Papum Pare,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Papum Pare,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Papum Pare,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Papum Pare,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Papum Pare,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,,3.0,2.0,,,2.0,1.0,,,,,9.0
Papum Pare,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Papum Pare,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,,3.0,2.0,,,3.0,1.0,,,,,10.0
Papum Pare,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Papum Pare,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Papum Pare,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Papum Pare,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Papum Pare,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Papum Pare,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,2.0,2.0,2.0,,4.0,2.0,3.0,1.0,4.0,3.0,2.0,25.0
Papum Pare,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,2.0,3.0,,2.0,2.0,1.0,1.0,3.0,3.0,,17.0
Papum Pare,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,2.0,4.0,5.0,,6.0,4.0,5.0,2.0,7.0,6.0,2.0,43.0
Papum Pare,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Papum Pare,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,2.0,,2.0,,,2.0,1.0,,,,,7.0
Papum Pare,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Papum Pare,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,2.0,,2.0,,,2.0,1.0,,,,,7.0
Papum Pare,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Papum Pare,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,1.0,,,,,,1.0
Papum Pare,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Papum Pare,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,1.0,,,,,,1.0
Papum Pare,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Papum Pare,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Papum Pare,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Papum Pare,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Papum Pare,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Papum Pare,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,1.0,1.0,,,2.0
Papum Pare,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Papum Pare,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,1.0,1.0,,,2.0
Papum Pare,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Papum Pare,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Papum Pare,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Papum Pare,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Papum Pare,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Papum Pare,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,1.0,,,,,,1.0
Papum Pare,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Papum Pare,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,1.0,,,,,,1.0
Papum Pare,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Papum Pare,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,1.0,,,1.0
Papum Pare,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Papum Pare,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,1.0,,,1.0
Papum Pare,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Papum Pare,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,1.0,1.0,1.0,,,,,2.0,1.0,,,,6.0
Papum Pare,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Papum Pare,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,1.0,1.0,1.0,1.0,,,,2.0,1.0,,,,7.0
Papum Pare,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Papum Pare,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Papum Pare,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Papum Pare,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Papum Pare,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Papum Pare,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Papum Pare,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Papum Pare,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Papum Pare,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Papum Pare,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,1.0,1.0,2.0,1.0,3.0,1.0,1.0,2.0,2.0,3.0,1.0,18.0
Papum Pare,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,,,,,2.0,,,,,1.0,,4.0
Papum Pare,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,1.0,1.0,1.0,2.0,1.0,5.0,1.0,1.0,2.0,2.0,4.0,1.0,22.0
Papum Pare,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Papum Pare,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,3.0,1.0,,2.0,,,3.0,1.0,1.0,1.0,12.0
Papum Pare,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,1.0,,,,,,1.0,1.0,3.0,2.0,8.0
Papum Pare,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,4.0,1.0,,2.0,,,4.0,2.0,4.0,3.0,20.0
Papum Pare,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,,,,,1.0,1.0,1.0,1.0,,,,5.0
Papum Pare,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,3.0,,6.0,8.0,2.0,4.0,7.0,6.0,7.0,6.0,9.0,4.0,62.0
Papum Pare,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,1.0,,4.0,4.0,,,,1.0,2.0,2.0,1.0,2.0,17.0
Papum Pare,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,5.0,,10.0,12.0,2.0,5.0,8.0,8.0,10.0,8.0,10.0,6.0,84.0
Tawang,1.1,Total number of pregnant women Registered for ANC,TOTAL,80.0,76.0,68.0,77.0,98.0,80.0,69.0,64.0,67.0,77.0,59.0,86.0,901.0
Tawang,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,32.0,44.0,40.0,25.0,44.0,44.0,25.0,36.0,59.0,29.0,38.0,57.0,473.0
Tawang,1.2,Number of Pregnant women registered under JSY,TOTAL,77.0,71.0,58.0,70.0,91.0,51.0,53.0,54.0,62.0,71.0,52.0,81.0,791.0
Tawang,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,12.0,18.0,12.0,10.0,11.0,23.0,19.0,22.0,15.0,23.0,22.0,26.0,213.0
Tawang,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,45.0,49.0,41.0,48.0,45.0,61.0,43.0,46.0,41.0,44.0,36.0,63.0,562.0
Tawang,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,28.0,28.0,26.0,42.0,37.0,42.0,42.0,24.0,23.0,24.0,25.0,58.0,399.0
Tawang,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,6.0,7.0,10.0,73.0,25.0,76.0,67.0,56.0,17.0,72.0,44.0,64.0,517.0
Tawang,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0
Tawang,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,12.0,33.0,30.0,48.0,44.0,34.0,9.0,3.0,15.0,22.0,29.0,22.0,301.0
Tawang,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0
Tawang,1.8,Number of pregnancy test kits used at SC level,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Tawang,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,0.0,4.0,5.0,8.0,7.0,6.0,4.0,8.0,3.0,7.0,1.0,53.0
Tawang,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,2.0,1.0,4.0,5.0,8.0,7.0,6.0,4.0,8.0,3.0,7.0,1.0,56.0
Tawang,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,2.0,1.0,1.0,2.0,8.0,7.0,6.0,2.0,8.0,3.0,7.0,1.0,48.0
Tawang,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,1.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Tawang,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,21.0,17.0,20.0,33.0,27.0,3.0,41.0,17.0,34.0,15.0,17.0,22.0,267.0
Tawang,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,5.0,15.0,18.0,30.0,25.0,3.0,37.0,17.0,32.0,15.0,15.0,21.0,233.0
Tawang,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,5.0,6.0,10.0,10.0,40.0,23.0,3.0,11.0,0.0,1.0,21.0,19.0,149.0
Tawang,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2.0,2.0,1.0,3.0,13.0,5.0,1.0,3.0,0.0,0.0,10.0,4.0,44.0
Tawang,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Tawang,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Tawang,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Tawang,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Tawang,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,2.0,2.0,2.0,3.0,2.0,3.0,4.0,0.0,2.0,0.0,1.0,0.0,21.0
Tawang,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tawang,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,2.0,2.0,2.0,3.0,2.0,3.0,4.0,0.0,2.0,0.0,1.0,0.0,21.0
Tawang,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Tawang,4.1.1.a,Number of male live births,TOTAL,13.0,11.0,18.0,23.0,20.0,14.0,18.0,17.0,24.0,14.0,11.0,12.0,195.0
Tawang,4.1.1.b,Number of female live births,TOTAL,11.0,7.0,6.0,15.0,24.0,19.0,28.0,10.0,17.0,6.0,11.0,11.0,165.0
Tawang,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,24.0,18.0,24.0,38.0,44.0,33.0,46.0,27.0,41.0,20.0,22.0,23.0,360.0
Tawang,4.1.2,Number of still births,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,1.0,0.0,3.0,0.0,7.0
Tawang,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,1.0,2.0,0.0,3.0,2.0,1.0,5.0,2.0,2.0,0.0,2.0,0.0,20.0
Tawang,4.2.1,Number of Newborns weighed at birth,TOTAL,24.0,17.0,20.0,33.0,28.0,30.0,40.0,17.0,33.0,17.0,15.0,22.0,296.0
Tawang,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,3.0,0.0,0.0,2.0,4.0,2.0,2.0,2.0,3.0,1.0,4.0,0.0,23.0
Tawang,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,24.0,17.0,20.0,33.0,28.0,28.0,40.0,17.0,33.0,17.0,15.0,22.0,294.0
Tawang,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,2.0,0.0,2.0,0.0,0.0,0.0,0.0,3.0,0.0,7.0
Tawang,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,17.0,0.0,2.0,3.0,2.0,23.0,4.0,0.0,2.0,0.0,3.0,0.0,56.0
Tawang,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tawang,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,17.0,0.0,2.0,5.0,2.0,25.0,4.0,0.0,2.0,0.0,6.0,0.0,63.0
Tawang,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Tawang,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,17.0,0.0,2.0,3.0,2.0,23.0,4.0,0.0,2.0,0.0,3.0,0.0,56.0
Tawang,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,4.0
Tawang,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,2.0,0.0,2.0,5.0,2.0,25.0,4.0,0.0,2.0,0.0,6.0,0.0,48.0
Tawang,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,13.0,0.0,2.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,17.0
Tawang,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,20.0,14.0,16.0,33.0,30.0,3.0,43.0,16.0,38.0,14.0,14.0,15.0,256.0
Tawang,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2.0,5.0,2.0,7.0,8.0,0.0,12.0,14.0,30.0,12.0,12.0,3.0,107.0
Tawang,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,13.0,1.0,4.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,21.0
Tawang,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,1.0,2.0,0.0,2.0,2.0,1.0,2.0,1.0,2.0,0.0,2.0,0.0,15.0
Tawang,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0
Tawang,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,1.0,2.0,0.0,3.0,2.0,1.0,2.0,2.0,2.0,0.0,2.0,0.0,17.0
Tawang,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,6.0,0.0,0.0,8.0
Tawang,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,0.0,4.0,0.0,1.0,8.0,3.0,0.0,5.0,2.0,9.0,8.0,6.0,46.0
Tawang,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,0.0,4.0,0.0,1.0,8.0,3.0,2.0,5.0,2.0,15.0,8.0,6.0,54.0
Tawang,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,5.0
Tawang,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tawang,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Tawang,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tawang,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Tawang,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0
Tawang,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tawang,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0
Tawang,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Tawang,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tawang,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Tawang,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,2.0,2.0,1.0,3.0,3.0,1.0,2.0,0.0,3.0,0.0,1.0,13.0,31.0
Tawang,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,1.0,1.0,1.0,2.0,2.0,3.0,1.0,0.0,0.0,1.0,1.0,13.0
Tawang,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,2.0,10.0,7.0,6.0,11.0,8.0,18.0,12.0,4.0,4.0,6.0,10.0,98.0
Tawang,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tawang,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,4.0,13.0,9.0,10.0,16.0,11.0,23.0,13.0,7.0,4.0,8.0,24.0,142.0
Tawang,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,1.0,0.0,0.0,0.0,1.0,1.0,2.0,1.0,0.0,0.0,0.0,0.0,6.0
Tawang,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Tawang,9.06,Number of IUCD removals,TOTAL,15.0,0.0,2.0,23.0,3.0,0.0,33.0,0.0,4.0,1.0,2.0,3.0,86.0
Tawang,9.07,Number of Oral Pills cycles distributed,TOTAL,141.0,81.0,118.0,105.0,50.0,42.0,21.0,144.0,65.0,96.0,109.0,109.0,1081.0
Tawang,9.08,Number of Condom pieces distributed,TOTAL,71.0,72.0,205.0,175.0,187.0,105.0,128.0,251.0,100.0,170.0,175.0,76.0,1715.0
Tawang,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,3.0,5.0,0.0,20.0,17.0,19.0,20.0,28.0,19.0,29.0,11.0,18.0,189.0
Tawang,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,1.0,2.0,3.0,1.0,1.0,,1.0,1.0,,,1.0,-1.0
Tawang,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,56.0,54.0,39.0,54.0,74.0,56.0,58.0,44.0,77.0,47.0,53.0,65.0,677.0
Tawang,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,50.0,68.0,43.0,51.0,59.0,62.0,50.0,74.0,65.0,47.0,56.0,79.0,704.0
Tawang,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,48.0,64.0,49.0,47.0,56.0,53.0,55.0,63.0,71.0,57.0,33.0,70.0,666.0
Tawang,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,55.0,52.0,41.0,53.0,67.0,52.0,48.0,58.0,56.0,62.0,38.0,53.0,635.0
Tawang,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,25.0,18.0,19.0,24.0,38.0,32.0,29.0,14.0,42.0,15.0,12.0,14.0,282.0
Tawang,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,50.0,68.0,40.0,51.0,59.0,62.0,52.0,74.0,65.0,50.0,56.0,79.0,706.0
Tawang,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,48.0,65.0,47.0,47.0,56.0,53.0,52.0,63.0,71.0,57.0,43.0,70.0,672.0
Tawang,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,55.0,56.0,43.0,53.0,67.0,52.0,51.0,58.0,57.0,62.0,38.0,53.0,645.0
Tawang,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,9.0,10.0,6.0,16.0,14.0,20.0,24.0,6.0,36.0,9.0,5.0,8.0,163.0
Tawang,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,50.0,68.0,40.0,51.0,60.0,62.0,52.0,74.0,65.0,50.0,56.0,79.0,707.0
Tawang,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,48.0,65.0,47.0,48.0,56.0,53.0,52.0,63.0,71.0,57.0,43.0,70.0,673.0
Tawang,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,55.0,56.0,43.0,52.0,66.0,52.0,51.0,58.0,57.0,62.0,38.0,53.0,643.0
Tawang,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,57.0,81.0,40.0,50.0,69.0,66.0,78.0,80.0,42.0,66.0,43.0,61.0,733.0
Tawang,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,40.0,56.0,48.0,46.0,60.0,44.0,41.0,51.0,51.0,35.0,37.0,42.0,551.0
Tawang,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,30.0,40.0,23.0,25.0,39.0,35.0,20.0,28.0,20.0,29.0,14.0,31.0,334.0
Tawang,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,26.0,36.0,17.0,25.0,24.0,31.0,23.0,24.0,21.0,35.0,16.0,24.0,302.0
Tawang,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,56.0,76.0,40.0,50.0,63.0,66.0,43.0,52.0,41.0,64.0,30.0,55.0,636.0
Tawang,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,40.0,61.0,48.0,47.0,60.0,49.0,44.0,51.0,65.0,36.0,44.0,57.0,602.0
Tawang,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,40.0,61.0,48.0,47.0,60.0,49.0,44.0,51.0,65.0,36.0,47.0,57.0,605.0
Tawang,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,9.0,17.0,3.0,3.0,11.0,4.0,0.0,12.0,19.0,0.0,4.0,0.0,82.0
Tawang,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,9.0,15.0,4.0,0.0,9.0,4.0,0.0,4.0,16.0,0.0,2.0,0.0,63.0
Tawang,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,18.0,32.0,7.0,3.0,20.0,8.0,0.0,16.0,35.0,0.0,6.0,0.0,145.0
Tawang,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,12.0,15.0,7.0,38.0,49.0,23.0,21.0,17.0,40.0,20.0,20.0,31.0,293.0
Tawang,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,6.0,20.0,7.0,8.0,9.0,13.0,8.0,8.0,7.0,3.0,8.0,6.0,103.0
Tawang,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,4.0,8.0,3.0,7.0,4.0,19.0,9.0,7.0,6.0,0.0,5.0,5.0,77.0
Tawang,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,23.0,22.0,21.0,20.0,16.0,20.0,22.0,21.0,23.0,21.0,21.0,21.0,251.0
Tawang,10.4.2,Number of Immunisation sessions held during the month,TOTAL,18.0,18.0,18.0,19.0,15.0,18.0,21.0,20.0,23.0,20.0,19.0,20.0,229.0
Tawang,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,7.0,7.0,3.0,2.0,4.0,6.0,5.0,6.0,7.0,4.0,2.0,6.0,59.0
Tawang,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,0.0,17.0,13.0,32.0,0.0,37.0,71.0,243.0,39.0,51.0,37.0,55.0,595.0
Tawang,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,0.0,0.0,2.0,14.0,11.0,21.0,34.0,12.0,28.0,14.0,19.0,37.0,192.0
Tawang,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,0.0,10.0,0.0,22.0,35.0,15.0,7.0,6.0,12.0,6.0,113.0
Tawang,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,115.0,54.0,63.0,29.0,142.0,56.0,119.0,64.0,76.0,65.0,43.0,100.0,926.0
Tawang,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,3.0
Tawang,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,0.0,0.0,8.0
Tawang,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,6.0,1.0,3.0,12.0
Tawang,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.0,4.0
Tawang,13.3,Number of School children detected with Refractive errors,TOTAL,5.0,8.0,15.0,15.0,15.0,16.0,25.0,50.0,30.0,10.0,10.0,25.0,224.0
Tawang,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,1.0,2.0,2.0,2.0,2.0,1.0,2.0,2.0,1.0,1.0,2.0,-1.0
Tawang,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,1.0,1.0,1.0,1.0,,2.0,,1.0,,1.0,,,-1.0
Tawang,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,67.0,65.0,92.0,96.0,78.0,50.0,55.0,49.0,52.0,83.0,67.0,93.0,-1.0
Tawang,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Tawang,14.05,Number of RKS meetings held during the month,TOTAL,1.0,1.0,0.0,0.0,2.0,2.0,2.0,2.0,0.0,0.0,1.0,2.0,13.0
Tawang,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,4.0,4.0,3.0,4.0,4.0,4.0,4.0,4.0,3.0,4.0,3.0,5.0,-1.0
Tawang,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,5.0,9.0,1.0,9.0,13.0,1.0,13.0,8.0,7.0,9.0,6.0,0.0,81.0
Tawang,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,2.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,,,,-1.0
Tawang,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Tawang,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,5.0,2.0,4.0,6.0,3.0,8.0,6.0,18.0,14.0,12.0,24.0,42.0,144.0
Tawang,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,28.0,6.0,25.0,22.0,34.0,17.0,25.0,54.0,58.0,52.0,53.0,73.0,447.0
Tawang,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,4.0,3.0,4.0,8.0,3.0,11.0,8.0,25.0,10.0,21.0,29.0,44.0,170.0
Tawang,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,18.0,16.0,22.0,33.0,39.0,53.0,59.0,44.0,70.0,66.0,51.0,75.0,546.0
Tawang,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,9.0,5.0,8.0,14.0,6.0,19.0,14.0,43.0,24.0,33.0,53.0,86.0,314.0
Tawang,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,46.0,22.0,47.0,55.0,73.0,70.0,84.0,98.0,128.0,118.0,104.0,148.0,993.0
Tawang,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,0.0,0.0,2.0,2.0,1.0,0.0,0.0,2.0,0.0,0.0,1.0,8.0
Tawang,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,0.0,3.0,1.0,1.0,1.0,1.0,0.0,0.0,1.0,2.0,10.0
Tawang,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,0.0,0.0,5.0,3.0,2.0,1.0,1.0,2.0,0.0,1.0,3.0,18.0
Tawang,14.11,In-Patient Head Count at midnight,TOTAL,51.0,1.0,0.0,0.0,0.0,0.0,0.0,140.0,0.0,0.0,0.0,0.0,192.0
Tawang,14.12.1,OPD attendance (All),TOTAL,4509.0,4616.0,5812.0,6588.0,5438.0,5105.0,4625.0,4392.0,3877.0,4546.0,4898.0,6224.0,60630.0
Tawang,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,2.0,2.0,3.0,2.0,3.0,4.0,0.0,2.0,0.0,1.0,1.0,20.0
Tawang,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,5.0
Tawang,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1.0,10.0,6.0,7.0,12.0,0.0,12.0,9.0,8.0,12.0,0.0,0.0,77.0
Tawang,14.14.a,Number of patients given AYUSH treatment,TOTAL,22.0,84.0,85.0,72.0,36.0,4.0,10.0,178.0,168.0,0.0,105.0,150.0,914.0
Tawang,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,460.0,509.0,791.0,555.0,462.0,392.0,427.0,479.0,342.0,357.0,304.0,351.0,5429.0
Tawang,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Tawang,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,40.0,98.0,80.0,74.0,76.0,55.0,69.0,94.0,56.0,53.0,104.0,51.0,850.0
Tawang,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,0.0,3.0,5.0,1.0,0.0,12.0,0.0,2.0,7.0,62.0,4.0,2.0,98.0
Tawang,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,24.0,38.0,32.0,0.0,7.0,6.0,8.0,11.0,5.0,1.0,0.0,5.0,137.0
Tawang,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,0.0,6.0,35.0,2.0,62.0,15.0,3.0,7.0,3.0,5.0,3.0,4.0,145.0
Tawang,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,62.0,55.0,43.0,47.0,0.0,43.0,40.0,31.0,43.0,41.0,2.0,40.0,447.0
Tawang,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Tawang,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,86.0,99.0,110.0,49.0,69.0,64.0,51.0,49.0,51.0,47.0,5.0,49.0,729.0
Tawang,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Tawang,15.2,Number of Widal tests conducted,Number tested,55.0,58.0,80.0,114.0,85.0,58.0,60.0,0.0,40.0,53.0,65.0,59.0,727.0
Tawang,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,1.0,2.0,4.0,8.0,0.0,2.0,6.0,0.0,4.0,27.0
Tawang,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,2.0,1.0,6.0,1.0,4.0,3.0,7.0,1.0,2.0,5.0,2.0,5.0,39.0
Tawang,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,47.0,61.0,42.0,43.0,53.0,48.0,40.0,36.0,36.0,36.0,41.0,48.0,531.0
Tawang,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,49.0,62.0,48.0,45.0,59.0,55.0,55.0,37.0,40.0,47.0,43.0,57.0,597.0
Tawang,15.4.1,Number of blood smears examined for Malaria,TOTAL,45.0,59.0,62.0,139.0,52.0,16.0,11.0,1.0,19.0,36.0,54.0,33.0,527.0
Tawang,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,4.0,1.0,3.0,4.0,1.0,3.0,2.0,1.0,0.0,3.0,0.0,2.0,24.0
Tawang,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,1.0,1.0,5.0,2.0,0.0,3.0,0.0,1.0,0.0,3.0,1.0,18.0
Tawang,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Tawang,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Tawang,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Tawang,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Tawang,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Tawang,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Tawang,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Tawang,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Tawang,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Tawang,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Tawang,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Tawang,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Tawang,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Tawang,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Tawang,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Tawang,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Tawang,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Tawang,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Tawang,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Tawang,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Tawang,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Tawang,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Tawang,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Tawang,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Tawang,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Tawang,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Tawang,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Tawang,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Tawang,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Tawang,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Tawang,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Tawang,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Tawang,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Tawang,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Tawang,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Tawang,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Tawang,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Tawang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Tawang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Tawang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Tawang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Tawang,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Tawang,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Tawang,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Tawang,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Tawang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Tawang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Tawang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Tawang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Tawang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Tawang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Tawang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Tawang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Tawang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Tawang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Tawang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Tawang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Tawang,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Tawang,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Tawang,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Tawang,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Tawang,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Tawang,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Tawang,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Tawang,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Tawang,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Tawang,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Tawang,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Tawang,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Tawang,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Tawang,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Tawang,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Tawang,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Tawang,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Tawang,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Tawang,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Tawang,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Tawang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Tawang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Tawang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Tawang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Tawang,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Tawang,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Tawang,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Tawang,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Tawang,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Tawang,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Tawang,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Tawang,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Tawang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Tawang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Tawang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Tawang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Tawang,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Tawang,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Tawang,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Tawang,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Tawang,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Tawang,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Tawang,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Tawang,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Tawang,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Tawang,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Tawang,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Tawang,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Tawang,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Tawang,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Tawang,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Tawang,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Tawang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Tawang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Tawang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Tawang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tawang,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Tawang,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Tawang,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Tawang,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Tawang,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Tawang,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Tawang,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Tawang,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,1.0,,,,,,1.0
Tawang,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Tawang,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,1.0,,,,,,1.0
Tawang,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,1.0,,,,,,,,,1.0
Tawang,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Tawang,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,1.0,,,,,,,,,1.0
Tawang,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Tawang,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Tawang,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Tawang,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Tawang,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,1.0,,,,,,,,,1.0
Tawang,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,1.0,,,,,,,,,1.0
Tawang,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Tawang,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Tawang,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Tawang,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Tawang,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Tawang,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Tawang,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Tawang,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Tawang,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Tawang,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Tawang,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Tawang,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Tawang,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Tawang,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Tawang,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Tawang,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Tawang,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Tawang,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Tawang,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Tawang,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,1.0,,,,,,,1.0,2.0
Tawang,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,1.0,,,,,,,1.0,2.0
Tawang,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Tawang,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Tawang,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Tawang,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Tawang,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Tawang,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Tawang,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Tawang,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Tawang,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Tawang,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Tawang,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Tawang,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Tawang,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Tawang,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Tawang,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,1.0,,,,,,,1.0,1.0,3.0
Tawang,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,1.0,,,,,,,1.0,1.0,3.0
Tawang,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Tawang,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Tawang,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Tawang,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Tawang,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Tawang,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Tawang,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Tawang,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Tawang,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Tawang,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Tawang,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Tawang,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Tawang,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Tawang,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Tawang,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Tawang,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Tawang,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Tawang,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Tawang,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Tawang,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Tawang,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Tawang,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Tawang,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Tawang,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Tawang,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Tawang,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Tawang,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Tawang,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Tawang,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Tawang,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Tawang,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Tawang,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,1.0,,,,,,,,1.0
Tawang,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Tawang,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Tawang,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Tawang,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Tawang,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Tawang,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Tawang,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Tawang,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Tawang,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Tawang,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,1.0,,1.0,,,,2.0
Tawang,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,1.0,,,,,1.0,,,,2.0
Tawang,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,1.0,,,1.0,,2.0,,,,4.0
Tawang,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Tawang,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,1.0,,,,1.0,2.0
Tawang,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Tawang,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,1.0,,,,1.0,2.0
Tawang,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Tawang,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,1.0,1.0,,,,,,,,2.0
Tawang,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Tawang,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,1.0,1.0,,,,,,,,2.0
Tirap,1.1,Total number of pregnant women Registered for ANC,TOTAL,183.0,171.0,150.0,185.0,210.0,177.0,205.0,142.0,133.0,142.0,105.0,110.0,1913.0
Tirap,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,67.0,74.0,60.0,67.0,65.0,74.0,85.0,52.0,44.0,45.0,39.0,38.0,710.0
Tirap,1.2,Number of Pregnant women registered under JSY,TOTAL,169.0,167.0,146.0,182.0,206.0,174.0,193.0,116.0,105.0,138.0,99.0,100.0,1795.0
Tirap,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,62.0,80.0,74.0,80.0,73.0,77.0,72.0,58.0,69.0,89.0,42.0,44.0,820.0
Tirap,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,165.0,154.0,159.0,177.0,176.0,169.0,189.0,147.0,182.0,130.0,101.0,111.0,1860.0
Tirap,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,119.0,118.0,123.0,138.0,155.0,118.0,136.0,105.0,149.0,86.0,96.0,87.0,1430.0
Tirap,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,92.0,66.0,91.0,71.0,98.0,69.0,112.0,144.0,128.0,149.0,102.0,127.0,1249.0
Tirap,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,3.0,3.0,5.0,4.0,3.0,5.0,5.0,4.0,3.0,4.0,5.0,3.0,47.0
Tirap,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,43.0,37.0,41.0,28.0,50.0,52.0,54.0,35.0,35.0,38.0,38.0,46.0,497.0
Tirap,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,1.0,0.0,3.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,4.0,0.0,9.0
Tirap,1.8,Number of pregnancy test kits used at SC level,TOTAL,8.0,6.0,8.0,3.0,13.0,13.0,14.0,8.0,5.0,0.0,0.0,0.0,78.0
Tirap,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,5.0,4.0,4.0,4.0,2.0,5.0,3.0,2.0,5.0,0.0,4.0,5.0,43.0
Tirap,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,23.0,18.0,11.0,15.0,17.0,15.0,17.0,18.0,14.0,11.0,18.0,12.0,189.0
Tirap,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,28.0,22.0,15.0,19.0,19.0,20.0,20.0,20.0,19.0,11.0,22.0,17.0,232.0
Tirap,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,9.0,10.0,6.0,9.0,8.0,7.0,7.0,10.0,11.0,8.0,17.0,14.0,116.0
Tirap,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Tirap,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,57.0,57.0,50.0,51.0,72.0,52.0,63.0,51.0,63.0,52.0,56.0,49.0,673.0
Tirap,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,53.0,49.0,37.0,36.0,53.0,33.0,41.0,35.0,49.0,25.0,37.0,31.0,479.0
Tirap,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,8.0,9.0,23.0,8.0,12.0,4.0,0.0,0.0,0.0,6.0,0.0,64.0,134.0
Tirap,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1.0,3.0,9.0,11.0,1.0,1.0,0.0,6.0,0.0,3.0,0.0,72.0,107.0
Tirap,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Tirap,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Tirap,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Tirap,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Tirap,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tirap,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Tirap,4.1.1.a,Number of male live births,TOTAL,47.0,39.0,34.0,43.0,40.0,33.0,44.0,42.0,33.0,37.0,38.0,36.0,466.0
Tirap,4.1.1.b,Number of female live births,TOTAL,36.0,40.0,30.0,27.0,50.0,39.0,39.0,29.0,48.0,24.0,39.0,27.0,428.0
Tirap,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,83.0,79.0,64.0,70.0,90.0,72.0,83.0,71.0,81.0,61.0,77.0,63.0,894.0
Tirap,4.1.2,Number of still births,TOTAL,2.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,1.0,3.0,11.0
Tirap,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,4.0,2.0,9.0,6.0,10.0,8.0,3.0,5.0,3.0,11.0,6.0,4.0,71.0
Tirap,4.2.1,Number of Newborns weighed at birth,TOTAL,67.0,73.0,57.0,66.0,89.0,71.0,80.0,71.0,75.0,58.0,76.0,56.0,839.0
Tirap,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,0.0,2.0,1.0,0.0,1.0,0.0,0.0,0.0,2.0,1.0,0.0,0.0,7.0
Tirap,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,67.0,73.0,57.0,66.0,89.0,71.0,80.0,71.0,75.0,61.0,76.0,61.0,847.0
Tirap,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,5.0,4.0,6.0,6.0,5.0,6.0,4.0,4.0,5.0,3.0,4.0,4.0,56.0
Tirap,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tirap,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,5.0,4.0,6.0,6.0,5.0,6.0,4.0,4.0,5.0,3.0,4.0,4.0,56.0
Tirap,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Tirap,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,5.0,4.0,6.0,6.0,5.0,6.0,4.0,4.0,5.0,3.0,4.0,4.0,56.0
Tirap,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,3.0,3.0,2.0,3.0,3.0,3.0,2.0,2.0,3.0,1.0,2.0,2.0,29.0
Tirap,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,5.0,4.0,6.0,6.0,5.0,6.0,4.0,4.0,5.0,3.0,4.0,4.0,56.0
Tirap,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,44.0,46.0,43.0,45.0,66.0,55.0,58.0,60.0,50.0,47.0,70.0,39.0,623.0
Tirap,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,31.0,29.0,24.0,19.0,27.0,20.0,31.0,33.0,31.0,14.0,14.0,25.0,298.0
Tirap,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,4.0,1.0,9.0,6.0,10.0,8.0,3.0,3.0,3.0,11.0,6.0,3.0,67.0
Tirap,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0
Tirap,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,4.0,1.0,9.0,6.0,10.0,8.0,3.0,5.0,3.0,11.0,6.0,3.0,69.0
Tirap,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,1.0,1.0,15.0,24.0,16.0,3.0,4.0,4.0,0.0,2.0,0.0,0.0,70.0
Tirap,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,2.0,0.0,7.0,21.0,25.0,5.0,6.0,3.0,0.0,9.0,2.0,0.0,80.0
Tirap,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,3.0,1.0,22.0,45.0,41.0,8.0,10.0,7.0,0.0,11.0,2.0,0.0,150.0
Tirap,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,3.0,1.0,22.0,45.0,41.0,8.0,10.0,7.0,0.0,11.0,2.0,0.0,150.0
Tirap,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tirap,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Tirap,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tirap,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Tirap,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tirap,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Tirap,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tirap,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Tirap,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,2.0,2.0,7.0,3.0,0.0,0.0,0.0,3.0,4.0,1.0,1.0,23.0
Tirap,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,4.0,5.0,5.0,3.0,2.0,2.0,2.0,4.0,1.0,4.0,8.0,7.0,47.0
Tirap,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tirap,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,4.0,7.0,7.0,10.0,5.0,2.0,2.0,4.0,4.0,8.0,9.0,8.0,70.0
Tirap,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Tirap,9.06,Number of IUCD removals,TOTAL,3.0,6.0,4.0,1.0,3.0,11.0,3.0,8.0,3.0,4.0,4.0,3.0,53.0
Tirap,9.07,Number of Oral Pills cycles distributed,TOTAL,90.0,98.0,88.0,191.0,90.0,137.0,131.0,74.0,113.0,90.0,67.0,151.0,1320.0
Tirap,9.08,Number of Condom pieces distributed,TOTAL,242.0,136.0,167.0,349.0,139.0,194.0,177.0,119.0,192.0,252.0,122.0,119.0,2208.0
Tirap,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,27.0,23.0,22.0,39.0,3.0,21.0,15.0,15.0,17.0,55.0,21.0,16.0,274.0
Tirap,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Tirap,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,99.0,105.0,119.0,145.0,181.0,141.0,123.0,126.0,163.0,79.0,141.0,102.0,1524.0
Tirap,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,154.0,122.0,164.0,147.0,211.0,181.0,138.0,166.0,250.0,118.0,152.0,138.0,1941.0
Tirap,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,139.0,132.0,159.0,160.0,169.0,153.0,117.0,145.0,297.0,116.0,160.0,145.0,1892.0
Tirap,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,125.0,117.0,142.0,203.0,200.0,182.0,119.0,127.0,237.0,146.0,174.0,128.0,1900.0
Tirap,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,35.0,32.0,28.0,40.0,54.0,33.0,23.0,33.0,35.0,23.0,40.0,7.0,383.0
Tirap,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,154.0,122.0,164.0,147.0,211.0,181.0,138.0,166.0,177.0,118.0,152.0,138.0,1868.0
Tirap,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,139.0,132.0,159.0,160.0,169.0,153.0,117.0,145.0,241.0,116.0,160.0,145.0,1836.0
Tirap,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,125.0,117.0,142.0,203.0,200.0,182.0,119.0,124.0,179.0,146.0,181.0,128.0,1846.0
Tirap,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,0.0,0.0,7.0,12.0,23.0,19.0,12.0,4.0,26.0,12.0,35.0,3.0,153.0
Tirap,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,106.0,92.0,111.0,128.0,182.0,154.0,104.0,124.0,147.0,83.0,141.0,118.0,1490.0
Tirap,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,139.0,130.0,159.0,159.0,169.0,151.0,116.0,145.0,299.0,116.0,161.0,145.0,1889.0
Tirap,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,126.0,116.0,143.0,203.0,200.0,181.0,120.0,128.0,236.0,149.0,175.0,128.0,1905.0
Tirap,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,109.0,111.0,142.0,170.0,174.0,167.0,118.0,121.0,287.0,109.0,129.0,70.0,1707.0
Tirap,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,19.0,49.0,113.0,52.0,105.0,86.0,80.0,60.0,54.0,41.0,43.0,50.0,752.0
Tirap,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,51.0,57.0,71.0,81.0,78.0,76.0,51.0,63.0,77.0,59.0,61.0,35.0,760.0
Tirap,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,57.0,57.0,71.0,80.0,62.0,72.0,49.0,49.0,76.0,50.0,56.0,35.0,714.0
Tirap,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,108.0,114.0,142.0,161.0,140.0,148.0,100.0,112.0,153.0,109.0,117.0,70.0,1474.0
Tirap,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,116.0,99.0,116.0,140.0,137.0,109.0,103.0,99.0,205.0,66.0,99.0,54.0,1343.0
Tirap,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,116.0,99.0,116.0,140.0,136.0,113.0,103.0,100.0,191.0,66.0,99.0,54.0,1333.0
Tirap,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,48.0,30.0,44.0,48.0,35.0,30.0,11.0,28.0,26.0,21.0,19.0,18.0,358.0
Tirap,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,43.0,32.0,41.0,45.0,41.0,36.0,7.0,22.0,17.0,18.0,13.0,15.0,330.0
Tirap,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,91.0,62.0,85.0,93.0,76.0,66.0,18.0,50.0,43.0,39.0,32.0,33.0,688.0
Tirap,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,23.0,40.0,62.0,45.0,59.0,60.0,30.0,56.0,45.0,22.0,45.0,32.0,519.0
Tirap,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,26.0,35.0,55.0,40.0,60.0,49.0,18.0,39.0,26.0,15.0,35.0,21.0,419.0
Tirap,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,15.0,16.0,56.0,33.0,36.0,33.0,10.0,36.0,14.0,12.0,23.0,15.0,299.0
Tirap,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,72.0,64.0,111.0,97.0,127.0,126.0,81.0,100.0,108.0,65.0,91.0,53.0,1095.0
Tirap,10.4.2,Number of Immunisation sessions held during the month,TOTAL,60.0,55.0,96.0,79.0,116.0,112.0,80.0,81.0,99.0,48.0,80.0,51.0,957.0
Tirap,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,7.0,7.0,46.0,33.0,62.0,37.0,34.0,39.0,58.0,2.0,22.0,1.0,348.0
Tirap,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,22.0,10.0,35.0,16.0,9.0,0.0,0.0,81.0,87.0,54.0,71.0,39.0,424.0
Tirap,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,160.0,78.0,124.0,80.0,111.0,553.0
Tirap,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,112.0,117.0,97.0,67.0,393.0
Tirap,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,195.0,230.0,223.0,260.0,165.0,143.0,178.0,125.0,157.0,124.0,112.0,87.0,1999.0
Tirap,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,3.0,16.0,20.0,10.0,16.0,2.0,2.0,0.0,0.0,0.0,0.0,69.0
Tirap,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Tirap,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,13.3,Number of School children detected with Refractive errors,TOTAL,65.0,38.0,8.0,3.0,6.0,6.0,8.0,9.0,41.0,15.0,41.0,15.0,255.0
Tirap,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Tirap,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Tirap,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,40.0,37.0,37.0,78.0,62.0,64.0,58.0,41.0,49.0,50.0,36.0,51.0,-1.0
Tirap,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,-1.0
Tirap,14.05,Number of RKS meetings held during the month,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.0,2.0,2.0,2.0,3.0,14.0
Tirap,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,9.0,9.0,9.0,9.0,9.0,9.0,10.0,10.0,10.0,10.0,10.0,10.0,-1.0
Tirap,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,50.0,45.0,33.0,43.0,52.0,36.0,50.0,40.0,46.0,30.0,39.0,35.0,499.0
Tirap,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Tirap,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Tirap,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,13.0,26.0,35.0,35.0,23.0,28.0,31.0,50.0,9.0,7.0,8.0,12.0,277.0
Tirap,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,76.0,51.0,74.0,98.0,73.0,94.0,114.0,57.0,49.0,35.0,43.0,33.0,797.0
Tirap,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,6.0,24.0,28.0,40.0,20.0,32.0,28.0,77.0,7.0,5.0,3.0,6.0,276.0
Tirap,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,88.0,74.0,93.0,127.0,140.0,143.0,107.0,64.0,92.0,93.0,64.0,81.0,1166.0
Tirap,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,19.0,50.0,63.0,75.0,43.0,60.0,59.0,127.0,16.0,12.0,11.0,18.0,553.0
Tirap,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,164.0,125.0,167.0,225.0,213.0,237.0,221.0,121.0,141.0,128.0,107.0,114.0,1963.0
Tirap,14.10.2.a,Number of death cases of Inpatient males,TOTAL,3.0,2.0,2.0,3.0,1.0,1.0,5.0,2.0,0.0,4.0,0.0,1.0,24.0
Tirap,14.10.2.b,Number of death cases of Inpatient females,TOTAL,1.0,0.0,0.0,1.0,1.0,0.0,0.0,3.0,0.0,1.0,1.0,1.0,9.0
Tirap,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,4.0,2.0,2.0,4.0,2.0,1.0,5.0,5.0,0.0,5.0,1.0,2.0,33.0
Tirap,14.11,In-Patient Head Count at midnight,TOTAL,176.0,167.0,204.0,322.0,198.0,218.0,203.0,177.0,154.0,129.0,83.0,125.0,2156.0
Tirap,14.12.1,OPD attendance (All),TOTAL,5795.0,6664.0,7549.0,9201.0,6854.0,6162.0,6361.0,6125.0,4962.0,4352.0,5364.0,5382.0,74771.0
Tirap,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,79.0,87.0,47.0,51.0,41.0,50.0,49.0,70.0,41.0,56.0,31.0,30.0,632.0
Tirap,14.14.a,Number of patients given AYUSH treatment,TOTAL,1005.0,1615.0,1810.0,2561.0,1615.0,1019.0,1773.0,1674.0,746.0,863.0,1671.0,863.0,17215.0
Tirap,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,232.0,246.0,229.0,357.0,316.0,167.0,134.0,84.0,113.0,91.0,73.0,151.0,2193.0
Tirap,14.14.c,Number of Adolescents counselled,TOTAL,2.0,2.0,3.0,3.0,7.0,4.0,5.0,1.0,2.0,1.0,4.0,0.0,34.0
Tirap,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,319.0,284.0,296.0,345.0,323.0,351.0,344.0,216.0,395.0,184.0,223.0,307.0,3587.0
Tirap,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,4.0,8.0,11.0,15.0,9.0,3.0,6.0,2.0,1.0,7.0,10.0,6.0,82.0
Tirap,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,23.0,28.0,22.0,25.0,35.0,17.0,18.0,24.0,20.0,24.0,33.0,19.0,288.0
Tirap,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,23.0,24.0,24.0,28.0,45.0,15.0,22.0,22.0,6.0,20.0,17.0,34.0,280.0
Tirap,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,37.0,49.0,66.0,37.0,44.0,31.0,48.0,33.0,21.0,31.0,46.0,67.0,510.0
Tirap,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,83.0,101.0,112.0,90.0,124.0,63.0,88.0,79.0,47.0,75.0,96.0,120.0,1078.0
Tirap,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,15.2,Number of Widal tests conducted,Number tested,118.0,130.0,254.0,185.0,281.0,217.0,101.0,27.0,115.0,72.0,61.0,92.0,1653.0
Tirap,15.3.a,Number of VDRL tests conducted on males,Number tested,1.0,1.0,1.0,6.0,2.0,4.0,2.0,1.0,3.0,2.0,28.0,12.0,63.0
Tirap,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,2.0,2.0,4.0,0.0,6.0,11.0,14.0,1.0,4.0,10.0,9.0,16.0,79.0
Tirap,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,54.0,48.0,76.0,65.0,60.0,35.0,60.0,39.0,33.0,37.0,50.0,91.0,648.0
Tirap,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,57.0,51.0,81.0,71.0,68.0,50.0,76.0,41.0,40.0,49.0,87.0,119.0,790.0
Tirap,15.4.1,Number of blood smears examined for Malaria,TOTAL,254.0,399.0,790.0,1378.0,826.0,716.0,700.0,532.0,199.0,140.0,272.0,201.0,6407.0
Tirap,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,14.0,23.0,59.0,75.0,73.0,47.0,28.0,21.0,8.0,10.0,25.0,12.0,395.0
Tirap,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,7.0,15.0,41.0,59.0,47.0,41.0,33.0,14.0,11.0,2.0,12.0,2.0,284.0
Tirap,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,2900.0,2860.0,1850.0,1750.0,1300.0,800.0,2330.0,2130.0,1800.0,1700.0,2500.0,2200.0,24120.0
Tirap,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,2000.0,0.0,0.0,0.0,1000.0,0.0,0.0,3000.0
Tirap,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,40.0,1010.0,100.0,450.0,500.0,470.0,200.0,330.0,100.0,200.0,300.0,350.0,4050.0
Tirap,16.1.1,Stock position of DPT vaccines,5. Total Stock,2860.0,1850.0,1750.0,1300.0,800.0,2330.0,2130.0,1800.0,1700.0,2500.0,2200.0,1850.0,23070.0
Tirap,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Tirap,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Tirap,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Tirap,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Tirap,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,2760.0,2560.0,920.0,640.0,400.0,0.0,2980.0,2780.0,2280.0,600.0,2660.0,3160.0,21740.0
Tirap,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,4000.0,0.0,0.0,0.0,3500.0,500.0,,8000.0
Tirap,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,200.0,1640.0,280.0,240.0,400.0,1020.0,200.0,500.0,1680.0,1440.0,0.0,300.0,7900.0
Tirap,16.1.2,Stock position of OPV vaccines,5. Total Stock,2560.0,920.0,640.0,400.0,0.0,2980.0,2780.0,2280.0,600.0,2660.0,3160.0,2860.0,21840.0
Tirap,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1000.0,650.0,2000.0,1620.0,1170.0,770.0,1350.0,1200.0,1000.0,900.0,1900.0,1700.0,15260.0
Tirap,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,2000.0,0.0,0.0,0.0,1500.0,0.0,0.0,0.0,1000.0,0.0,0.0,4500.0
Tirap,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.1.3,Stock position of TT vaccines,4. Stock Distributed,350.0,650.0,380.0,450.0,400.0,920.0,150.0,200.0,100.0,0.0,200.0,150.0,3950.0
Tirap,16.1.3,Stock position of TT vaccines,5. Total Stock,650.0,2000.0,1620.0,1170.0,770.0,1350.0,1200.0,1000.0,900.0,1900.0,1700.0,1550.0,15810.0
Tirap,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2300.0,2150.0,1430.0,1100.0,750.0,600.0,3100.0,3100.0,2770.0,1870.0,2170.0,1970.0,23310.0
Tirap,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,3000.0,0.0,0.0,0.0,500.0,0.0,0.0,3500.0
Tirap,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,150.0,720.0,330.0,350.0,150.0,500.0,0.0,330.0,900.0,200.0,200.0,200.0,4030.0
Tirap,16.1.5,Stock position of BCG vaccines,5. Total Stock,2150.0,1430.0,1100.0,750.0,600.0,3100.0,3100.0,2770.0,1870.0,2170.0,1970.0,1770.0,22780.0
Tirap,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1300.0,0.0,1340.0,940.0,560.0,320.0,1800.0,1800.0,1525.0,1025.0,1525.0,1175.0,13310.0
Tirap,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,1750.0,0.0,0.0,0.0,2000.0,0.0,0.0,0.0,500.0,0.0,0.0,4250.0
Tirap,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,1150.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1150.0
Tirap,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,150.0,410.0,400.0,380.0,240.0,520.0,0.0,275.0,500.0,0.0,350.0,150.0,3375.0
Tirap,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,1340.0,940.0,560.0,320.0,1800.0,1800.0,1525.0,1025.0,1525.0,1175.0,1025.0,13035.0
Tirap,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1500.0,1150.0,1620.0,1460.0,980.0,840.0,2800.0,2750.0,2560.0,2100.0,1950.0,1850.0,21560.0
Tirap,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,1000.0,0.0,0.0,0.0,2500.0,0.0,0.0,0.0,0.0,0.0,0.0,3500.0
Tirap,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,350.0,530.0,160.0,480.0,140.0,540.0,50.0,190.0,460.0,150.0,100.0,350.0,3500.0
Tirap,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1150.0,1620.0,1460.0,980.0,840.0,2800.0,2750.0,2560.0,2100.0,1950.0,1850.0,1500.0,21560.0
Tirap,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,125.0,125.0,105.0,75.0,75.0,75.0,75.0,60.0,60.0,40.0,620.0,620.0,2055.0
Tirap,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,600.0,0.0,0.0,600.0
Tirap,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,20.0,30.0,0.0,0.0,0.0,15.0,0.0,20.0,20.0,0.0,50.0,155.0
Tirap,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,125.0,105.0,75.0,75.0,75.0,75.0,60.0,60.0,40.0,620.0,620.0,570.0,2500.0
Tirap,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,300.0,250.0,190.0,90.0,690.0,490.0,290.0,290.0,290.0,190.0,1490.0,990.0,5550.0
Tirap,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,1000.0,0.0,0.0,0.0,0.0,0.0,6000.0,0.0,0.0,7000.0
Tirap,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,50.0,60.0,100.0,400.0,200.0,200.0,0.0,0.0,100.0,4700.0,500.0,200.0,6510.0
Tirap,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,250.0,190.0,90.0,690.0,490.0,290.0,290.0,290.0,190.0,1490.0,990.0,790.0,6040.0
Tirap,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,200.0,150.0,110.0,60.0,660.0,460.0,250.0,250.0,200.0,150.0,1950.0,1850.0,6290.0
Tirap,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,1000.0,0.0,0.0,0.0,0.0,0.0,2800.0,0.0,0.0,3800.0
Tirap,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,50.0,40.0,50.0,400.0,200.0,210.0,0.0,50.0,50.0,1000.0,100.0,300.0,2450.0
Tirap,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,150.0,110.0,60.0,660.0,460.0,250.0,250.0,200.0,150.0,1950.0,1850.0,1550.0,7640.0
Tirap,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,150.0,100.0,60.0,40.0,290.0,140.0,140.0,100.0,100.0,100.0,1200.0,1100.0,3520.0
Tirap,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,500.0,0.0,0.0,0.0,0.0,0.0,5000.0,0.0,0.0,5500.0
Tirap,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,50.0,40.0,20.0,250.0,150.0,0.0,40.0,0.0,0.0,3900.0,100.0,150.0,4700.0
Tirap,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,100.0,60.0,40.0,290.0,140.0,140.0,100.0,100.0,100.0,1200.0,1100.0,950.0,4320.0
Tirap,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5500.0,4000.0,4000.0,4000.0,17500.0
Tirap,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,0.0,0.0,0.0,10000.0
Tirap,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4500.0,1500.0,0.0,0.0,1000.0,7000.0
Tirap,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5500.0,4000.0,4000.0,4000.0,3000.0,20500.0
Tirap,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,540.0,510.0,510.0,500.0,2060.0
Tirap,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,584.0,0.0,0.0,0.0,0.0,584.0
Tirap,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,44.0,30.0,0.0,10.0,0.0,84.0
Tirap,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,540.0,510.0,510.0,500.0,500.0,2560.0
Tirap,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,295.0,295.0,215.0,215.0,115.0,0.0,800.0,800.0,765.0,765.0,1765.0,1565.0,7595.0
Tirap,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,1000.0,0.0,0.0,0.0,2000.0,0.0,0.0,3000.0
Tirap,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,80.0,0.0,100.0,115.0,200.0,0.0,35.0,0.0,1000.0,200.0,600.0,2330.0
Tirap,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,295.0,215.0,215.0,115.0,0.0,800.0,800.0,765.0,765.0,1765.0,1565.0,965.0,8265.0
Tirap,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,1700.0,1700.0,4900.0,4900.0,2900.0,2500.0,4200.0,4200.0,7300.0,6900.0,5900.0,4900.0,52000.0
Tirap,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,4800.0,0.0,0.0,0.0,3000.0,0.0,4000.0,0.0,0.0,0.0,0.0,11800.0
Tirap,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,1600.0,0.0,2000.0,400.0,1300.0,0.0,900.0,400.0,1000.0,1000.0,0.0,8600.0
Tirap,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,1700.0,4900.0,4900.0,2900.0,2500.0,4200.0,4200.0,7300.0,6900.0,5900.0,4900.0,4900.0,55200.0
Tirap,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,120.0,120.0,80.0,80.0,80.0,60.0,60.0,40.0,40.0,40.0,40.0,40.0,800.0
Tirap,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tirap,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,40.0,0.0,0.0,20.0,0.0,20.0,0.0,0.0,0.0,0.0,40.0,120.0
Tirap,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,120.0,80.0,80.0,80.0,60.0,60.0,40.0,40.0,40.0,40.0,40.0,0.0,680.0
Tirap,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Tirap,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Tirap,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Tirap,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Tirap,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Tirap,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Tirap,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Tirap,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Tirap,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Tirap,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Tirap,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Tirap,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Tirap,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Tirap,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Tirap,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Tirap,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Tirap,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Tirap,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Tirap,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Tirap,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Tirap,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Tirap,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Tirap,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Tirap,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Tirap,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Tirap,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Tirap,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Tirap,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Tirap,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Tirap,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Tirap,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Tirap,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Tirap,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Tirap,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,1.0,,1.0,,,2.0
Tirap,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,1.0,,,,,,,1.0,,,2.0
Tirap,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,1.0,,,,,1.0,,2.0,,,4.0
Tirap,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Tirap,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,1.0,,1.0
Tirap,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Tirap,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,,,,,,,,,,1.0,,2.0
Tirap,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Tirap,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Tirap,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Tirap,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Tirap,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Tirap,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,,,,1.0,,,1.0,,1.0,,,4.0
Tirap,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Tirap,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,,1.0,,1.0,,,1.0,,1.0,,,5.0
Tirap,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Tirap,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Tirap,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Tirap,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Tirap,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Tirap,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,2.0,,,,1.0,3.0
Tirap,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Tirap,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,2.0,,,,1.0,3.0
Tirap,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Tirap,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Tirap,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Tirap,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,1.0,,,,,,1.0
Tirap,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Tirap,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Tirap,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Tirap,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Tirap,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Tirap,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Tirap,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Tirap,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Tirap,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Tirap,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Tirap,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Tirap,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Tirap,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Tirap,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Tirap,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Tirap,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Tirap,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Tirap,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Tirap,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Tirap,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Tirap,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Tirap,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Tirap,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Tirap,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Tirap,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Tirap,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Tirap,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Tirap,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Tirap,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Tirap,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Tirap,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Tirap,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,1.0,,,,,,1.0
Tirap,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Tirap,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,,,,,,,,,,,,1.0
Tirap,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Tirap,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,,,,,,,,,,,,1.0
Tirap,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Tirap,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Tirap,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Tirap,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Tirap,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Tirap,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,3.0,,,1.0,,,4.0
Tirap,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,1.0,1.0
Tirap,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,3.0,,,1.0,,1.0,5.0
Tirap,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Tirap,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,1.0,1.0,,,,,,,,1.0,,,3.0
Tirap,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Tirap,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,1.0,1.0,,,,,,,,1.0,,,3.0
Upper Siang,1.1,Total number of pregnant women Registered for ANC,TOTAL,61.0,54.0,57.0,77.0,69.0,66.0,53.0,68.0,52.0,59.0,67.0,92.0,775.0
Upper Siang,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,20.0,25.0,33.0,32.0,35.0,29.0,27.0,35.0,24.0,28.0,25.0,30.0,343.0
Upper Siang,1.2,Number of Pregnant women registered under JSY,TOTAL,41.0,49.0,56.0,74.0,57.0,56.0,48.0,41.0,48.0,52.0,58.0,80.0,660.0
Upper Siang,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,44.0,27.0,26.0,34.0,33.0,44.0,38.0,21.0,27.0,33.0,24.0,27.0,378.0
Upper Siang,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,40.0,31.0,35.0,42.0,52.0,34.0,37.0,37.0,35.0,39.0,45.0,51.0,478.0
Upper Siang,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,33.0,28.0,30.0,34.0,46.0,23.0,35.0,34.0,36.0,23.0,25.0,48.0,395.0
Upper Siang,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,48.0,23.0,47.0,73.0,38.0,38.0,21.0,43.0,19.0,25.0,31.0,29.0,435.0
Upper Siang,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,10.0,10.0
Upper Siang,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
Upper Siang,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,37.0,33.0,32.0,33.0,28.0,36.0,32.0,26.0,28.0,34.0,42.0,111.0,472.0
Upper Siang,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,4.0,1.0,0.0,,1.0,4.0,1.0,2.0,0.0,,,1.0,14.0
Upper Siang,1.8,Number of pregnancy test kits used at SC level,TOTAL,0.0,,,,1.0,,,2.0,,,1.0,,4.0
Upper Siang,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,2.0,6.0,1.0,4.0,5.0,4.0,5.0,3.0,1.0,2.0,2.0,3.0,38.0
Upper Siang,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,0.0,,,,,2.0,,,,1.0,3.0,6.0
Upper Siang,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,2.0,6.0,1.0,4.0,5.0,4.0,7.0,3.0,1.0,2.0,3.0,6.0,44.0
Upper Siang,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,2.0,5.0,1.0,2.0,2.0,3.0,4.0,3.0,1.0,,1.0,2.0,26.0
Upper Siang,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,1.0,,,2.0,2.0,,,,,,,6.0
Upper Siang,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,19.0,27.0,17.0,20.0,21.0,28.0,22.0,32.0,5.0,27.0,7.0,22.0,247.0
Upper Siang,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,6.0,8.0,7.0,11.0,7.0,6.0,9.0,16.0,24.0,33.0,33.0,22.0,182.0
Upper Siang,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,4.0,24.0,15.0,12.0,17.0,28.0,1.0,4.0,3.0,5.0,88.0,34.0,235.0
Upper Siang,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,3.0,7.0,9.0,9.0,6.0,15.0,,3.0,2.0,2.0,32.0,4.0,92.0
Upper Siang,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,0.0,,,,,,,2.0,1.0,8.0,,11.0
Upper Siang,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Upper Siang,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Upper Siang,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Upper Siang,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Upper Siang,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,1.0,,1.0
Upper Siang,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,1.0,,,,2.0,2.0,,1.0,,,6.0
Upper Siang,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,3.0,,0.0,,,4.0,1.0,1.0,,221.0,2.0,6.0,238.0
Upper Siang,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Upper Siang,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,3.0,,1.0,,,4.0,3.0,3.0,,222.0,3.0,6.0,245.0
Upper Siang,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Upper Siang,4.1.1.a,Number of male live births,TOTAL,10.0,14.0,12.0,14.0,16.0,16.0,24.0,23.0,18.0,28.0,18.0,16.0,209.0
Upper Siang,4.1.1.b,Number of female live births,TOTAL,13.0,22.0,8.0,12.0,10.0,23.0,19.0,15.0,10.0,15.0,20.0,11.0,178.0
Upper Siang,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,23.0,36.0,20.0,26.0,26.0,39.0,43.0,38.0,28.0,43.0,38.0,27.0,387.0
Upper Siang,4.1.2,Number of still births,TOTAL,0.0,1.0,1.0,0.0,0.0,,1.0,1.0,1.0,,1.0,2.0,8.0
Upper Siang,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,2.0,2.0,1.0,2.0,1.0,1.0,1.0,3.0,,3.0,1.0,,17.0
Upper Siang,4.2.1,Number of Newborns weighed at birth,TOTAL,23.0,29.0,18.0,26.0,25.0,39.0,35.0,27.0,12.0,16.0,16.0,28.0,294.0
Upper Siang,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,0.0,1.0,0.0,0.0,0.0,,1.0,,1.0,3.0,1.0,,7.0
Upper Siang,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,23.0,16.0,20.0,26.0,25.0,33.0,35.0,29.0,13.0,37.0,37.0,25.0,319.0
Upper Siang,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,1.0,,1.0,8.0,2.0,2.0,1.0,3.0,2.0,2.0,3.0,2.0,27.0
Upper Siang,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Upper Siang,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,4.0,,,,,,,4.0
Upper Siang,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Upper Siang,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,1.0,,1.0,8.0,2.0,6.0,1.0,3.0,2.0,2.0,3.0,2.0,31.0
Upper Siang,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Upper Siang,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,1.0,,1.0,3.0,2.0,2.0,1.0,,2.0,2.0,3.0,2.0,19.0
Upper Siang,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,0.0,,0.0,,,,,,,,0.0
Upper Siang,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,1.0,5.0,2.0,7.0,1.0,3.0,2.0,5.0,22.0,6.0,54.0
Upper Siang,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
Upper Siang,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1.0,7.0,5.0,12.0,17.0,13.0,22.0,26.0,24.0,39.0,33.0,24.0,223.0
Upper Siang,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,17.0,25.0,12.0,17.0,,20.0,15.0,4.0,12.0,17.0,9.0,6.0,154.0
Upper Siang,6.3,PNC maternal complications attended,TOTAL,,0.0,,3.0,2.0,2.0,,,1.0,2.0,3.0,2.0,15.0
Upper Siang,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,8.0,5.0,5.0,11.0,7.0,5.0,5.0,3.0,5.0,6.0,10.0,16.0,86.0
Upper Siang,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,5.0,0.0,,0.0,,,,,,,,5.0
Upper Siang,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,8.0,10.0,5.0,11.0,7.0,5.0,5.0,3.0,5.0,6.0,10.0,16.0,91.0
Upper Siang,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
Upper Siang,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,3.0,1.0,1.0,0.0,0.0,,,2.0,,1.0,1.0,1.0,10.0
Upper Siang,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,5.0,12.0,9.0,2.0,6.0,1.0,2.0,1.0,2.0,2.0,4.0,2.0,48.0
Upper Siang,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,8.0,13.0,10.0,2.0,6.0,1.0,2.0,3.0,2.0,3.0,5.0,3.0,58.0
Upper Siang,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,10.0,9.0,7.0,6.0,1.0,2.0,4.0,,,,,2.0,41.0
Upper Siang,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
Upper Siang,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
Upper Siang,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Upper Siang,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Upper Siang,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
Upper Siang,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Upper Siang,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Upper Siang,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Upper Siang,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Upper Siang,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Upper Siang,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
Upper Siang,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Upper Siang,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Upper Siang,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Upper Siang,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,1.0,2.0,1.0,2.0,1.0,5.0,2.0,,1.0,16.0,6.0,8.0,45.0
Upper Siang,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Upper Siang,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,1.0,2.0,1.0,2.0,1.0,5.0,2.0,,1.0,16.0,6.0,8.0,45.0
Upper Siang,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Upper Siang,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Upper Siang,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Upper Siang,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,1.0,,,,2.0,2.0,,,,3.0,1.0,2.0,11.0
Upper Siang,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Upper Siang,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,1.0,,,,2.0,2.0,,,,3.0,1.0,2.0,11.0
Upper Siang,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Upper Siang,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
Upper Siang,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,1.0,1.0,1.0,,3.0
Upper Siang,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,2.0,,1.0,,1.0,1.0,,,,2.0,,2.0,9.0
Upper Siang,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,10.0,12.0,13.0,5.0,7.0,10.0,2.0,3.0,7.0,7.0,6.0,14.0,96.0
Upper Siang,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Upper Siang,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,12.0,12.0,14.0,5.0,8.0,11.0,2.0,3.0,8.0,10.0,7.0,16.0,108.0
Upper Siang,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,,,,,,,,,,,,0.0
Upper Siang,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Upper Siang,9.06,Number of IUCD removals,TOTAL,3.0,2.0,3.0,4.0,4.0,52.0,5.0,2.0,3.0,3.0,1.0,1.0,83.0
Upper Siang,9.07,Number of Oral Pills cycles distributed,TOTAL,92.0,91.0,87.0,66.0,84.0,78.0,78.0,152.0,66.0,60.0,99.0,46.0,999.0
Upper Siang,9.08,Number of Condom pieces distributed,TOTAL,276.0,131.0,188.0,277.0,330.0,333.0,272.0,425.0,534.0,306.0,211.0,242.0,3525.0
Upper Siang,9.09,Number of Centchroman (weekly) pills given,TOTAL,,0.0,,,,,4.0,,7.0,10.0,2.0,,23.0
Upper Siang,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,19.0,44.0,20.0,18.0,40.0,37.0,43.0,41.0,45.0,26.0,30.0,12.0,375.0
Upper Siang,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
Upper Siang,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
Upper Siang,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
Upper Siang,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
Upper Siang,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
Upper Siang,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
Upper Siang,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,1.0,,-1.0
Upper Siang,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,29.0,40.0,22.0,31.0,31.0,46.0,29.0,37.0,29.0,43.0,42.0,28.0,407.0
Upper Siang,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,33.0,46.0,32.0,33.0,33.0,44.0,43.0,37.0,31.0,33.0,43.0,43.0,451.0
Upper Siang,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,32.0,38.0,37.0,31.0,26.0,29.0,40.0,47.0,31.0,41.0,38.0,41.0,431.0
Upper Siang,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,41.0,38.0,30.0,31.0,39.0,38.0,29.0,38.0,37.0,34.0,34.0,32.0,421.0
Upper Siang,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,,,,,,0.0,,,,,0.0
Upper Siang,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,,,,,,,,,,,0.0
Upper Siang,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,,,,,,0.0,,,,,0.0
Upper Siang,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,23.0,34.0,16.0,31.0,28.0,32.0,23.0,35.0,26.0,35.0,30.0,25.0,338.0
Upper Siang,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,34.0,35.0,30.0,33.0,33.0,44.0,44.0,40.0,33.0,33.0,41.0,43.0,443.0
Upper Siang,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,34.0,38.0,39.0,31.0,26.0,29.0,41.0,44.0,31.0,41.0,38.0,40.0,432.0
Upper Siang,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,40.0,34.0,30.0,31.0,39.0,38.0,29.0,35.0,33.0,32.0,34.0,32.0,407.0
Upper Siang,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,16.0,22.0,12.0,17.0,21.0,5.0,13.0,20.0,18.0,27.0,24.0,16.0,211.0
Upper Siang,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,36.0,40.0,29.0,33.0,33.0,44.0,38.0,29.0,31.0,36.0,43.0,43.0,435.0
Upper Siang,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,33.0,32.0,39.0,31.0,26.0,28.0,31.0,36.0,29.0,36.0,38.0,37.0,396.0
Upper Siang,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,43.0,32.0,30.0,31.0,39.0,38.0,23.0,31.0,35.0,34.0,34.0,35.0,405.0
Upper Siang,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,21.0,49.0,41.0,43.0,53.0,45.0,40.0,36.0,29.0,24.0,51.0,62.0,494.0
Upper Siang,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,16.0,20.0,21.0,32.0,17.0,8.0,11.0,14.0,22.0,22.0,17.0,32.0,232.0
Upper Siang,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,0.0,,,,,,,4.0,,,,4.0
Upper Siang,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,12.0,30.0,17.0,21.0,22.0,23.0,21.0,14.0,21.0,17.0,20.0,23.0,241.0
Upper Siang,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,9.0,15.0,10.0,20.0,22.0,20.0,13.0,12.0,8.0,11.0,26.0,26.0,192.0
Upper Siang,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,21.0,45.0,27.0,41.0,44.0,43.0,34.0,26.0,29.0,28.0,46.0,49.0,433.0
Upper Siang,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,22.0,19.0,18.0,28.0,30.0,28.0,24.0,11.0,21.0,36.0,29.0,51.0,317.0
Upper Siang,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,22.0,18.0,16.0,30.0,28.0,28.0,25.0,11.0,19.0,36.0,30.0,52.0,315.0
Upper Siang,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,1.0,4.0,,2.0,,7.0,4.0,3.0,11.0,32.0
Upper Siang,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,7.0,9.0,7.0,17.0,9.0,10.0,6.0,4.0,7.0,14.0,11.0,15.0,116.0
Upper Siang,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,4.0,6.0,6.0,12.0,7.0,7.0,7.0,3.0,6.0,10.0,17.0,17.0,102.0
Upper Siang,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,11.0,15.0,13.0,29.0,16.0,17.0,13.0,7.0,13.0,24.0,28.0,32.0,218.0
Upper Siang,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,6.0,16.0,6.0,9.0,10.0,13.0,8.0,13.0,10.0,7.0,5.0,3.0,106.0
Upper Siang,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,7.0,16.0,6.0,12.0,9.0,17.0,4.0,15.0,30.0,6.0,3.0,8.0,133.0
Upper Siang,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,16.0,20.0,9.0,9.0,14.0,30.0,2.0,17.0,17.0,,16.0,11.0,161.0
Upper Siang,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,1.0,,,,1.0,,,,,2.0
Upper Siang,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
Upper Siang,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
Upper Siang,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,54.0,51.0,42.0,42.0,26.0,56.0,56.0,49.0,68.0,69.0,56.0,26.0,595.0
Upper Siang,10.4.2,Number of Immunisation sessions held during the month,TOTAL,34.0,32.0,31.0,32.0,24.0,36.0,26.0,36.0,30.0,38.0,31.0,29.0,379.0
Upper Siang,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,28.0,24.0,25.0,28.0,20.0,23.0,17.0,41.0,26.0,23.0,24.0,21.0,300.0
Upper Siang,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
Upper Siang,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,32.0,28.0,10.0,28.0,20.0,27.0,33.0,178.0
Upper Siang,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,8.0,6.0,3.0,9.0,15.0,21.0,62.0
Upper Siang,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,2.0,,,,2.0
Upper Siang,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Upper Siang,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Upper Siang,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Upper Siang,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Upper Siang,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Upper Siang,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,2.0,,6.0,2.0,,3.0,2.0,,,,,15.0
Upper Siang,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,109.0,99.0,96.0,114.0,92.0,140.0,35.0,36.0,63.0,61.0,43.0,57.0,945.0
Upper Siang,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,7.0,9.0,3.0,1.0,14.0,4.0,3.0,17.0,1.0,,,,59.0
Upper Siang,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,1.0,3.0,4.0,89.0,24.0,16.0,56.0,27.0,32.0,11.0,11.0,10.0,284.0
Upper Siang,13.1,Number of Patients operated for cataract,TOTAL,,0.0,,,,,,,,,,,0.0
Upper Siang,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,0.0,,,,,,,,,,,0.0
Upper Siang,13.3,Number of School children detected with Refractive errors,TOTAL,,0.0,,,,,,,,,,,0.0
Upper Siang,13.4,Number of children provided free glasses,TOTAL,,0.0,,,,,,,,,,,0.0
Upper Siang,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
Upper Siang,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
Upper Siang,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,1.0,1.0,1.0,,2.0,3.0,3.0,2.0,3.0,4.0,4.0,-1.0
Upper Siang,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,2.0,1.0,1.0,2.0,2.0,1.0,1.0,1.0,2.0,1.0,1.0,-1.0
Upper Siang,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,19.0,68.0,14.0,16.0,10.0,12.0,11.0,5.0,8.0,55.0,13.0,10.0,-1.0
Upper Siang,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,2.0,1.0,3.0,5.0,,3.0,2.0,2.0,2.0,1.0,3.0,4.0,-1.0
Upper Siang,14.05,Number of RKS meetings held during the month,TOTAL,1.0,1.0,2.0,0.0,1.0,,1.0,0.0,,1.0,2.0,2.0,11.0
Upper Siang,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,4.0,4.0,6.0,7.0,2.0,5.0,4.0,4.0,3.0,5.0,4.0,2.0,-1.0
Upper Siang,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,15.0,29.0,12.0,15.0,10.0,17.0,1.0,1.0,5.0,7.0,20.0,9.0,141.0
Upper Siang,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,,1.0,1.0,,1.0,,2.0,1.0,1.0,,1.0,-1.0
Upper Siang,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,0.0,,,,,,,,,-1.0
Upper Siang,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,9.0,5.0,12.0,7.0,16.0,7.0,4.0,11.0,7.0,5.0,5.0,5.0,93.0
Upper Siang,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,34.0,45.0,57.0,75.0,57.0,67.0,37.0,29.0,30.0,22.0,20.0,30.0,503.0
Upper Siang,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,9.0,8.0,18.0,14.0,12.0,5.0,1.0,12.0,9.0,5.0,10.0,13.0,116.0
Upper Siang,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,65.0,61.0,95.0,100.0,99.0,93.0,65.0,25.0,52.0,65.0,53.0,55.0,828.0
Upper Siang,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,18.0,13.0,30.0,21.0,28.0,12.0,5.0,23.0,16.0,10.0,15.0,18.0,209.0
Upper Siang,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,99.0,106.0,152.0,175.0,156.0,160.0,102.0,54.0,82.0,87.0,73.0,85.0,1331.0
Upper Siang,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,2.0,1.0,1.0,1.0,1.0,,1.0,1.0,2.0,,10.0
Upper Siang,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,1.0,,1.0,,,,,,1.0,,3.0
Upper Siang,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,3.0,1.0,2.0,1.0,1.0,,1.0,1.0,3.0,,13.0
Upper Siang,14.11,In-Patient Head Count at midnight,TOTAL,15.0,33.0,49.0,85.0,37.0,32.0,10.0,16.0,59.0,21.0,33.0,14.0,404.0
Upper Siang,14.12.1,OPD attendance (All),TOTAL,3651.0,3976.0,4416.0,4991.0,4566.0,4202.0,3203.0,2176.0,2813.0,2651.0,2540.0,3147.0,42332.0
Upper Siang,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,107.0,,60.0,,,40.0,59.0,80.0,43.0,389.0
Upper Siang,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,63.0,,,2.0,,,,,,65.0
Upper Siang,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,73.0,71.0,30.0,59.0,65.0,76.0,10.0,39.0,31.0,40.0,25.0,82.0,601.0
Upper Siang,14.14.a,Number of patients given AYUSH treatment,TOTAL,39.0,250.0,220.0,335.0,364.0,410.0,2.0,226.0,367.0,285.0,1.0,228.0,2727.0
Upper Siang,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,4.0,5.0,10.0,,0.0,1.0,,,,2.0,,,22.0
Upper Siang,14.14.c,Number of Adolescents counselled,TOTAL,10.0,85.0,22.0,21.0,24.0,54.0,,20.0,22.0,21.0,18.0,26.0,323.0
Upper Siang,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,185.0,171.0,266.0,211.0,174.0,161.0,150.0,136.0,149.0,43.0,168.0,243.0,2057.0
Upper Siang,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,7.0,3.0,8.0,1.0,4.0,4.0,2.0,2.0,5.0,,,8.0,44.0
Upper Siang,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,5.0,11.0,6.0,2.0,5.0,3.0,3.0,2.0,1.0,4.0,26.0,9.0,77.0
Upper Siang,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
Upper Siang,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,8.0,14.0,12.0,9.0,9.0,7.0,10.0,3.0,8.0,3.0,33.0,24.0,140.0
Upper Siang,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,1.0,,,,,,,1.0
Upper Siang,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,27.0,26.0,31.0,37.0,28.0,15.0,25.0,24.0,15.0,14.0,19.0,12.0,273.0
Upper Siang,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,7.0,3.0,,6.0,5.0,,,21.0
Upper Siang,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,40.0,51.0,49.0,48.0,42.0,25.0,38.0,29.0,24.0,21.0,78.0,45.0,490.0
Upper Siang,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,8.0,3.0,,6.0,5.0,,,22.0
Upper Siang,15.2,Number of Widal tests conducted,Number tested,103.0,134.0,368.0,527.0,138.0,103.0,268.0,41.0,124.0,55.0,47.0,15.0,1923.0
Upper Siang,15.3.a,Number of VDRL tests conducted on males,Number tested,6.0,6.0,6.0,3.0,5.0,1.0,5.0,5.0,3.0,,10.0,4.0,54.0
Upper Siang,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,9.0,17.0,19.0,8.0,11.0,11.0,5.0,4.0,8.0,7.0,7.0,,106.0
Upper Siang,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,29.0,32.0,36.0,44.0,29.0,28.0,31.0,26.0,20.0,31.0,19.0,24.0,349.0
Upper Siang,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,44.0,55.0,61.0,55.0,45.0,40.0,41.0,35.0,31.0,38.0,36.0,28.0,509.0
Upper Siang,15.4.1,Number of blood smears examined for Malaria,TOTAL,210.0,318.0,437.0,461.0,652.0,243.0,197.0,141.0,120.0,85.0,171.0,160.0,3195.0
Upper Siang,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,18.0,21.0,20.0,27.0,25.0,5.0,21.0,6.0,4.0,1.0,5.0,2.0,155.0
Upper Siang,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,7.0,12.0,10.0,2.0,6.0,4.0,25.0,2.0,2.0,2.0,,,72.0
Upper Siang,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Siang,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Upper Siang,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Upper Siang,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Upper Siang,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Siang,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Siang,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Upper Siang,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Upper Siang,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Upper Siang,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Siang,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Siang,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Upper Siang,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Upper Siang,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Upper Siang,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Siang,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Siang,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Upper Siang,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Upper Siang,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Upper Siang,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Siang,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Siang,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Upper Siang,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Upper Siang,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Upper Siang,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Siang,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Siang,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Upper Siang,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Upper Siang,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Upper Siang,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Siang,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Siang,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Upper Siang,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Upper Siang,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Upper Siang,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Siang,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Siang,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Upper Siang,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Upper Siang,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Upper Siang,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Siang,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Siang,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Upper Siang,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Upper Siang,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Upper Siang,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Siang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Upper Siang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Upper Siang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Upper Siang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Upper Siang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Siang,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Upper Siang,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Upper Siang,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Upper Siang,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Upper Siang,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Siang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Upper Siang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Upper Siang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Upper Siang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Upper Siang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Siang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Upper Siang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Upper Siang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Upper Siang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Upper Siang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Siang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Upper Siang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Upper Siang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Upper Siang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Upper Siang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Siang,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Siang,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Upper Siang,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Upper Siang,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Upper Siang,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Siang,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Siang,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Upper Siang,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Upper Siang,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Upper Siang,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Siang,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Siang,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Upper Siang,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Upper Siang,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Upper Siang,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Siang,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Siang,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Upper Siang,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Upper Siang,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Upper Siang,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Siang,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Siang,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Upper Siang,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Upper Siang,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Upper Siang,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Siang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Siang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Upper Siang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Upper Siang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Upper Siang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Siang,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Siang,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Upper Siang,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Upper Siang,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Upper Siang,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Siang,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Upper Siang,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Upper Siang,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Upper Siang,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Upper Siang,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Siang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Upper Siang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Upper Siang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Upper Siang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Upper Siang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Siang,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Siang,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Upper Siang,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Upper Siang,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Upper Siang,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Siang,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Upper Siang,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Upper Siang,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Upper Siang,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Upper Siang,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Siang,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Upper Siang,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Upper Siang,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Upper Siang,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Upper Siang,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Siang,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Upper Siang,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Upper Siang,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Upper Siang,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Upper Siang,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Siang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Upper Siang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Upper Siang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Upper Siang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Upper Siang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Siang,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,1.0,,,,,,,,,,1.0
Upper Siang,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Upper Siang,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Upper Siang,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Upper Siang,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Upper Siang,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Upper Siang,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Upper Siang,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Upper Siang,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Upper Siang,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Upper Siang,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Upper Siang,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Upper Siang,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Upper Siang,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Upper Siang,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Upper Siang,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Upper Siang,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Upper Siang,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Upper Siang,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Upper Siang,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Upper Siang,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Upper Siang,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Upper Siang,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Upper Siang,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Upper Siang,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Upper Siang,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Upper Siang,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Upper Siang,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Upper Siang,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Upper Siang,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Upper Siang,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Upper Siang,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Upper Siang,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Upper Siang,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Upper Siang,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Upper Siang,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Upper Siang,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Upper Siang,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Upper Siang,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Upper Siang,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Upper Siang,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Upper Siang,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Upper Siang,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Upper Siang,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Upper Siang,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Upper Siang,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Upper Siang,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Upper Siang,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Upper Siang,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Upper Siang,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Upper Siang,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Upper Siang,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Upper Siang,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Upper Siang,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Upper Siang,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Upper Siang,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Upper Siang,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Upper Siang,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Upper Siang,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Upper Siang,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Upper Siang,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Upper Siang,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Upper Siang,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Upper Siang,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Upper Siang,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,1.0,,,,,,,,,1.0
Upper Siang,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Upper Siang,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Upper Siang,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Upper Siang,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Upper Siang,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Upper Siang,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Upper Siang,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Upper Siang,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Upper Siang,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Upper Siang,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Upper Siang,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Upper Subansiri,1.1,Total number of pregnant women Registered for ANC,TOTAL,78.0,164.0,156.0,107.0,160.0,183.0,192.0,106.0,149.0,151.0,139.0,119.0,1704.0
Upper Subansiri,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,27.0,41.0,29.0,30.0,26.0,34.0,43.0,30.0,62.0,32.0,32.0,35.0,421.0
Upper Subansiri,1.2,Number of Pregnant women registered under JSY,TOTAL,27.0,98.0,83.0,76.0,92.0,85.0,79.0,59.0,70.0,70.0,85.0,68.0,892.0
Upper Subansiri,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,22.0,43.0,35.0,23.0,33.0,54.0,36.0,22.0,30.0,42.0,39.0,32.0,411.0
Upper Subansiri,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,45.0,61.0,40.0,54.0,68.0,71.0,63.0,45.0,50.0,43.0,49.0,61.0,650.0
Upper Subansiri,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,52.0,45.0,56.0,40.0,65.0,46.0,48.0,46.0,48.0,42.0,36.0,40.0,564.0
Upper Subansiri,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,77.0,104.0,208.0,107.0,145.0,186.0,173.0,29.0,26.0,92.0,25.0,78.0,1250.0
Upper Subansiri,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0
Upper Subansiri,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Upper Subansiri,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,31.0,56.0,53.0,80.0,76.0,111.0,58.0,47.0,40.0,63.0,88.0,42.0,745.0
Upper Subansiri,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,1.0,2.0,1.0,2.0,0.0,2.0,4.0,8.0,3.0,0.0,0.0,23.0
Upper Subansiri,1.8,Number of pregnancy test kits used at SC level,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,0.0,0.0,1.0,1.0,0.0,0.0,1.0,1.0,1.0,4.0,2.0,2.0,13.0
Upper Subansiri,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,0.0,1.0,1.0,0.0,0.0,4.0,0.0,1.0,0.0,0.0,0.0,7.0
Upper Subansiri,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,0.0,0.0,2.0,2.0,0.0,0.0,5.0,1.0,2.0,4.0,2.0,2.0,20.0
Upper Subansiri,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,0.0,0.0,1.0,2.0,1.0,0.0,6.0,0.0,2.0,1.0,1.0,2.0,16.0
Upper Subansiri,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,1.0,6.0
Upper Subansiri,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,70.0,57.0,64.0,76.0,88.0,99.0,90.0,76.0,78.0,81.0,69.0,62.0,910.0
Upper Subansiri,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,65.0,56.0,64.0,75.0,87.0,98.0,87.0,70.0,75.0,81.0,64.0,22.0,844.0
Upper Subansiri,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,4.0,5.0,17.0,6.0,5.0,10.0,5.0,4.0,4.0,3.0,1.0,3.0,67.0
Upper Subansiri,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,3.0,5.0,15.0,3.0,3.0,10.0,5.0,4.0,3.0,3.0,0.0,2.0,56.0
Upper Subansiri,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,3.0,1.0,1.0,11.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0
Upper Subansiri,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Upper Subansiri,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Upper Subansiri,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Upper Subansiri,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Upper Subansiri,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,1.0,0.0,0.0,2.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,4.0
Upper Subansiri,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Upper Subansiri,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,1.0,0.0,0.0,2.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,4.0
Upper Subansiri,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Upper Subansiri,4.1.1.a,Number of male live births,TOTAL,36.0,34.0,32.0,42.0,41.0,48.0,55.0,31.0,38.0,51.0,30.0,25.0,463.0
Upper Subansiri,4.1.1.b,Number of female live births,TOTAL,36.0,24.0,31.0,35.0,43.0,47.0,45.0,47.0,41.0,28.0,42.0,41.0,460.0
Upper Subansiri,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,72.0,58.0,63.0,77.0,84.0,95.0,100.0,78.0,79.0,79.0,72.0,66.0,923.0
Upper Subansiri,4.1.2,Number of still births,TOTAL,0.0,1.0,2.0,1.0,2.0,1.0,7.0,4.0,3.0,3.0,1.0,0.0,25.0
Upper Subansiri,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,8.0,5.0,0.0,0.0,11.0,9.0,11.0,17.0,19.0,13.0,13.0,16.0,122.0
Upper Subansiri,4.2.1,Number of Newborns weighed at birth,TOTAL,69.0,49.0,62.0,76.0,83.0,93.0,83.0,74.0,78.0,77.0,70.0,58.0,872.0
Upper Subansiri,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,2.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,11.0,0.0,0.0,15.0
Upper Subansiri,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,69.0,49.0,62.0,76.0,81.0,94.0,82.0,74.0,79.0,78.0,69.0,59.0,872.0
Upper Subansiri,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Upper Subansiri,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Upper Subansiri,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,65.0,56.0,48.0,69.0,80.0,91.0,84.0,66.0,75.0,73.0,66.0,57.0,830.0
Upper Subansiri,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,65.0,56.0,44.0,64.0,74.0,87.0,77.0,66.0,72.0,71.0,58.0,55.0,789.0
Upper Subansiri,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,5.0,3.0,0.0,0.0,7.0,6.0,8.0,10.0,10.0,13.0,13.0,16.0,91.0
Upper Subansiri,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,3.0,2.0,0.0,0.0,4.0,3.0,2.0,6.0,8.0,0.0,0.0,0.0,28.0
Upper Subansiri,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,8.0,5.0,0.0,0.0,11.0,9.0,10.0,16.0,18.0,13.0,13.0,16.0,119.0
Upper Subansiri,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,20.0,14.0,9.0,6.0,19.0,7.0,6.0,0.0,12.0,3.0,7.0,3.0,106.0
Upper Subansiri,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,34.0,57.0,48.0,32.0,58.0,7.0,12.0,0.0,56.0,0.0,46.0,9.0,359.0
Upper Subansiri,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,54.0,71.0,57.0,38.0,77.0,14.0,18.0,0.0,68.0,3.0,53.0,12.0,465.0
Upper Subansiri,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Upper Subansiri,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Upper Subansiri,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Upper Subansiri,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Upper Subansiri,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Upper Subansiri,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Upper Subansiri,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
Upper Subansiri,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,15.0,31.0,35.0,2.0,11.0,0.0,0.0,0.0,0.0,0.0,94.0
Upper Subansiri,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Upper Subansiri,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,15.0,31.0,35.0,2.0,11.0,0.0,0.0,2.0,0.0,0.0,96.0
Upper Subansiri,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Upper Subansiri,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,2.0,1.0,7.0
Upper Subansiri,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,5.0
Upper Subansiri,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,16.0,29.0,21.0,26.0,18.0,16.0,22.0,15.0,27.0,18.0,21.0,5.0,234.0
Upper Subansiri,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Upper Subansiri,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,18.0,30.0,21.0,26.0,18.0,16.0,23.0,16.0,28.0,20.0,24.0,6.0,246.0
Upper Subansiri,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,3.0
Upper Subansiri,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Upper Subansiri,9.06,Number of IUCD removals,TOTAL,18.0,14.0,12.0,8.0,16.0,31.0,17.0,11.0,18.0,15.0,24.0,6.0,190.0
Upper Subansiri,9.07,Number of Oral Pills cycles distributed,TOTAL,42.0,53.0,59.0,61.0,81.0,119.0,64.0,97.0,89.0,127.0,133.0,89.0,1014.0
Upper Subansiri,9.08,Number of Condom pieces distributed,TOTAL,29.0,78.0,160.0,110.0,156.0,242.0,110.0,94.0,128.0,129.0,169.0,224.0,1629.0
Upper Subansiri,9.09,Number of Centchroman (weekly) pills given,TOTAL,1.0,4.0,5.0,10.0,5.0,2.0,8.0,8.0,7.0,8.0,9.0,5.0,72.0
Upper Subansiri,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,5.0,8.0,6.0,9.0,10.0,13.0,9.0,9.0,8.0,6.0,20.0,15.0,118.0
Upper Subansiri,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,9.12,Number of Institutions having NSV trained doctors,TOTAL,4.0,4.0,4.0,4.0,4.0,3.0,2.0,3.0,3.0,5.0,4.0,4.0,-1.0
Upper Subansiri,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,63.0,76.0,58.0,69.0,89.0,115.0,100.0,83.0,78.0,100.0,78.0,76.0,985.0
Upper Subansiri,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,71.0,85.0,73.0,77.0,68.0,91.0,103.0,95.0,100.0,100.0,96.0,89.0,1048.0
Upper Subansiri,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,75.0,82.0,71.0,81.0,77.0,81.0,88.0,81.0,96.0,90.0,83.0,120.0,1025.0
Upper Subansiri,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,66.0,87.0,78.0,87.0,78.0,76.0,67.0,70.0,91.0,98.0,78.0,100.0,976.0
Upper Subansiri,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,43.0,59.0,48.0,47.0,66.0,95.0,50.0,63.0,67.0,84.0,73.0,28.0,723.0
Upper Subansiri,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,69.0,85.0,75.0,73.0,66.0,91.0,103.0,96.0,100.0,100.0,94.0,91.0,1043.0
Upper Subansiri,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,71.0,82.0,72.0,80.0,78.0,81.0,89.0,82.0,96.0,92.0,80.0,120.0,1023.0
Upper Subansiri,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,67.0,78.0,79.0,79.0,76.0,75.0,72.0,70.0,92.0,98.0,80.0,102.0,968.0
Upper Subansiri,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,41.0,5.0,6.0,9.0,22.0,10.0,17.0,9.0,14.0,12.0,8.0,29.0,182.0
Upper Subansiri,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,76.0,86.0,75.0,75.0,67.0,93.0,92.0,93.0,97.0,100.0,84.0,73.0,1011.0
Upper Subansiri,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,80.0,83.0,71.0,87.0,76.0,85.0,95.0,84.0,97.0,89.0,90.0,121.0,1058.0
Upper Subansiri,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,68.0,82.0,80.0,87.0,81.0,75.0,67.0,79.0,91.0,98.0,76.0,97.0,981.0
Upper Subansiri,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,47.0,94.0,98.0,99.0,102.0,81.0,73.0,90.0,92.0,73.0,69.0,95.0,1013.0
Upper Subansiri,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,41.0,47.0,49.0,66.0,39.0,40.0,31.0,22.0,34.0,41.0,64.0,71.0,545.0
Upper Subansiri,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,20.0,46.0,51.0,44.0,50.0,48.0,49.0,41.0,37.0,33.0,39.0,32.0,490.0
Upper Subansiri,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,28.0,43.0,41.0,54.0,44.0,32.0,52.0,46.0,53.0,38.0,28.0,47.0,506.0
Upper Subansiri,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,48.0,89.0,92.0,98.0,94.0,80.0,101.0,87.0,90.0,71.0,67.0,79.0,996.0
Upper Subansiri,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,65.0,79.0,67.0,93.0,52.0,69.0,41.0,49.0,47.0,77.0,90.0,98.0,827.0
Upper Subansiri,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,69.0,81.0,68.0,89.0,59.0,65.0,42.0,51.0,47.0,79.0,92.0,98.0,840.0
Upper Subansiri,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,4.0,2.0,1.0,0.0,0.0,0.0,6.0,10.0,1.0,0.0,1.0,1.0,26.0
Upper Subansiri,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,22.0,27.0,32.0,46.0,40.0,26.0,24.0,8.0,28.0,26.0,42.0,33.0,354.0
Upper Subansiri,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,25.0,29.0,27.0,35.0,27.0,22.0,19.0,12.0,19.0,19.0,33.0,43.0,310.0
Upper Subansiri,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,47.0,56.0,59.0,81.0,67.0,48.0,43.0,20.0,47.0,45.0,75.0,76.0,664.0
Upper Subansiri,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,0.0,0.0,6.0,1.0,1.0,2.0,3.0,3.0,2.0,4.0,0.0,11.0,33.0
Upper Subansiri,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,17.0,28.0,15.0,15.0,16.0,17.0,36.0,26.0,26.0,17.0,22.0,14.0,249.0
Upper Subansiri,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,14.0,25.0,17.0,33.0,28.0,30.0,33.0,20.0,29.0,26.0,30.0,21.0,306.0
Upper Subansiri,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,0.0,0.0,2.0,6.0
Upper Subansiri,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,37.0,30.0,29.0,31.0,33.0,35.0,38.0,43.0,38.0,39.0,36.0,42.0,431.0
Upper Subansiri,10.4.2,Number of Immunisation sessions held during the month,TOTAL,30.0,26.0,26.0,27.0,29.0,32.0,33.0,40.0,35.0,39.0,34.0,39.0,390.0
Upper Subansiri,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,36.0,42.0,37.0,27.0,34.0,48.0,38.0,44.0,38.0,42.0,40.0,41.0,467.0
Upper Subansiri,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Upper Subansiri,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,0.0,3.0,0.0,0.0,0.0,0.0,0.0,110.0,98.0,29.0,73.0,87.0,400.0
Upper Subansiri,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1.0,1.0,0.0,0.0,0.0,0.0,0.0,8.0,8.0,5.0,72.0,76.0,171.0
Upper Subansiri,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,4.0,15.0,15.0,39.0
Upper Subansiri,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,2.0,4.0,10.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0
Upper Subansiri,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,46.0,68.0,76.0,54.0,81.0,82.0,52.0,81.0,60.0,43.0,81.0,46.0,770.0
Upper Subansiri,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,51.0,40.0,82.0,54.0,62.0,112.0,42.0,44.0,36.0,11.0,43.0,33.0,610.0
Upper Subansiri,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,6.0,1.0,2.0,0.0,4.0,17.0,4.0,20.0,14.0,6.0,1.0,2.0,77.0
Upper Subansiri,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,3.0,4.0,3.0,4.0,3.0,3.0,4.0,4.0,4.0,1.0,3.0,3.0,-1.0
Upper Subansiri,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,1.0,1.0,,,1.0,,,,,,,-1.0
Upper Subansiri,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,9.0,11.0,15.0,14.0,14.0,15.0,14.0,20.0,11.0,14.0,29.0,16.0,-1.0
Upper Subansiri,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,4.0,3.0,4.0,5.0,4.0,4.0,5.0,5.0,3.0,4.0,4.0,-1.0
Upper Subansiri,14.05,Number of RKS meetings held during the month,TOTAL,5.0,8.0,7.0,7.0,7.0,10.0,10.0,8.0,7.0,4.0,4.0,3.0,80.0
Upper Subansiri,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,3.0,5.0,3.0,4.0,4.0,3.0,3.0,4.0,4.0,3.0,4.0,3.0,-1.0
Upper Subansiri,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,0.0,45.0,12.0,25.0,35.0,44.0,31.0,26.0,22.0,34.0,33.0,25.0,332.0
Upper Subansiri,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,1.0,2.0,4.0,4.0,3.0,4.0,2.0,2.0,3.0,3.0,2.0,-1.0
Upper Subansiri,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,1.0,4.0,4.0,0.0,0.0,0.0,0.0,0.0,-1.0
Upper Subansiri,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,13.0,38.0,33.0,34.0,34.0,42.0,24.0,14.0,5.0,6.0,13.0,0.0,256.0
Upper Subansiri,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,55.0,51.0,78.0,129.0,70.0,59.0,85.0,58.0,16.0,35.0,43.0,25.0,704.0
Upper Subansiri,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,13.0,44.0,39.0,24.0,23.0,15.0,12.0,17.0,2.0,5.0,14.0,0.0,208.0
Upper Subansiri,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,59.0,51.0,59.0,112.0,78.0,72.0,62.0,41.0,48.0,30.0,44.0,25.0,681.0
Upper Subansiri,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,26.0,82.0,72.0,58.0,57.0,57.0,36.0,31.0,7.0,11.0,27.0,0.0,464.0
Upper Subansiri,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,114.0,102.0,137.0,241.0,148.0,131.0,147.0,99.0,64.0,65.0,87.0,50.0,1385.0
Upper Subansiri,14.10.2.a,Number of death cases of Inpatient males,TOTAL,1.0,0.0,0.0,3.0,5.0,3.0,1.0,2.0,3.0,2.0,0.0,3.0,23.0
Upper Subansiri,14.10.2.b,Number of death cases of Inpatient females,TOTAL,1.0,1.0,0.0,2.0,2.0,3.0,2.0,2.0,2.0,0.0,0.0,4.0,19.0
Upper Subansiri,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,2.0,1.0,0.0,5.0,7.0,6.0,3.0,4.0,5.0,2.0,0.0,7.0,42.0
Upper Subansiri,14.11,In-Patient Head Count at midnight,TOTAL,19.0,58.0,57.0,186.0,62.0,55.0,165.0,116.0,61.0,71.0,104.0,13.0,967.0
Upper Subansiri,14.12.1,OPD attendance (All),TOTAL,4346.0,4059.0,4641.0,5856.0,4663.0,3743.0,2686.0,3239.0,3822.0,3926.0,3663.0,4203.0,48847.0
Upper Subansiri,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,5.0,2.0,3.0,6.0,7.0,2.0,2.0,7.0,7.0,3.0,3.0,0.0,47.0
Upper Subansiri,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,26.0,12.0,14.0,14.0,20.0,16.0,10.0,19.0,8.0,19.0,14.0,17.0,189.0
Upper Subansiri,14.14.a,Number of patients given AYUSH treatment,TOTAL,157.0,278.0,111.0,579.0,351.0,117.0,77.0,255.0,158.0,134.0,119.0,118.0,2454.0
Upper Subansiri,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,165.0,162.0,158.0,187.0,157.0,160.0,90.0,119.0,113.0,122.0,117.0,131.0,1681.0
Upper Subansiri,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Upper Subansiri,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,67.0,72.0,100.0,79.0,113.0,114.0,86.0,69.0,42.0,91.0,122.0,43.0,998.0
Upper Subansiri,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,0.0,1.0,1.0,1.0,2.0,0.0,2.0,0.0,1.0,0.0,0.0,0.0,8.0
Upper Subansiri,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,59.0,39.0,36.0,31.0,19.0,27.0,33.0,0.0,16.0,10.0,7.0,5.0,282.0
Upper Subansiri,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,37.0,38.0,41.0,40.0,36.0,44.0,26.0,0.0,15.0,12.0,16.0,11.0,316.0
Upper Subansiri,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,24.0,43.0,51.0,25.0,32.0,72.0,47.0,0.0,44.0,33.0,30.0,22.0,423.0
Upper Subansiri,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,120.0,120.0,128.0,96.0,87.0,143.0,106.0,0.0,75.0,55.0,53.0,38.0,1021.0
Upper Subansiri,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,15.2,Number of Widal tests conducted,Number tested,9.0,4.0,8.0,20.0,13.0,2.0,1.0,3.0,0.0,9.0,0.0,0.0,69.0
Upper Subansiri,15.3.a,Number of VDRL tests conducted on males,Number tested,20.0,11.0,17.0,6.0,57.0,7.0,6.0,0.0,12.0,6.0,7.0,3.0,152.0
Upper Subansiri,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,10.0,11.0,20.0,12.0,29.0,6.0,3.0,0.0,12.0,12.0,16.0,8.0,139.0
Upper Subansiri,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,24.0,42.0,36.0,20.0,30.0,1.0,9.0,0.0,44.0,33.0,30.0,0.0,269.0
Upper Subansiri,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,54.0,64.0,73.0,38.0,116.0,14.0,18.0,0.0,68.0,51.0,53.0,11.0,560.0
Upper Subansiri,15.4.1,Number of blood smears examined for Malaria,TOTAL,104.0,98.0,123.0,523.0,259.0,103.0,109.0,117.0,65.0,89.0,105.0,99.0,1794.0
Upper Subansiri,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,22.0,34.0,28.0,124.0,56.0,33.0,28.0,31.0,12.0,15.0,28.0,14.0,425.0
Upper Subansiri,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,15.0,9.0,15.0,46.0,24.0,10.0,13.0,13.0,6.0,12.0,10.0,9.0,182.0
Upper Subansiri,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Subansiri,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Upper Subansiri,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Upper Subansiri,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Upper Subansiri,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Subansiri,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Upper Subansiri,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Upper Subansiri,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Upper Subansiri,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Subansiri,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Upper Subansiri,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Upper Subansiri,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Upper Subansiri,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Subansiri,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Upper Subansiri,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Upper Subansiri,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Upper Subansiri,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Subansiri,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Upper Subansiri,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Upper Subansiri,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Upper Subansiri,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Subansiri,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Upper Subansiri,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Upper Subansiri,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Upper Subansiri,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Subansiri,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Upper Subansiri,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Upper Subansiri,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Upper Subansiri,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Subansiri,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Upper Subansiri,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Upper Subansiri,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Upper Subansiri,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Subansiri,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Upper Subansiri,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Upper Subansiri,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Upper Subansiri,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Upper Subansiri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Upper Subansiri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Upper Subansiri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Upper Subansiri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Upper Subansiri,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Upper Subansiri,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Upper Subansiri,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Upper Subansiri,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Upper Subansiri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Upper Subansiri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Upper Subansiri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Upper Subansiri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Upper Subansiri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Upper Subansiri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Upper Subansiri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Upper Subansiri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Upper Subansiri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Upper Subansiri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Upper Subansiri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Upper Subansiri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Subansiri,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Upper Subansiri,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Upper Subansiri,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Upper Subansiri,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Subansiri,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Upper Subansiri,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Upper Subansiri,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Upper Subansiri,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Subansiri,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Upper Subansiri,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Upper Subansiri,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Upper Subansiri,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Subansiri,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Upper Subansiri,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Upper Subansiri,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Upper Subansiri,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Subansiri,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Upper Subansiri,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Upper Subansiri,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Upper Subansiri,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Subansiri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Upper Subansiri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Upper Subansiri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Upper Subansiri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Subansiri,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Upper Subansiri,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Upper Subansiri,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Upper Subansiri,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Upper Subansiri,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Upper Subansiri,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Upper Subansiri,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Upper Subansiri,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Upper Subansiri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Upper Subansiri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Upper Subansiri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Upper Subansiri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Upper Subansiri,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Upper Subansiri,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Upper Subansiri,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Upper Subansiri,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Upper Subansiri,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Upper Subansiri,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Upper Subansiri,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Upper Subansiri,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Upper Subansiri,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Upper Subansiri,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Upper Subansiri,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Upper Subansiri,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Upper Subansiri,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Upper Subansiri,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Upper Subansiri,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Upper Subansiri,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Upper Subansiri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Upper Subansiri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Upper Subansiri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Upper Subansiri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Upper Subansiri,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Upper Subansiri,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Upper Subansiri,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Upper Subansiri,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Upper Subansiri,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Upper Subansiri,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Upper Subansiri,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Upper Subansiri,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Upper Subansiri,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Upper Subansiri,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Upper Subansiri,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Upper Subansiri,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Upper Subansiri,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Upper Subansiri,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Upper Subansiri,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Upper Subansiri,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Upper Subansiri,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Upper Subansiri,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Upper Subansiri,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Upper Subansiri,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Upper Subansiri,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Upper Subansiri,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Upper Subansiri,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Upper Subansiri,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Upper Subansiri,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Upper Subansiri,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Upper Subansiri,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Upper Subansiri,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Upper Subansiri,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Upper Subansiri,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Upper Subansiri,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Upper Subansiri,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Upper Subansiri,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Upper Subansiri,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Upper Subansiri,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Upper Subansiri,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Upper Subansiri,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Upper Subansiri,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Upper Subansiri,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Upper Subansiri,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Upper Subansiri,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Upper Subansiri,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Upper Subansiri,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Upper Subansiri,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Upper Subansiri,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Upper Subansiri,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Upper Subansiri,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Upper Subansiri,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Upper Subansiri,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Upper Subansiri,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Upper Subansiri,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Upper Subansiri,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Upper Subansiri,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Upper Subansiri,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Upper Subansiri,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Upper Subansiri,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Upper Subansiri,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Upper Subansiri,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Upper Subansiri,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Upper Subansiri,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Upper Subansiri,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Upper Subansiri,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Upper Subansiri,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Upper Subansiri,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Upper Subansiri,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Upper Subansiri,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Upper Subansiri,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Upper Subansiri,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Upper Subansiri,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Upper Subansiri,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Upper Subansiri,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Upper Subansiri,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Upper Subansiri,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Upper Subansiri,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Upper Subansiri,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
West Kameng,1.1,Total number of pregnant women Registered for ANC,TOTAL,222.0,266.0,331.0,276.0,254.0,254.0,243.0,243.0,268.0,302.0,303.0,288.0,3250.0
West Kameng,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,75.0,67.0,200.0,135.0,89.0,197.0,206.0,178.0,105.0,141.0,78.0,104.0,1575.0
West Kameng,1.2,Number of Pregnant women registered under JSY,TOTAL,202.0,107.0,122.0,122.0,228.0,108.0,108.0,158.0,139.0,121.0,204.0,145.0,1764.0
West Kameng,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,77.0,29.0,64.0,124.0,123.0,117.0,128.0,117.0,108.0,124.0,165.0,126.0,1302.0
West Kameng,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,92.0,83.0,150.0,113.0,115.0,91.0,75.0,148.0,92.0,111.0,106.0,161.0,1337.0
West Kameng,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,66.0,38.0,78.0,97.0,75.0,96.0,71.0,89.0,68.0,99.0,88.0,106.0,971.0
West Kameng,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,172.0,170.0,213.0,222.0,176.0,614.0,378.0,769.0,1367.0,244.0,605.0,802.0,5732.0
West Kameng,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,0.0,0.0,2.0,0.0,0.0,9.0,2.0,11.0,2.0,3.0,1.0,6.0,36.0
West Kameng,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,3.0
West Kameng,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,20.0,23.0,34.0,98.0,26.0,26.0,19.0,16.0,10.0,21.0,28.0,17.0,338.0
West Kameng,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,1.0,0.0,0.0,0.0,2.0,1.0,1.0,0.0,10.0,0.0,0.0,0.0,15.0
West Kameng,1.8,Number of pregnancy test kits used at SC level,TOTAL,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,0.0,0.0,0.0,1.0,0.0,1.0,10.0,0.0,1.0,1.0,0.0,1.0,15.0
West Kameng,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,2.0,0.0,5.0
West Kameng,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,0.0,0.0,0.0,1.0,0.0,1.0,10.0,1.0,2.0,2.0,2.0,1.0,20.0
West Kameng,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,2.0,2.0,0.0,0.0,8.0
West Kameng,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,69.0,51.0,59.0,82.0,69.0,81.0,77.0,96.0,74.0,89.0,68.0,80.0,895.0
West Kameng,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,45.0,50.0,53.0,74.0,69.0,78.0,75.0,96.0,73.0,89.0,68.0,76.0,846.0
West Kameng,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,52.0,35.0,55.0,62.0,57.0,81.0,72.0,86.0,60.0,88.0,45.0,70.0,763.0
West Kameng,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,28.0,21.0,39.0,52.0,36.0,36.0,40.0,37.0,12.0,19.0,15.0,21.0,356.0
West Kameng,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
West Kameng,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
West Kameng,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
West Kameng,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
West Kameng,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,1.0,1.0,1.0,0.0,2.0,0.0,2.0,2.0,0.0,2.0,2.0,5.0,18.0
West Kameng,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
West Kameng,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,1.0,1.0,1.0,0.0,2.0,0.0,2.0,2.0,0.0,2.0,2.0,5.0,18.0
West Kameng,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
West Kameng,4.1.1.a,Number of male live births,TOTAL,33.0,24.0,26.0,41.0,35.0,48.0,47.0,51.0,36.0,51.0,38.0,39.0,469.0
West Kameng,4.1.1.b,Number of female live births,TOTAL,33.0,24.0,33.0,41.0,33.0,33.0,38.0,39.0,38.0,39.0,33.0,42.0,426.0
West Kameng,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,66.0,48.0,59.0,82.0,68.0,81.0,85.0,90.0,74.0,90.0,71.0,81.0,895.0
West Kameng,4.1.2,Number of still births,TOTAL,3.0,3.0,1.0,1.0,1.0,0.0,2.0,1.0,2.0,6.0,1.0,1.0,22.0
West Kameng,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,2.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,5.0
West Kameng,4.2.1,Number of Newborns weighed at birth,TOTAL,66.0,48.0,59.0,79.0,68.0,81.0,81.0,88.0,73.0,89.0,69.0,79.0,880.0
West Kameng,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,2.0,1.0,12.0,5.0,2.0,6.0,3.0,4.0,6.0,3.0,7.0,1.0,52.0
West Kameng,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,66.0,48.0,58.0,80.0,68.0,81.0,85.0,92.0,73.0,89.0,69.0,79.0,888.0
West Kameng,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,15.0,0.0,4.0,10.0,11.0,20.0,62.0
West Kameng,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
West Kameng,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,1.0,7.0,2.0,0.0,0.0,0.0,0.0,2.0,5.0,5.0,28.0,50.0
West Kameng,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
West Kameng,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,1.0,10.0,2.0,0.0,0.0,15.0,0.0,6.0,15.0,16.0,48.0,113.0
West Kameng,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
West Kameng,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,3.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,6.0,12.0
West Kameng,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,10.0,6.0,5.0,3.0,4.0,14.0,15.0,62.0,4.0,10.0,11.0,36.0,180.0
West Kameng,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,8.0,0.0,7.0,3.0,0.0,2.0,10.0,3.0,2.0,5.0,5.0,6.0,51.0
West Kameng,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,61.0,50.0,58.0,77.0,68.0,65.0,75.0,82.0,69.0,89.0,63.0,74.0,831.0
West Kameng,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,42.0,33.0,40.0,47.0,35.0,52.0,47.0,58.0,42.0,69.0,43.0,57.0,565.0
West Kameng,6.3,PNC maternal complications attended,TOTAL,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,6.0
West Kameng,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,11.0,9.0,14.0,12.0,10.0,6.0,8.0,12.0,5.0,8.0,3.0,6.0,104.0
West Kameng,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
West Kameng,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,11.0,9.0,14.0,13.0,11.0,6.0,8.0,12.0,5.0,8.0,3.0,6.0,106.0
West Kameng,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,,,,,,,,,,,,0.0
West Kameng,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,16.0,10.0,23.0,3.0,5.0,14.0,13.0,2.0,9.0,5.0,2.0,7.0,109.0
West Kameng,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,19.0,22.0,30.0,67.0,64.0,49.0,67.0,9.0,63.0,8.0,2.0,12.0,412.0
West Kameng,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,35.0,32.0,53.0,70.0,69.0,63.0,80.0,11.0,72.0,13.0,4.0,19.0,521.0
West Kameng,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,68.0,0.0,0.0,0.0,68.0
West Kameng,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
West Kameng,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
West Kameng,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
West Kameng,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
West Kameng,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0
West Kameng,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
West Kameng,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0
West Kameng,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
West Kameng,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
West Kameng,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
West Kameng,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,1.0,1.0,1.0,3.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,9.0
West Kameng,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,11.0,0.0,16.0,14.0,8.0,9.0,3.0,4.0,3.0,8.0,9.0,8.0,93.0
West Kameng,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,19.0,6.0,8.0,10.0,18.0,10.0,5.0,11.0,19.0,9.0,5.0,7.0,127.0
West Kameng,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,23.0,20.0,25.0,41.0,30.0,24.0,23.0,23.0,20.0,14.0,20.0,31.0,294.0
West Kameng,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
West Kameng,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,54.0,27.0,50.0,68.0,57.0,44.0,31.0,38.0,43.0,31.0,34.0,46.0,523.0
West Kameng,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,5.0
West Kameng,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
West Kameng,9.06,Number of IUCD removals,TOTAL,16.0,15.0,8.0,13.0,25.0,9.0,11.0,8.0,15.0,21.0,2.0,14.0,157.0
West Kameng,9.07,Number of Oral Pills cycles distributed,TOTAL,137.0,227.0,202.0,182.0,412.0,265.0,341.0,416.0,428.0,400.0,369.0,607.0,3986.0
West Kameng,9.08,Number of Condom pieces distributed,TOTAL,468.0,349.0,165.0,1296.0,390.0,3501.0,2327.0,1318.0,804.0,580.0,208.0,816.0,12222.0
West Kameng,9.09,Number of Centchroman (weekly) pills given,TOTAL,18.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,60.0,0.0,10.0,88.0
West Kameng,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,44.0,40.0,40.0,20.0,33.0,50.0,41.0,90.0,116.0,122.0,27.0,72.0,695.0
West Kameng,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,,,,,,,,,,,,-1.0
West Kameng,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,96.0,81.0,112.0,107.0,103.0,118.0,105.0,147.0,140.0,99.0,98.0,113.0,1319.0
West Kameng,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,59.0,69.0,115.0,101.0,110.0,101.0,116.0,115.0,115.0,118.0,117.0,139.0,1275.0
West Kameng,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,81.0,46.0,106.0,86.0,100.0,94.0,78.0,107.0,95.0,94.0,112.0,117.0,1116.0
West Kameng,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,72.0,60.0,89.0,91.0,105.0,95.0,91.0,101.0,76.0,83.0,82.0,147.0,1092.0
West Kameng,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,3.0
West Kameng,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,66.0,58.0,70.0,79.0,73.0,83.0,80.0,82.0,85.0,73.0,72.0,61.0,882.0
West Kameng,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,59.0,69.0,115.0,101.0,110.0,101.0,116.0,105.0,115.0,118.0,117.0,140.0,1266.0
West Kameng,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,81.0,46.0,106.0,86.0,100.0,94.0,78.0,107.0,95.0,94.0,112.0,117.0,1116.0
West Kameng,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,72.0,60.0,89.0,91.0,105.0,95.0,91.0,106.0,76.0,83.0,82.0,147.0,1097.0
West Kameng,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,5.0,6.0,18.0,12.0,22.0,8.0,25.0,20.0,17.0,26.0,21.0,180.0
West Kameng,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,51.0,68.0,87.0,95.0,103.0,86.0,117.0,147.0,108.0,92.0,115.0,145.0,1214.0
West Kameng,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,60.0,56.0,101.0,96.0,96.0,85.0,84.0,104.0,106.0,101.0,121.0,120.0,1130.0
West Kameng,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,82.0,48.0,92.0,79.0,104.0,93.0,103.0,107.0,83.0,85.0,85.0,149.0,1110.0
West Kameng,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,52.0,45.0,109.0,107.0,120.0,100.0,73.0,95.0,87.0,86.0,67.0,99.0,1040.0
West Kameng,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,50.0,40.0,80.0,65.0,94.0,71.0,44.0,51.0,67.0,40.0,78.0,86.0,766.0
West Kameng,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,28.0,20.0,50.0,52.0,41.0,45.0,35.0,40.0,52.0,36.0,31.0,42.0,472.0
West Kameng,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,24.0,18.0,48.0,56.0,70.0,55.0,34.0,29.0,42.0,42.0,37.0,50.0,505.0
West Kameng,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,52.0,38.0,98.0,108.0,111.0,100.0,69.0,69.0,94.0,78.0,68.0,92.0,977.0
West Kameng,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,45.0,55.0,65.0,69.0,101.0,71.0,49.0,46.0,82.0,49.0,74.0,87.0,793.0
West Kameng,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,45.0,55.0,65.0,69.0,101.0,71.0,49.0,47.0,82.0,49.0,74.0,87.0,794.0
West Kameng,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,0.0,6.0,20.0,17.0,55.0,76.0,12.0,24.0,50.0,20.0,48.0,32.0,360.0
West Kameng,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,0.0,3.0,16.0,20.0,58.0,66.0,14.0,23.0,27.0,24.0,34.0,25.0,310.0
West Kameng,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,0.0,9.0,36.0,37.0,113.0,142.0,26.0,47.0,77.0,44.0,82.0,57.0,670.0
West Kameng,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1.0,0.0,8.0,1.0,7.0,1.0,0.0,0.0,3.0,5.0,23.0,14.0,63.0
West Kameng,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,7.0,5.0,24.0,11.0,15.0,13.0,22.0,25.0,14.0,24.0,15.0,64.0,239.0
West Kameng,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,13.0,7.0,32.0,12.0,27.0,22.0,17.0,30.0,19.0,30.0,22.0,45.0,276.0
West Kameng,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,17.0,22.0,41.0,22.0,28.0,18.0,30.0,29.0,22.0,29.0,34.0,42.0,334.0
West Kameng,10.4.2,Number of Immunisation sessions held during the month,TOTAL,17.0,22.0,30.0,20.0,21.0,18.0,26.0,25.0,20.0,24.0,30.0,40.0,293.0
West Kameng,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,17.0,22.0,29.0,20.0,21.0,18.0,25.0,41.0,19.0,22.0,29.0,37.0,300.0
West Kameng,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,102.0,154.0,86.0,63.0,68.0,473.0
West Kameng,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0,51.0,27.0,33.0,84.0,207.0
West Kameng,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0,211.0,3.0,2.0,10.0,237.0
West Kameng,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,11.0,11.0,14.0,12.0,0.0,6.0,3.0,0.0,10.0,3.0,70.0
West Kameng,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,3.0,1.0,4.0,3.0,1.0,1.0,2.0,1.0,1.0,1.0,0.0,0.0,18.0
West Kameng,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,107.0,101.0,131.0,200.0,133.0,86.0,69.0,66.0,57.0,54.0,64.0,103.0,1171.0
West Kameng,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,1.0,8.0,6.0,7.0,8.0,2.0,0.0,2.0,0.0,0.0,0.0,1.0,35.0
West Kameng,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,3.0,6.0,0.0,0.0,28.0,81.0,12.0,21.0,8.0,10.0,5.0,36.0,210.0
West Kameng,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,2.0,31.0,83.0,8.0,17.0,16.0,9.0,0.0,0.0,13.0,18.0,197.0
West Kameng,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,2.0,2.0,2.0,2.0,2.0,2.0,1.0,1.0,1.0,1.0,1.0,-1.0
West Kameng,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,4.0,4.0,3.0,4.0,4.0,4.0,5.0,5.0,6.0,6.0,6.0,-1.0
West Kameng,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2.0,11.0,20.0,31.0,30.0,23.0,38.0,42.0,42.0,11.0,42.0,33.0,-1.0
West Kameng,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,-1.0
West Kameng,14.05,Number of RKS meetings held during the month,TOTAL,0.0,3.0,4.0,4.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,20.0
West Kameng,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,8.0,8.0,8.0,8.0,8.0,8.0,8.0,9.0,8.0,9.0,9.0,9.0,-1.0
West Kameng,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,16.0,19.0,17.0,38.0,28.0,55.0,58.0,36.0,42.0,31.0,34.0,51.0,425.0
West Kameng,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
West Kameng,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
West Kameng,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,14.0,17.0,25.0,27.0,30.0,18.0,9.0,12.0,9.0,7.0,14.0,14.0,196.0
West Kameng,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,67.0,71.0,74.0,98.0,107.0,77.0,65.0,65.0,53.0,49.0,52.0,49.0,827.0
West Kameng,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,15.0,14.0,29.0,39.0,31.0,21.0,19.0,32.0,11.0,7.0,14.0,20.0,252.0
West Kameng,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,133.0,116.0,148.0,170.0,171.0,149.0,135.0,96.0,126.0,124.0,111.0,140.0,1619.0
West Kameng,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,29.0,31.0,54.0,66.0,61.0,39.0,28.0,44.0,20.0,14.0,28.0,34.0,448.0
West Kameng,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,200.0,187.0,222.0,268.0,278.0,226.0,200.0,161.0,179.0,173.0,163.0,189.0,2446.0
West Kameng,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,1.0,2.0,3.0,3.0,7.0,1.0,4.0,4.0,3.0,4.0,1.0,33.0
West Kameng,14.10.2.b,Number of death cases of Inpatient females,TOTAL,1.0,1.0,2.0,3.0,3.0,0.0,1.0,3.0,0.0,3.0,2.0,0.0,19.0
West Kameng,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,1.0,2.0,4.0,6.0,6.0,7.0,2.0,7.0,4.0,6.0,6.0,1.0,52.0
West Kameng,14.11,In-Patient Head Count at midnight,TOTAL,229.0,218.0,276.0,334.0,339.0,265.0,228.0,205.0,199.0,185.0,191.0,223.0,2892.0
West Kameng,14.12.1,OPD attendance (All),TOTAL,5432.0,4889.0,5989.0,7494.0,7171.0,6521.0,5262.0,5118.0,3929.0,4346.0,4380.0,4908.0,65439.0
West Kameng,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,1.0,0.0,0.0,2.0,0.0,2.0,2.0,0.0,0.0,2.0,5.0,14.0
West Kameng,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0
West Kameng,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,12.0,5.0,0.0,8.0,8.0,16.0,0.0,0.0,0.0,6.0,2.0,7.0,64.0
West Kameng,14.14.a,Number of patients given AYUSH treatment,TOTAL,7.0,69.0,353.0,275.0,25.0,58.0,253.0,87.0,285.0,152.0,21.0,27.0,1612.0
West Kameng,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,463.0,248.0,252.0,334.0,408.0,387.0,348.0,341.0,472.0,382.0,311.0,362.0,4308.0
West Kameng,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,96.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,96.0
West Kameng,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,182.0,222.0,252.0,238.0,244.0,225.0,169.0,154.0,150.0,161.0,176.0,168.0,2341.0
West Kameng,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,1.0,4.0,5.0,6.0,10.0,4.0,6.0,4.0,13.0,4.0,3.0,1.0,61.0
West Kameng,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,69.0,151.0,114.0,52.0,93.0,20.0,147.0,330.0,167.0,95.0,201.0,85.0,1524.0
West Kameng,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,116.0,42.0,68.0,50.0,43.0,12.0,37.0,93.0,197.0,82.0,78.0,54.0,872.0
West Kameng,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,51.0,73.0,88.0,93.0,98.0,90.0,78.0,52.0,68.0,166.0,183.0,159.0,1199.0
West Kameng,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,236.0,266.0,270.0,195.0,234.0,122.0,262.0,475.0,432.0,343.0,462.0,298.0,3595.0
West Kameng,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,15.2,Number of Widal tests conducted,Number tested,90.0,88.0,172.0,247.0,169.0,165.0,95.0,54.0,54.0,52.0,49.0,107.0,1342.0
West Kameng,15.3.a,Number of VDRL tests conducted on males,Number tested,2.0,26.0,5.0,3.0,3.0,12.0,6.0,3.0,9.0,20.0,27.0,24.0,140.0
West Kameng,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,8.0,18.0,9.0,16.0,12.0,8.0,10.0,6.0,11.0,4.0,33.0,53.0,188.0
West Kameng,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,57.0,77.0,123.0,99.0,107.0,83.0,56.0,74.0,74.0,67.0,88.0,112.0,1017.0
West Kameng,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,67.0,121.0,137.0,118.0,122.0,103.0,72.0,83.0,94.0,91.0,148.0,189.0,1345.0
West Kameng,15.4.1,Number of blood smears examined for Malaria,TOTAL,90.0,107.0,181.0,522.0,314.0,226.0,82.0,118.0,104.0,42.0,124.0,164.0,2074.0
West Kameng,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,3.0,6.0,9.0,25.0,4.0,5.0,5.0,3.0,1.0,2.0,1.0,3.0,67.0
West Kameng,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,3.0,14.0,21.0,11.0,2.0,1.0,3.0,1.0,2.0,0.0,2.0,62.0
West Kameng,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
West Kameng,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
West Kameng,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
West Kameng,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
West Kameng,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
West Kameng,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
West Kameng,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
West Kameng,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
West Kameng,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
West Kameng,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
West Kameng,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
West Kameng,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
West Kameng,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
West Kameng,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
West Kameng,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
West Kameng,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
West Kameng,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
West Kameng,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
West Kameng,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
West Kameng,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
West Kameng,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
West Kameng,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
West Kameng,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
West Kameng,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
West Kameng,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
West Kameng,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
West Kameng,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
West Kameng,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
West Kameng,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
West Kameng,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
West Kameng,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
West Kameng,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
West Kameng,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
West Kameng,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
West Kameng,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
West Kameng,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
West Kameng,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
West Kameng,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
West Kameng,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
West Kameng,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
West Kameng,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
West Kameng,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
West Kameng,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
West Kameng,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
West Kameng,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
West Kameng,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
West Kameng,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
West Kameng,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
West Kameng,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
West Kameng,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
West Kameng,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
West Kameng,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
West Kameng,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
West Kameng,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
West Kameng,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
West Kameng,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
West Kameng,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
West Kameng,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
West Kameng,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
West Kameng,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
West Kameng,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
West Kameng,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
West Kameng,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
West Kameng,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
West Kameng,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
West Kameng,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
West Kameng,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
West Kameng,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
West Kameng,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
West Kameng,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
West Kameng,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
West Kameng,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
West Kameng,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
West Kameng,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
West Kameng,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
West Kameng,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
West Kameng,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
West Kameng,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
West Kameng,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
West Kameng,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
West Kameng,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
West Kameng,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
West Kameng,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
West Kameng,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
West Kameng,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
West Kameng,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
West Kameng,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
West Kameng,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
West Kameng,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
West Kameng,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
West Kameng,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
West Kameng,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
West Kameng,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
West Kameng,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
West Kameng,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
West Kameng,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
West Kameng,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
West Kameng,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
West Kameng,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
West Kameng,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
West Kameng,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
West Kameng,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
West Kameng,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
West Kameng,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
West Kameng,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
West Kameng,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
West Kameng,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
West Kameng,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
West Kameng,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
West Kameng,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
West Kameng,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
West Kameng,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
West Kameng,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Kameng,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
West Kameng,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
West Kameng,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
West Kameng,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
West Kameng,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
West Kameng,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
West Kameng,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
West Kameng,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
West Kameng,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
West Kameng,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
West Kameng,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,1.0,,,1.0
West Kameng,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
West Kameng,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,1.0,,,1.0
West Kameng,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
West Kameng,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,1.0,,1.0
West Kameng,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,1.0,,1.0
West Kameng,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
West Kameng,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
West Kameng,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
West Kameng,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
West Kameng,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
West Kameng,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
West Kameng,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
West Kameng,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
West Kameng,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
West Kameng,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,2.0,,2.0,,,,,,,,4.0
West Kameng,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,1.0,,1.0
West Kameng,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,2.0,,2.0,,,,,,1.0,,5.0
West Kameng,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
West Kameng,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,1.0,,,,,,,1.0
West Kameng,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
West Kameng,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,1.0,,,,,,,1.0
West Kameng,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
West Kameng,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
West Kameng,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
West Kameng,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
West Kameng,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
West Kameng,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,1.0,,1.0,1.0,1.0,4.0
West Kameng,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,1.0,,,,1.0
West Kameng,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,1.0,1.0,1.0,1.0,1.0,5.0
West Kameng,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
West Kameng,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
West Kameng,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
West Kameng,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
West Kameng,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
West Kameng,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,1.0,1.0,,,,,,,2.0
West Kameng,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
West Kameng,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,1.0,1.0,,,,,,,2.0
West Kameng,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
West Kameng,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
West Kameng,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
West Kameng,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
West Kameng,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
West Kameng,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
West Kameng,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
West Kameng,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
West Kameng,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
West Kameng,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,1.0,1.0,,,,,,2.0
West Kameng,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
West Kameng,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,1.0,1.0,,,,,,2.0
West Kameng,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
West Kameng,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
West Kameng,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
West Kameng,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
West Kameng,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
West Kameng,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,1.0,,,,,,,,,,,1.0
West Kameng,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
West Kameng,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,1.0,,,,,,,,,,,1.0
West Kameng,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
West Kameng,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
West Kameng,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
West Kameng,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
West Kameng,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
West Kameng,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
West Kameng,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
West Kameng,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
West Kameng,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
West Kameng,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
West Kameng,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
West Kameng,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
West Kameng,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
West Kameng,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
West Kameng,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
West Kameng,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
West Kameng,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
West Kameng,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
West Kameng,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
West Kameng,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
West Kameng,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
West Kameng,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,1.0,1.0,1.0,3.0
West Kameng,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
West Kameng,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,1.0,1.0,1.0,3.0
West Kameng,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
West Kameng,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
West Kameng,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
West Kameng,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
West Kameng,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
West Kameng,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,1.0,1.0,,,,,1.0,3.0
West Kameng,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
West Kameng,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,1.0,1.0,,,,,1.0,3.0
West Kameng,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
West Kameng,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
West Kameng,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,1.0,,,,,,,,,,1.0
West Kameng,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,1.0,,,,,,,,,,1.0
West Kameng,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
West Kameng,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
West Kameng,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
West Kameng,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
West Siang,1.1,Total number of pregnant women Registered for ANC,TOTAL,176.0,189.0,176.0,182.0,148.0,151.0,142.0,126.0,109.0,129.0,135.0,184.0,1847.0
West Siang,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,45.0,76.0,47.0,58.0,44.0,33.0,35.0,32.0,24.0,27.0,20.0,27.0,468.0
West Siang,1.2,Number of Pregnant women registered under JSY,TOTAL,176.0,186.0,176.0,182.0,148.0,149.0,142.0,126.0,109.0,129.0,134.0,182.0,1839.0
West Siang,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,55.0,66.0,85.0,102.0,90.0,75.0,109.0,55.0,66.0,72.0,53.0,70.0,898.0
West Siang,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,168.0,140.0,151.0,171.0,128.0,108.0,123.0,109.0,92.0,90.0,86.0,148.0,1514.0
West Siang,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,57.0,72.0,81.0,102.0,91.0,65.0,106.0,86.0,73.0,78.0,63.0,90.0,964.0
West Siang,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,152.0,155.0,138.0,148.0,131.0,39.0,105.0,98.0,85.0,75.0,84.0,142.0,1352.0
West Siang,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,0.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
West Siang,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,76.0,100.0,98.0,11.0,74.0,87.0,65.0,35.0,51.0,32.0,59.0,90.0,778.0
West Siang,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
West Siang,1.8,Number of pregnancy test kits used at SC level,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,0.0,0.0,1.0,1.0,1.0,1.0,0.0,1.0,1.0,2.0,1.0,0.0,9.0
West Siang,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
West Siang,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,0.0,0.0,1.0,1.0,1.0,1.0,0.0,1.0,1.0,4.0,1.0,0.0,11.0
West Siang,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,0.0,0.0,1.0,1.0,1.0,1.0,0.0,1.0,1.0,2.0,0.0,0.0,8.0
West Siang,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,111.0,87.0,98.0,94.0,132.0,107.0,83.0,113.0,96.0,102.0,87.0,94.0,1204.0
West Siang,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,105.0,83.0,94.0,85.0,119.0,100.0,80.0,74.0,86.0,82.0,81.0,89.0,1078.0
West Siang,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
West Siang,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
West Siang,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
West Siang,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
West Siang,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,8.0,4.0,4.0,8.0,10.0,7.0,3.0,8.0,10.0,5.0,6.0,5.0,78.0
West Siang,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
West Siang,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,8.0,4.0,4.0,8.0,10.0,7.0,3.0,8.0,10.0,5.0,6.0,5.0,78.0
West Siang,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
West Siang,4.1.1.a,Number of male live births,TOTAL,56.0,45.0,50.0,50.0,74.0,56.0,43.0,64.0,39.0,55.0,40.0,39.0,611.0
West Siang,4.1.1.b,Number of female live births,TOTAL,55.0,45.0,49.0,44.0,65.0,50.0,40.0,49.0,56.0,50.0,47.0,54.0,604.0
West Siang,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,111.0,90.0,99.0,94.0,139.0,106.0,83.0,113.0,95.0,105.0,87.0,93.0,1215.0
West Siang,4.1.2,Number of still births,TOTAL,0.0,1.0,1.0,1.0,4.0,2.0,0.0,0.0,2.0,1.0,1.0,1.0,14.0
West Siang,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,13.0,13.0,21.0,25.0,11.0,16.0,13.0,23.0,19.0,10.0,23.0,21.0,208.0
West Siang,4.2.1,Number of Newborns weighed at birth,TOTAL,110.0,87.0,98.0,94.0,129.0,106.0,83.0,113.0,95.0,101.0,84.0,90.0,1190.0
West Siang,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,5.0,3.0,4.0,4.0,6.0,11.0,5.0,4.0,4.0,5.0,4.0,3.0,58.0
West Siang,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,110.0,87.0,98.0,94.0,129.0,106.0,80.0,43.0,95.0,100.0,75.0,90.0,1107.0
West Siang,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,5.0,3.0,9.0,8.0,18.0,4.0,0.0,9.0,4.0,60.0
West Siang,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,7.0,0.0,,8.0,0.0,0.0,0.0,10.0,0.0,0.0,6.0,0.0,31.0
West Siang,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
West Siang,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,7.0,0.0,0.0,13.0,3.0,9.0,8.0,28.0,4.0,0.0,15.0,4.0,91.0
West Siang,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
West Siang,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,4.0,0.0,0.0,8.0,0.0,3.0,2.0,13.0,0.0,0.0,6.0,0.0,36.0
West Siang,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
West Siang,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,3.0,0.0,3.0,5.0,3.0,6.0,6.0,15.0,3.0,3.0,9.0,4.0,60.0
West Siang,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,10.0,6.0,9.0,3.0,8.0,13.0,9.0,66.0,12.0,9.0,58.0,8.0,211.0
West Siang,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2.0,0.0,6.0,1.0,2.0,16.0,3.0,16.0,2.0,0.0,11.0,2.0,61.0
West Siang,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,2.0,0.0,7.0
West Siang,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,11.0,13.0,20.0,24.0,10.0,14.0,11.0,20.0,3.0,10.0,23.0,21.0,180.0
West Siang,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,1.0,1.0,1.0,2.0,1.0,2.0,2.0,0.0,0.0,0.0,10.0
West Siang,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,11.0,13.0,21.0,25.0,11.0,16.0,12.0,22.0,5.0,10.0,23.0,21.0,190.0
West Siang,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,30.0,0.0,5.0,2.0,1.0,34.0,6.0,3.0,6.0,6.0,25.0,2.0,120.0
West Siang,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,23.0,0.0,8.0,4.0,2.0,18.0,11.0,5.0,6.0,10.0,15.0,6.0,108.0
West Siang,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,53.0,0.0,13.0,6.0,3.0,52.0,17.0,8.0,12.0,16.0,40.0,8.0,228.0
West Siang,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
West Siang,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
West Siang,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
West Siang,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
West Siang,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,1.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
West Siang,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,6.0,0.0,0.0,11.0,6.0,2.0,5.0,11.0,0.0,10.0,8.0,14.0,73.0
West Siang,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
West Siang,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,7.0,0.0,0.0,11.0,10.0,2.0,5.0,11.0,0.0,10.0,8.0,14.0,78.0
West Siang,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
West Siang,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
West Siang,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
West Siang,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,4.0,4.0,3.0,2.0,1.0,3.0,1.0,0.0,0.0,1.0,2.0,3.0,24.0
West Siang,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,2.0,5.0,10.0,14.0,8.0,6.0,6.0,11.0,7.0,5.0,8.0,4.0,86.0
West Siang,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,16.0,21.0,25.0,35.0,20.0,13.0,15.0,11.0,16.0,0.0,19.0,19.0,210.0
West Siang,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
West Siang,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,22.0,30.0,38.0,51.0,29.0,22.0,22.0,22.0,23.0,6.0,29.0,26.0,320.0
West Siang,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,0.0,0.0,0.0,3.0,3.0,2.0,0.0,12.0,0.0,0.0,1.0,21.0
West Siang,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
West Siang,9.06,Number of IUCD removals,TOTAL,11.0,14.0,32.0,20.0,30.0,35.0,53.0,15.0,18.0,16.0,20.0,4.0,268.0
West Siang,9.07,Number of Oral Pills cycles distributed,TOTAL,66.0,73.0,61.0,71.0,29.0,52.0,75.0,68.0,90.0,59.0,92.0,71.0,807.0
West Siang,9.08,Number of Condom pieces distributed,TOTAL,147.0,76.0,54.0,259.0,102.0,190.0,30.0,142.0,77.0,280.0,214.0,226.0,1797.0
West Siang,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
West Siang,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,0.0,5.0,3.0,4.0,2.0,4.0,16.0,5.0,39.0
West Siang,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,9.12,Number of Institutions having NSV trained doctors,TOTAL,2.0,2.0,1.0,2.0,3.0,2.0,,2.0,2.0,2.0,2.0,2.0,-1.0
West Siang,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,139.0,141.0,155.0,149.0,171.0,145.0,104.0,128.0,145.0,156.0,143.0,133.0,1709.0
West Siang,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,83.0,107.0,108.0,128.0,113.0,135.0,130.0,125.0,135.0,138.0,133.0,164.0,1499.0
West Siang,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,106.0,108.0,110.0,125.0,113.0,133.0,134.0,114.0,131.0,113.0,141.0,138.0,1466.0
West Siang,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,108.0,103.0,106.0,118.0,112.0,110.0,99.0,84.0,148.0,136.0,109.0,151.0,1384.0
West Siang,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,4.0,0.0,0.0,0.0,7.0
West Siang,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,5.0
West Siang,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0
West Siang,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,32.0,42.0,55.0,58.0,44.0,57.0,45.0,5.0,53.0,1.0,58.0,6.0,456.0
West Siang,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,83.0,107.0,108.0,128.0,112.0,135.0,130.0,125.0,135.0,138.0,133.0,164.0,1498.0
West Siang,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,106.0,108.0,110.0,125.0,113.0,133.0,134.0,114.0,132.0,113.0,141.0,138.0,1467.0
West Siang,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,108.0,103.0,106.0,118.0,111.0,110.0,99.0,84.0,149.0,136.0,109.0,151.0,1384.0
West Siang,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,0.0,0.0,4.0,0.0,0.0,7.0,0.0,0.0,0.0,1.0,0.0,0.0,12.0
West Siang,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,81.0,107.0,108.0,128.0,125.0,132.0,117.0,125.0,121.0,139.0,115.0,164.0,1462.0
West Siang,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,102.0,105.0,110.0,125.0,133.0,131.0,130.0,108.0,136.0,115.0,138.0,138.0,1471.0
West Siang,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,113.0,103.0,105.0,118.0,113.0,110.0,99.0,85.0,125.0,131.0,109.0,151.0,1362.0
West Siang,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,69.0,57.0,154.0,152.0,87.0,127.0,106.0,92.0,115.0,106.0,98.0,118.0,1281.0
West Siang,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,62.0,58.0,85.0,99.0,63.0,86.0,64.0,71.0,96.0,67.0,84.0,89.0,924.0
West Siang,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,1.0,0.0,4.0,9.0
West Siang,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,32.0,46.0,71.0,71.0,47.0,60.0,50.0,44.0,60.0,45.0,42.0,51.0,619.0
West Siang,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,31.0,29.0,83.0,78.0,40.0,66.0,53.0,50.0,52.0,58.0,56.0,55.0,651.0
West Siang,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,63.0,75.0,154.0,149.0,87.0,126.0,103.0,94.0,112.0,103.0,98.0,106.0,1270.0
West Siang,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,62.0,57.0,83.0,104.0,63.0,86.0,67.0,75.0,96.0,68.0,84.0,90.0,935.0
West Siang,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,62.0,57.0,83.0,104.0,63.0,86.0,67.0,75.0,96.0,68.0,84.0,90.0,935.0
West Siang,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,40.0,31.0,41.0,53.0,33.0,49.0,24.0,42.0,43.0,38.0,43.0,48.0,485.0
West Siang,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,20.0,25.0,41.0,39.0,27.0,37.0,38.0,29.0,42.0,30.0,41.0,44.0,413.0
West Siang,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,60.0,56.0,82.0,92.0,60.0,86.0,62.0,71.0,85.0,68.0,84.0,92.0,898.0
West Siang,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,4.0,10.0,16.0,33.0,19.0,39.0,22.0,23.0,37.0,15.0,17.0,10.0,245.0
West Siang,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,22.0,24.0,28.0,21.0,9.0,25.0,17.0,30.0,36.0,25.0,26.0,33.0,296.0
West Siang,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,28.0,25.0,29.0,37.0,6.0,25.0,34.0,17.0,32.0,20.0,30.0,36.0,319.0
West Siang,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,101.0,34.0,41.0,41.0,25.0,44.0,41.0,40.0,38.0,43.0,38.0,38.0,524.0
West Siang,10.4.2,Number of Immunisation sessions held during the month,TOTAL,51.0,34.0,41.0,41.0,24.0,37.0,40.0,40.0,38.0,42.0,33.0,37.0,458.0
West Siang,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,51.0,34.0,41.0,37.0,24.0,37.0,40.0,29.0,38.0,20.0,35.0,33.0,419.0
West Siang,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,68.0,107.0,78.0,108.0,105.0,466.0
West Siang,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,66.0,85.0,53.0,62.0,52.0,318.0
West Siang,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,19.0,31.0,26.0,8.0,57.0,141.0
West Siang,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,43.0,50.0,61.0,31.0,18.0,36.0,26.0,29.0,27.0,42.0,62.0,44.0,469.0
West Siang,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,7.0,0.0,0.0,0.0,6.0,4.0,1.0,2.0,6.0,2.0,4.0,7.0,39.0
West Siang,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,3.0,0.0,15.0,28.0,6.0,26.0,16.0,9.0,30.0,20.0,18.0,10.0,181.0
West Siang,13.1,Number of Patients operated for cataract,TOTAL,6.0,7.0,0.0,5.0,8.0,4.0,3.0,6.0,1.0,8.0,5.0,6.0,59.0
West Siang,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,6.0,0.0,0.0,0.0,4.0,0.0,5.0,1.0,8.0,5.0,6.0,35.0
West Siang,13.3,Number of School children detected with Refractive errors,TOTAL,16.0,5.0,12.0,15.0,12.0,5.0,0.0,16.0,4.0,13.0,0.0,10.0,108.0
West Siang,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
West Siang,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,6.0,,,,,1.0,1.0,1.0,1.0,1.0,-1.0
West Siang,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,340.0,318.0,349.0,340.0,340.0,367.0,367.0,367.0,367.0,367.0,367.0,367.0,-1.0
West Siang,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,7.0,7.0,7.0,7.0,6.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,-1.0
West Siang,14.05,Number of RKS meetings held during the month,TOTAL,1.0,1.0,12.0,2.0,2.0,3.0,0.0,1.0,0.0,1.0,2.0,2.0,27.0
West Siang,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,16.0,18.0,17.0,17.0,16.0,17.0,21.0,13.0,13.0,13.0,13.0,13.0,-1.0
West Siang,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,1.0,3.0,10.0,11.0,8.0,14.0,4.0,12.0,4.0,0.0,9.0,7.0,83.0
West Siang,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,7.0,7.0,7.0,7.0,6.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,-1.0
West Siang,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
West Siang,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,4.0,9.0,14.0,6.0,15.0,12.0,28.0,10.0,4.0,3.0,16.0,33.0,154.0
West Siang,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,49.0,98.0,47.0,71.0,91.0,87.0,59.0,51.0,32.0,50.0,63.0,57.0,755.0
West Siang,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,9.0,4.0,11.0,7.0,17.0,14.0,48.0,12.0,2.0,2.0,12.0,40.0,178.0
West Siang,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,69.0,59.0,99.0,114.0,120.0,113.0,38.0,70.0,36.0,44.0,73.0,69.0,904.0
West Siang,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,13.0,13.0,25.0,13.0,32.0,26.0,76.0,22.0,6.0,5.0,28.0,73.0,332.0
West Siang,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,118.0,157.0,146.0,185.0,211.0,200.0,97.0,121.0,68.0,94.0,136.0,126.0,1659.0
West Siang,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,3.0,3.0,3.0,2.0,0.0,0.0,2.0,4.0,0.0,1.0,1.0,19.0
West Siang,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,1.0,4.0,1.0,0.0,0.0,1.0,2.0,0.0,0.0,0.0,0.0,9.0
West Siang,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,4.0,7.0,4.0,2.0,0.0,1.0,4.0,4.0,0.0,1.0,1.0,28.0
West Siang,14.11,In-Patient Head Count at midnight,TOTAL,174.0,295.0,429.0,517.0,497.0,265.0,238.0,183.0,151.0,184.0,270.0,264.0,3467.0
West Siang,14.12.1,OPD attendance (All),TOTAL,6256.0,5874.0,7972.0,10627.0,7873.0,6547.0,5714.0,5557.0,4625.0,5144.0,5838.0,6324.0,78351.0
West Siang,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,5.0,8.0,9.0,2.0,0.0,2.0,1.0,10.0,10.0,6.0,2.0,55.0
West Siang,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,16.0,40.0,41.0,41.0,39.0,34.0,35.0,32.0,27.0,16.0,19.0,18.0,358.0
West Siang,14.14.a,Number of patients given AYUSH treatment,TOTAL,132.0,33.0,372.0,252.0,312.0,336.0,397.0,530.0,300.0,241.0,535.0,747.0,4187.0
West Siang,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,174.0,309.0,588.0,203.0,162.0,303.0,330.0,379.0,297.0,275.0,326.0,418.0,3764.0
West Siang,14.14.c,Number of Adolescents counselled,TOTAL,2.0,1.0,2.0,3.0,3.0,4.0,0.0,19.0,3.0,4.0,5.0,5.0,51.0
West Siang,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,136.0,138.0,150.0,61.0,112.0,134.0,132.0,99.0,66.0,121.0,133.0,185.0,1467.0
West Siang,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,3.0,5.0,7.0,4.0,7.0,1.0,0.0,2.0,6.0,10.0,9.0,2.0,56.0
West Siang,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,80.0,126.0,42.0,183.0,100.0,76.0,92.0,368.0,147.0,106.0,128.0,106.0,1554.0
West Siang,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,38.0,71.0,50.0,68.0,67.0,42.0,79.0,87.0,65.0,78.0,62.0,97.0,804.0
West Siang,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,129.0,138.0,109.0,99.0,88.0,105.0,118.0,89.0,89.0,80.0,100.0,131.0,1275.0
West Siang,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,247.0,335.0,201.0,350.0,255.0,223.0,289.0,544.0,301.0,264.0,290.0,334.0,3633.0
West Siang,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,15.2,Number of Widal tests conducted,Number tested,193.0,206.0,308.0,478.0,626.0,379.0,284.0,216.0,116.0,142.0,219.0,270.0,3437.0
West Siang,15.3.a,Number of VDRL tests conducted on males,Number tested,41.0,40.0,1.0,11.0,69.0,57.0,25.0,167.0,15.0,61.0,26.0,25.0,538.0
West Siang,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,37.0,27.0,41.0,2.0,47.0,18.0,31.0,51.0,46.0,39.0,23.0,92.0,454.0
West Siang,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,126.0,138.0,105.0,104.0,97.0,107.0,77.0,79.0,75.0,68.0,110.0,134.0,1220.0
West Siang,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,204.0,205.0,147.0,117.0,213.0,182.0,133.0,297.0,136.0,168.0,159.0,251.0,2212.0
West Siang,15.4.1,Number of blood smears examined for Malaria,TOTAL,82.0,91.0,310.0,722.0,558.0,360.0,453.0,269.0,115.0,137.0,209.0,196.0,3502.0
West Siang,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,7.0,13.0,17.0,88.0,116.0,67.0,54.0,46.0,14.0,14.0,30.0,47.0,513.0
West Siang,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,4.0,3.0,5.0,15.0,36.0,33.0,12.0,11.0,12.0,1.0,5.0,12.0,149.0
West Siang,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,3010.0,2460.0,3370.0,2750.0,1590.0,1300.0,4070.0,2540.0,3040.0,1090.0,,,25220.0
West Siang,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,1500.0,0.0,,,3000.0,,2000.0,0.0,3000.0,,,9500.0
West Siang,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,,,,,,0.0,0.0,,,0.0
West Siang,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,550.0,590.0,620.0,1160.0,290.0,230.0,1530.0,1500.0,1950.0,2090.0,,,10510.0
West Siang,16.1.1,Stock position of DPT vaccines,5. Total Stock,2460.0,3370.0,2750.0,1590.0,1300.0,4070.0,2540.0,3040.0,1090.0,2000.0,0.0,0.0,24210.0
West Siang,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,,,,,,0.0,0.0,,,0.0
West Siang,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,,,,,,0.0,0.0,,,0.0
West Siang,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,,,,,,0.0,0.0,,,0.0
West Siang,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,,,,,,0.0,0.0,,,0.0
West Siang,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,3940.0,3640.0,3040.0,2480.0,1260.0,4060.0,4070.0,2070.0,4070.0,2070.0,,,30700.0
West Siang,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,2000.0,0.0,,4000.0,1000.0,,4000.0,0.0,24000.0,,,35000.0
West Siang,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,,,,,,0.0,0.0,,,0.0
West Siang,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,300.0,2600.0,560.0,1220.0,1200.0,990.0,2000.0,2000.0,2000.0,21720.0,,,34590.0
West Siang,16.1.2,Stock position of OPV vaccines,5. Total Stock,3640.0,3040.0,2480.0,1260.0,4060.0,4070.0,2070.0,4070.0,2070.0,4350.0,0.0,0.0,31110.0
West Siang,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,3400.0,3180.0,4280.0,3480.0,2780.0,3300.0,3270.0,1950.0,3250.0,1830.0,,,30720.0
West Siang,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,2000.0,0.0,,1000.0,1000.0,,2500.0,0.0,1000.0,,,7500.0
West Siang,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,,,,,,0.0,0.0,,,0.0
West Siang,16.1.3,Stock position of TT vaccines,4. Stock Distributed,220.0,900.0,800.0,700.0,480.0,1030.0,1320.0,1200.0,1420.0,600.0,,,8670.0
West Siang,16.1.3,Stock position of TT vaccines,5. Total Stock,3180.0,4280.0,3480.0,2780.0,3300.0,3270.0,1950.0,3250.0,1830.0,2230.0,0.0,0.0,29550.0
West Siang,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,,,,,,0.0,0.0,,,0.0
West Siang,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,,,,,,0.0,0.0,,,0.0
West Siang,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,,,,,,0.0,0.0,,,0.0
West Siang,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,,,,,,0.0,0.0,,,0.0
West Siang,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1390.0,600.0,2550.0,2250.0,1950.0,2500.0,2300.0,1350.0,1300.0,1100.0,,,17290.0
West Siang,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,2500.0,0.0,,1000.0,,,250.0,0.0,500.0,,,4250.0
West Siang,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,,,,,,0.0,0.0,,,0.0
West Siang,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,790.0,550.0,300.0,300.0,450.0,200.0,950.0,300.0,200.0,300.0,,,4340.0
West Siang,16.1.5,Stock position of BCG vaccines,5. Total Stock,600.0,2550.0,2250.0,1950.0,2500.0,2300.0,1350.0,1300.0,1100.0,1300.0,0.0,0.0,17200.0
West Siang,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,2200.0,1990.0,3690.0,3000.0,2200.0,1565.0,1215.0,615.0,2900.0,2100.0,,,21475.0
West Siang,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,2500.0,0.0,,,,,2500.0,0.0,500.0,,,5500.0
West Siang,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,,,,,,0.0,0.0,,,0.0
West Siang,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,210.0,800.0,690.0,800.0,635.0,350.0,600.0,215.0,800.0,710.0,,,5810.0
West Siang,16.1.6,Stock position of Measles vaccines,5. Total Stock,1990.0,3690.0,3000.0,2200.0,1565.0,1215.0,615.0,2900.0,2100.0,1890.0,0.0,0.0,21165.0
West Siang,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,,,,,,0.0,0.0,,,0.0
West Siang,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,,,,,,0.0,0.0,,,0.0
West Siang,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,,,,,,0.0,0.0,,,0.0
West Siang,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,,,,,,0.0,0.0,,,0.0
West Siang,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,3830.0,3520.0,4930.0,3890.0,2980.0,4000.0,3200.0,1880.0,3480.0,2020.0,,,33730.0
West Siang,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,2000.0,0.0,,1500.0,,,2400.0,0.0,2400.0,,,8300.0
West Siang,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,,,,,,0.0,0.0,,,0.0
West Siang,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,310.0,590.0,1120.0,910.0,480.0,800.0,1320.0,800.0,1460.0,1500.0,,,9290.0
West Siang,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,3520.0,4930.0,3810.0,2980.0,4000.0,3200.0,1880.0,3480.0,2020.0,2920.0,0.0,0.0,32740.0
West Siang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,400.0,350.0,300.0,300.0,250.0,200.0,200.0,150.0,100.0,100.0,,,2350.0
West Siang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,,,,,,0.0,0.0,,,0.0
West Siang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,,,,,0.0,0.0,,,0.0
West Siang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,50.0,50.0,0.0,50.0,50.0,,50.0,50.0,0.0,50.0,,,350.0
West Siang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,350.0,300.0,300.0,250.0,200.0,200.0,150.0,100.0,100.0,50.0,0.0,0.0,2000.0
West Siang,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,139000.0,81000.0,38000.0,30000.0,25000.0,15000.0,15000.0,10000.0,15000.0,10000.0,,,378000.0
West Siang,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,,,,,10000.0,0.0,0.0,,,10000.0
West Siang,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,,,,,,0.0,0.0,,,0.0
West Siang,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,58000.0,43000.0,8000.0,5000.0,10000.0,,5000.0,5000.0,5000.0,2000.0,,,141000.0
West Siang,16.3.07,Stock Position of IFA Tablets,5. Total Stock,81000.0,38000.0,30000.0,25000.0,15000.0,15000.0,10000.0,15000.0,10000.0,8000.0,0.0,0.0,247000.0
West Siang,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,,,,,,424.0,0.0,0.0,,,424.0
West Siang,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,,,,,,195.0,0.0,0.0,,,195.0
West Siang,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,229.0,0.0,0.0,0.0,0.0,229.0
West Siang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,,,,,,,229.0,200.0,,,429.0
West Siang,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,,,,,,,0.0,460.0,,,460.0
West Siang,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,,,,,,,29.0,400.0,,,429.0
West Siang,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,200.0,260.0,0.0,0.0,460.0
West Siang,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,,,,,,,0.0,0.0,,,0.0
West Siang,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Siang,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,800.0,600.0,700.0,600.0,600.0,1200.0,1000.0,700.0,900.0,600.0,,,7700.0
West Siang,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,200.0,0.0,0.0,1000.0,,,400.0,0.0,200.0,,,1800.0
West Siang,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,,0.0,,,,0.0,0.0,,,0.0
West Siang,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,200.0,100.0,100.0,0.0,400.0,200.0,300.0,200.0,300.0,100.0,,,1900.0
West Siang,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,600.0,700.0,600.0,600.0,1200.0,1000.0,700.0,900.0,600.0,700.0,0.0,0.0,7600.0
West Siang,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,6000.0,5200.0,6800.0,6300.0,6000.0,10000.0,8500.0,5500.0,8300.0,6300.0,,,68900.0
West Siang,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,2400.0,0.0,,4800.0,,,4000.0,0.0,0.0,,,11200.0
West Siang,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,,0.0,,,,0.0,0.0,,,0.0
West Siang,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,800.0,800.0,500.0,300.0,800.0,1500.0,3000.0,1200.0,2000.0,1000.0,,,11900.0
West Siang,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,5200.0,6800.0,6300.0,6000.0,10000.0,8500.0,5500.0,8300.0,6300.0,5300.0,0.0,0.0,68200.0
West Siang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,300.0,250.0,200.0,200.0,150.0,550.0,450.0,300.0,400.0,300.0,,,3100.0
West Siang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,,500.0,,,200.0,0.0,0.0,,,700.0
West Siang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,,0.0,,,,0.0,0.0,,,0.0
West Siang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,50.0,50.0,0.0,50.0,100.0,100.0,150.0,100.0,100.0,50.0,,,750.0
West Siang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,250.0,200.0,200.0,150.0,550.0,450.0,300.0,400.0,300.0,250.0,0.0,0.0,3050.0
West Siang,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
West Siang,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
West Siang,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
West Siang,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
West Siang,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
West Siang,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
West Siang,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
West Siang,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
West Siang,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
West Siang,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
West Siang,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
West Siang,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
West Siang,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
West Siang,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
West Siang,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
West Siang,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
West Siang,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
West Siang,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
West Siang,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
West Siang,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
West Siang,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
West Siang,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
West Siang,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
West Siang,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
West Siang,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
West Siang,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
West Siang,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
West Siang,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
West Siang,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
West Siang,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
West Siang,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
West Siang,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
West Siang,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
West Siang,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
West Siang,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
West Siang,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
West Siang,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
West Siang,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
West Siang,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
West Siang,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
West Siang,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
West Siang,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
West Siang,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
West Siang,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
West Siang,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
West Siang,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
West Siang,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
West Siang,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
West Siang,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
West Siang,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
West Siang,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
West Siang,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
West Siang,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
West Siang,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
West Siang,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
West Siang,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
West Siang,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
West Siang,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
West Siang,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
West Siang,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
West Siang,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
West Siang,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
West Siang,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
West Siang,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
West Siang,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
West Siang,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
West Siang,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
West Siang,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
West Siang,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
West Siang,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
West Siang,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
West Siang,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
West Siang,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
West Siang,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
West Siang,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
West Siang,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
West Siang,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
West Siang,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
West Siang,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
West Siang,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
West Siang,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
West Siang,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
West Siang,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
West Siang,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
West Siang,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
West Siang,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
West Siang,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
West Siang,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
West Siang,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
West Siang,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
West Siang,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
West Siang,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
West Siang,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
West Siang,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
West Siang,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
West Siang,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
West Siang,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
West Siang,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
West Siang,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
West Siang,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
West Siang,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
West Siang,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
West Siang,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
West Siang,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
West Siang,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
West Siang,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
West Siang,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
West Siang,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
